Characterisation of proteins involved in CRISPR-mediated antiviral defence in Sulfolobus solfataricus by Kerou, Melina L.
CHARACTERISATION OF PROTEINS INVOLVED IN
CRISPR-MEDIATED ANTIVIRAL DEFENCE IN
SULFOLOBUS SOLFATARICUS
Melina Louiza Kerou
A Thesis Submitted for the Degree of PhD
at the
University of St Andrews
2012
Full metadata for this item is available in
Research@StAndrews:FullText
at:
http://research-repository.st-andrews.ac.uk/
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10023/3088
This item is protected by original copyright
Characterisation of proteins involved in 
CRISPR-mediated antiviral defence 
in Sulfolobus solfataricus 
Melina Louiza Kerou
A Thesis Submitted for the Degree of 
Doctor of Philosophy
March 2012

Table of contents
......................................................................................Figures and tables vii
.............................................................................................Abbreviations xii
................................................................................................Declaration xv
...................................................................................................Abstract xvii
Acknowledgements

xviii
.................................................................................................Introduction 1
.........................................................................1.1 Defence mechanisms in prokaryotes 1
.....................................................................1.1.1 Restriction-modification systems 3
.............................................................................................1.1.2 Abortive infection 4
...................1.1.3 Dissemination, evolution and additional roles of defence systems  6
...........1.2 Discovery and characterisation of the CRISPR arrays in prokaryotic genomes 8
1.3 CRISPR-associated protein families and current classification of the CRISPR/Cas 
.....................................................................................................................system 13
...............................................1.4 The three stages of the CRISPR/Cas mode of action 17
.......................1.4.1 Stage I: Spacer selection and integration into CRISPR arrays  17
................................1.4.2 Stage II: CRISPR expression and biogenesis of crRNAs 21
.................................................1.4.2.1 Regulation of CRISPR transcription 22
.........................................................1.4.2.2 CRISPR transcript processing 23
..............1.4.3 Stage III: Recognition of invader sequences and target interference 29
.1.4.4 Protospacer selection, self/non-self discrimination and autoimmunity issues 34
................................1.5 Evolution, mobility and distribution of the CRISPR/Cas system 37
.....................................................................1.6 CRISPR/Cas and the eukaryotic RNAi 38
...................................................1.7 Applications and alternative roles for CRISPR/Cas 40
Table of contents
i
......................................................1.8 CRISPR/Cas systems of Sulfolobus solfataricus 41
..............................................................................Materials and Methods  45
.................................................................................................2.1 Cloning procedures  45
......................................................................................2.1.1 Cloning and vectors  45
............................................................................2.1.2 Site-directed mutagenesis  46
..........................................................................2.2 Protein expression and purification 46
..............................................................2.2.1 Expression of recombinant proteins 46
..............................................................2.2.2 Purification of recombinant proteins 47
................................................................2.3 Crystallization screening and optimisation 49
..........................................................................................................2.4 Immuno - blot 50
..................................................................................................2.5 Protein Interactions 50
......................................................2.5.1 Analytical size exclusion chromatography 50
2.5.2 Determination of protein interactions using magnetic precharged nickel 
.........................................................................................................particles 51
..................................................2.6 Generation of nucleic acid substrates and markers 52
......................................................................2.6.1 Purification of oligonucleotides  52
..................................2.6.2 Assembly and purification of double-strand substrates 54
..............................................................................2.6.3 CRISPR locus constructs 55
.......................................2.6.4 T7 RNA polymerase-mediated in vitro transcription 55
...............................................................................2.6.5 Sanger DNA sequencing 56
.......................................................................2.6.6 RNA alkaline hydrolysis ladder 56
..............................................................2.7 Sulfolobus solfataricus in vitro transcription 57
..................................................2.8 Extraction of RNA from purified native aCASCADE 57
................................................................2.9 Nucleic acid binding and catalytic assays 58
............................................................................................2.9.1 Helicase assays  58
...................................................................................2.9.2 Endonuclease assays  58
.................................................................................2.9.3 ATP hydrolysis reaction 59
...................................................2.9.4 Electrophoretic Mobility Shift Assay (EMSA) 59
..............................................2.9.5 Strand annealing and strand exchange assays 60
Table of contents
ii
.................................................................................2.9.6 R-loop formation assay 60
The CMR complex from Sulfolobus solfataricus: native isolation and 
.........................................................................recombinant components  63
.............................................................................................................3.1 Introduction 63
.................................3.1.1 The Repeat-Associated Mysterious Proteins (RAMPs) 63
.............................................................3.1.2 The CRISPR-RAMP module (CMR) 65
....................................................3.2 Expression and purification of recombinant Cmr7 69
................................................................................3.3 Crystallographic study of Cmr7 70
..............................................3.3.1 Crystallisation and structure solution of Cmr7 70
........................................................................................3.3.2 Structure of Cmr7 71
....................................................3.5 Expression and purification of recombinant Cmr1 74
..................................3.6 Protein interactions between recombinant CMR components  75
.................................................3.7 Nucleic acid binding by recombinant CMR proteins 78
............................3.8 Isolation of the native CMR complex from Sulfolobus solfataricus 80
...............................3.8.1 Antibody assisted purification of the SsoCMR complex 80
.......3.8.2 Identification of the CMR complex components by mass spectrometry 84
..............................3.9 Initial functional characterisation of the native SsoCMR complex 87
...............................3.9.1 The SsoCMR complex does not bind ssDNA or ssRNA 87
3.9.2 The SsoCMR complex does not exhibit nuclease activity against CRISPR 
...................................................................................................................RNA 89
........................3.9.3 The SsoCMR complex does not exhibit polymerase activity 90
...............................................................................................................3.8 Discussion 92
Purification and characterisation of Csa2-Cas5a: An archaeal CASCADE-
.......................................like complex for CRISPR-mediated viral defence 98
.............................................................................................................4.1 Introduction 98
.............4.1.1 Biochemical and structural characterisation of the E. coli CASCADE 98
..........................................................4.1.2 An archaeal orthologue of CASCADE 101
........................................................................4.2 Site-directed mutagenesis of Csa2 103
4.3 Expression and purification of recombinant wild-type and mutant Csa2 and the Csa2-
......................................................................................................Cas5a complex 103
Table of contents
iii
4.4 Investigation of the native Csa2-Cas5a complex from Sulfolobus solfataricus P2 and 
............................................................................................its accessory proteins 107
...........................................4.4.1. Nucleic acid content of the native aCASCADE 109
4.5 Size determination and stoichiometry of the native and recombinant Csa2-Cas5a 
.................................................................................................................complex 111
.................4.6  In vitro  protein interactions of the recombinant Csa2-Cas5a complex. 113
.................4.7 Investigating the properties of the leader sequence of CRISPR locus A 115
4.9 The recombinant Csa2-Cas5a complex binds crRNA and forms ternary complexes 
.....................................................................................................with target DNA 122
......................................................................4.9.1 Substrate analysis of crRNA 123
.........4.9.2 Csa2 is the main crRNA binding subunit of the Csa2-Cas5a complex 125
4.9.3 The crRNA - loaded Csa2-Cas5a complex recognises and binds target DNA
.................................................................................................................... 126
4.9.4 The protospacer adjacent motif (PAM) is not required for target DNA recognition by 
..................................................................the recombinant Csa2-Cas5a complex 129
........................................................................4.10 Structural studies and discussion 131
................................................................................4.10.1 The structure of Csa2 131
........4.10.2 Arrangement of the native aCASCADE and mechanistic implications  135
.................4.10.3 Emerging model for CRISPR-mediated interference in Archaea 137
Initial biochemical characterisation of  Cas3’ from S. solfataricus: a 
....................................................predicted CRISPR-associated helicase 142
...........................................................................................................5.1 Introduction 142
................................5.1.2 The DExD/H-box families of RNA-remodeling proteins 144
........................5.1.3 The CRISPR-associated putative DExH-box helicase Cas3  147
.............................................................................5.2 Cas3’ in Sulfolobus solfataricus 152
................................................................5.3 Expression and purification of SsoCas3’ 153
................................................5.4 Site-directed mutagenesis of SsoCas3’ (Sso1440) 154
..................................................................................5.5 ATPase activity of SsoCas3’ 156
.........................................5.6 Helicase activity and substrate preference of SsoCas3’ 159
..................................5.6.1 SsoCas3’ is not able to process long duplex regions  165
..........................................................................5.7 Nucleic acid binding by SsoCas3’ 166
..................................5.8 Strand annealing and strand exchange activity of SsoCas3’ 167
Table of contents
iv
.........................5.8.1 Initial attempt to investigate R-loop formation by SsoCas3’ 171
....................................................................................5.9 Discussion and future work 172
...................................................................Conclusions and future work 178
..............................................................................................References  183
.................................................................................................................APPENDIX I 203
............................................................................................CRISPR locus constructs  203
................................................................................................................APPENDIX II 204
......................................................................................Multiple sequence alignments  204
................................................A.2.1 Conserved motifs of Cmr2 family members  204
......................................A.2.2 Multiple sequence alignment of Csa2 orthologues  208
......................................A.2.3 Multiple sequence alignment of Cas6 orthologues  210
Table of contents
v
Table of contents
vi
Figures and tables
Figure 1.1 Classification of phage infection types and prokaryotic 
resistance mechanisms in respect to their effect on the fitness 
of the host and the phage.
2
Figure 1.2 The general course of a phage or viral infection 3
Figure 1.3 Outline of toxin-antitoxin systems 5
Figure 1.4 Characteristic behavior of selfish genetic elements 7
Figure 1.5 Graphic representation of a CRISPR locus and the adjacent 
cas gene operon in a prokaryotic genome
10
Figure 1.6 Outline of the CRISPR/Cas mode of action 12
Figure 1.7 Outline of the main types and subtypes of the CRISPR/Cas 
systems and their phylogenetic relations
14
Figure 1.8 Crystal structure of Cas1 15
Figure 1.9 Crystal structure of Cas2 16
Figure 1.10 Structure of putative transcriptional regulator Csa3 from S. 
solfataricus
23
Figure 1.11 Outline of the second stage of CRISPR functioning 23
Figure 1.12 Structures of processing endonucleases Cse3 and Csy4 25
Figure 1.13 Crustal structure of PfuCas6 26
Figure 1.14 Model for CRISPR RNA processing in type II systems 28
Figure 1.15 Gene organisation of Cas operons of studied organisms 32
Figure 1.16 Basepairing between crRNA and protospacer upon target 
recognition in E. coli
33
Figure 1.17 Model for target recognition by CASCADE 34
Figure 1.18 Orientation of protospacers in regard to their PAM 35
Figure 1.19 Model for discriminating between self and non-self DNA during 
CRISPR target recognition
36
Figure 1.20 General pathway and key proteins for RNA interference 39
Figure 1.21 Cas genes in S. solfataricus P2 42
Figure 2.1 Amplified fragments of the S. solfataricus CRISPR locus A 55
Figure 2.2 Mechanism of RNA hydrolysis under alkaline conditions 56
Figure 3.1 Conserved RAMP superfamily motifs and individual RAMP 
families
64
Figures and Tables
vii
Figure 3.2 Crystal structure of Tthb192 - CasE/Cse3 homologue 64
Figure 3.3 Crystal structures of Cmr5 67
Figure 3.4 Gene organisation of the type III systems in S. solfataricus 68
Figure 3.5 Domain organisation of SsoCmr2 (Sso1991), indicating the 
location of the conserved potential active sites on the 
sequence.
68
Figure 3.6 Purification of Cmr7 70
Figure 3.7 Crystals of Cmr7, grown under the conditions mentioned in the 
text
71
Figure 3.8 Structure of the Cmr7 monomer 72
Figure 3.9 Cmr7 dimer and conserved surfaces 73
Figure 3.10 Purification of Cmr4 74
Figure 3.11 Purification of Cmr1 75
Figure 3.12 Experimental setup for detecting protein-protein interactions 
using Ni-loaded magnetic beads
76
Figure 3.13 Interactions between recombinant Cmr subunits 77
Figure 3.14 Electrophoretic Mobility Shift Assays investigating the binding 
affinity of recombinant Cmr proteins to various nucleic acid 
substrates, carried out in collaboration with Paul Talbot
79
Figure 3.15 Effect of Cmr3 on Cmr1 RNA binding 80
Figure 3.16 First step of SsoCMR purification by affinity chromatography 81
Figure 3.17 Second step of SsoCMR purification by size exclusion 
chromatography.
81
Figure 3.18 Third step of SsoCMR purification by cation exchange 
chromatography
82
Figure 3.19 Fourth step of SsoCMR purification by anion exchange 
chromatography.
83
Figure 3.20 Optimisation of the SsoCMR purification procedure by Paul 
Talbot with a larger starting culture.
84
Figure 3.21 Binding of native SsoCMR to CRISPR ssDNA and RNA 
substrates.
88
Figure 3.22 Substrates used for assaying the nuclease activity of the 
SsoCmr complex
89
Figure 3.23 Nuclease assays of SsoCMR 90
Figure 3.24 Outline of in vitro transcription with the SsoRNA polymerase 91
Figure 3.25 Reverse transcriptase assays for SsoCMR 92
Figure 3.26 Mode of action of the PfuCmr complex 93
Figures and Tables
viii
Figure 4.1 Structure of the E. coli CASCADE and the Csy complex from P. 
aeruginosa
100
Figure 4.2 Gene names and operon organisation of type I-A CRISPR/Cas 
in S. solfataricus
102
Figure 4.3 Purification of recombinant Csa2-Cas5a and Csa2 WT, H160A 105
Figure 4.4 ESI-TOF mass spectrometry of Csa2 WT and H160A 106
Figure 4.5 Isolation of native aCASCADE from S. solfataricus 107
Figure 4.6 Nucleic acid content of the aCASCADE 110
Figure 4.7 Analytical size-exclusion chromatography on native and 
recombinant Csa2-Cas5a complex
112
Figure 4.8 Experimental setup for in vitro protein interaction assay 114
Figure 4.9 Protein interactions of the recombinant Csa2-Cas5a complex 115
Figure 4.10 CRISPR locus A constructs 116
Figure 4.11 In vitro transcription of CRISPR locus with SsoRNAP 116
Figure 4.12 Mapping the transcription initiation site 118
Figure 4.13 Multiple sequence alignment of leader sequences of S. 
islandicus, S. solfataricus 98/2, S. solfataricus P2 CRISPR A 
and B and Acidianus hospitalis
118
Figure 4.14 Structure of PfuCas6 and model of SsoCas6 120
Figure 4.15 CRISPR transcript processing by SsoCas6 121
Figure 4.16 Binding of Csa2-Cas5a to crRNA 124
Figure 4.17 Comparative binding of aCASCADE individual subunits and the 
complex to crRNA
125
Figure 4.18 cr-RNA mediated binding of Csa2-Cas5a to DNA target 127
Figure 4.19 Absence of nuclease activity on DNA protospacer targets by 
aCASCADE
128
Figure 4.20 Effect of the Protospacer Adjacent Motif on crRNA -guided 
binding of DNA targets by the aCASCADE.
130
Figure 4.21 Structure of SsoCsa2 133
Figure 4.22 Electrostatic surface map of Csa2 134
Figure 4.23 Quaternary structural models of native aCASCADE 136
Figure 4.24 Emerging model for CRISPR interference in Archaea 140
Figure 5.1 Sequence and structural organization of the conserved motifs 
of SF1 and SF2 NTPases - translocases
143
Figure 5.2 Phylogenetic relationships and motif conservation between the 
SF2 families and between SF1 and SF2 families
144
Figure 5.3 Comparison of DExH-box and DEAD-box RNA helicases 146
Figures and Tables
ix
Figure 5.4 Proposed mechanism of action for Cas3 in type I-E systems 150
Figure 5.5 Structure of the HD-domain of Cas3 from T. thermophilus 151
Figure 5.6 Domain arrangement of SsoCas3’ 152
Figure 5.7 Structural model of SsoCas3’, generated by Phyre2 153
Figure 5.8 Purification of recombinant SsoCas3’ 154
Figure 5.9 ESI-TOF mass spectrometry of SsoCas3’ WT and K46A 155
Figure 5.10 ATPase activity of WT and mutant SsoCas3’ 158
Figure 5.11 Helicase activity of SsoCas3’ on CRISPR substrates 161
Figure 5.12 Temperature dependance on the helicase activity of SsoCas3’ 162
Figure 5.13 Helicase activity of SsoCas3’ is dependent on protein 
concentration
162
Figure 5.14 Helicase activity of SsoCas3’ on blunt RNA-DNA 
heteroduplexes
163
Figure 5.15 SsoCas3’ in unable to unwind radiolabeled non-CRISPR 
related substrates
164
Figure 5.16 SsoCas3’ is unable to unwind “crRNA-protospacer”-like 
substrates
165
Figure 5.17 SsoCas3’ is unable to unwind long duplex substrates 166
Figure 5.18 Nucleic acid binding by SsoCas3’ 167
Figure 5.19 Strand annealing activity of SsoCas3’ 168
Figure 5.20 Strand exchange activity of SsoCas3’ 170
Figure 5.21 Potential R-loop formation by SsoCas3’ 172
Figures and Tables
x
Table 1.1 Taxonomic distribution of CRISR-Cas systems in 706 analysed 
genomes
11
Table 1.2 CRISPR loci in S. solfataricus P2 42
Table 1.3 Characteristics of the Cas proteins in S. solfataricus P2 43
Table 2.1 Expression conditions of Cas proteins from S. solfataricus 47
Table 2.2 Oligonucleotides used in chapter 3 52
Table 2.3 Oligonucleotides used in chapter 4 53
Table 2.4 Oligonucleotides used in chapter 5 54
Table 3.1 The Cmr family B cluster in S. solfataricus 69
Table 3.2 Mass Spectrometry analysis of two different purifications of 
SsoCMR.
86
Table 4.1 Composition of the E. coli CASCADE 100
Table 4.2 Co-purifying Cas proteins in the partially purified native 
aCASCADE sample as identified by solution trypsin digestion 
followed by LC - MS/MS
108
Table 4.3 Synthetic oligonucleotides used in chapter 4 122
Table 4.4 Apparent Kd values for Csa2-Cas5a and the various RNA 
substrates
124
Table 5.1 Oligonucleotides used to generate substrates used in chapter 5 159
Table 5.2 Structures of ds substrates used for helicase assays 160
	
	
Figures and Tables
xi
Abbreviations
3’ 3 prime DNA end
5’ 5 prime DNA end
a.a. aminoacid
Abi Abortive infection
[γ-32P] ATP Adenosine triphosphate with a 32-phosphate radioactive 
isotope in the gamma phosphate position
Afu Archaeoglobus fulgidus
AMP-PNP Adenosine 5’-(β, γ-imido) triphosphate
APS Ammonium persulphate
ATP Adenosine 5’-triphosphate
ATP-γS adenosin 5’-(O)-(3-thio)triphosphate
bp base pair
BSA Bovine serum albumin
Cas CRISPR-associated
CMR CRISPR module RAMP
COG Cluster of orthologous groups
CRISPR Clustered regularly interspersed short palindromic repeat
CV Column volume
ds / ssDNA Double / single-stranded deoxyribonucleic acid
DTT 1,4 – dithiothreitol
EDTA Ethylenediaminetetraacid acid
EMSA Electrophoretic mobility shift assay
ESI-TOF MS Electrospray ionisation-time of flight mass spectrometry
GTP guanosine 5’-triphosphate
HCl Hydrochloric acid
HGT Horizontal gene transfer
HMM Hidden Markov Model
IPTG Isopropyl-beta-D-thiogalactopyranoside
Abbreviations
xii
KD Dissociation constant
(k)Da (Kilo)Dalton
KOH Potassium hydroxide
LB Luria Bertani
LGT Lateral gene transfer
MALDI-TOF Matrix-assisted laser desorption/ ionisation-time of flight
MS Mass spectrometry
MT Methyltransferase
MW Molecular weight
NA Nucleic acid
nt nucleotide
NTP Nucleotide triphosphate
OD Optical density
PBS Phosphate buffered saline
Pfu Pyrococcus furiosus
PNK Polynucleotide kinase
RAMP Repeat associated mysterious proteins
RE Restriction endonuclease
RM Restriction-modification 
RNA Ribonucleic acid
RNApol RNA polymerase
RNP Ribonucleoprotein
rpm Revolutions per minute
RT Room temperature
Sac Sulfolobus acidocaldarius
SAXS Small-angle X-ray scattering
SDS Sodium dodecyl sulphate
SDS-PAGE SDS-polyacrylamide gel electrophoresis
SF Superfamily
Sso Sulfolobus solfataricus
Sto Sulfolobus tokodaii
TA Toxin-antitoxin
Abbreviations
xiii
TEM Transmission electron microscopy
TBE Tris-borate EDTA
TEMED Tetramethylethylenediamine
TEV Tobacco Etch virus
TPB Tryptone-phosphate broth
UV Ultraviolet
WT Wild type
	
	
Abbreviations
xiv
Declaration
1. Candidate’s declarations:
I, Melina - Louiza Kerou, hereby certify that this thesis, which is approximately 64000 words in 
length, has been written by me, that it is the record of work carried out by me and that it has 
not been submitted in any previous application for a higher degree. 
I was admitted as a research student in October 2007 and as a candidate for the degree of 
PhD in October 2008; the higher study for which this is a record was carried out in the 
University of St Andrews between 2007 and 2010. 
Date ….......….....                               signature of candidate ….......….....
2. Supervisor’s declaration:
I hereby certify that the candidate has fulfilled the conditions of the Resolution and Regulations 
appropriate for the degree of PhD in the University of St Andrews and that the candidate is 
qualified to submit this thesis in application for that degree. 
Date ….......….....                               signature of supervisor ….......….....
3. Permission for electronic publication: (to be signed by both candidate and supervisor)
In submitting this thesis to the University of St Andrews I understand that I am giving 
permission for it to be made available for use in accordance with the regulations of the 
University Library for the time being in force, subject to any copyright vested in the work not 
being affected thereby.  I also understand that the title and the abstract will be published, and 
that a copy of the work may be made and supplied to any bona fide library or research worker, 
that my thesis will be electronically accessible for personal or research use unless exempt by 
award of an embargo as requested below, and that the library has the right to migrate my 
thesis into new electronic forms as required to ensure continued access to the thesis. I have 
obtained any third-party copyright permissions that may be required in order to allow such 
access and migration, or have requested the appropriate embargo below. 
Declaration
xv
The following is an agreed request by candidate and supervisor regarding the electronic 
publication of this thesis:
Access to printed copy but embargo of of electronic publication of thesis for a period of 1 year 
on the following ground(s):
publication would be commercially damaging to the researcher, or to the supervisor, or the 
University; 
publication would preclude future publication; 
Date ……......      signature of candidate ……..........        signature of supervisor .......………
  
Declaration
xvi
Abstract
 One of the most surprising realisations to emerge from metagenomics studies 
in the early ‘00s was that the population of viruses and phages in nature is about 10 
times larger than the population of prokaryotic organisms. Thus, bacteria and archaea 
are under constant pressure to develop resistance methods against a population of 
viruses with extremely high turnover and evolution rates, in what has been described 
as an evolutionary “arms race”. A novel, adaptive and heritable immune system 
encoded by prokaryotic genomes is the CRISPR/Cas system. Arrays of clustered 
regularly interspersed short palindromic repeats (CRISPR) are able to incorporate viral 
or plasmid sequences which are then used to inactivate the corresponding invader 
element via an RNA interference mechanism. A number of CRISPR-associated (Cas) 
protein families are responsible for the maintenance, expansion and function of the 
CRISPR loci. This system can be classified in a number of types and subtypes that 
differ widely in their gene composition and mode of action. 
	 This thesis describes the biochemical characteristics of CRISPR-mediated 
defense in the crenarchaeon Sulfolobus  solfataricus. The process of CRISPR loci 
transcription and their subsequent maturation into small guide crRNA units by the 
processing endonuclease of the system (Cas6) is investigated. After this step, different 
pathways and effector proteins are involved in the recognition and silencing of DNA or 
RNA exogenous nucleic acids. This thesis reports the identification and purification of 
a native multiprotein complex from S. solfataricus  P2, the Cmr complex, a homologue 
of which has been found to recognise and cleave RNA targets in P. furiosus. The 
recognition and silencing of DNA targets in E. coli has been shown to involve a 
multiprotein complex termed CASCADE as well as Cas3, a putative helicase-HD 
nuclease. S. solfataricus  encodes orthologues for the core proteins of this complex, 
and the formation and function of an archaeal CASCADE is investigated in this thesis. 
Abstract
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Chapter 1
Introduction
“Well, in our country,” said Alice, still panting a little, 
“you’d generally get to somewhere else - if you run 
very fast for a long time, as we’ve been doing.”
“A slow sort of country!” said the Queen. “Now, here, 
you see, it takes all the running you can do, to keep in 
the same place. If you want to get somewhere else, you 
must run at least twice as fast as that!”
-- Lewis Carroll, Through the Looking-Glass, 1871
1.1 Defence mechanisms in prokaryotes
 This excerpt from the Red Queen’s race in Lewis Carroll’s novel Through the 
Looking-Glass  illustrates one of the most influential hypotheses in evolutionary 
biology, termed the Red Queen’s Hypothesis. Originally proposed by Van Valen in 
1973, the hypothesis states that in a dynamic evolutionary system, constant 
adaptation of all co-dependent species is necessary to maintain their fitness relative to 
one another. In a system comprising of species with a predator-prey relationship, a 
higher evolutionary rate exhibited by one species ensures the accumulation of fitness-
increasing adaptations via natural selection. This provides the species in question with 
a competitive advantage over the slow-evolving species, which leads to a decrease in 
their fitness and can compromise their survival chances. Therefore, in order to 
maintain a relative fitness balance and ensure their survival, co-evolving species must 
exhibit comparably high evolutionary rates. In the prokaryotic kingdom, this 
hypothesis is especially accurate in describing virus-host dynamics and the evolution 
of molecular resistance and anti-resistance mechanisms (Stern and Sorek, 2010).  
 Resistance mechanisms are found at every stage of phage or virus infection 
(figures 1.1, 1.2) with variable outcomes on the phage and host survival (figure 1.1). 
Passive defence strategies mainly rely on adsorption resistance mechanisms, which 
prevent the attachment of a phage or virus to appropriate receptors on the prokaryotic 
cell surface (reviewed in Hyman and Abedon, 2010). A wide range of surface exposed 
molecules can act as virus receptors, including proteins, lipopolysaccharides, teichoic 
acids and capsules. One of the mechanisms which confer resistance is the production 
of layers of extracellular polymers which shield the receptor molecules. The 
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composition and efficiency of these polymers, as well as their mode of production, 
vary widely among bacteria, and phage-encoded counter-resistance has been 
detected in the form of enzymes which degrade certain polymers. A more effective 
mechanism is the loss or structural modification of a receptor molecule so that it will 
not be recognised by phages/viruses. Random mutations are usually the cause of the 
structural modifications, and sometimes the physiological receptor function might not 
be affected (Hyman and Abedon, 2010). The next line of defence operates at the post-
adsorption level, in order to prevent the virus or phage genetic material from entering 
the host cytoplasm and taking over the host metabolism. The outcome of these 
systems can be positive for the prokaryotic cell and deleterious to the phage/virus. 
Prophage-encoded superinfection exclusion mechanisms (Sie), which prevent the 
injection of the phage DNA into the cytoplasm, are mostly common in Gram-negative 
bacteria (Mahony et al. 2008). Some of the most well-studied active resistance 
mechanisms also operate at this stage, including the restriction-modification system 
(RM) and the newly discovered CRISPR/Cas system (Stern and Sorek, 2010). Finally, 
in the case of a successful infection a number of systems lead to abortive infection 
(Abi), a term which describes the controlled “suicide” of the infected cell in order to 
completely prevent the release and spread of the new virus particles (Chopin et al. 
2005, Hyman and Abedon, 2010, Stern and Sorek, 2010). The restriction-modification 
and abortive infection systems will be briefly presented and the rest of the chapter will 
focus on the novel adaptive prokaryotic immune system encoded by the CRISPR/Cas 
loci in the majority of bacteria and archaea.
Figure 1.1 Classification of phage infection types and prokaryotic resistance mechanisms in 
respect to their effect on the fitness of the host and the phage.  
Adapted from Hyman and Abedon, 2010.
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Figure 1.2: The general course of a phage or viral infection
The scheme includes  the defence mechanisms  likely to be encountered at each stage of the 
infection and all possible outcomes (adapted from Hyman and Abedon, 2010).
1.1.1 Restriction-modification systems 
 Restriction-modification (RM) systems are encoded by almost 90% of 
sequenced bacterial and archaeal genomes (Roberts et al. 2010), and can confer 
resistance to a wide variety of extrachromosomal elements (viruses, phages and 
plasmids, reviewed in Hyman and Abedon, 2010; Tock and Dryden, 2005). Two types 
of enzymes compose the core of this system: restriction endonucleases (REases), 
which perform sequence specific cleavage of foreign DNA, and methyltransferases 
(MTases), which protect the endogenous DNA from cleavage by modifying specific 
bases in the same sequence recognised by their REase partner. The recognition 
sequence is usually 4-8 bp in length and modifications consist typically of methylation 
of adenine or cytosine bases, taking place after replication of the prokaryotic genome. 
Thus, all genetic elements that do not contain the appropriate modifications are 
recognised as “foreign” by the REase and cleaved. Cleavage can occur either within 
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or at locations up to 1000bp from the recognition site, which requires ATP-dependent 
translocation of the RM complex on the DNA. Depending on the subunit combination, 
characteristics of the recognition and cleavage site and cofactor requirements, the RM 
systems can be classified into four main groups (I-IV, Tock and Dryden, 2005). Type IV 
systems do not contain an MTase activity, but instead recognise and cleave modified 
DNA substrates. Type III systems are often found in phage genomes. 
	 In response to this system, a variety of escape mechanisms has been found in 
phages, viruses and conjugational plasmids. Anti-restriction strategies include, but are 
not limited to: i) encoding of or stimulation of the host MTase to methylate the phage 
genome in the same pattern as the host in order to avoid recognition; ii) loss or re-
orientation of recognition sequences; iii) incorporation of unusual bases within their 
genome; iv) shielding of the recognition sequences upon injection by DNA-binding 
proteins encoded by the phage or plasmid; v) degradation of RE cofactors (e.g. S-
adenosyl methionine or SAM); v) obstruction of RM enzymatic activity by encoding 
inhibitor proteins (e.g. DNA-mimicking proteins such as the Ocr protein of phage T7) 
(reviewed in Tock and Dryden, 2005). Additionally, RNA viruses evade this system. The 
fact that the RM systems are leaky or can by subverted can also be beneficial to the 
cell, in the sense that horizontal gene transfer can be a mechanism by which 
prokaryotes gain novel functional activities (Tock and Dryden, 2005).
1.1.2 Abortive infection
 Abortive infection (Abi) is the common phenotype caused by a number of 
resistance mechanisms that can vary in their specific molecular mechanisms and have 
little or no evolutionary relationship. These mechanisms operate after the virus 
adsorption and injection of its genetic material into the cytoplasm, and can inhibit 
various stages of the virus life cycle inside the host cell, such as the transcription and 
replication of the virus/phage genome, protein production and virus assembly (Chopin 
et al. 2005). The common result is the complete inhibition of virus proliferation and 
death of the host cell. This “programmed suicide” is advantageous to the bacterial 
population as a whole since it prevents the spread of the infection, and for this reason 
it has been hypothesised that it represents a form of bacterial altruism (reviewed in 
Chopin et al. 2005; Hyman and Abedon, 2010). Abi systems are widespread among 
Gamma-proteobacteria, Actinobacteria, Cyanobacteria and Firmicutes, and many 
were isolated first in lactococci (Chopin et al. 2005). The majority are plasmid-encoded 
and frequently consist only of one gene. Abi mechanisms can be quite specific, with 
each mechanism targeting only certain groups of phages. Some of these mechanisms 
are under tight cellular regulation and their toxic activity is phage-induced (e.g. AbiD1, 
which inhibits the resolution of branched DNA structures), but others are constitutively 
expressed at low levels (e.g. AbiA, AbiB, AbiK) (Chopin et al. 2005). 
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	 It has been shown that a number of toxin-antitoxin (TA) systems also mediate 
abortive infection upon phage/virus infection among their other functions (e.g. 
inducing stasis or cell death as a stress response, ensuring maintenance of mobile 
genetic elements, regulating pathogenicity etc, reviewed in Van Melderen, 2010; 
Blower et al. 2011). TA cassettes consist of a single promoter controlling the 
expression of a gene pair, encoding for the unstable antitoxin and the stable toxin 
(figure 1.3). Both elements can be proteins or RNA molecules according to the system 
classification (Bukowski et al. 2011). Formation of a toxin-antitoxin complex inhibits 
toxin activity, which can manifest in a variety of mechanisms, but is either lethal or 
restrict cellular growth (Van Melderen, 2010; Blower et al. 2011). TA systems are 
widespread in bacteria as well as archaea (Makarova et al. 2009), although the three 
systems that mediate Abi have been characterised from bacteria.
Figure 1.3: Outline of toxin-antitoxin systems
The two genes form a bicistronic operon. (a) In type I systems the toxin is  a protein and the 
antitoxin is  an antisense RNA. Silencing takes place at the RNA level. (b) In type II systems 
both the toxin and the antitoxin are proteins which can form a tight complex, preventing the 
action of the toxin. The antitoxin can get degraded by cellular proteases  and release the toxin. 
(c) In type III systems the antitoxin is an RNA transcribed by an array of repeat sequences, 
which interacts and inhibits  the protein toxin. Regulation is  mediated by a transcriptional 
terminator (stem-loop structure) between the two genes (adapted from Blower et al. 2011).
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	 In particular, it has been shown that TA cassette mazEF is stimulated by and 
can abort infection by phage P1 in E. coli by inhibiting translation, as toxin MazF is an 
mRNA interferase (Hazan and Engelberg-Kulka, 2004; Nariya and Inouye, 2008). 
Secondly, TA system hok-sok encoded in plasmid R1 of Gram-negative bacteria is 
stimulated by phage T4 and causes cell membrane damage by toxin Hok (Thisted and 
Gerdes, 1992). Finally, the plasmid-encoded ToxIN system has also been shown to 
mediate Abi in Gram-negative bacteria, but its mode of action is still unclear (Fineran 
et al. 2009). 
	 Evidently, phages have developed mechanisms to overcome damage caused 
by Abi agents and avoid abortion of infection. This has been observed so far either by 
recombination with a cognate prophage or by point mutations within the phage 
genome (Chopin et al. 2005), however the nature of the Abi phenotype renders the 
characterisation of both the defence mechanisms and the anti-abortive phage 
strategies extremely difficult. 
1.1.3 Dissemination, evolution and additional roles of defence systems
	 All the prokaryotic defence systems described here seem to share three 
common characteristics: they propagate mostly via horizontal gene transfer (HGT), 
exhibit extremely high rates of molecular evolution and display traits of selfish genetic 
elements (Stern and Sorek, 2010). 
 Evidence for the lateral mode of distribution is provided by the facts that a 
large number of these systems are encoded by plasmids, phages, prophages or 
hypervariable loci in the prokaryotic chromosome, and by homology found between 
distantly related strains. Often, they exhibit a codon usage bias and GC content 
different from the rest of the genome they reside in (Kobayashi, 2001; Gogarten et al. 
2002; Chopin et al. 2005; Godde and Bickerton, 2006; Makarova et al. 2009). An 
obvious question is how HGT takes place and bypasses the pre-existing resistance 
mechanisms of a given organism. This is attainable due to the “leaky” nature of all the 
mechanisms discussed here, the fact that the rapid evolutionary rates enable invading 
elements to continuously develop anti-resistance strategies, and the fact that many of 
these systems are under tight control in certain development stages of the organism, 
or are subject to “phase variation” (Hoskisson and Smith, 2007). The latter refers to 
the alternate expression of different combinations of subunits in an RM system, or 
even the reversible inactivation of the system itself.   
 The extreme selection pressures acting on both host resistance and invader 
anti-resistance systems lead to rapid evolutionary rates, in what has been described 
as a co-evolutionary “arms race” (Hoskisson and Smith, 2007; Stern and Sorek, 2010). 
This is evident in the wide array of classes and types of RM mechanisms, systems 
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mediating Abi and CRISPR/Cas subtypes (discussed later), and even hypervariability 
of the target recognition domains in RM systems. 
 Inherent characteristics of certain genetic elements can lead to an increase of 
their relative frequency within a given population. These types of genetic elements are 
characterised as “selfish”. This theory has been put forward to explain the behavior of 
several prokaryotic defence mechanisms, especially the RM systems (Kobayashi, 
2001) and TA modules (Makarova et al. 2009). The following observations support this 
theory: i) loss of these systems results has deleterious effects on the host cell (figure 
1.4 A); ii) if a competing genetic element enters the cell (e.g. another RM or TA 
system), competitive exclusion between the two will lead either to attack and 
destruction of the invader or to host death, thus preventing the competing system 
from establishing itself in the population (figure 1.4 B); iii) these systems display 
extreme mobility between genomes. 
 As a consequence, it can be argued that participation of these systems in cellular 
defence is primarily a self-maintenance strategy, that happens to be advantageous to 
the host cell (Kobayashi, 2001; Makarova et al. 2009; Stern and Sorek, 2010).  
Figure 1.4: Characteristic behavior of selfish genetic elements 
(A) Post-segregational killing of the carrier that loses the element, establishing its maintenance 
in the population. (B) Competitive exclusion between two equally deleterious  selfish elements 
(adapted from Kobayashi, 2001). 
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 All of the prokaryotic resistance mechanisms described here seem to be 
implicated in additional pathways within the host cell. This has been extensively 
studied in TA systems, which are known to be activated in response to various types 
of cellular stress and also maintain genomic integrity by preventing loss of certain 
mobile genetic elements (Van Melderen, 2010). The induction modes and reversible 
effects of certain Abi systems has also led to the suggestion that they might also serve 
other cellular functions (Chopin et al. 2005). In several RM systems, following loss of 
the REase activity the MTase adopts a regulatory role in various aspects of DNA 
metabolism. Moreover, the “phase variation” controlled expression of RM systems is 
linked to several regulatory functions, such as allowing for differential epigenetic 
modifications of the genome, enhancing pathogenicity and enabling acquisition of 
foreign DNA (reviewed in Stern and Sorek, 2010). Putative alternate roles of the 
CRISPR system will be discussed later in this chapter. This versatility of prokaryotic 
defence systems seem to be an important and defining characteristic, highlighting the 
extreme plasticity and dynamic nature of the prokaryotic genome and its exceptional 
ability to adapt. 
1.2 Discovery and characterisation of the CRISPR arrays in prokaryotic genomes
	 In contrast to eukaryotic genomes, less than 5% of the genome of most 
prokaryotic phyla comprises of repetitive DNA (Ussery et al. 2004). Therefore, it has 
been proposed that its existence offers certain advantageous characteristics to the 
carrier, since it survived natural selection over evolutionary time.
	 A distinct family of direct repetitive DNA sequences in prokaryotic genomes are 
the clustered regularly interspaced short palindromic repeats (CRISPR). This family 
was first identified as a distinct class of interspersed short sequence repeats (SSR), 
adjacent to the isozyme-converting alkaline phosphatase (iap) gene by Ishino et al. in 
1987 and Nakata et al. in 1989 in Escherichia coli K12. The same class of repeats was 
found soon in other prokaryotic species such as Mycobacterium tuberculosis 
(Hermans et al. 1991), Haloferax mediterranei (Mojica et al. 1995), and Thermotoga 
maritima (Nelson et al. 1999). They were recognized as a defined prokaryotic family of 
short regularly spaced repeats (SRSR) by Mojica et al. in 2000, who in agreement with 
Jansen et al. introduced the acronym CRISPR in an initial study of the CRISPR-
associated system in 2002. 
	 The main, conserved features of the CRISPR system are the following, outlined 
in figure 1.5 (reviewed in Sorek et al, 2008; van der Oost et al. 2009; Horvath and 
Barrangou, 2010; Karginov and Hannon, 2010; Marraffini and Sontheimer, 2010; 
Deveau et al. 2010; Al-Attar et al. 2011):
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i. These elements consist of direct repeat sequences which range in size from 21-48 
bp (with an average size of 32bp) and in number from 2-375 repeats per locus (with 
an average of 27). The repeat sequences can be partially palindromic, in the form of 
inner and terminal imperfect inverted repeats of up to 11bp (Godde et al. 2006). 
CRISPR loci are usually homogenous in their repeat sequence. In terms of 
sequence conservation, phylogenetically distant species generally show greater 
variation of the repeat sequences than closely related species, although many 
exceptions have been observed (Jansen et al. 2002). The repeats can be divided 
into 12 clusters based on sequence similarity and secondary structure formation 
(Kunin et al. 2007). Six of these clusters exhibit high and intermediate RNA folding 
scores indicating that the repeats, when transcribed, form stable secondary stem-
loop structures mediated by the palindromic sequences, hypothetically facilitating 
recognition by CRISPR-associated proteins. Moreover, some of the clusters contain 
the conserved sequence GAAA(C/G) in their 3’-terminus, indicating a possible 
protein binding site. .
ii. The repeat sequences are regularly spaced by unique intervening sequences 
(spacers) of variable length, which range in size from 26-72 bp. A fraction of the 
spacer sequences was found to exhibit significant similarity to sequences from 
phage DNA and conjugative plasmids, with the highest degree of similarity for a 
given spacer found within genetic elements associated to the carrier. Taking into 
account the limited number of characterized viral genomes and conjugative 
plasmid sequences, it was concluded that the spacer sequences originate from 
these foreign genetic elements (Mojica et al. 2005, Pourcel et al. 2005). In support 
of this theory, 40% of the spacers in lactic acid bacteria CRISPR loci were found to 
be homologous to streptococci phage genomes and the respective conjugative 
plasmids (Bolotin et al. 2005). Crenarchaeal CRISPR spacers yield matches to 
fuselloviruses, rudiviruses and β-lipothrixviruses. Spacer sequence matches were 
found in both the sense and anti-sense strands and both gene coding and 
intergenic regions of phage genomes (Shah et al. 2009). The viral or plasmid 
sequence that is complementary to a given spacer sequence is known as a 
“protospacer” 
iii. Leader sequences of a size order of 100-550 bp have been detected in association 
with several (but not all) CRISPR loci. They are located directly upstream of the 
cluster, with respect to the strand orientation of the repeat sequence. These 
sequences appear to have a high A-T content, are rich in homopolynucleotide 
regions, lack open reading frames and are generally not conserved between 
distantly related species (Jansen et al. 2002), but exhibit similarity between related 
species. Analysis of the primary transcripts of CRISPR loci in several species 
revealed that transcription initiates within the leader region (Hale et al. 2009; 
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Lillestol et al. 2006), and putative promoter motifs were identified in leader regions 
of Sulfolobus acidocaldarius  (Lillestol et al. 2006) and E. coli K12 (Pul et al. 2010) 
confirming that these regions act as transcription promoters for the sense strand of 
the CRISPR arrays. Moreover, it was initially deduced by comparative analysis 
(Lillestol et al. 2006) and subsequently confirmed by genetic studies in 
Streptococcus thermophilus  (Barrangou et al. 2007) that novel spacers are 
incorporated along with a novel repeat into the leader proximal end of the CRISPR 
loci. Therefore, leader regions seem to be playing the dual role of controlling 
CRISPR transcription and the growth of the array, by interacting with the 
appropriate proteins for the addition of new spacers. 
iv. A number of protein families have been designated CRISPR-associated (Cas), and 
together with the repeat cluster are regarded as a unified system (Jansen et al. 
2002; Haft et al. 2005; Makarova et al. 2006). These families are present only in 
CRISPR containing species, located adjacent to the repeat cluster with a generally 
conserved orientation. No homologues of the cas  genes were found in eukaryotic 
or CRISPR-negative genomes. Only one set of cas  genes is present in species 
carrying multiple CRISPR loci with the same repeat sequence, but if multiple loci 
with varied repeat sequence are present, then a respective number of cas  gene 
sets is observed. A cas  gene region can comprise of as many as 20 different, 
tandem-arranged genes with no preferential direction of their reading frames, and 
can be found on either side of a CRISPR locus. An analysis of the Cas genes will be 
presented in the following section. 
Figure 1.5: Graphic representation of a CRISPR locus and the adjacent cas gene operon in a 
prokaryotic genome
Cas  genes are depicted as blue arrows, the leader sequence in red, repeats as dark grey boxes 
and interspersing spacers as colored, numbered boxes. Direction of transcription is indicated 
by the black arrow. 
	 The number of CRISPR loci per genome ranges from 0 to 20, with 
Methanocaldococcus  jannaschii containing the highest number found to date (Jansen 
et al. 2002, Godde et al. 2006, Lillestol et al. 2006). According to most recent reviews 
CRISPR loci are present in 90% of the sequenced archaeal genomes, covering both 
phyla of Crenarchaeota and Euryarchaeota, and in 40% of the sequenced bacterial 
genomes, adding up to 639 genomes analysed up to date (table 1.1, Makarova et al. 
CAS genes leader repeat spacer
1 2 3 4
transcription
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2011a). It has been observed that archaeal clusters, especially from thermophilic 
organisms, are in general multiple and larger than the bacterial ones, and can 
represent up to 1% of the prokaryotic genome. Clusters are also present in archaeal 
conjugative plasmids, such as pNOB8 and pKEF9 of Sulfolobus  sp and bacterial 
megaplasmids such as pTT27 of Thermus  thermophilus  (Lillestol et al. 2006, Godde et 
al. 2006). 
Taxonomic 
group
Genomes 
analysed 
Genomes 
containing 
cas1
proportion of 
cas1-containing 
genomes (%)
type I 
system
type II 
system
type III 
system
Archaea
Crenarchaeota 17 15 88 15 0 16
Euryarchaeota 47 37 79 33 0 23
Total 67 54 81 50 0 40
Bacteria
Actinobacteria 72 26 36 28 15 8
Aquificae 7 5 71 7 1 4
Bacteroidetes-
Chlorobi group
32 16 50 14 2 6
Chlamydiae–
Verrucomicrobia 
group
10 2 20 0 1 1
Chloroflexi 10 9 90 9 2 7
Cyanobacteria 14 7 50 7 1 7
Firmicutes 126 56 44 40 17 23
Proteobacteria 318 107 34 117 20 22
Spirochaetes 13 3 23 2 1 0
Thermotogae 11 10 91 10 0 9
Total 639 256 40 245 65 99
Table 1.1: Taxonomic distribution of CRISR-Cas systems in 706 analysed genomes
Different CRISPR system types can coexist in different genomes. Adapted from Makarova et al. 
2011a.
	
	 The origin of spacer sequences and the analogies observed by Makarova et al. 
(2006) between the system components and the eukaryotic RNA interference led a 
number of groups to propose that the CRISPR loci and their associated genes 
represent an adaptive prokaryotic resistance system against infections from 
extrachromosomal elements, functioning via RNA interference (Mojica et al. 2005, 
Pourcel et al. 2005, Bolotin et al. 2005, Makarova et al. 2006). Moreover, Mojica et al. 
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(2005) had already combined reports of foreign genetic elements such as viruses and 
conjugative plasmids failing to infect CRISPR-carrier strains whose spacers exhibited 
homology with these elements. The first experimental validation of the CRISPR 
function was achieved in 2007 by Barrangou et al. when CRISPR loci of 
Streptococcus thermophilus  were shown to incorporate new spacers homologous to 
phage genomic sequences during the generation of phage-resistant mutants, and 
resistance specificity was shown to depend on the spacer sequence content. In the 
same study, knockout of two cas  genes resulted in loss of phage resistance and 
inability to incorporate new spacers respectively, confirming the functional association 
of the cas genes with the CRISPR elements (Barrangou et al. 2007).
Figure 1.6: Outline of the CRISPR/Cas mode of action
The current model for the three stages (adaptation, expression and interference) of CRISPR 
functioning for each subtype, as  inferred by genetic and biochemical studies discussed in this 
chapter (adapted from Makarova et al. 2011a).
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	 According to the proposed mechanism (Makarova et al. 2006), the entire 
CRISPR repeat region is theoretically transcribed as a single primary transcript, and 
after a series of processing steps small interfering antisense RNA molecules of the 
size of a repeat/spacer unit (referred to as mature crRNAs or psiRNAs in the literature) 
are produced. This procedure could be under regulation by Cas proteins and induced 
by stress or phage infection. The mature psiRNA molecules could then anneal to the 
respective foreign mRNA, resulting in translation repression or cleavage of the dsRNA 
molecule, thus silencing the foreign genes and inhibiting phage or plasmid 
proliferation (figure 1.6). The Cas proteins are proposed to comprise the protein 
machinery of this immune system, mediating the generation and maintenance of the 
CRISPR loci, the processing and integration of new spacers as well as the RNA 
silencing process. The discrete stages of this mechanism will be discussed in more 
detail in subsequent sections.  
1.3 CRISPR-associated protein families and current classification of the CRISPR/
Cas system
	 The neighborhood of cas  genes (comprising of more than 20 genes) was 
initially identified and characterized by Makarova et al. in 2002 by genomic context 
analysis, but it was wrongly predicted to be a novel DNA repair system specific for 
thermophiles, as no connection with CRISPR was detected at the time. Almost 
simultaneously, Jansen et al. identified by in silico analysis four genes located in the 
vicinity of CRISPR loci that were designated CRISPR-associated (cas1-4; Jansen et al. 
2002). The first protein found to bind to CRISPR loci was a genus-specific 
uncharacterized protein in Sulfolobus  species corresponding to sso454 (Peng et al. 
2003), recognizing double and single repeat DNA sequences and producing an 
opening on the opposite side. Haft et al. in 2005 identified a guild of 45 Cas protein 
families by Hidden Markov models, a categorization refined by Makarova et al. in 2006 
taking into account genomic context information, resulting in 25 Cas protein families 
(Makarova et al. 2006). These families are proposed to be involved in the generation, 
expansion, maintenance, transfer between genomes and function of the CRISPR 
elements.
	 With the rapid growth of experimental characterisation and identification of 
novel CRISPR systems in more prokaryotic genomes, it became apparent that existing 
CRISPR/Cas classification systems grew increasingly inadequate and did not reflect 
the emerging phylogenetic relationships between the system components. Moreover, 
with the elucidation of many Cas protein structures from different families and analysis 
of an increasing number of gene sequences, previously undetected homologous 
relationships emerged which enabled the unification of certain Cas families and the 
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identification of novel ones (Makarova et al. 2011b). As a result, recently Makarova and 
colleagues (2011a) proposed an updated, polythetic classification of CRISPR/Cas 
systems based on gene composition, operon organisation and the phylogenetic and 
functional relationships between Cas genes. According to the novel classification, 
CRISPR/Cas systems are organised into three phylogenetically distinct types (I-III), 
and each major type can be further divided into individual subtypes (Makarova et al. 
2011a and b). This classification is summarised in figure 1.7 and the subtypes 
distribution in table 1.1.  
Figure 1.7: Outline of the main types and subtypes of the CRISPR/Cas systems and their 
phylogenetic relations
The most common composition and arrangement of cas genes is shown for each subtype, but 
gene order may vary in each organism. Gene families are color-coded and the family name can 
be seen under each gene. Signature genes for each main type are highlighted in green, and for 
each subtype in red. The star in gene cas10d indicates  a putative inactivated polymerase - HD 
domain. The letters above certain genes  stand for: RE: processing endonuclease for crRNA 
maturation; L: large subunits  of effector complexes mediating interference; S: small subunits of 
effector complexes; R: subunits  of effector complexes that belong to the RAMP superfamily 
(Repeat Associated Mysterious Proteins; described in chapter 3). Dashed genes in type III 
systems may not be part of the same operon. Adapted from Makarova et al. 2011a.
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	 The three main CRISPR/Cas types share a common core of two genes, cas1 
and cas2, which are highly conserved and are found in almost all CRISPR-containing 
species. Cas1 a highly conserved, basic protein that belongs to COG1518 (all COG 
groups mentioned in this text refer to the analysis performed by Makarova et al. 2002). 
Comparative sequence analysis and certain conserved residue patterns indicate that it 
might be a putative novel nuclease and/or integrase (Makarova et al. 2002). Metal-
dependent nuclease activity on ss/ds DNA (non-sequence specific) was confirmed by 
Wiedenheft et al. (2009) along with the elucidation of the Cas1 structure from P. 
aeruginosa which revealed a unique fold (figure 1.8). Additionally, Cas1 from S. 
solfataricus  exhibited a high binding affinity for ss/ds DNA, ss/ds RNA and DNA-RNA 
hybrids, as well as strand annealing activity (Han et al. 2009). 

Figure 1.8: Crystal structure of 
Cas1
Cartoon representation of the 
P. a e r u g i n o s a C a s 1 
homodimer (adapted from 
Wiedenheft et al. 2009). The 
N-terminal domain of chain A 
is colored in yellow, and the 
C-terminal α-helical domain 
which contains the active site 
in gray. Chain B  is colored in 
light blue. Conserved residues 
making up the active site are 
in red. Three of the residues 
(E190, H254 and D268) 
coordinate a manganese ion 
(green sphere).
The cas2 gene encodes a small (80-120aa) protein member of COG1343. Distant 
similarities were found between members of this COG and a class of sequence-
dependent, single-strand RNA nucleases called PIN-domain nucleases (after their 
identification in the N-terminus of the pilin biogenesis PilT protein), leading to the 
speculation that Cas2 might also possess ribonuclease activity (Makarova et al. 2006). 
The structure of Cas2 from S. solfataricus  was solved by Beloglazova et al. (2008) 
revealing an RRM-like domain (RNA recognition motif; structural motif consisting of 
four β-strands and two helices arranged in a α/β sandwich) (figure 1.9), while the 
protein exhibited metal-dependent ssRNAse activity. The universal distribution of this 
gene pair along with experimental evidence discussed in subsequent paragraphs, has 
led to the assumption that Cas1 and Cas2 mediate the integration of novel spacer 
sequences into the CRISPR loci (reviewed in Sorek et al. 2008; van der Oost et al. 
2009; Horvath and Barrangou, 2010; Karginov and Hannon, 2010; Marraffini and 
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Sontheimer, 2010; Deveau et al. 2010; Al-Attar et al. 2011). The role of these core 
proteins in the current scheme of the CRISPR mode of action will be discussed later.
Figure 1.9: Crystal structure of Cas2
Structure of Cas2 from S. solfataricus, solved by the 
SSPF (PDB  code: 2IVY). The active conformation is a 
homodimer, with the interface formed by the tandem β-
sheets in each monomer that make up the RRM motif. 
Conserved residues are located on the loops at the edge 
of the central cleft, at the bottom of the structure.
	 Type I systems are characterised by the presence of cas3 (COG1203), a gene 
encoding for a protein with conserved superfamily II helicase motifs and an additional 
HD-nuclease domain, encoded separately in certain subtypes (Makarova et al. 2002). 
Type I systems also contain multiple representatives of the RAMP superfamily (Repeat 
associated mysterious proteins), which are suggested to form large heteromeric 
complexes and take part in invader silencing (Brouns et al. 2008). The RAMP 
superfamily encompasses a large variety of protein families with ferredoxin-like folds, 
predicted to have RNA-binding activity (Makarova et al. 2002, 2006; Haft et al. 2005) 
and will be discussed in more detail in chapter 3. Characteristic RAMP families 
associated with type I subtypes include Cas5, Cas6 and Cas7 (COG1857) protein 
families (Makarova et al. 2011a). Cas6 has been shown to possess metal-
independent, sequence specific RNAse activity, and is the processing endonuclease 
that generates the mature interfering RNA units (referred to as crRNAs from now on) 
from the primary CRISPR transcript, in every type/subtype it is associated with. An 
additional protein found in four out of six type I subtypes and a type II subtype is Cas4 
(COG1468), a member of the RecB  exonuclease family (Jansen et al. 2002, Makarova 
et al. 2002). A number of studies have concluded that the targets of type I systems are 
DNA viruses and plasmids (among others Brouns et al. 2008; Marraffini et al. 2008, 
Garneau et al. 2010). 
	 Type II systems have been found only in bacteria and contain only the 
signature gene cas9  (COG3513), the core cas1/cas2  genes and either cas4 or csn2, a 
modular gene (Makarova et al. 2011a). Cas9 family members are predicted to be large 
(about 1000 residues), multidomain proteins including an N-terminal RuvC-like domain 
(RuvC is a Holliday junction resolvase that belongs to the RNase H fold; Aravind et al. 
2000) and an HNH nuclease domain, common in restriction endonucleases (Makarova 
et al. 2002). Targeting of plasmid and phage DNA was demonstrated in  vivo for this 
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system, and Cas9 is implicated in the interference stage although no biochemical 
characterisation has been presented (Barrangou et al. 2007; Garneau et al. 2010). 
 Type III systems are characterised by the presence of cas10 (COG1353). 
Among the identified domains of this large multidomain protein (~1000 residues) is a 
permuted HD-superfamily hydrolase near the N-terminus, a globular uncharacterised 
α+β domain, a Zinc-ribbon (well-known nucleic acid interacting domain) and the core 
palm domain of DNA/RNA polymerases and nucleotide cyclases near the C-terminus 
(Makarova et al. 2002, 2006). The function of this protein is yet to be elucidated, but it 
has been shown to form multimeric complexes with the additional RAMP Cas proteins 
in type III-B operons which can effectively target RNA in  vitro (Hale et al. 2009). 
Targeting of DNA has also been demonstrated in vivo for type III-A systems (Marraffini 
and Sontheimer, 2008). cas6 is also part of type III systems. The core cas1 and cas2 
genes are occasionally missing from type III operons, but in these cases they are 
found to co-exist with other CRISPR/Cas systems (type I or type II) encoding cas1 and 
cas2  in the same genome. This supports the theory that cas1 and cas2 are involved in 
a different stage of CRISPR functioning, and co-regulation is not necessary (Makarova 
et al. 2011a). Mechanistic details of each stage in every CRISPR/Cas type will be 
discussed in detail in subsequent sections. 
1.4 The three stages of the CRISPR/Cas mode of action
	 The CRISPR/Cas system functioning can be divided into three mechanistically 
distinct stages (Makarova et al. 2006; van der Oost et al. 2009). The first stage 
involves the first encounter with the invader extrachromosomal element, the selection 
of the protospacer among the invader DNA sequences and the incorporation of the 
invader-derived short DNA sequence into the CRISPR array as a novel spacer. The 
second stage, termed CRISPR expression, consists of the transcription and 
processing of the CRISPR arrays to generate mature crRNAs (CRISPR RNAs), which 
are bound by Cas effector proteins and serve as guide sequences for the third stage 
of CRISPR-mediated defence. During this final stage, the crRNA-Cas protein 
complexes recognize, bind and inactivate the invading virus or plasmid, most likely by 
direct Cas-mediated degradation of the target nucleic acid. The current state of 
understanding of the molecular mechanisms and protein machinery taking part in 
these three stages are described below, and summarised in figure 1.6.
1.4.1 Stage I: Spacer selection and integration into CRISPR arrays
 This stage is also known as the adaptation stage of CRISPR functioning, as the 
incorporation of novel spacers enables the swift adaptation of prokaryotic cells to the 
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dynamic environmental pool of mobile invader genetic elements. The growing CRISPR 
arrays serve as heritable “libraries” of past infective events that render their carrier 
immune to subsequent attacks by previously encountered viruses or plasmids.  
	 The first experimental evidence of novel spacer acquisition and the 
implications for CRISPR mediated anti-viral defence was provided by Barrangou et al. 
(2007) in Streptococcus  thermophilus  (type II CRISPR/Cas system). In this study it was 
demonstrated that during the natural generation of resistant mutants by phage 
challenging, the surviving mutants contained novel phage-specific spacers in their 
CRISPR loci. Thus it was proven that the cells adapt to the new threat by altering their 
CRISPR loci to accommodate invader-derived sequences. The new spacers originated 
from both strands of the phage genome, without preferential targeting of coding or 
intergenic regions, providing also the first indication that DNA is the ultimate target. 
The level of resistance against a single pathogen correlated with the number of 
spacers acquired from that particular pathogen, and also with the level of identity 
between the protospacer/spacer sequences, as only the spacers without mismatches 
conveyed resistance. Deletion of the novel spacers resulted in increased sensitivity of 
the produced strains, thus establishing the link between CRISPR spacer content and 
phage resistance. This was also the first study to demonstrate the direct involvement 
of the Cas genes in the integration process, because inactivation of csn2 rendered the 
mutant unable to acquire new spacers. 
	 Since then, apart from additional studies of the S. thermophilus  system 
(Deveau et al. 2008, Horvath et al. 2008), adaptation by spacer incorporation has 
either been shown to occur naturally in a number of species  such as Streptococcus 
mutans  (van der Ploeg et al. 2009), or inferred by comparative genomic analysis of 
closely related strains (among others: Yersinia pestis, Pourcel et al. 2005; Thermotoga 
sp. DeBoy et al. 2006; Thermococcales, Portillo et al. 2009; Sulfolobales, Lillestol et al. 
2009, Held et al. 2010; lactic acid bacteria: Lactobacillales  and Actinobacteria, 
Horvath et al. 2009), and metagenomic analysis of natural microbial populations 
(Tyson et al. 2008; Andersson et al. 2008; Heidelberg et al. 2009). A common 
observation in all studies was the polarized addition of new spacers at the leader-
proximal end of the CRISPR locus along with the duplication of a repeat sequence, 
leading to the expansion of the array by a complete repeat-spacer unit (Pourcel et al. 
2005; Lillestol et al. 2006; Andersson and Banfield, 2008; Tyson and Banfield, 2008). A 
consequence of this is that comparison of the spacer content of CRISPR arrays 
reflects shared ancestry between related strains and can be used to reconstruct their 
recent evolutionary history and monitor virus/host interaction dynamics in microbial 
communities. The growth of CRISPR loci is also controlled by deletion of spacer 
regions via internal recombination events, as the unlimited expansion of the arrays is 
unsustainable for the cells. Internal recombination results in preferential deletion of 
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older spacers, which correspond to past infection events and are presumably less 
important for the survival of the organism (Horvath et al. 2008, Tyson and Banfield 
2008). 
	 The fact that the incorporation of new spacers occurs at the leader-proximal 
end of the loci suggests a role for the leader sequence other that transcription 
promoter (Lillestol et al. 2006; Marraffini and Sontheimer, 2008). It is possible that it 
contains binding sites for Cas/host proteins involved in spacer integration and repeat 
duplication. Interestingly, comparative analysis of the leader sequences in Sulfolobales 
revealed a series of more or less conserved motifs, albeit of low sequence complexity, 
with a different content/arrangement for each CRISPR family (Lillestol et al. 2009), of 
yet unknown significance. 
	 The molecular mechanism of this stage is currently the least understood part of 
CRISPR biology. Due to the architecture of the CRISPR arrays it has been proposed 
that the insertion of new spacers proceeds through homologous recombination with 
the genomic CRISPR region, accompanied by (or preceded by) a repeat duplication 
event (Makarova et al. 2006). Initially it was also suggested that the putative reverse 
transcriptase function of the gene now classified as cas10 could play a role in 
acquiring spacers from RNA sources, but with the elucidation of its role in the Cmr 
complex (multiprotein complex mediating interference in type III systems, described 
later) this proposition was discarded. 
  One of the key proteins thought to be involved in this stage is core protein 
Cas1, due to the following reasons: i) the universal distribution among CRISPR/Cas 
subtypes, indicating its essential role for the system, ii) initial bioinformatics analysis 
classifying Cas1 as a putative “nuclease/integrase” (Makarova et al. 2006), iii) the fact 
that in all subtypes studied until now it has not been found to associate with the 
protein machinery performing the crRNA processing and target interference (Brouns et 
al. 2008; Hale et al. 2009), and iv) its deletion has no effect on the second and third 
stage of CRISPR interference (Brouns et al. 2008). Experimental data on Cas1 
homologs have so far been somewhat contradictory, but overall seem to support this 
hypothesis. The first biochemical and structural studies of Cas1 were performed by 
Wiedenheft et al. and Han et al. (2009) with orthologs from Pseudomonas  aeruginosa 
and Sulfolobus  solfataricus  P2 respectively. Cas1 from P. aeruginosa was shown to be 
a metal-dependent sequence unspecific DNA endonuclease, capable of recognizing 
and cleaving ss and ds DNA substrates independent of their methylation pattern 
(Wiedenheft et al. 2009). The generated ds DNA products had an average size of 80bp 
which is much longer than the average spacer length for this organism (32 bp), 
suggesting that Cas1 interacts with additional Cas/host proteins in order to complete 
this step. In contrast, no nuclease activity was detected for the SsoCas1 ortholog, 
which appeared to bind ss/ds DNA, ss/ds RNA and DNA-RNA hybrids with 
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comparable affinities in the nanomolar range. Moreover, the protein displayed strand 
annealing activity in the presence of magnesium ions (Han et al. 2009), indicating its 
potential role in the final stages of spacer integration, when recombination-like events 
are likely to take place. The functional state of both Cas1 orthologs in solution was 
shown to be a dimer (figure 1.8 A). The latest study on Cas1 from E. coli (Babu et al. 
2011) confirms that it is a multifunctional metal-dependent, nuclease which, apart 
from linear ss/ds DNA and ssRNA substrates, can also cleave branched DNA 
oligonucleotides such as Holliday junctions, replication forks and 5’/3’ flaps in a 
sequence independent manner. These types of branched and cruciform-like 
substrates normally represent intermediates of DNA repair and recombination, and 
could potentially be formed by the palindromic repeat sequences within CRISPR 
repeats. Nuclease assays showed that the protein generated multiple cleavage 
products ranging in size from 5 nt to 34 nt and had a lower substrate size requirement 
than P. aeruginosa Cas1 as it was unable to cleave 60 bp DNA duplexes. The ability of 
E. coli Cas1 to cleave short branched substrates might be essential in the final steps 
of spacer integration, if indeed this step proceeds via recombination (Mojica et al. 
2009). Interestingly, it was demonstrated than in E. coli Cas1 interacts physically with 
CasC (Cse4) and CasE (Cse3), two subunits of a multiprotein complex involved in the 
last stage of target interference termed CASCADE (CRISPR-associated complex for 
antiviral defence, described later), suggesting a previously unconsidered CASCADE 
involvement in the adaptation stage, and physically and genetically with with the DNA 
repair/recombination associated proteins RecB, RecC, RuvB and UvrC, triggering 
hypotheses about the possibility that certain Cas components participate in DNA 
repair pathways (Babu et al. 2011). Overall, the current state of research on Cas1 
seems to support its key role in the adaptation stage of CRISPR functioning, as well 
as pointing out the need to identify its functional partners. 
	 Fusion or conserved gene synteny between Cas1 and Cas4 has been 
observed in a large number of genomes harboring type I systems, indicating a 
potential functional as well as physical association of these core system proteins 
(Makarova et al. 2006). Cas4 is one of the first CRISPR proteins for which a function 
prediction could be made, as it features conserved motifs characteristic of the RecB 
family exonucleases including a cysteine-rich motif responsible for DNA binding. The 
E. coli RecB protein is associated with recombinational DNA repair as a subunit of the 
larger RecBCD recombinase complex, and this role could be consonant with a 
theoretical recombination mechanism for spacer integration (Al-Attar et al. 2011). In 
type II-A systems it is proposed that csn2 is the functional analogue of cas4, and 
indeed inactivation of this gene in S. thermophilus  resulted in inability to acquire new 
spacers. (Barrangou et al. 2007). 
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 The final protein proposed to take part in this stage is Cas2, which together 
with Cas1 form the core of the three distinct types of CRISPR systems. Deletion of the 
cas1-cas2 gene pair did not have any effect on target interference in E. coli, and Cas2 
has not been shown to interact strongly with any other Cas protein (Beloglazova  et al. 
2008). Biochemical characterisation of Cas2 homologs from a number of species 
including S. solfataricus  P2 revealed that they are metal-dependent 
endoribonucleases specific for ssRNA substrates, cleaving preferentially in U-rich 
regions (Beloglazova et al. 2008). In agreement with the biochemical data, elucidation 
of the crystal structure of SsoCas2 (Sso1404) suggested that these proteins contain a 
βαββαβ RNA-recognition motif (RRM) and their physiological state is a homodimer 
with a central cleft formed by the tandem arrangement of the β-sheets of each 
monomer (figure 1.9). Cas2 proteins were classified as a novel superfamily of the 
ferredoxin-like fold, as they are the first characterised nucleases to adopt this fold. 
The fact that neither Cas1 nor Cas2 exhibit any type of sequence or structure 
specificity in terms of substrate preference remains incomprehensible, as some 
mechanism of protospacer selection must exist, either in the form of a protospacer 
adjacent motif (PAMs: conserved di- or tri-nucleotide motifs associated with 
protospacers; described in 1.4.4) or a different sequence characteristic. This also 
renders necessary the existence of additional Cas components taking part in the 
adaptation stage, potentially by interacting specifically with the nucleic acids involved, 
recruiting Cas1/Cas2 or even fine-tuning their function by allosteric regulation. 
Moreover, it is hard to speculate on the biological role of Cas2 in systems that have 
been shown to target and incorporate DNA-derived spacers, although simultaneous 
integration of mRNA-derived protospacers or inhibition of invader proliferation by 
transcript degradation cannot be ruled out. 
1.4.2 Stage II: CRISPR expression and biogenesis of crRNAs
	 The first observation that CRISPR loci are transcribed came from high-
throughput analyses of non-coding RNAs in the archaeons Archaeoglobus  fulgidus 
and Sulfolobus  solfataricus  P2 (Tang et al. 2002, 2005). The size distribution of the 
transcripts ranged from a minimum length corresponding to the distance between two 
successive repeats in the CRISPR cluster to higher order multiples of this single 
repeat-spacer unit. The detected sequences corresponded to various positions of the 
CRISPR arrays, implying that the whole loci are transcribed as long precursors (pre-
crRNA), which are subsequently processed into smaller repeat-spacer units. 
Transcription of CRISPR loci has since been shown in a number of species, such as E. 
coli (Brouns et al. 2008), Pyrococcus  furiosus  (Hale et al. 2009), Staphylococcus 
epidermidis  (Marrafini et al. 2008), S. solfataricus  and S. acidocaldarius  (Tang et al. 
2005; Lillestol et al. 2009), Xanthomonas  oryzae (Semenova et al. 2009). A constant 
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observation in all studies is the unidirectional transcription from the leader proximal 
end of the loci in all but one of the species studied so far, indicating the existence of a 
promoter within the leader region. Indeed, analysis of the transcription start sites and 
leader regions of the Sulfolobales  revealed putative BRE and TATA box motifs within 
25 nt of the transcription start side in the leader sequence (Lillestol et al. 2009). 
Reverse transcripts of the repeat clusters have only been detected in S. solfataricus 
and S. acidocaldarius  by Lillestol et al. (2009), but their processing seems to be less 
efficient and therefore it remains unknown whether they produce functional repeat-
spacer units. The authors attribute the production of the reverse transcripts to the 
existence of putative BRE and TATA box elements downstream of the CRISPR arrays, 
but whether this is a universal characteristic or purely coincidental remains 
unexplained, as does the functional relevance of the reverse crRNAs. 
1.4.2.1 Regulation of CRISPR transcription
	 The factors that control the transcription of the CRISPR arrays and also the 
transcription and translation of Cas genes are still poorly understood. This procedure 
appears to be strikingly different between various CRISPR systems studied until now, 
which further highlights the remarkable versatility and ability of CRISPR systems to 
adapt and evolve according to environmental pressures. Transcription of CRISPR 
arrays and Cas genes have been shown to be either:
i) constitutive, regardless of whether there is an ongoing infection or the state of it, 
consistent with a surveillance mode of action; interestingly, this is the case in all 
archaea studied to date (Tang et al. 2002; Hale et al. 2009; Semenova et al. 2009; 
Lillestol et al. 2006, 2009).
ii) upregulated in response to phage infection, under control of the cAMP receptor 
protein (Agari et al. 2010). This pathway is also activated during carbon limitation 
stress. A recent study suggests that cas gene expression is also upregulated in 
response to envelope stress (Perez-Rodriguez et al. 2011)
iii) subject to negative regulation by DevS along with the dev operon controlling 
developmental stages in Myxococcus xanthus (Viswanathan et al. 2007) 
iv) regulated by the antagonists H-NS and LeuO in E. coli. In this case, transcription 
under normal laboratory growth conditions is inhibited by the Heat-stable Nucleoid 
Structuring protein (H-NS, a typical transcriptional repressor in Gram-negative 
bacteria), which is bound to the promoter regions of the CRISPR locus and the Cas 
operon (Pul et al. 2019). This repression is relieved by the transcriptional regulator 
LeuO, by binding to the same genomic region and reversing the cooperative binding 
of H-NS dimers along the DNA, and also by directly or indirectly causing the 
enhancement of CRISPR-associated transcription (Westra et al. 2010).
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Additionally, two novel putative transcriptional regulator families have been described 
recently in Archaea in the forms of csa3 (casRa, COG0640/TIGR01884) and csx1 
(COG1517) (Lintner et al. 2011). Their activity and potential binding sites are still 
unknown/undetected, but the structure of Csa3 from S. solfataricus  reveals a 
conserved binding site for a still unidentified allosteric small effector molecule, such as 
a dinucleoside polyphosphate (figure 1.10).
Figure 1.10: Structure of putative 
transcriptional regulator Csa3 from S. 
solfataricus 
The active conformation is a 
homodimer. Chains are colored in teal 
and yellow/brown, and docked to 
dsDNA (adapted from Lintner et al. 
2011).
1.4.2.2 CRISPR transcript processing
	 In contrast to the first stage of CRISPR functioning, processing of the CRISPR 
RNA transcript has been clarified for the most part in all three major CRISPR systems. 
This procedure is mediated by a single Cas processing endonuclease in each system, 
and at least in one case host RNAses have been shown to participate. Two specific 
functions have to be carried out by these enzymes, the first being the recognition of 
the precursor transcript and cleavage within a single site in each repeat to generate 
the mature form of crRNAs (figure 1.11), and the second the retention of the 
processed mature crRNA for subsequent usage by the respective effector proteins or 
complexes that mediate interference.
Figure 1.11: Outline of the second stage of CRISPR functioning
5’ handle spacer 3’ handle
mature crRNAs
precursor CRISPR 
transcript
processing by system 
endonucleases
5’
5’ 5’ 5’
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	 In CRISPR/Cas types I & III, a single superfamily of endonucleases, namely 
Cas6, are responsible for the processing of the primary transcript of the CRISPR locus 
into mature crRNA units that include a complete spacer flanked by parts of the repeat 
sequence (Carte et al. 2008, 2010). Cas6 family members are associated with 
subtypes I-A, I-B, I-D, III-A and III-B, while different families are found in subtypes I-E 
(names used in the literature: CasE/Cse3/Cas6e) and I-F (Csy4/Cas6f). These proteins 
are part of the RAMP superfamily (Repeat-Associated Mysterious Proteins) and have 
been shown to contain tandem or single ferredoxin-like folds, which contain the RRM 
motifs used to bind the target pre-crRNA (Carte et al. 2010; Haurwitz et al. 2010; 
Wang et al. 2011). Despite their shared fold and structural topology, the distinct 
families associated with each subtype exhibit remarkably different mechanisms for 
target RNA recognition and cleavage, although the final product is similar. This 
functional versatility is related to the specific repeat family of each subtype, as 
identified by Kunin et al. in 2007, as the propensity of each repeat sequence to form 
stable secondary structures (typically a stem-loop structure, depending on the 
palindromic nature of the repeat sequence) influences its mode of recognition and 
binding by the respective Cas proteins. Representatives of the three Cas6 families 
have been characterised biochemically and structurally, and their mode of action will 
be briefly described here.  
 In types I-E  and I-F systems, the processing endonucleases (Cse3 and Csy4 
respectively) are also subunits of the large multiprotein effector complexes that 
mediate interference. The first identified complex of this type was characterised in E. 
coli (type I-E) and termed CRISPR-Associated Complex for Antiviral Defence 
(acronym: CASCADE) (Brouns et al. 2008; Wiedenheft et al. 2011). The repeat 
sequences associated with this system is predicted to form a stable hexanucleotide 
stem with a tetranucleotide loop. The structure of Cse3 from T. thermophilus  (Gesner 
et al. 2011; Sashital et al. 2011) is composed of a double ferredoxin-like fold, with a 
four strand antiparallel β-sheet forming the central positively charged cleft of the 
protein, where the phosphate backbone of the 3’ strand of the stem loop is bound. 
Upon binding to RNA, the protein undergoes a conformational change whereby a 
previously disordered accessory β-hairpin recognizes the major groove of the RNA 
helix, and a previously disordered loop interacts with the base of the stem loop, 
positioning the scissile phosphate in the active site (figure 1.12 A). The protein 
interacts specifically with four residues located either side of the stem loop. Cleavage 
occurs at a G-A bond at the 3’ base of the stem-loop. Mature crRNAs in this system, 
as sequenced from E. coli during the characterisation of CASCADE, comprise of a 
complete spacer sequence flanked by 8 nt of repeat derived sequence at the 5’ end 
and the remaining 21 nt of repeat containing the stem-loop on the 3’ end. A degree of 
heterogeneity was observed for the 3’ end, highlighting the importance of the 5’ 
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handle (or 5’ psi-tag in the literature) for potential protein recognition and potentially in 
self-nonself discrimination (Brouns et al. 2008; Jore et al. 2011). In type I-F systems, 
the C-terminal domain of Csy4 adopts an extended conformation although the basic 
secondary structure connectivity again resembles a ferredoxin-like fold (Haurwitz et al. 
2010). The N-terminal domain is a typical ferredoxin-like fold. The stem-loop structure 
of the repeat interacts extensively with an arginine-rich helix in the C-terminal domain, 
while the ssRNA-dsRNA junction is positioned in the positively charged cleft between 
the two domains (figure 1.12 B). 
Figure 1.12: Structures of processing endonucleases Cse3 and Csy4
(A) Superimposition of two T. thermophilus Cse3 structures  (in orange and blue) bound to 
synthetic CRISPR repeat RNA. The arrow indicates the conformational change occurring upon 
RNA binding. RNA is illustrated as  a light orange tube, while the scissile phosphate as an 
orange sphere (adapted from Sashital et al. 2011). (B) Ribbon diagram and electrostatic surface 
representation of the structure of Csy4 from P. aeruginosa bound to the RNA CRISPR repeat 
substrate. The RNA backbone is represented with orange sticks. Blue shaded areas  indicate 
the positively charged and red areas the negatively charged regions. Adapted from Haurwitz et 
al. (2010).
	
A
180o
B
CHAPTER 1: Introduction
25
Sequence-specific hydrogen bonds tether the substrate in the active site so that the 
cleavage takes place immediately downstream of the hairpin, 8 nucleotides upstream 
of the spacer sequence. Both proteins remain bound to the cleavage products via the 
base-specific and electrostatic interactions formed with the RNA, which enables the 
subsequent use of the mature crRNAs by CASCADE and the analogous Csy complex. 
 A representative of the Cas6 family protein associated with subtypes I-A, I-B, I-
D, III-A and III-B  has been characterised in Pyrococcus  furiosus  (Carte et al. 2008, 
2010; Wang et al. 2011). Although the architecture of this protein also consists of two 
ferredoxin-like domains it is apparent that the molecular mechanism for recognition 
and cleavage of the pre-crRNA has evolved to accommodate the type of unstructured 
repeat that is predicted to associate with these subtypes (Kunin et al. 2007). The 
conserved positively charged central cleft between the two ferredoxin-like domains is 
responsible for interaction with ssRNA, where conserved residues form contacts with 
specific conserved nucleotides near the 5’ terminus of the CRISPR repeat, anchoring 
the RNA in position for the cleavage reaction taking place on the opposite surface of 
the protein (figure 1.13). Mutation analysis confirmed that the catalytic active site and 
binding site are physically distinct, with the connecting substrate interacting weakly or 
transiently with the signature Gly-rich loop. Metal-independent cleavage of the pre-
crRNA transcript occurs 8 nt upstream of each spacer, producing the conserved 5’ 
handle (termed psi-tag) present in the mature crRNA form and the 22 nt repeat-
derived sequence at the 3’ end.
 Figure 1.13: Crustal structure of PfuCas6
(A) Ribbon diagram of the apo structure of PfuCas6. 
Helices  and strands are numbered from N to C terminus. 
The G-rich loop is  highlighted in red and catalytic 
residues  in green. (B) Electrostatic surface potential of the 
RNA-bound PfuCas6 illustrating the path of the bound 
RNA from the binding site to the catalytic site (His46), via 
the G-loop region. The RNA is  represented with red 
sticks, and the numbers  correspond to nucleotides. 
Figures  adapted from Carte et al. (2008) and Wang et al. 
(2011).
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 The product remains bound to Cas6 until transferred to the respective effector 
complex (Cmr complex or an archaeal version of CASCADE, in the case of P. furiosus 
which contains both type I and III systems). The 3’ end of the mature crRNA in P. 
furiosus  in vivo is processed further by an unknown nuclease, but this seems to vary in 
different organisms (e.g. S. solfataricus). Cas6 family proteins have not been found to 
associate tightly with any effector Cas protein or complex, which grants them the 
flexibility needed to associate with multiple subtypes that potentially differ at the 
interference stage.                                                
 The catalytic mechanism used by all three types of processing endonucleases 
seems to rely on a histidine and a tyrosine residue in the active site, along with a 
variable lysine or serine, all of which are necessary for acid-base catalysis. Moreover, 
the glycine-rich loop characteristic of RAMP proteins is potentially implicated in 
correct substrate orientation. However, all three proteins use distinct sequence and 
structure-specific recognition mechanisms to select their respective substrates, 
illustrating the versatility of the characteristic duplicate ferredoxin-like fold in RAMPs 
and providing a mechanistic illustration of the coevolution of CRISPR repeat 
sequences and Cas proteins (Shah et al. 2010). To summarize, biogenesis of mature 
crRNAs in type I & III systems proceeds through single cleavage events within the 
repeat sequences 8 nt upstream of the beginning of the spacer. The generated 
sequence therefore consists of three elements: i) the strictly conserved repeat-derived 
5’ handle, predicted to be responsible for recognition and binding by the CASCADE-
like effector complexes and/or determine target recognition as a self-nonself 
discrimination mechanism (discussed later); ii) the spacer sequence, responsible for 
target recognition by basepairing; iii) a heterogeneous repeat-derived 3’ end, with a 
size range from 0 to 22 nt (Brouns et al. 2008; Hale et al. 2009; Carte et al. 2008; 
Haurwitz et al. 2010; Lintner et al. 2011). The processing events that lead to trimming 
of the 3’ end are still unidentified, as is the functional significance (if any) of this 
heterogeneity.  
 A quite remarkable procedure for CRISPR RNA maturation takes place in type 
II systems, as discovered in Streptococcus  pyogenes  by Delcheva et al. (2011). In this 
system, a novel RNA species was found in high copy number and identified as the 
transcript of the opposite strand of a region upstream from the start of the cas  operon 
and the CRISPR array. Interestingly, a 25 nt region of this transcript, termed tracrRNA 
(trans-activating CRISPR RNA), was complementary to the repeat sequence of S. 
pyogenes  (with only one mismatch), which is predicted to be unstructured. It was 
demonstrated that an RNA duplex formed by the tracrRNA and a repeat sequence in 
the pre-crRNA is sufficient to guide the cleavage of both strands at specific positions 
within the duplex region by the host RNase III, producing 1x crRNA units that consist 
of a complete spacer sequence flanked by the partial repeats. Further processing 
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takes place on the 5’ end of the spacer sequence by a still unidentified nuclease, 
resulting in the mature crRNA form for this system (figure 1.14, Delcheva et al. 2011). 
The latter comprises solely of a 5’ 20 nt spacer-derived sequence and a 19-22 nt 
repeat-derived sequence on the 3’ end. This composition is strikingly different from 
the mature form of crRNAs found in types I and III in that it lacks the characteristic 5’ 
repeat-derived handle. This feature could indicate a distinct mechanism for crRNA 
recognition by the proteins mediating the interference and potentially for the 
interference itself. The only Cas protein implicated in this stage is Cas9 (Csn1) 
although its exact function is unknown. In the model proposed by the authors the 
duplex formation between the tracrRNA and the pre-crRNA is enabled by Cas9, prior 
to recognition and cleavage of both strands by the host RNase III in a process termed 
trans RNA mediated activation of crRNA maturation (Delcheva et al. 2011). Cas9 
contains a McrA/HNH-nuclease domain and a RuvC-like (RNase H-like) domain 
(Makarova et al. 2006), making it a suitable candidate for the second cleavage event. 
There is no indication that the role of Cas9 is restricted at this stage, as it is possible 
that it also participates in the interference mechanism as deletion of cas9  in S. 
thermophilus  resulted in loss of phage resistance (Barrangou et al. 2007). To this date, 
this is the first example of a host factor implicated in CRISPR function, highlighting the 
exceptional economy and versatility of this system. 
Figure 1.14: Model for CRISPR RNA processing in type II systems
In the first processing event, basepairing between the tracrRNA and the repeats (black) in the 
precursor CRISPR transcript (spacers are in green), lead to site-specific cleavage by RNAseIII 
in the repeat sequence, generating repeat-spacer units. The second, still unidentified 
processing event takes  place within the spacer sequence, generating the mature crRNA units 
in type II systems. (adapted from Delcheva et al. 2011)
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1.4.3 Stage III: Recognition of invader sequences and target interference
 The identity of the molecular target of the CRISPR system has been a subject 
of debate since the discovery of its role in defence against extrachromosomal 
elements. The first bioinformatics studies providing an initial thorough description and 
classification of the system’s protein and genetic components (Jansen et al. 2002, 
Haft et al. 2005, Makarova et al. 2006) detected a functional analogy with the 
eukaryotic siRNA-interference system and hypothesised that RNA would be targeted. 
Subsequent studies overturned this hypothesis, as a closer inspection of the 
distribution of protospacers in phage, viral and plasmid genomes revealed that both 
sense and antisense strands were represented in CRISPR spacers, and no bias to 
gene-coding regions or conserved genes was observed (Shah et al. 2009). This result 
had two implications: firstly it suggested that the source of the spacers is the invader 
DNA itself in a random and non-directional manner, and not the viral or plasmid mRNA 
transcripts, and secondly it indicated that interference could also occur at the DNA 
level and not at a gene expression level (Shah et al. 2009). Additionally, if RNA was 
indeed the target, an over-representation of phage and viral genes that are expressed 
early in the lytic cycle would be expected as a more efficient inhibitory mechanism, 
which is not the case. This random unified distribution was demonstrated for the 
CRISPR spacers, virus families and plasmids of the Sulfolobales  (Lillestol et al. 2006; 
Shah et al. 2009), other crenarchaeal neutrothermophiles such as Aeropyrum pernix 
and Pyrobaculum sp. (Shah et al. 2009), phages and plasmids of Streptococcus 
thermophilus  (Barrangou et al. 2007; Deveau et al. 2008; Horvath et al. 2008), pro-
phages and non-viral regions of the Yersinia pestis  chromosome (Cui et al. 2008) and 
plant pathogen X. oryzae (Semenova et al. 2009). Moreover, as mentioned in the 
previous paragraph transcription of the CRISPR loci in most organisms has been 
shown to be unidirectional, suggesting that the generated crRNAs must be able to 
recognise their complementary targets regardless on whether they are located on the 
sense or antisense strand. Finally, it has to be noted that the current characterisation 
of RNA viruses is poor, therefore it is unsurprising that no spacer matches to RNA 
bacteriophages have been identified yet for bacterial CRISPR systems, and no RNA 
archaeal viruses have been isolated. 
 Solid experimental evidence regarding this matter has been provided in four 
bacterial systems to date, namely E. coli, Staphylococcus  epidermidis, Streptococcus 
thermophilus  and Pseudomonas aeruginosa. E. coli carries a type I-E CRISPR/Cas 
system, comprising of eight cas genes (figure 1.15), the core cas1-3 and subtype 
specific cse1-4 and cse5e, and a single CRISPR locus. Brouns et al. (2008) 
demonstrated that a large multimeric complex composed of Cse1-5e (alternatively 
named CasA-CasE) can be co-purified from E. coli lysate by affinity chromatography, 
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and termed it CASCADE (Crispr Associated Complex for Antiviral Defence). The 
complex could process transcribed crRNA from E. coli and bind the mature crRNA 
units, which in E. coli consist of a complete spacer with the last eight nucleotides of 
the repeat sequence on the 5’ end (5’ psitag) and a less defined 3’ end with the 
remaining nucleotides of the repeat (3’ handle). Construction of artificial crRNAs 
against both the coding and template strands of phage lamda resulted in inhibition of 
virus proliferation when CASCADE and Cas3 were present, providing the first direct 
evidence that DNA is the target of interference. In this context, the complex-bound 
crRNA serves as a guide to identify invading DNA and recruit the effector molecule, in 
this case Cas3, that will complete the silencing procedure presumably by degradation 
of the target sequence. A functionally analogous complex was isolated from the type 
I-F system of P. aeruginosa, comprising of subunits csy1-4 (Wiedenheft et al. 2011). 
	 In the second case, a clinical isolate of S. epidermidis  was found to carry a 
type III-A CRISPR/Cas system consisting of core genes cas1, cas2, cas6, subtype 
specific genes csm1-6 and a single CRISPR locus (figure 1.15). Staphylococcal 
conjugative plasmids contain a protospacer match within the conserved nickase gene, 
the transcription of which in the recipient cell is not essential for conjugation. 
Marraffini et al. (2008) demonstrated that conjugative transfer of the plasmid was 
inhibited in the strain that contained the CRISPR system, providing a first clue that 
DNA is targeted in this system. Insertion of a self-splicing intron into the centre of the 
protospacer resulted in the disruption of the original target at the DNA level, but after 
conjugation, transcription of the respective gene and splicing of the mRNA, the target 
would be reconstituted at the RNA level. The plasmid was able to propagate 
efficiently, indicating that the target mRNA was not recognised by the CRISPR system. 
Additional experiments in which plasmid transformation was inhibited due to 
interference against matching protospacers regardless of their orientation in the 
plasmid or their active transcription, confirmed that invader DNA is the original target 
regardless of its source (plasmid or virus) or the transfer mechanism (infection, 
conjugation or transformation). 
 Finally, it was established directly that the CRISPR/Cas type II system of 
Streptococcus thermophilus  is able to cleave both bacteriophage and plasmid DNA in 
vivo. The CAS gene cluster associated with CRISPR locus 1 in S. thermophilus 
consists of genes cas9, cas1, cas2, csn2 (figure 1.15) and addition of novel spacers 
after exposure to foreign genetic elements such as plasmids or bacteriophages was 
observed only in this locus out of the four found in this organism. Garneau et al. (2010) 
managed to isolate linearised plasmids from adapted strains exhibiting only partial 
interference, and map the cleavage site in the protospacer sequence, 3  bp upstream 
of the protospacer adjacent motif (PAM: conserved tri- or dinucleotide motif found at 
the 3’ end of protospacers, see 1.4.4). The same result was observed in 
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bacteriophage DNA extracted from infected strains carrying appropriate CRISPR 
spacers. The location of the cleavage sites in the phage genome was identical to 
those observed in the linearised plasmid. Additionally, a second cleavage site was 
detected in protospacers in the positive strand of the phage genome, 19 or 20 bases 
upstream of the PAM. This suggests a measuring mechanism anchored in the 3’ end 
of the protospacer (where the PAM is located), and is reminiscent of the crRNA-guided 
cleavage of the RNA target in Pyrococcus  furiosus  (Hale et al. 2009). In sensitive 
strains or in strains where cas9  was deleted only the circular form of the plasmid or 
the intact bacteriophage genome was detected, confirming the previously suggested 
involvement of Cas9 in the interference stage (Barrangou et al. 2007). It should be 
noted that inactivation of Csn2 inhibited the insertion of new spacers and the 
generation of new resistance mutants, confirming its involvement in the adaptation 
stage. Thus it is demonstrated that the interference-mediating protein in this system 
(possibly Cas9, since it contains an HNH nuclease domain) exhibits endonuclease 
activity against foreign dsDNA (either plasmid or phage) using a molecular ruler 
mechanism guided potentially by the crRNA, and producing blunt ends. The 
orientation-dependent differential cleavage pattern between protospacers located in 
the sense or antisense strand of the invading element remains unexplained. The 
number of cleavage sites in the phage genome corresponded to the number of 
protospacer matches, in accordance with the authors’ previous observation that the 
number of acquired spacers against a particular invading element has a cumulative 
effect on the resistance displayed against the respective element. The mechanistic 
details of this system are still unknown, therefore we do not know whether the target 
identification proceeds via the formation of an R-loop as exhibited for the CRISPR I-E 
system in E. coli.  
	 The first archaeal system in which CRISPR/Cas mediated defence was 
demonstrated in vivo was the crenarchaeon Sulfolobus, in particular strains S. 
solfataricus  P2 (Manica et al. 2011, Gudbergsdottir et al. 2011) and S. islandicus 
REY15A (Gudbergsdottir et al. 2011). Types I-A and III-B  CRISPR/Cas systems coexist 
in this archaeon, and the gene organisation of type I operons in S. solfataricus  P2 can 
be seen in figure 1.15. Manica et al. exploited the fact that a natural spacer in CRISPR 
locus B of S. solfataricus  P2 matches a gene-coding region of the conjugative plasmid 
pNOB8. Transformation efficiencies for a recombinant SSV1 virus carrying the 
aforementioned protospacer in S. solfataricus  P2 strain were very low compared to 
strain S. solfataricus  P1(which does not carry the respective spacer) regardless of 
whether the protospacer was transcribed and despite the fact that it was not essential 
for the virus propagation. Additionally, recombinant SSV1 shuttle vectors carrying a 
mini-CRISPR locus with self-targeting spacers (against a chromosomal gene) in both 
orientations were unstable in the host S. solfataricus  P2 strain and underwent 
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recombination in order to eliminate the self-targeting spacer. Similarly, Gudbergsdottir 
et al. observed that when challenged with shuttle vectors containing viral genes with 
CRISPR-matching protospacers, very few transformants were able to survive only 
after deleting part of the chromosomal CRISPR locus including the relevant spacer, or 
whole CRISPR/Cas modules, regardless of whether the protospacers were 
transcribed. Both these observations indicate that interference occurs at a DNA level, 
although it was not resolved which Cas type was responsible for this phenotype.
Figure 1.15: Gene organisation of Cas operons of studied organisms
Cas  gene neighbourhoods of S. solfataricus  (CMR operon not illustrated here), E. coli, S. 
thermophilus, S. epidermidis  and P. furiosus, organisms for which CRISPR functioning has 
been characterised experimentally. Numbers in arrows represent ORFs. Colour-coding 
indicates homology, except between blank arrows which indicate subtype-specific or non-cas 
genes. Orientation of the arrowheads indicates direction of transcription. Arrows outlined in 
black indicate signature genes for the specific subtype. Nomenclature according to Makarova 
et al. 2011. 
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 Conveniently, all the cases described above cover all three major CRISPR/Cas 
types (although not all the subtypes), suggesting that crRNA-directed DNA recognition 
and cleavage is a general mechanism for CRISPR mediated interference. Considering 
the complexity and diversity of the system components and their organisation, it is 
obvious that general predictions cannot be made and multiple pathways will emerge, 
as this diversity is also reflected at a biochemical level. However, from the host cells’ 
point of view the physiological importance of interference occurring at the DNA level is 
enormous, as it would dramatically increase the target and temporal activity range of 
the defence system. 
 The exact mechanism by which Cas-crRNA effector complexes recognise and 
access their target sequence within a given DNA genome has recently been 
determined by studies with the multiprotein CASCADE-like complexes in E. coli and P. 
aeruginosa (Wiedenheft et al. 2011; Semenova et al. 2011). In both systems the target 
is recognised by base-pairing to an 8 nt or 7 nt “seed” sequence located at the 5’ end 
of the spacer sequence in the crRNA (figures 1.16, 1.17). Affinity for the rest of the 
spacer sequence was shown to be much smaller, accounting for the tolerance for 
protospacer mismatches observed in many cases (Deveau et al. 2008; Gudbergsdottir 
et al. 2011 among others).
CRISPR array
Figure 1.16: Basepairing between crRNA and protospacer upon target recognition in E. coli
The high-affinity seed sequence consists  of 7 nt (non-contiguous) on the 3’ end of the 
protospacer, adjacent to the PAM. Numbering starts  from the first nucleotide of the cRNA 
spacer. In the CRISPR array, repeats are drawn as  rhombi, spacers as rectangles  (adapted 
from Semenova et al. 2011).
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Figure 1.17: Model for target recognition by CASCADE
The search and initial recognition of a protospacer is mediated by its seed sequence. Initial 
binding promotes  further hybridisation between the full crRNA spacer sequence and the 
protospacer, leading to localised duplex unwinding (adapted from Semenova et al. 2011).
	 The only example of RNA targeting by a CRISPR/Cas system comes from 
Pyrococcus  furiosus  (Hale et al. 2009). As described in detail in Chapter 3, the type III-
B  Cmr complex (acronym standing for CRISPR module RAMP) (figure 1.15) from this 
hyperthermophilic euryarchaeon exhibits cr-RNA guided endoribonuclease activity 
against ssRNA targets in  vitro. This type of interference in vivo has not yet been 
demonstrated, and the spacer sequences from P. furiosus  do not contain matches to 
any known viruses or plasmids, therefore the questions raised about the biological 
function of such an activity cannot be answered. 
1.4.4 Protospacer selection, self/non-self discrimination and autoimmunity issues    
	 The subjects of protospacer selection from the invader genome for 
incorporation into CRISPR loci and discrimination between the exogenous and the 
host DNA are two of the most important unanswered questions in CRISPR 
functioning. An increasing number of studies suggest that short sequence motifs 
adjacent to the protospacer are implicated in both processes, albeit with a still 
unknown mechanism. 
 Deveau et al. (2008) and Horvath et al. (2008) first identified a highly conserved 
tetranucleotide motif located two nucleotides downstream of phage protospacer 
sequences matching CRISPR spacers in S. thermophilus. Mutations in this motif 
enabled phages to escape CRISPR immunity, suggesting a role in target recognition. 
These motifs were identified as a universal CRISPR characteristic by Mojica et al. 
(2009), who found that strict motif conservation was limited to 2-3 nt located one 
position after the 3’ end of the protospacer and introduced the term Protospacer 
Adjacent Motifs (PAMs). The consensus motif sequences depend on the CRISPR 
repeat group, as assigned by Kunin et al. (2007). Moreover, the PAMs appear to 
determine the spacer orientation in relation to the protospacer, as the spacer end that 
corresponds to the PAM - proximal side of the protospacer is always oriented towards 
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the leader sequence (figure 1.18, Mojica et al. 2009). This conserved orientation along 
with the fact that novel spacers are always added at the leader-proximal end of a 
CRISPR locus indicates a potential role in the selection of protospacer sequences and 
integration procedure, presumably as a binding sequence for Cas proteins (Mojica et 
al. 2009).  
Figure 1.18: Orientation of 
protospacers in regard to their PAM
Protospacers  1 and 2 are located in 
opposite strands, but are always 
incorporated with the PAM-proximal 
side towards the leader (adapted 
from Mojica et al. 2009). 
	 Subsequent studies confirmed the role of the PAMs in interference efficiency, 
as any mutation within the motif prevented CRISPR interference and led to successful 
infection of the virus/plasmid carrying the respective mutation, while an intact PAM 
motif was required for interference (Semenova et al. 2009; Marraffini and Sontheimer, 
2010; Gudbergsdottir et al. 2010). However, studies  in P. furiosus  (type III-A) and  S. 
solfataricus  (types I-A and III-B) did not detect a role for the PAM in CRISPR 
interference (Hale et al. 2009; Manica et al. 2011), indicating that the importance of 
this motif is still elusive.  
 The mechanism by which the CRISPR system distinguishes the cognate 
CRISPR spacers from the invader protospacer sequences (both of which would 
exhibit perfect complementarity to the respective crRNA and would therefore 
constitute interference targets in the absence of such a mechanism) was elucidated by 
Marraffini and Sontheimer (2010) using engineered conjugative plasmids of 
Staphylococcus  epidermidis  (type III-A). The authors demonstrated that the differential 
complementarity between the generally conserved 5’ handle of crRNA and the 3’ 
region downstream of the target protospacer (that is, beyond the region of complete 
basepairing between the crRNA spacer and the target protospacer) is responsible for 
discrimination between self and non-self sequences and subsequent interference. 
This region is fully complementary only to the endogenous CRISPR repeat sequences, 
and if basepairing occurs (especially in positions -2, -3 and -4 of the 5’ handle), then 
the target DNA is protected. If no complementarity is found between the 5’ handle and 
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the downstream region of the protospacer, then the system proceeds with target 
cleavage (figure 1.19). Although the region screened for complementarity on the 
invader DNA corresponds to the PAM location, involvement of a specific motif was not 
observed in this mechanism, supporting the putative role of PAM in protospacer 
selection. 

Figure 	 1.19: Model for discriminating between self and non-self DNA during CRISPR target 
recognition
Complementarity between the repeat-derived 5’ and 3’ handles  of the crRNA and the target 
DNA ensures  protection of the endogenous  CRISPR locus (adapted from Marraffini and 
Sontheimer, 2010).
	 The deleterious consequences of autoimmunity are well known for all existing 
immunity systems, whether prokaryotic or eukaryotic. In the CRISPR/Cas system, this 
risk is manifested with the incorporation of a spacer into a CRISPR array that targets a 
cognate sequence. Although not abundant, self-targeting spacers have been detected 
in CRISPR loci (Mojica et al. 2005; Bolotin et al. 2005; Horvath et al. 2008, 2009; Shah 
et al. 2009), leading to the suggestion that, in analogy to the eukaryotic RNAi, CRISPR 
arrays could also have a regulatory role within the organism (van der Oost et al. 2009). 
An extensive case analysis by Stern et al. (2010) disproved this theory by 
demonstrating that, although self-targeting spacers were present in 18% of the 
CRISPR-encoding strains analysed in this study (330 total), they do not exhibit 
conservation across species (as would be expected for a successful regulatory 
element) and are always accompanied by one of the following adaptations: deletion of 
the respective spacer, loss of the Cas operon, inactivation of the CRISPR locus, 
degeneration of the flanking repeats, mutation of the target self-protospacer, or 
inferred deletion of the whole CRISPR array (Stern et al. 2010). These observations 
confirm that the accidental incorporation of a self-targeting spacer leads to negative 
autoimmunity effects potentially lethal for the host, and various adaptations have been 
observed to ensure inactivation of the specific spacer. 
	 This procedure was documented in  vivo by Manica et al. (2011), when a 
plasmid containing an engineered small CRISPR locus carrying spacers against an 
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endogenous host gene was introduced in S. solfataricus. The attack was lethal, and 
the few surviving cells had either lost the plasmid, or recombination had occurred 
between the plasmid and the genomic CRISPR loci in order to replace the self-
targeting spacer. 
1.5 Evolution, mobility and distribution of the CRISPR/Cas system
	 Phylogenetic analysis of cas  genes and the presence of CRISPR loci on 
conjugative plasmids has led to the conclusion that CRISPR/Cas, like previously 
described prokaryotic defence systems, is a mobile genetic element dispersed among 
species by horizontal gene transfer (Haft et al. 2005; Makarova et al. 2006; Godde et 
al. 2006). 
	 CRISPR loci also exhibit a great degree of plasticity and rapid evolution rates, 
as can be observed by the hypervariability of CRISPR regions in terms of repeat/
spacer content between closely related strains or between generations (Lillestol et al. 
2009; Andersson and Banfield, 2008; He and Deem, 2010). For example, studies in 
natural microbial communities have shown that CRISPR regions evolved rapidly 
enough by incorporating/losing spacer sequences in response to environmental 
pressure to promote cell individuality, therefore ensuring population immunity (Tyson 
and Banfield, 2008; Andersson and Banfield, 2008). Large deletions produced by low 
levels of spontaneous internal recombination of CRISPR loci are also common, and it 
is thought to be a way of limiting the ever-increasing size of the arrays and the 
energetic cost to the organism (Lillestol et al. 2009; Gudbergsdottir et al. 2010). 
	 Makarova et al. (2011a) attempted to resolve the evolutionary and phylogenetic 
relationships between the CRISPR/Cas systems by combining phylogenetic 
information from Cas1 homologues (being the universal CRISPR signature gene), 
genomic context analysis of the Cas operons and correlation with the CRISPR repeat 
groups (as defined by Kunin et al. 2007). The resulting dendrogram is illustrated in the 
left part of figure 1.7. 
	 CRISPR/Cas systems exhibit a differential distribution among the main 
archaeal and bacterial taxa. In general, the system is overrepresented in the kingdom 
of Archaea, with almost 90% presence in the sequenced genomes compared to about 
40% in bacterial genomes (table 1.1, Makarova et al. 2011a). Moreover, type III 
systems are more often associated with archaea, in particular thermophilic species, 
while type II systems seem to solely present in bacteria (table 1.1, Makarova et al. 
2011a). Also, archaea tend to carry more than one unrelated CRISPR/Cas systems, 
occupying up to 1% of their chromosome. Drawing from these observations, it has 
been proposed by Makarova et al. (2011a and b) that the system originated in an 
elementary form in thermophilic archaea, and subsequently spread by HGT. 
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1.6 CRISPR/Cas and the eukaryotic RNAi
	 RNA interference (RNAi) is a method of sequence-specific gene silencing 
mediated by a variety of non-coding, small RNA species with the aid of specific 
protein complexes in eukaryotes. Different pathways of this mechanism involve RNA 
species of different origin and serve different functions (reviewed in Hannon, 2002; 
Meister and Tuschl, 2004; Malone and Hannon, 2009; Carthew and Sontheimer, 2009): 
i) genome-encoded microRNAs are involved in post-transcriptional regulation of gene 
expression in the miRNA pathway; ii) exogenous dsRNA is processed into short 
interfering RNAs (siRNAs) which are then used to silence the invading element; iii) 
endogenous piwi-interfering RNAs are used to silence transposons in animal germ cell 
lines. This by no means represents an exhaustive list, as novel classes of small RNA 
species with distinct functions are still being discovered, while the stages of small 
RNA biogenesis and target silencing are not yet fully elucidated. A brief summary of 
the general RNAi pathway will be presented here (as reviewed in Carthew and 
Sontheimer, 2009; Siomi and Siomi, 2009), in order to discuss the proposed analogies 
with the CRISPR system. 
 In the first stage, long dsRNA molecules of exogenous origin are processed 
into 21-25 nt duplex RNA fragments with a 3’ overhang (siRNAs) by an RNAse III 
endonuclease called Dicer. The cleavage is non-sequence specific, but Dicer operates 
as a “molecular ruler” determining the size of the produced siRNAs. In contrast, the 
precursor molecules for miRNAs are transcribed from the organism’s chromosome 
(often encoded within introns) and fold into an imperfect stem-loop structure, which is 
then processed into miRNAs 21-25 nt in length by Dicer. In the second stage, the 
siRNA is unwound and one strand (termed the guide strand) is selected for 
incorporation in the active version of a large ribonucleprotein complex called RISC 
(RNA-Induced Silencing Complex). The composition of the RISC varies in different 
organisms, but the core component is always a member of the Argonaute protein 
family, also known as Slicer. This protein binds the guide ssRNA and uses it to locate 
complementary RNA strands, which are subsequently cleaved by a conserved domain 
of the Argonaute (PIWI domain). The cleavage site is determined again by a “molecular 
ruler” mechanism based on the size of the guide RNA. The RISC complex is then 
recycled and can repeat the silencing procedure. The outcome of the RISC encounter 
with the target RNA depends largely on the degree of complementarity exhibited 
between the guide and the target RNA, the type of Argonaute protein, the specific 
subunits of the RISC complex and other proteins interacting with the target and/or the 
RISC (summary in figure 1.20).
	 Functional analogies were detected initially by Makarova et al. (2006) between 
the then-hypothetical mode of CRISPR functioning and RNAi. Strategic similarities 
focused on the following facts: they both rely on an anti-sense RNA mechanism for 
sequence-specific target silencing; mature RNA molecules (crRNA and siRNA) derive 
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from long RNA precursors and contain invader-derived sequences; target RNA 
cleavage by a Cas multiprotein complex had been demonstrated in  vitro (Hale et al. 
2009); the abundance of conserved RNA and DNA-manipulating domains within the 
array of proteins associated with each system (reviewed in Marraffini and Sontheimer, 
2010). This led to the hypothesis that CRISPR is homologous to RNAi and represents 
a prokaryotic version of the same system (Makarova et al. 2006). However, with the 
elucidation of the mechanistic details of the various stages of CRISPR functioning, this 
hypothesis was eventually discarded. First, the respective protein machineries and the 
small RNA biogenesis were proven to be completely different. Second, the ultimate 
target for CRISPR interference was shown to be DNA (with the exception of the RNA-
targeting Cmr complex in P. furiosus; Hale et al. 2009). Third, each system seemed to 
have distinct physiological roles, with RNAi involved (among other functions) in gene 
regulation, chromosome stability, transposon and invader silencing, while the CRISPR 
system seems to be predominantly an immune system (reviewed in Marraffini and 
Sontheimer, 2010; Horvath and Barrangou, 2010).
Figure 1.20: General pathway and key proteins for RNA interference
(A) The sources  of long dsRNA precursors can be genomic or exogenous. Processing by Dicer 
generates the mature siRNAs or miRNAs. The guide strand (red) of each si- or miRNA is  loaded 
onto the Argonaute (Ago) protein, and used to recognise the complementary target. The exact 
method of silencing depends the location and nature of the target. Domain organisation and 
structure of Dicer (B), loaded with dsRNA and the Argonaute (C). Adapted from Carthew and 
Sontheimer, 2009.
CHAPTER 1: Introduction
39
1.7 Applications and alternative roles for CRISPR/Cas
	 The extreme sequence variability and mechanistic differences observed 
between the CRISPR/Cas subtypes, along with the biased spacer content detected in 
certain cases (Lillestol et al. 2009) have raised the possibility that the various system 
subtypes might be functionally distinct (Kunin et al. 2007), or that the CRISPR/Cas 
system may be involved in other cellular processes apart from antiviral defence 
(Deveau et al. 2010; Karginov and Hannon, 2010). The presence of self-targeting 
spacers, although proven to be unsustainable and deleterious to the host by Stern et 
al. (2010) is still suggested as a putative function in certain cases (Shah et al. 2009, 
Touchon et al. 2010). CRISPR loci, due to their extensive repeat homology, were 
involved in large-scale genome rearrangements in Thermotogales (DeBoy et al. 2006). 
In P. aeruginosa, the CRISPR/Cas system was implicated in regulating group 
behaviors such as swarming motility and biofilm formation in response to 
lysogenisation by the DMS3 phage (Zeagans et al. 2009). These phenotypes where 
lost if the DMS3 phage infected a strain harboring a matching CRISPR spacer, 
indicating that this loss is potentially a resistance mechanism, as it would prevent the 
phage from spreading to the population by proximity. In Myxococcus  xanthus, 
regulation of the cas operon is linked to the dev operon, a cluster involved in fruiting 
body development (Viswanathan et al. 2007). Purified Cas1 from E. coli was shown to 
interact with essential DNA repair enzymes such as RecB, RecC and RuvB  (Babu et al. 
2010). A potential functional association was supported when Cas1 or CRISPR loci 
deletion strains exhibited sensitivity to DNA damage and impaired cell division. Finally, 
recently the CRISPR system in E. coli was shown to be  upregulated by factors 
involved in detecting and triggering downstream responses to envelope stress (Perez-
Rodriguez et al. 2011). It should be noted here that this would not be the first example 
of a prokaryotic defence system involved in additional functions, especially stress 
response pathways (see paragraph 1.1). The adaptability and versatility of the 
prokaryotic resistance systems seems to be a general feature, but for the time being 
these examples only refer to individual cases and no function other than immunity has 
been widely associated with the CRISPR/Cas systems. 
	 The current and potential applications of the CRISPR/Cas system are the 
following (as summarised by Sorek et al. 2007; Al-Attar et al. 2011): 
i) CRISPR regions are already used for strain identification using a method called 
spacer-oligotyping (spoligotyping) (Kamerbeek et al. 1997)
ii)  Engineering anti-viral systems for bacterial strains in dairy industry, targeted 
against desired phages.
iii) Selective gene silencing in bacteria/archaea by exploiting the RNA interference 
mechanism, thus avoiding the laborious knockout procedure.
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iv) Exploit the unmatched spacer content to identify novel viruses in natural 
samples. (Snyder et al. 2010)
1.8 CRISPR/Cas systems of Sulfolobus solfataricus
	 The hyperthermophilic crenarchaeon Sulfolobus  solfataricus  has been a model 
organism for the physiological and biochemical studies of Archaea and their 
evolutionary relations to Bacteria and Eukaryotes, even before the sequencing and 
publishing of its genome (She et al. 2001). Cas systems in this organism belong to 
subtypes I-A and III-B with multiple operons for each subtype, the organisation of 
which and respective gene names can be seen in figure 1.21  
 S. solfataricus  strain P2 contains seven CRISPR loci with a total of 425 
repeats, the properties of which can be seen in table 1.2. Five of the loci have 
adjoining partially conserved leader sequences, (Lillestol et al. 2006), indicating that 
they are active. Indeed, transcripts could only be detected from the leader-carrying 
loci (Lillestol et al. 2009). Comparative analysis of the repeat sequences, leader motifs, 
spacer matches and proximal cas  operons of CRISPR/Cas systems of the 
Sulfolobales enabled the classification of the CRISPR loci in three major families (I-III) 
and elucidation of their phylogenetic relationship (Lillestol et al. 2009). Distinct PAM 
motifs were identified in the matching protospacers for each family, namely CC for 
family I, TC for family II and GT for family III protospacers. The authors did not detect 
preferential incorporation of spacers from specific viruses/plasmids into any of the 
families, therefore it remains unknown whether they have a functional distinction. 
Analysis of the leader regions preceding each locus revealed the presence of low 
complexity conserved sequence motifs, which appear to correlate with the respective 
CRISPR family of the locus. The importance of these motifs is yet to be determined, 
although it is hypothesised that they consist of recognition elements for Cas protein 
binding, or serve other regulatory functions (Lillestol et al. 2009). S. solfataricus 
CRISPR loci belong to families I and II. Analysis of 415 spacers in S. solfataricus  with 
an average length of 38-42 bp revealed similarities to sequences from Rudiviruses, β -
Lipothrixviruses, Fuselloviruses, STIV, ATV, SIRV viruses, pRN family plasmids and the 
conjugative plasmid pNOB8 (Mojica et al. 2005; Shah et al. 2009). No self-targeting 
spacer was identified within the total of 135 matched spacers. The repeat sequences 
in the CRISPR loci of S. solfataricus  are not predicted to form any significant 
secondary structures, as they belong to a repeat cluster with extremely low folding 
scores and therefore predicted to be unfolded (cluster 7), as classified by Kunin et al. 
(2007).
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Figure 1.21: Cas genes in S. solfataricus P2
Operon organisation and gene names of the type I-A and III-B  systems. Homologous genes are 
color-coded. 
CRISPR 
locus
Family repeats genome 
location
consensus repeat
A (3) II 103 1233466-
1239959
GATTAATCCCAAAAGGAATTGAAAG
B (4) II 95 1254482-
1260452
GATTAATCCCAAAAGGAATTGAAAG
C (5) I 32 1297153-
1299148
GATAATCTCTTATAGAATTGAAAG
D (6) I 96 1305539-
1311637
GATAATCTCTTATAGAATTGAAAG
E (9) I 8 1744007-
1744417
GATAATCTACTATAGAATTGAAAG
F (10+11) I 89 1809772-
1815557
GCTAATCTACTATAGAATTGAAAG
Table 1.2: CRISPR loci in S. solfataricus P2
CRISPR loci names and families  as in Lillestol et al. (2009). Numbers in parenthesis  refer to the 
CRISPR database loci numbering (Grissa et al. 2007). 
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Gene 
name
COG putative or confirmed 
activity
Stage 
involved
notes 
Cas1 1518 ss and dsDNA 
endonuclease, binding RNA 
and DNA
adaptation? Structure solved 
(3GOD, 3LFX, 2YZS)
Cas2 1343 endoribonuclease adaptation? Structure solved 
(2IVY, 2I8E, 3EXC)
Cas3’ 1203 putative DExH-box helicase interference
Cas3’’ 
(HDnuc)
2254 HD nuclease, cleaving 
dsDNA and dsRNA
interference Structure solved 
(3M5F)
Cas4 1468 predicted RecB-like 
nuclease
adaptation?
Cas5a 1688 interference subunit of CASCADE-
like complex
Cas6 1583 endoribonuclease CRISPR 
transcript 
processing
Structure solved 
(3I4H)
Cas7 1857 interference subunit of CASCADE-
like complex
Cas8a2 ? subunit of CASCADE-
like complex?
Csa3 0640 putative transcriptional 
regulator
Structure solved 
(2WTE)
Csa5 ? interference subunit of CASCADE-
like complex
Cmr1, 
Cmr3, 
Cmr4, 
Cmr6
RAMP interference subunit of CMR 
complex
Cmr2 
(Cas10)
1353 contains HD nuclease, 
putative polymerase domain, 
Zn-ribbon 
interference subunit of CMR 
complex
Cmr5 3337 interference subunit of CMR 
complex. structure 
solved (2OEB
and 2ZOP)
Table 1.3: Characteristics of the Cas proteins in S. solfataricus P2
COG numbers from Makarova et al. (2006). Activities refer to either experimentally
confirmed or predicted activities, as described in text. For available structures, PDB
identifiers are mentioned in parentheses.
CHAPTER 1: Introduction
43
CHAPTER 1: Introduction
44
Chapter 2 
Materials and Methods
2.1 Cloning procedures
2.1.1 Cloning and vectors
 The Sulfolobus  solfataricus  P2 type III-B  cas  genes encoding Cmr1 (gene name 
sso1989), Cmr2 (sso1991), Cmr3 (sso1992), Cmr4 (sso1987), Cmr5 (sso1988), Cmr6 
(sso1990) and Cmr7 (sso1986)  were amplified from  S. Solfataricus  P2 genomic DNA 
by PCR and cloned into vectors pEHISTEV and pDEST14 to allow for polyhistidine-
tagged protein expression. The sequences of the primers used are available upon 
request. Genes sso1986, 1988, 1990 were cloned into the 5’ NcoI / 3’ BamHI 
restriction sites of the pEHISTEV vector (Liu and Naismith, 2009), while the genes 
sso1987, 1989, 1992 were cloned into the pDEST14 vector of the Gateway cloning 
system (Invitrogen). The rationale for the alternate cloning of sequential genes into 
these two vectors was to enable co-expression studies of various gene combinations 
by co-transformation of the two compatible vectors into the same host.
 The Gateway cloning system is based on the site-specific recombination 
properties of bacteriophage lamda. A modified version of this system was developed 
and described by the SSPF (Oke et al. 2010), in which a third 5’ common primer is 
used for the amplification of the gene of interest in addition to the two gene-specific 
primers. This 118bp common primer contains the attB1 recombination site and adds 
to the construct the following elements: a ribosome binding site, a transcription start 
codon, an N-terminal six-histidine tag and a TEV protease cleavage site.
 The cas  genes sso1440 (cas3’), sso1441 (cas5), sso1442 (csa2) and sso2004 
(cas6) were also cloned into vector pDEST14 using the modified Gateway system. The 
sequence encoding for the first fourteen residues of the N-terminus of Sso1440 
(Cas3’) were removed, as comparative sequence analysis indicated that it is probably 
a misannotation event. To enable co-expression studies of sso1441 and sso1442, the 
two genes were cloned into a modified version of pRSFDuet-1 (Novagen), named 
pRSFDuetHISTEV (Oke et al. 2010), using restriction sites BspHI/BamHI and NdeI/
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XhoI respectively. The modified vector enables the addition of a TEV cleavable six-
histidine tag to the gene cloned into the first multiple cloning site. In this case 
Sso1441 would be expressed with the cleavable six-histidine tag while Sso1442 
would be co-expressed in the native form. Cloning reactions were carried out by Dr. 
Huanting Liu (SSPF, University of St Andrews).
	 Cas genes sso1437 (cas6) and sso1443 (csa5) were cloned into expression 
vector pET151/D-TOPO using the TOPO TA Cloning sustem (Invitrogen) by honours 
student Maryam Qurashi. 
	 All genes mentioned in this study were amplified from Sulfolobus  solfataricus  
genomic DNA, isolated from exponentially growing cells using the animal tissue 
protocol of the QIAGEN DNeasy Tissue Kit. All primer sequences are available upon 
request and were purchased by Eurofins MWG Operon, Dharmacon and Eurogentec. 
	 All plasmid constructs were sequenced at The Sequencing Service, School of 
Life Sciences, Dundee.
2.1.2 Site-directed mutagenesis
 Site-specific mutants of the sso1440 and sso1442 genes were generated using 
the Stratagene QuikChange XL Site-Directed Mutagenesis Kit as per the 
manufacturer’s instructions. The primer sequences used are available upon request. 
The base mutations were confirmed by DNA sequencing and the amino acid 
substitutions were verified by mass spectrometry of the purified protein.  
 The mutations were designed to target the conserved lysine in the Walker A 
motif of helicase Cas3’ (Sso1440), and substitute it with an alanine, thus generating 
the mutant Sso1440-K46A. The mutations in Csa2 (Sso1442) were designed to 
replace a conserved histidine at position 160 identified by multiple sequence 
alignment with an alanine residue, in an attempt to gain more information about the 
protein activity.
2.2 Protein expression and purification 
2.2.1 Expression of recombinant proteins 
	 The Escherichia coli competent cells BL21(DE3) and C43 (DE3) (Stratagene) 
were used for protein expression in all cases. The latter strain contains at least one 
uncharacterized mutation conferring tolerance to toxic proteins, and is derived from 
strain C41 (DE3), which in turn derives from BL21(DE3). 
 Luria-Bertani (LB; 10 g/l tryptone, 5 g/l yeast extract, 10 g/l NaCl) and 
Tryptone-phosphate broth (TPB; 20 g/l tryptone, 2 g/l K2HPO4, 2 g/l KH2PO4, 5 g/l 
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NaCl) were used as growth media supplemented with the appropriate antibiotic, either 
ampicillin or kanamycin at a final concentration of 100 μg/ml or 35 μg/ml respectively. 
	 For large scale protein expression 10 ml overnight starter cultures were used to 
inoculate 1 litre LB or TPB  (plus antibiotic) cultures in 2-litre flasks, which were 
incubated at 37oC, 180 rpm until the cells reached mid-log growth phase (OD600 
~0.6-0.8). Protein expression was then induced with 0.4 mM IPTG and cultures were 
incubated overnight (~14 hours) at 25oC with shaking at 180 rpm. The cells were 
harvested by centrifugation at 6 krpm, 4oC for 15 min using a Beckman JLA 8.10000 
rotor in an Avanti J-20 XP centrifuge and stored at -80oC until required. The 
expression conditions of the CAS proteins in this project are summarized in table 2.1. 
The cloned genes not mentioned in table 2.1 were also subjected to expression trials 
but were either insoluble or not expressed at all. 	
ORF 
(sso)
Name Vector Antibiotic 
resistance
Medium Induction post-
induction 
growth 
conditions
1440 Cas3’’ pDEST14 Ampr TPB 0.4mM 
IPTG
25oC o/n
1442 Csa2 pDEST14 Ampr LB 0.4mM 
IPTG
25oC o/n
1441/14
42
Cas5/
Csa2
pRSFDuetHI
STEV
Kanr LB 0.4mM 
IPTG
25oC o/n
1443 Csa5 pET151/D-
TOPO
Ampr LB 0.4mM 
IPTG
25oC o/n
1437 Cas6 pET151/D-
TOPO
Ampr LB 0.4mM 
IPTG
25oC o/n
1986 Cmr7 pEHISTEV Kanr LB - 25oC o/n
1987 Cmr4 pDEST14 Ampr LB 0.1 mM 
IPTG
25oC o/n
1989 Cmr1 pDEST14 Ampr TPB 0.4mM 
IPTG
25oC o/n
Table 2.1 Expression conditions of Cas proteins from S. solfataricus
2.2.2 Purification of recombinant proteins
 The general purification scheme employed in this study is the following, with 
the various adjustments described for each protein in the end. Cell pellets were 
resuspended at a 1:5 (w/v) ratio in affinity binding buffer (20 mM NaH2PO4/Na2HPO4 
pH 7.4, 500 mM NaCl, 10 mM imidazole, 10% glycerol) supplemented with 1 mg/ml 
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lysozyme (Sigma), 50 μg/ml DNAse I (Sigma) and protease inhibitor cocktail tablets 
(“Complete mini Protease Inhibitor mix EDTA-free” tablets, Roche Diagnostics, 1 tablet 
per 50 ml) prior to cell lysis by sonication for 12 min (6x2 min)  on ice. The cell lysate 
was centrifuged for 30 min at 20 krpm, 4oC (Beckman JA 25.50 rotor) and the 
supernatant was filtered with a sterile syringe-driven 0.45 μm filter (Milipore) prior to 
purification by nickel-chelate affinity chromatography. The filtered lysate was loaded 
onto a 5 ml HisTrap HP Ni-sepharose column (GE Healthcare) pre-equilibrated with 
affinity binding buffer and the target protein was eluted over a 30 mM - 500 mM linear 
imidazole gradient. The protein-containing fractions were pooled together and 
subjected to cleavage of the six-histidine tag by the tobacco etch virus (TEV) protease 
in buffer containing 20 mM NaH2PO4/Na2HPO4 pH 7.4, 500 mM NaCl, 10% glycerol, 
0.5 mM EDTA, 1 mM DTT, overnight at room temperature or 4oC, depending on the 
protein stability. The protein sample was then applied to an equilibrated with affinity 
binding buffer 5 ml HisTrap HP Ni-sepharose column (GE Healthcare) in order to 
remove the cleaved six-histidine tag, the histidine tagged TEV protease and other 
contaminants. The column flow-through, containing the untagged target protein, was 
concentrated to an appropriate volume and then loaded onto a HiLoad 26/60 
Superdex 200 gel filtration column (GE Healthcare) equilibrated with the appropriate 
gel filtration buffer (depending on the protein and the subsequent purification step) 
from which the protein eluted as a single monodispersed peak. The gel filtration 
buffers used consisted of 20 mM MES pH 6 or 20 mM Tris-HCl pH 7.5, 500 mM NaCl, 
1 mM EDTA, 0.5 mM DTT, 10% glycerol. All chromatographic purification steps were 
performed on a BioLogic DuoFlow chromatography system (Bio-Rad) and an AKTA 
Xpress automatic protein purification system. The efficiency of the procedure and the 
purity of the sample at each purification step was confirmed by SDS-PAGE 
electrophoresis on 4-12% NuPage gels (Invitrogen). The identity of the target protein 
was confirmed by MALDI-TOF and ESI mass spectrometry. Purified protein samples 
were pooled together, concentrated to an appropriate concentration with Vivaspin 
concentrators (Sartorius Stedim Biotech GmbH), flash-freezed in liquid nitrogen and 
stored at -80oC. The protein-containing samples were kept on ice at all times, unless 
otherwise stated.  
 Cas3’ (Sso1440) (both wild-type and mutant versions) was purified as 
described above and stored in a final buffer containing 20 mM MES pH 6, 500 mM 
NaCl, 1 mM EDTA, 0.5 mM DTT, 10% glycerol. All purification procedures were carried 
out on ice due to partial protein degradation, unless otherwise stated. 
	 Csa2 (Sso1442) was purified as described above with the addition of a third 
purification step, a 5 ml HiTrap Heparin HP column pre-equilibrated with a 20 mM 
MES pH 6, 50 mM NaCl, 1 mM EDTA, 0.5 mM DTT, 10% glycerol buffer, from which 
the protein eluted with a 50 mM - 1 M NaCl linear gradient. The six-histidine tag was 
uncleavable. 
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	 For the purification of the Csa2/Cas5 protein complex all procedures were 
carried out at room temperature and in the absence of DNAse to prevent carry-over 
contamination. The soluble fraction was incubated at 65oC for 20 min to precipitate 
most of the E. coli contaminant proteins and centrifuged at 40 krpm in a Beckman 
Coulter Optima L-90K Ultracentrifuge with a Beckman 70Ti rotor prior to metal-chelate 
affinity purification. The six-histidine tag was not cleaved and a third purification step 
on a 5 ml HiTrap Heparin HP column was employed as described for Csa2. In the case 
of the Csa2/Cas5 complex the purification through a heparin column enabled also the 
separation of the biologically relevant complex dimer from the excess of expressed 
Csa2 subunits. 
	 Cas6 (Sso2004) was purified by Dr Shirley Graham as described above and 
stored in 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 % glycerol. 
	 Cmr4 (Sso1987) and Cmr1 (Sso1989) were purified as described above, with 
the addition of 0.5% Triton X-100 in the lysis buffer. 
  Protein concentrations were calculated from the sample absorbance at 280 
nM, measured on a Varian Cary 50Bio UV-Visible spectrophotometer, and the 
theoretical molar extinction coefficient obtained from the ExPASy ProtParam analysis 
of the protein sequence, using Beer Lamber’s law. In the case of Csa2 (Sso1442) 
which lacks tryptophan residues, the Bradford reagent (Bio-Rad) was also used to 
calculate protein concentrations as per the manufacturer’s instructions using a BSA 
standard curve. 
2.3 Crystallization screening and optimisation
	 The optimal concentration for crystallisation screens was determined by 
performing the Pre-crystallization Test (Hampton Research), which evaluates the 
sensitivity of the protein to salt and polymer concentrations and the homogeneity and 
purity of the sample. 
 Commercial sparse matrix crystallisation screens (Classics and JCSG by 
Qiagen, JMac, Wizard by Emerald Biosystems, PEGs and JMac by Hampton 
Research, Proplex by Molecular Dimensions and stochastic screens prepared by the 
SSPF) were used to determine initial crystallisation conditions. The sitting drop 
vapour-diffusion method was used for all the initial crystallisation experiments. 
Screening experiments with 300 nl drops (150 nl protein plus 150 nl crystallisation 
buffer) or 450 nl drops (300 nl protein plus 150 nl crystallisation buffer) were set by the 
Cartesian Honeybee nanodispenser robotic system (Genomic Solutions), or 2 μl drops 
(1 μl of protein solution plus 1 μl of crystallisation buffer) were set manually on 96-well 
crystallisation plates. The crystal trays were sealed, kept at 20oC and examined 
regularly under an optical microscope or using the Rhombix Vision visualisation robot.
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 Conditions resulting in the formation of some form of microcrystals or 
crystalline precipitant were selected for optimisation trials, in which a grid screen or a 
stochastic screen was designed around the initial conditions in order to optimise 
crystal formation. The screens were set manually using the hanging-drop vapour 
diffusion method in 24-well trays. The drops were formed by mixing 2 μl and 1 μl of 
protein solution with 1 μl and 0.5 μl of crystallisation buffer respectively, and the 
reservoir volume was set to 450 μl. The crystal trays were sealed, kept at 20oC and 
examined under an optical microscope.
	 All the screening experiments were carried out in collaboration with the SSPF. 
The SSPF personnel also handled the crystal harvesting, data collection and structure 
solution of the protein targets.  
2.4 Immuno - blot
	 In order to identify fractions containing the Cmr protein complex in S. 
solfataricus  extract  through sequential purification steps, the Dot blot method was 
employed using antibodies raised against the desired component protein. 
 Sheep antiserum containing polyclonal antibodies against Cmr7 was 
purchased by the Scottish National Blood Transfusion Service. Two microlitres of each 
fraction were blotted on a HyBond ECL nitrocellulose membrane (Amersham 
Biosciences) and incubated in blocking buffer consisting of PBS, 5% milk powder, 
0.5% Tween-20 (Sigma) for 10 min. To enable the antibody-protein interaction the 
membrane was incubated in a 1:2000 or 1:1000 dilution of the primary antibody (anti-
Cmr7) in PBS, 2% milk powder, 0.2% Tween-20 for 30 min to 1 hou r. After washing 
3x10 min with fresh blocking buffer the membrane was incubated in a 1:10,000 
dilution of the secondary antibody (rabbit anti-goat, ImmunoPure Antibody, Pierce) for 
30 min. Finally the membrane was washed in blocking buffer (3 x 10 min) and 
ultrapure water (3 x 5 min). All the incubation and washing steps were performed at 
room temperature with gentle shaking. For the detection of the chemiluminescent 
signal the SuperSignal West Pico Chemiluminescent Substrate or Femto Maximum 
Sensitivity Substrate Kits (Pierce) were used as per the manufacturer’s instructions. 
The signal was visualized on a Fuji Luminescent Image Analyser LAS-1000 and Image 
Reader software.
 
2.5 Protein Interactions
2.5.1 Analytical size exclusion chromatography
 Gel filtration chromatography can be used for the detection and 
characterization of stable protein-protein interactions. The formation of a stable 
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protein complex would result in different partitioning between the mobile and the 
stationary phase of the column compared to the complex components, due to the 
larger Stokes’ radius of the complex. 
 A SuperoseTM 12 10/300 GL (TricornTM) (GE Healthcare) was equilibrated with 
20 mM MES pH 6, 250 mM NaCl, 10% glycerol, 1 mM EDTA, 0.5 mM DTT and 
calibrated with known molecular weight standards (blue dextran, β-amylase, alcohol 
dehydrogenase, albumin, carbonic anhydrase and cytochrome C (Sigma)) in order to 
obtain a linear calibration curve of the logarithms of the known molecular weight 
standards against their respective Ve/Vo values. The protein samples (either single 
purified protein samples in order to determine their oligomeric state or mixed samples 
of potentially interacting proteins) were run through the column at a flow rate of 0.5 ml/
min and the eluted peak fractions were analysed by SDS PAGE and mass 
spectrometry. The apparent molecular weights of the loaded samples were calculated 
using their elution volumes (Ve) and the calibration curve. 
2.5.2 Determination of protein interactions using magnetic precharged nickel 
particles
 Interactions between recombinant proteins can also be identified by making 
use of the six-histidine tag, in the same principle as nickel-chelating affinity 
chromatography. The histidine tagged protein, bound to the nickel-loaded particles, 
can be used as “bait” to affinity purify any interacting proteins from a pool of proteins 
in solution. To identify interactions between the recombinant Cmr subunits, Ni-NTA 
magnetic agarose beads (Qiagen) were used. In an eppendorf tube, 25 μl of magnetic 
agarose beads with covalently bound nickel chelating nitrilotriacetic acid (NTA) groups 
were incubated with 7.5 μg of polyhistidine-tagged protein in 25 μl of affinity binding 
buffer (10 mM Tris-Cl pH 8, 100 mM NaCl, 10 mM imidazole, 5 mM MgCl2), for 1 hour 
at room temperature. After removal of the unbound protein, the interacting partner 
was added to the beads at an equimolar concentration and incubated for 1 hour at 
room temperature. After a series of washes with increasing NaCl (250 mM and 500 
mM) and imidazole concentration (50 mM and 100 mM), the tagged protein is eluted 
with 25 μl of 10 mM Tris-Cl pH 8, 500 mM NaCl, 500 mM imidazole, 5 mM MgCl2. Any 
remaining protein is eluted further by incubating the beads at 95oC for 5 min and the 
samples are analysed by SDS-PAGE. Non-specific interactions between the non-
tagged proteins and the Ni-NTA beads were also tested. If the tagged and untagged 
proteins are forming a complex under the assay conditions, they would be found in 
the elution fraction. 
 To characterize interactions between recombinant Csa2, Cas5, Cas6, Csa5, 
Cas3’ in the presence or absence of crRNA, MagneHis Ni-Particles (Promega) were 
used. These experiments were carried out in collaboration with Dr Shirley Graham. In 
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an eppendorf tube, 20 μl of magnetic nickel-loaded particles were incubated with 12 
μg of polyhistidine-tagged protein in affinity binding buffer for 10 min at 40oC. The 
unbound protein was removed and the bound “bait” protein was incubated with an 
equimolar concentration of the potential interacting partner(s) in the presence or 
absence of crRNA for 10 min at 40oC. In the samples containing Cas3’, ATP / MgCl2 
was also added at a concentration of 1 mM. The magnetic beads were then washed 
with increasing concentrations of imidazole and NaCl and finally the bound proteins 
were eluted from the beads with 25 μl of 10 mM Tris-Cl pH 8, 500 mM NaCl, 500 mM 
imidazole. The samples were analysed by SDS-PAGE. Where indicated, the beads 
were resuspended in SDS-PAGE loading buffer and incubated at 90oC for 5 min 
before loading on the gel. This final step ensured that all the tightly bound proteins 
would removed from the beads. 
          
2.6 Generation of nucleic acid substrates and markers
2.6.1 Purification of oligonucleotides
	 Synthetic RNA and DNA oligonucleotides (purchased from Integrated DNA 
Technologies and Eurofins MWG Operon respectively) were denatured in 50% 
formamide (Promega) at 80oC for 10 min and transferred on ice until separated on a 
denaturing  12% polyacrylamide / 7 M urea gel for 90 min at 22W. The gel was pre-run 
for 30 min and wells were thoroughly rinsed before samples were loaded. Bands were 
visualised by UV shadowing, excised from the gel and incubated overnight at 4oC in 
TE buffer (10 mM Tris pH 7.5, 1 mM EDTA). The DNA or RNA was purified by ethanol 
precipitation, resuspended in TE buffer or the RNA Storage Solution (Ambion) for RNA 
oligonucleotides, and stored at -20oC.
Name Sequence 5’ to 3’
CRISPR _compF DNA CTTTCAATTCTATAGTAGATTAGC
CRISPR _compF RNA CUUUCAAUUCUAUAGUAGAUUAGC
CRISPR _compB DNA CTTTCAATTCCTTTTGGGATTAATC
CRISPR _compB RNA CUUUCAAUUCCUUUUGGGAUUAAUC
Table 2.2: Oligonucleotides used in chapter 3
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Name Sequence 5’ to 3’
crRNA-A1
 
AUUGAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAAAUA
AU GAUUAAUCCCAAAA 
crRNA-A1_Δ3 AUUGAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAAAUAAU 
crRNA-A1_Δ5 GAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAAAUAAU GAUUAAUCCCAAAAGGA 
A1P control AGGGUAUUAUUUGUUUGUUUUCUUCUAAACUAUAAGCUAGUUC 
tA1f +PAM
TAATACGACTCACTATAGGGT 
ATTATTTGTTTGTTTTCTTCTAAACTATAAGCTAGTTCTGGAGA
GAAGGTG 
tA1r +PAM
CACCTTCTCTCCAGAACTAGCTTATAGTTTAGAAGAAAACAAAC
AAATAATACCCTATAGTGAGTCGTATTA 
tA1f-PAM 
TAATACGACTCACTATAGGGTATTATTTGTTTGTTTTCTTCTAA
ACTATAAGCTAGTTCCCCAGAGAGGTG 
RNA_tA1f
AGGGUAUUAUUUGUUUGUUUUCUUCUAAACUAUAAGCUAGUUCU
GGAGA
crRNA native
AUUGAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAAAUA
AUGAUUAAUCCCAAAAGGA
 U15 CRISPR repeat  locus B UUUUUUUUUUUUUUUGAUUAAUCCCAAAAGGAAUUGAAAG
 Table 2.3: Oligonucleotides used in chapter 4
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Name Sequence 5’ to 3’
CRISPR locus B DNA CTTTCAATTCCTTTTGGGATTAATC
CRISPR locus B RNA CUUUCAAUUCCUUUUGGGAUUAAUC
CRISPR 3’ oh DNA GATTAATCCCAAAAGGAATTGAAAGTTTTTTTTTTTTTTT
CRISPR 5’ oh DNA TTTTTTTTTTTTTTTGATTAATCCCAAAAGGAATTGAAAG
CRISPR 5’ oh RNA UUUUUUUUUUUUUUUGAUUAAUCCCAAAAGGAAUUGAAAG
CRISPR  B complement GATTAATCCCAAAAGGAATTGAAAG
MKDNAf GCTCCTAGGTCCTTCGTGGCATCTG
MKDNAr CGAGGATCCAGGAAGCACCGTAGAC
MKDNA5’oh AAAACAAAACAAAATCAGATGCCACGAAGGACCTAGGAGC
MKDNA3’oh CAGATGCCACGAAGGACCTAGGAGCTAAAACAAAACAAAA
MKRNAf GCUCCUAGGUCCUUCGUGGCAUCUG
MKRNAr CGAGGAUCCAGGAAGCACCGUAGAC
MKRNA5’oh AAAACAAAACAAAAUCAGAUGCCACGAAGGACCUAGGAGC
MKRNA3’oh CAGAUGCCACGAAGGACCUAGGAGCUAAAACAAAACAAAA
MKDNAcomp CAGATGCCACGAAGGACCTAGGAGC
MKRNAcomp CAGAUGCCACGAAGGACCUAGGAGC
Table 2.4: Oligonucleotides used in chapter 5
2.6.2 Assembly and purification of double-strand substrates
 The purified DNA or RNA oligonucleotides designed to serve as substrates for 
catalytic assays were either already purchased with a 5’ fluorescein label or 5’ end 
labelled with [γ-32P] ATP (4500 Ci / mmol, MP Biomedicals) using T4 PNK (Fermentas) 
as per the manufacturer’s instructions. The labelled oligonucleotides were annealed 
into various structures (Appendix I) by slow cooling from 85oC to room temperature 
overnight and purified with 10% Ficoll on a native 12% polyacrylamide / 50 mM NaCl 
gel. The duplex constructs were eluted overnight at 4oC in TE / 50 mM NaCl, ethanol 
precipitated, resuspended in TE - 50 mM NaCl and stored at -20oC.  
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2.6.3 CRISPR locus constructs
 Part of the S. solfataricus  CRISRP locus A consisting of the leader sequence 
directly upstream of the repeats and 4 repeat-spacer units was amplified from S. 
solfataricus  genomic DNA by polymerase chain reaction. Two constructs were 
generated corresponding to either the whole leader sequence (245bp upstream from 
the start of the CRISPR locus) or part of it (165bp upstream) and four repeat-spacer 
units, named CRISPR I, II (figure 2.1) The amplified CRISPR fragments were cloned 
into pCR2.1 TOPO vector as per the manufacturer’s instructions, transformed into 
competent E. coli DH5a cells and isolated plasmids from the resulting colonies were 
sequenced to verify the presence and orientation of the insert.
	 A different construct containing the T7 promoter sequence directly upstream of 
the first two repeat-spacer units of CRISPR locus A was generated by PCR in order to 
serve as template for in  vitro transcription (CRISPR T7). The generated sequences can 
be found in Appendix I. 
Figure 2.1: Amplified fragments of the S. solfataricus CRISPR locus A
Leader sequence is illustrated as a red box, repeat sequences as black arrows and spacer 
sequences  as numbered light gray boxes. The T7 promoter is illustrated as a green box. 
Relative sizes are not up to scale. 
2.6.4 T7 RNA polymerase-mediated in vitro transcription
 The T7 CRISPR PCR fragment was purified by gel extraction (Qiagen Gel 
Extraction Kit) and used as template for in vitro transcription using T7 RNA 
polymerase Plus (Ambion) as per the manufacturer’s instructions. The crRNA 
transcript was uniformly labelled with [α-32P] UTP (3000 Ci / mmol, MP Biomedicals) 
and purified on a 15% denaturing polyacrylamide/urea gel. Before loading the sample 
was heated at 65oC for 15 min to denature any secondary structures and mixed with 
formamide loading dye. The transcript was ethanol precipitated and resuspended in 
TE buffer or the RNA storage solution (Ambion). The transcript concentration was too 
low to measure by the sample absorbance at 260 nM. 
CRISPR I: 519 bp
CRISPR II: 417 bp 165 bp 1 2 3 4
repeat
245 bp 1 2 3 4
Leader spacer
1 2T7 promoterCRISPR T7
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2.6.5 Sanger DNA sequencing
 The CycleReaderTM DNA Sequencing Kit (Fermentas) was used to sequence 
the amplified CRISPR locus fragments and map the transcription initiation site within 
the CRISPR leader sequence. This method is based on Sanger sequencing of the 
DNA template, where the polymerase-mediated synthesis of a new strand begins at 
the 3’ end of a primer annealed to the template DNA and is terminated by 
incorporation of dideoxynucleotides (ddNTPs), which cannot form subsequent 
phosphodiester 3‘ - 5‘ bonds as they lack the 3’ hydroxyl group. By performing four 
separate reactions with the four different ddNTPs, a population of DNA strands 
complementary to the template strand is generated with a fixed 5’ end and variable 3’ 
ends, covering the whole length of the template sequence. By comparing the length of 
the terminated strands with the original transcript produced by the same template, the 
native transcription initiation site can be determined. 
 20 - 60 fmol of the CRISPR locus construct II described in paragraph 2.6.3 was 
used as sequencing template (either as PCR fragment or linearized plasmid construct) 
and  20 pmoles of the reverse complement oligonucleotide for spacer 1 was used as a 
primer for the kit’s thermostable Taq DNA polymerase. The thermal sequencing 
reactions were carried out in a Techne TC-512 thermal cycler as described in the 
manufacturer’s manual using the direct label incorporation protocol, which enables the 
incorporation of [α-32P] dATP in the produced strands. Reaction products were 
analysed on a denaturing 15% PAA, 7 M urea gel. 
2.6.6 RNA alkaline hydrolysis ladder
 To generate a gel electrophoresis ladder of 
hydrolyzed RNA fragments 0.1-3 μg of end-labelled 
RNA were incubated in 50 mM [NaHCO3 / Na2Co3] pH 
9.2, 1 mM EDTA in a final volume of 10 μl, for 15 min at 
95oC. Samples were mixed with 2x formamide-based 
gel loading dye (95% formamide, 0.025% bromophenol 
blue, 0.025% xylene cyanol FF, 5 mM EDTA pH 8, 
0.025% SDS) and stored at -20oC. The RNA fragments 
generated with this reaction have the phosphate group 
attached to the 3’ hydroxyl group (figure 2.2). 
Figure 2.2: Mechanism of RNA hydrolysis under alkaline 
conditions 
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2.7 Sulfolobus solfataricus in vitro transcription
 To determine whether the leader sequence of CRISPR locus A contains a 
canonical promoter sequence that could be responsible for transcription in vivo, we 
performed in vitro transcription using the S. solfataricus  system components. The 
pCR2.1 TOPO vectors containing the CRISPR locus constructs described in 2.6.3 
were digested with HindIII (Fermentas) to produce linear DNA template for 
transcription. The reaction mix consisting of 100 ng linearised plasmid template, 2x 
transcription buffer (40 mM Tris-HCl pH 8, 20 mM MgCl2, 4mM DTT, 440 mM KCl), 40 
nM SsoRNApol, 80 nM SsoTFB-1, 80 nM SsoTBP, 300 nM BSA was incubated at 
70oC for 10 min to allow for the transcription initiation complex to form. The reaction 
was initiated with the addition of rNTPs (200 μM each) in a final reaction volume of 50 
μl and incubated for a further 20 min. The S. solfataricus  RNA polymerase, TFB-1 and 
TBP were kindly provided by Dr Sonia Paytubi. 
 The transcribed RNA was subsequently used as a template for a primer 
extension reaction. The primers used were complementary to the final spacer 
sequence of each cloned CRISPR fragment (CRISPR +252r, CRISPR+126r, see 
Appendix I) and were 5’ end labelled with [γ-32P] ATP. An appropriate volume of the 
transcription reaction and 300 fmol of the labelled reverse primer were incubated at 
70oC for 5 min to enable hybridisation with the RNA  transcript and chilled on ice. The 
primer extension reaction mix (5x Fermentas RevertAid H-Minus MMuLV RT buffer, 25 
mM dNTPs, 4u RNasin (Promega)) was added to the hybridised transcript and primer 
solution and incubated for 5 min at 37oC. 1 μl of RevertAid H-Minus MMuLV Reverse 
Transcriptase (Fermentas, 200 u/μl) were added and the reactions were incubated at 
42oC for 1 hour. The products were separated on a 20 % polyacrylamide / 7M urea 
gel, ran at 92W, 45oC for 90 min. The gel was exposed to a phosphoscreen overnight 
and then visualised by phosphorimaging on a a Fujifilm FLA500 scanner using 
ImageGauge software (Fuji).
2.8 Extraction of RNA from purified native aCASCADE
 Samples of aCASCADE purified from Sulfolobus  solfataricus  P2 cells were 
kindly provided by Dr Nathanael Lintner and Dr Martin Lawrence in Montana State 
University Bozeman. 20 μl samples of purified aCASCADE at 1-3 mg/ml 
concentrations were diluted with DEPC-treated water to 100 μl volume, to which 1 μl 
RNAsin and 100 μl phenol (Sigma) were added. After mixing the samples for 1 min by 
vortexing and centrifuging for 1 min at room temperature, the aqueous phase was 
transferred to a new eppendorf tube with 100 μl 24:1 (v/v) chloroform:isoamylalcohol 
(Sigma). The last step was repeated, and the aqueous phase was again transferred to 
a new eppendorf tube. Nucleic acids were precipitated for 1 hour at 80oC with 12 μl of 
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3 M sodium acetate and 250 μl 100% ethanol, centrifuged for 30 min at 4oC and the 
pellet washed with 75 % ethanol. Centrifugation was repeated and the pellet was air-
dried and resuspended overnight at 4oC in 10 μl DEPC-treated water. The extracted 
nucleic acids were labeled with [γ-32P] ATP as described in previous paragraphs and 
analysed on denaturing  20 % polyacrylamide, 7M urea gel, ran at 92W, 45oC for 90 
min. Gel was exposed to a phosphoscreen overnight and then visualised by 
phosphorimaging on a a Fujifilm FLA500 scanner using ImageGauge software (Fuji). 
2.9 Nucleic acid binding and catalytic assays 
2.9.1 Helicase assays
 Helicase activity assays for Cas3’ were carried out in 20 mM MES pH 6.5, 100 
mM potassium glutamate, 1 mM MgCl2, 1 mM ATP, 0.1 mg/ml BSA, 25 nM fluorescein 
or 32P-labelled duplex DNA or RNA substrate and over a protein concentration range 
of 20 nM to 250 nM. The reaction mix (minus ATP / MgCl2) was incubated at 37oC 
(unless otherwise stated) for 1 min and the reaction started with the addition of an 
ATP / MgCl2 mix to a final concentration of 1 mM. 10 μl samples were removed at 
appropriate time points and immediately added to 20 μl of chilled stop solution 
consisting of 10 mM Tris-HCl pH 8, 5 mM EDTA, 0.5% SDS, 1mg/ml Proteinase K, 5 
μM competitor DNA (unlabelled DNA complementary to the displaced strand to 
prevent reannealing). Samples were incubated at room temperature for 15 min to allow 
proteinase K digestion, mixed with 10% Ficoll and loaded onto a native 12% 
polyacrylamide:TBE gel. The gel was run at 150V for 2-3 hours and visualised by 
phosphorimaging on a Fujifilm FLA500 scanner. In the case of 32P-labelled substrates, 
the gels were first exposed to phosphoscreens overnight and then visualised by 
phosphorimaging. ImageGauge software (Fuji) was used to quantify the data and 
estimate the percentage of duplex unwinding  as the ratio of (unwound/total substrate) 
x100. KaleidaGraph software was used to plot the unwound (%) substrate over time. 
	 The following control reactions were prepared: i) without protein and ATP and 
incubated at the assay temperature to indicate substrate stability, ii) without protein 
and ATP and incubated at 95oC for 2min prior to cooling on ice to indicate substrate 
melting, iii) without ATP to show ATP activity dependance of the protein. 
2.9.2 Endonuclease assays
 Nuclease activity of Cas6 (and potential activity of Csa2) was assayed in 
reaction buffer (20 mM MES pH 6.0, 100 mM potassium glutamate, 0.5 mM DTT, 5 
mM EDTA) at 45°C or 60°C for 15-30 min with 1 µM recombinant protein and 100 nM 
synthetic RNA substrate or 1 μl crRNA transcript (unknown concentration). At 
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appropriate time points 10 μl aliquots were removed and treated with 0.1 mg 
Proteinase K for 15 min at room temperature. The samples were mixed with 10μl 
formamide loading dye, heated at 65oC for 5 min to denature secondary structures 
and the products were separated on 20 % polyacrylamide, 7M urea gels, ran at 92W, 
45oC for 90 min. Cleavage products visualized by phosphorimaging, as described in 
the previous paragraph and quantified with ImageGauge software. 
2.9.3 ATP hydrolysis reaction
 The Malachite Green Phosphate Assay Kit (BioAssay Systems) was used to 
characterize the ATP hydrolysis activity of Cas3’. A standard curve of free phosphate 
pmoles over OD620  was made with serial dilutions of K2PO3 as per the manufacturer’s 
instructions. Reactions were preformed in 20 mM MES pH 6.5, 100 mM potassium 
glutamate, 1 mM MgCl2, 1 mM ATP, 0.1mg/ml BSA, 2 μM protein and 2 μM nucleic 
acid substrates (unless otherwise stated). Reactions were incubated at 55°C for 1 min 
and initiated by the addition of 1 mM ATP / MgCl2. At appropriate time points 40 μl 
samples were removed and immediately added to 40 μl chilled 0.3M perchloric acid in 
a 96 well plate. Once all samples were collected, 20 μl malachite green solution were 
added to each sample and incubated at room temperature for 12 min. Absorbance at 
620 nM was measured on a SpectraMAX 250 Microplate Reader (Molecular Devices). 
All reactions were performed in triplicate. Appropriate control reactions without protein 
were performed and subtracted as background. The rate of ATP hydrolysis was 
plotted as pmoles of free phosphate over time with KaleidaGraph software. 
2.9.4 Electrophoretic Mobility Shift Assay (EMSA) 
	 To detect DNA or RNA binding by the CAS proteins gel mobility shift assays 
were performed, in which protein-nucleic acid complexes are observed as their rate of 
migration on native polyacrylamide gels is slower than for free oligonucleotides. 
 In the case of the Csa2-Cas5 complex, radiolabelled substrate (25 nM final 
concentration) was pre-incubated in binding buffer (20 mM MES pH 6.0, 50 mM 
potassium glutamate, 0.5 mM DTT, 5 mM EDTA, 5% glycerol and 100 nM unlabeled 
crRNA where indicated) at 55°C for 1 min and reactions were initiated by the addition 
of the Csa2/Cas5 complex at different concentrations between 250 nM - 5 μM. Where 
unlabeled crRNA was present, the protein was pre-incubated with the unlabeled RNA 
prior to the addition of the labeled substrate. Reactions were incubated at 55°C for 10 
min, mixed with 10% ficoll loading dye and separated on native 10% polyacrylamide 
gels at 120V for 3 hours. Results were visualised by phosphorimaging as described for 
helicase assays. 
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 To characterize the DNA binding abilities of the recombinant CMR complex 
subunits, serial dilutions of the proteins were incubated in 50 mM Tris-HCl pH 8, 100 
mM KCl, 5 mM MgCl2, 1 mM DTT at 37°C or 50°C for 20 min with 1 μM labelled DNA 
or RNA substrate. Samples were mixed with 10% ficoll loading dye, separated on 
native 8% polyacrylamide gels at 120V for 2-3 hours and visualised by 
phosphorimaging. 
2.9.5 Strand annealing and strand exchange assays 
 Strand annealing reactions for Cas3’ were carried out in 20 mM MES pH 6.5, 
100 mM potassium glutamate, 1 mM MgCl2, 0.1 μl RNAsin (RNAse inhibitor, Ambion 
Biosciences), 10 nM individually purified, 25 nt DNA or RNA strands and 1 μΜ protein. 
Only one of the strands was 5’ fluorescein-labeled. The protein was incubated with the 
first strand at 37oC for 3 min, and the second strand was added to initial the reaction. 
At indicated time points, 10 μl samples were removed and added to 15 μl chilled stop 
solution consisting of 10 mM Tris-HCl pH 8, 5 mM EDTA, 0.5% SDS, 1 mg/ml 
Proteinase K, 5 μM competitor DNA (unlabelled DNA complementary to the unlabelled 
strand to prevent reannealing). Samples were incubated at room temperature for 15 
min to allow proteinase K digestion, mixed with 10% Ficoll and loaded onto a native 
12% polyacrylamide:TBE gel. The gel was run at 150V for 2-3 hours and visualised by 
phosphorimaging on a Fujifilm FLA500 scanner.
 For strand exchange reactions, 500 nM of protein were incubated with 50 nM 
unlabelled single strand substrate in 20 mM MES pH 6.5, 100 mM potassium 
glutamate, 1 mM MgCl2, 50 mM NaCl, 0.1 μl RNAsin for 3 min at 37oC or 30oC as 
indicated. Reactions were initiated with the addition of 30 nM labelled double strand 
substrate and 1 mM ATP where indicated. At specific time points, 10 μl samples were 
removed, added to 15 μl chilled stop solution (10 mM Tris-HCl pH 8, 5 mM EDTA, 
0.5% SDS, 1 mg/ml Proteinase K) and processed as in annealing reactions. 
Substrates were designed so that initial and product double strand species would be 
different in size. 
2.9.6 R-loop formation assay
 To investigate whether Cas3’ would promote invasion of a ssRNA into a 
complementary dsDNA substrate to form an R-loop, the following reactions were 
carried out. 5 μΜ of Cas3’’’ were incubated with 200 ng supercoiled pET151/D-TOPO 
plasmid containing a 25 bp protospacer region in 20 mM MES pH 6.5, 100 mM 
potassium glutamate, 0.1 μl RNAsin, 0.5 mM DTT at 55oC for 5 min. To initiate the 
reaction, 1 μΜ of 5’ [32P]-end labelled ssRNA containing a complementary spacer 
region was added to a final reaction volume of 10 μl. After 1 hr incubation at 55oC, 
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reactions were added to 15 μl chilled stop solution (10 mM Tris-HCl pH 8, 5 mM EDTA, 
0.5% SDS, 1 mg/ml Proteinase K) and incubated at 37oC for 15 min to allow for 
Proteinase K digestion. 2 μl of loading dye (60 % glycerol, 0.25 % bromophenol blue, 
0.25 % xylene cyanol) were added to the reactions and products were analysed by 
electrophoresis on a 0.8 % agarose-TBE gel at 90 V for 3 hrs . Gels were visualised by 
EtBr staining/ UV imaging and phosphorimaging. Reactions were also carried out in 
the presence of 5 μM recombinant or native Csa2-Cas5a complex and 1 mM ATP / 
MgCl2  (added at the reaction initiation stage) where indicated. 
CHAPTER 2: MATERIALS AND METHODS
61
CHAPTER 2: MATERIALS AND METHODS
62
Chapter 3
The CMR complex from Sulfolobus 
solfataricus: native isolation and 
recombinant components
3.1 Introduction
3.1.1 The Repeat-Associated Mysterious Proteins (RAMPs)
 A distinct set of CAS proteins belong to the superfamily of Repeat-Associated 
Mysterious Proteins (hereafter referred to as RAMPs), as identified by Makarova et al. 
in 2002. The discovery of this superfamily ensued initially as a result of the sequence 
analysis and secondary structure prediction of proteins from COGs 1336, 1367, 1604, 
1337, 1332 that were associated with what was then thought to be a novel prokaryotic 
DNA repair system. Members of this superfamily show extremely weak sequence 
conservation but appear to share the same fold, a fact which was confirmed when the 
first CMR protein structures were solved (discussed later). Five specific structural 
motifs were identified by multiple alignment of members of this superfamily, including 
a β-strand followed by a conserved glycine near the N-terminus (motif I), a loop 
followed by an α-helix (motif II) and a C-terminal glycine-rich loop (motif V) (figure 3.1) 
(Makarova et al, 2002). Subsequent analysis and identification of more RAMP protein 
families revealed that this is the most diverse and over-represented CRISPR-
associated superfamily, with representatives found in all CAS subtypes.
	 The RAMP protein structures solved to date happen to be also the processing 
endonucleases of various CRISPR/CAS subtypes, which process the CRISPR RNA 
transcripts into the small crRNA effector sequences that perform the invader silencing. 
The first structure to be solved by x-ray crystallography was the CAS protein TTHB192 
from Thermus  thermophilus  HB8 (CasE/Cse3/Cas6e homolog, YgcH-like family, Ecoli 
subtype, Ebihara et al. 2006).
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Figure 3.1: Conserved RAMP superfamily motifs and individual RAMP families
Adapted from Makarova et al. (2006). h: hydrophobic residue, p: polar residue, t: residue with 
high turn-forming propensity, +: positively charged residue.
 The structure contained a double ferredoxin-like fold with the signature 
βαββαβ secondary structure arrangement in each domain, and an RRM motif formed 
from the basic surface of the four-stranded β-sheet. The conserved Gly-rich loop was 
inserted between the last α-helix and β-strand of the polypeptide chain (figure 3.2). 
These domains are generally associated with RNA-binding proteins (e.g. ribosomal 
proteins S6 and S10, spliceosome subunits) (Maris et al. 2005). This fact, along with 
the results of various structure similarity search programs, led Makarova et al. (2006) 
to speculate that RAMPs function as RNA-binding proteins specializing in crRNA 
fragments of different sizes, and could form hetero-oligomeric complexes, analogous 
to the RNA-binding proteins of the eukaryotic RISCs implicated in the eukaryotic 
RNAi. 
A B
Figure 3.2: Crystal structure of Tthb192 - CasE/Cse3 homologue 
(A) Ribbon diagram of the Tthb192 structure, adapted from Ebihara et al. (2008). α-helices  are 
colored in green, β-strands  in orange and numbered from the N to the C-terminus. The N and 
C termini are labeled, and the G-rich loop is  highlighted in red. (B) Electrostatic surface 
potential illustrating the conserved basic patch on the β-sheet platform of the protein. Blue 
shaded areas indicate the positively charged regions (+20kBT) and red areas  the negatively 
charged regions (-20kBT).
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	 Subsequent crystal structures of RAMP proteins such as Cas6 from 
Pyrococcus  furiosus  (PfuCas6, Carte et al. 2008; Carte et al. 2010; Wang et al. 2011) 
and Csy4 from Pseudomonas  aeruginosa (Haurwitz et al. 2010) revealed the 
ferredoxin-like folds and RRM motifs that seem to be characteristic of this superfamily, 
although their sequence identity is below 10%. While this seems to suggest a similar 
mechanism for RNA processing, biochemical and structural studies of these proteins 
along with co-crystals obtained with crRNA sequences from the respective organisms 
illustrated the distinct recognition and catalytic mechanisms these proteins employ in 
vivo (discussed in chapter 1). This is to be expected, considering the different 
CRISPR/CAS subtypes the proteins belong to and the different properties of the 
CRISPR repeats they encounter. Cas6 is associated with subtypes I-A, I-B, I-D, III-A, 
III-B  while Csy4 with subtype I-F (Makarova et al. 2011a). All three proteins use distinct 
sequence and structure-specific recognition mechanisms to discriminate their 
respective substrates, illustrating the versatility of the characteristic duplicate 
ferredoxin-like fold in RAMPs and providing a mechanistic illustration of the 
coevolution of CRISPR repeat sequences and Cas proteins (Shah et al. 2010).
	 Recently, Makarova and colleagues (2011b) proposed the expansion of the 
RAMP superfamily family and its reorganization into three main groups, Cas5, Cas6 
and Cas7, based on secondary and tertiary structure similarity scores and sequence 
conservation (HMM motifs). A single or tandem RRM motifs are found or predicted in 
families belonging to all three groups, but the characteristic G-rich loop is present in 
all families except from the Cas7 family (Makarova et al. 2011b)
3.1.2 The CRISPR-RAMP module (CMR)
 Genes belonging to the RAMP superfamily from COGs 1769, 1336, 1367, 
1604, 1337, 1332, 1567, 1583 along with genes from COGs 1353, 3337 typically form 
a cluster of six genes (cmr1-6) with conserved order, which was termed the CRISPR 
RAMP module (cmr) by Haft and colleagues (2005). This module exists in genomes in 
combination with other CRISPR subtypes, either physically linked or not, and is over-
represented in thermophilic archaea and bacteria. The same operon was termed 
“polymerase-cassette module” by Makarova et al. in 2006, because the core 
COG1353 gene contains characteristic palm-domain RNA or DNA polymerase motifs 
(discussed later). Phylogenetic and comparative genomic analyses revealed that the 
Cmr gene cluster operates as a single genetic element and co-segregates during 
horizontal gene transfer events, which strongly supported the fact that these proteins 
would interact. Distinct hidden Markov models (HMMs) have been built for each 
protein family and deposited in the TIGRFAMs database (Haft et al.2005). In a recent 
review of the various classification and nomenclature systems of the CRISPR/CAS, 
Makarova et al. (2011) proposed a new “polythetic” classification system in which the 
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polymerase-RAMP module proteins belong to the Type III CRISPR/Cas system. In 
combination  with Cas1-Cas2, this system is predicted to be able to carry out both the 
adaptation and interference functions of the CRISPR/Cas.  
 The main component of the CMR module is the multidomain protein of 
COG1353 (Cas10). Among the identified domains is a permuted HD-superfamily 
hydrolase near the N-terminus, a globular uncharacterised α+β domain, a Zinc-ribbon 
(well-known nucleic acid interacting domain) and the core palm domain of DNA/RNA 
polymerases and nucleotide cyclases near the C-terminus. Sequence analysis and 
structure threading revealed that this core fold domain is found in reverse 
transcriptases, viral RNA polymerases, superfamily A & B  DNA polymerases, signal-
transducing adenylyl and nucleotide cyclases (termed the GGDEF domain). The 
conserved motifs within the extended similarity region contain several acidic residues 
(usually aspartates) which function as metal-coordinators in the active sites of 
polymerases, as well as an RRM fold motif. The co-existence of these domains and 
the analysis performed by Makarova et al. (2002) led to the suggestion that these 
proteins function as novel polymerases, with the N-terminal HD domains functioning 
either as pyrophosphatases in the context of the polymerisation reaction or as 
accessory nucleases.
 The structure of Cmr5, the second CMR protein component not belonging to 
the RAMP superfamily has been solved from Thermus  thermophilus  HB8 (Tthb164, 
PDB: 2ZOP) (Sakamoto et al. 2008) and Archaeoglobus fulgidus  DSM 4304 (Afu1862, 
PDB: 2OEB). The protein monomers in both cases are composed of six α-helices 
arranged in a barrel-like fold, with the assymetric unit of TthCmr5 occupied by a 
homotrimer. The trimer surfaces present an asymmetric charge distribution, with one 
almost uniformly basic surface and discontinuous acidic patches on the opposite side. 
Within the Cmr complex, these charged surfaces could function either as protein-
interaction or RNA binding platforms. Secondary and tertiary structure prediction 
programs such as Phyre (Kelley and Sternberg, 2009) reveal that SsoCmr5 (Sso1988) 
can be modeled with an estimated precision of 100% onto the structure of AfuCmr5 
(Afu1862). In figure 3.3  we can observe that the whole sequence of Sso1988 can be 
threaded onto the AfuCmr5 structure, with the only outlier being an extended loop 
between residues 59-73.  
	 Phylogenetic analysis of archaeal Cas10 homologues revealed that the type III 
systems (often referred to as Cmr modules in the literature) in archaea can be 
classified into five families A, B, C, D and E (Garrett et al. 2011). Subtype III-B Cmr2 
family members are distributed into families B  and C, subtype III-A Csm1 family 
representatives compose families D and E, while Csx11 family members which are 
part of yet unclassified type III systems form family A. In Sulfolobus  solfataricus, we 
encounter two complete CMR gene clusters. The first consists of genes sso1424-
CHAPTER 3: THE SsoCMR COMPLEX
66
sso1432, is located between CRISPR loci B and C, and belongs to family D, indicating 
that this is probably a type III-A system. The second consists of genes sso1986-
sso1992, is adjacent to CRISPR locus F and belongs to family B, classifying it as a 
type III-B  system. The gene organization can be seen in figure 3.4.  Two partial 
clusters are located between CRISR loci C and D, consisting of genes sso1514-
sso1510 and sso1725-sso1730 (without sso1728, which is a transposase), but since 
they lack the full set of Cmr protein components, they are considered inactive. The 
operons of type III systems present in Sulfolobus  solfataricus  do not contain the cas1-
cas2 gene pair. However, they most likely interact in  trans  with the cas1 and cas2 
genes that are part of type I-A systems also  present in the genome.
Figure 3.3: Crystal structures of Cmr5 
Ribbon diagrams and electrostatic surface representations  of (A) trimeric TthCmr5 (adapted 
from Sakamoto et al. 2009) and (B) monomeric AfuCmr5. (C) Superimposition of the SsoCmr5 
model generated by PHYRE (green) and the AfuCmr5 (red), where we can observe the 
extended loop region.
180o
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Figure 3.4: Gene organisation of the type III systems in S. solfataricus
Orthologous genes  are colour-coded according to the Cas  family key. The genes were 
assigned to their respective family according to their COG and their TIGR family (Makarova et 
al. 2011a,b). RAMP families are indicated by a black border. Genes belonging to the RAMP 
superfamily but not assigned to a specific family, or their classification is unresolved are 
coloured in light red.  
	
 Sequence analysis of the Cmr2/Cas10 protein Sso1991 (Cmr family B) reveals 
the conserved HD nuclease motif in the N-terminus (H15, D16), the conserved four 
cysteine residues (C466, C469, C514, C517) comprising the Zn-coordination domain 
(Zn-ribbon) and the “GGDEF” domain shared by polymerases and adenylyl cyclases 
(YAGGDDLL sequence, a.a.806-811) near the C-terminus. The domain organization of 
the protein can be seen in figure 3.5. Multiple sequence alignments illustrating the 
conservation of the functional motifs can be found in Appendix II. The COG1353 
protein of the Cmr family D operon appears split in two in the annotated genome: 
Sso1428 and Sso1429, most likely due to misannotation. Nonetheless, sequence 
analysis reveals the presence of all three of the catalytic motifs, with the HD nuclease 
and Zn-ribbon motif in the N-terminus (Sso1428 sequence) and the predicted 
polymerase palm domain in the C-terminus (Sso1429 sequence). The third Cmr2 
homologue in the genome, Sso1729, lacks the HD nuclease motif and the third 
cysteine which would coordinate the Zinc molecule in the Zn-ribbon motif. Although 
the “GGDEF” motif is intact, it would be reasonable to assume that this protein is 
inactive, which correlates with the degeneration of this Cmr cluster.  
C 1045
15aa 460aa 810aa
HD nuclease 
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Figure 3.5: Domain organisation of SsoCmr2 (Sso1991), indicating the location of the 
conserved potential active sites on the sequence.
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	 In this chapter we describe the isolation of the native Cmr family B  complex 
from Sulfolobus  solfataricus  cell lysate, as well as our attempts to reconstruct the 
complex in vitro by recombinant expression of its individual components. Initial 
functional characterisation experiments were based on the bioinformatics predictions 
and mechanistic models and hypotheses about the CRISPR outlined in the relevant 
literature until the first half of 2008.
Gene 
annotation
CAS name COG TIGRfam Protein 
length 
(aa)
MW 
(kD)
pI Notes
sso1986 cmr7 _ 197 22.2 7.08
sso1987 cmr4 1336 TIGR02580 307 34.4 5.44 RAMP
sso1988 cmr5 3337 TIGR01881 156 18.2 8.66 Structure of 
homologue 
available
sso1989 cmr1 1367 TIGR01894 467 54.9 8.32 RAMP
sso1990 cmr6 1604 TIGR01898 284 32.5 8.8 RAMP
sso1991 cmr2/cas10 1353 TIGR02577 1045 121.69 7.95 HD domain, Zn-
ribbon, palm 
domain
sso1992 cmr3 1769 TIGR01888 314 36.19 5.68 RAMP
Table 3.1: The Cmr family B cluster in S. solfataricus. 
3.2 Expression and purification of recombinant Cmr7 
	 The gene encoding Cmr7 (sso1986) was amplified by PCR from S. solfataricus  
genomic DNA and successfully cloned into the pEHISTEV vector to enable expression 
of the recombinant protein with an N-terminal polyhistidine tag. The construct was 
sequenced to verify its integrity and lack of mutations  and transformed into the E. coli 
expression host strain BL21 (DE3). Protein was expressed as described in chapter 2 
and purified to homogeneity with a two-step purification scheme which included 
affinity (nickel-chelating) and size-exclusion chromatography, from which it eluted as a 
monomer. The N-terminal polyhistidine tag was cleaved by incubation with the TEV 
protease overnight at room temperature, as described in Materials and Methods. 
Protein identity was confirmed by mass spectrometry.  
 The expression levels of recombinant Cmr7 were very high and the protein was 
highly soluble with only a minimum amount of the total expressed protein lost in the 
insoluble cell fraction, as illustrated in figure 3.6. This can be attributed to aggregation 
due to the high amounts of the expressed protein in the cell. The protein was purified 
to homogeneity with a final recovery of 14 mg protein per litre of culture, 1 mg of 
which was used for the production of polyclonal sheep antibodies. The outcome of 
each purification step can be seen in figure 3.6. The proteins’ estimated molecular 
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weight from SDS-PAGE analysis is in agreement with the calculated molecular weight 
of 22,151 Da. The protein eluted as a single monodispersed peak from gel filtration 
chromatography, which is a prerequisite to continue with crystallographic studies of 
the protein. 
Figure 3.6: Purification of Cmr7
Purification stages  monitored by SDS-PAGE. Lanes (A): M, protein size marker; 1, whole cell 
extract; 2, insoluble fraction; 3, soluble fraction; 4, flow-through; 5, wash; 6-7, Cmr7 elution 
from first Ni-affinity column; 8, protein sample after TEV cleavage; Dashed line indicates  non- 
contiguous  lanes in gel (B): M, protein size marker;  1-2,  flow-through from second Ni-affinity 
column containing cleaved Cmr7; 3-8 peak fractions from gel filtration column containing pure 
Cmr7. ( C): Chromatogram of Cmr7 purification by gel filtration chromatography.
3.3 Crystallographic study of Cmr7
3.3.1 Crystallisation and structure solution of Cmr7
	 The crystallisation and structure solution of Cmr7 was carried out in 
collaboration with the SSPF (Oke et al. 2011). The Pre-Crystallisation Test (Hampton 
Research) for Cmr7 indicated that the optimal concentration for crystallisation screens 
was 10 mg/ml. The Classics and JCSG crystal screens were set up manually as 
described in chapter 2 and after 3 days microcrystals were observed in 1 M lithium 
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chloride, 0.1 M trisodium citrate pH 4 and 20 % PEG 6000 (JCSG). Stochastic 
optimisation screens were designed around this condition with the assistance of Dr 
Kenneth Johnson, varying the following parameters: the precipitant type and 
concentration (PEG 4000, 6000, 8000), the salt (LiCl, LiS) and its concentration, the 
buffer pH (pH 4, 4.5, 5), the concentration of additives such as glycerol and ethylene 
glycol and the protein concentration (10 mg/ml, 5 mg/ml) in order to enable the 
formation of single, well-ordered crystals by delaying nucleation.  
 The growth of small, bipyramidal crystals was observed in 10mg/ml protein, 
19.2% PEG 6000, 0.1 M sodium citrate pH 4, 0.93 M LiCl and 9.5 % ethylene glycol 
(figure 3.7). Crystals were cryo-protected in 21.0 % PEG 6000, 0.1 M Na-Citrate pH 
4.0, 0.5 M LiCl, 25 % ethylene glycol, frozen in liquid nitrogen and sent to the 
European Synchrotron Radiation Facility (ESRF, Grenoble) for diffraction data 
collection. Crystals for SAD phasing were soaked in 200 mM Me3PbCl, 500 mM 
K2OsO4 and 200 mM K2OsCl6.  The collected dataset had a resolution of 2.05 Å and 
the structure was solved and refined by the SSPF as described in Oke et al. (2010). 
The final structure coordinates and refinement statistics have been deposited in the 
protein data bank with accession code 2X5Q.
Figure 3.7 : Crystals of Cmr7, grown under
 the conditions mentioned in the text
3.3.2 Structure of Cmr7
 Two monomers of Cmr7 (Sso1986) were found in the asymmetric unit of the 
crystal, suggesting that the protein is a dimer. The final model consists of 184 amino 
acid residues, arranged in 4 α-helices and 15 β-strands. Residues 1-7 and 125-131 
are missing from the final model as the electron density was not defined. The structure 
of the Cmr7 protomer reveals a two-domain α+β architecture, with a small helical 
domain connected to a larger all-β domain. The latter is comprised by three twisted 
antiparallel β-sheets, formed by strands β2-β3-β4-β10 (sheet 1), β8-β9-β16-β15 
(sheet 2) and β1-β10-β7 (sheet 3), while the β5-β6 hairpin interacts with the helical 
bundle formed by α2-α4 (figure 3.8 A, C). Two monomers interact via the β-sheet 
domains to form the dimer (figure 3.9 A). The electrostatic surface calculations by the 
APBS software package (Baker et al. 2001) reveal a positive surface wrapping around 
the protein, and a smaller region of negative charge concentrated on one side, in what 
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appears to be a small “tunnel” (figure 3.8 B). The two monomers exhibit slight 
structural variation, indicating a certain degree of conformational flexibility. 
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Figure 3.8: Structure of the Cmr7 monomer
(A) Cartoon diagram of the Cmr7 monomer. The 
secondary structure elements are numbered as in 
(C) Figures generated with MacPymol. (B) 
Electrostatic surface of the Cmr7 monomer 
generated with APBS tools, oriented as  in (A). (C) 
Topology diagram of Cmr7, illustrating the 
connectivity of the various  secondary structure 
elements. 
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Figure 3.9: Cmr7 dimer and conserved surfaces
(A) Cartoon diagram of the Cmr7 dimer. The two chains are colored in orange-red (chain A) and 
blue-green (chain B). (B) Surface representation of the Cmr7 dimer illustrating the location of 
conserved residues (red). Orientation as in (A). 
 Structural similarity searches using DALI (Holm and Rosenstrom, 2010) did not 
reveal any significant structural neighbours, indicating that it is a novel fold. This was 
expected since previous sequence analysis failed to detect any conserved motifs or 
classify this sequence to any known protein family, and located homologues of Cmr7 
only in Sulfolobales. A series of residues forming the first half of strand β10 seem to 
be strictly conserved among all Cmr7 homologues, which along with a conserved Arg-
Lys pair seem to cluster on the positive surface side of the molecule (figure 3.9 B). No 
functional predictions can be made for this Cmr subunit at this point. 
3.4 Expression and purification of recombinant Cmr4
	 The gene encoding Cmr4 (sso1987) was amplified by PCR and cloned into the 
pDEST14 expression vector as described in Materials and Methods in order to enable 
N-histidine-tagged protein expression. The construct was fully sequenced to verify the 
absence of mutations and protein was expressed in E. coli C43 (DE3) as described in 
Materials and Methods. Purification involved affinity (nickel-chelating) 
chromatography, TEV cleavage of the polyhistidine tag and a final polishing step with 
size exclusion chromatography (figure 3.10). The protein identity was confirmed by 
mass spectrometry. All steps were carried out on ice due to protein precipitation at 
elevated temperatures. 
 Protein expression levels were moderate and a significant portion of the 
expressed protein was found in the insoluble fraction. One possible explanation is 
inadequate cell lysis, but a more probable one is that the protein would require its 
physiological partners to enhance its stability and solubility in solution. Typical yields 
ranged from 0.19 - 0.26  mg/L of culture, with predictable losses during concentration 
A B
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and chromatography steps. The calculated molecular weight of the protein as 
confirmed on SDS-PAGE is 34.7 kDa. Analytical gel filtration performed on a 
Superdex 200 10-300 column (GE Healthcare) by the SSPF indicated that the Cmr4 
migrated as a trimer in 150 mM NaCl, although this is not necessarily the protein’s 
oligomeric state within the Cmr complex. 
Figure 3.10: Purification of Cmr4
(A): Stages  of purification on SDS-PAGE. 1, insoluble cell fraction; 2, soluble cell fraction; 3, 
Cmr4 eluting from first nickel-chelating affinity chromatography; 4-6, peak fractions from gel 
filtration chromatography; 7, sample before TEV cleavage of six-histidine tag; 8, pure Cmr4 
after TEV cleavage; M, protein size marker. Dashed lines indicate non-contiguous  lanes in 
different gels. (B) Chromatogram of Cmr4 purification by gel filtration chromatography.
3.5 Expression and purification of recombinant Cmr1 
	 The S. solfataricus  cmr1 gene (sso1989) was PCR amplified and cloned into 
the pDEST14 expression vector as described in Materials and Methods. The construct 
was sequenced to confirm it was free of base pair mutations and protein was 
expressed in host E. coli strain C43 (DE3). The protein was purified by a two-step 
purification scheme, consisting of affinity (nickel-chelating) and size exclusion 
chromatography. After the first affinity column, the protein-containing sample was 
subjected to a 2 hour incubation with TEV protease at room temperature and passed 
through a second affinity column in order to separate tagged from untagged protein. 
Protein identity was verified by mass spectrometry. The protein-containing samples 
were kept on ice due to protein instability at higher temperatures. An overview of the 
purification can be seen in figure 3.11. 
 Expression levels were moderate with a final yield of 0.4 -1 mg/L culture. Only 
a fraction of the total expressed protein was soluble, a situation to be expected as the 
Cmr proteins in vivo form part of a larger complex and would not be expressed on 
their own. The observed molecular weight of Cmr1 on SDS-PAGE analysis confirmed 
the calculated molecular weight of 54.8 kDa. The protein migrated as a monomer 
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during analytical gel filtration performed by the SSPF on a Superdex 200 10-300 
column, but as explained for Cmr4 this does not necessarily reflect the protein’s state 
within the Cmr complex.
Figure 3.11: Purification of Cmr1
Purification stages  monitored by SDS-PAGE. Lanes (A): 1, whole cell extract; 2, soluble 
fraction; 3, Cmr1 elution from first Ni-affinity column; 4, protein sample after TEV cleavage; M, 
protein size marker; (B): 1, flow-through from second Ni-affinity column containing cleaved 
Cmr1; 2-7 peak fractions from gel filtration column containing pure Cmr1; M, protein size 
marker. Dashed lines indicate non-contiguous lanes in different gels. (C): Chromatogram of 
Cmr1 purification by gel filtration chromatography.
3.6 Protein interactions between recombinant CMR components
	  With the addition of recombinant Cmr3 (Sso1992), expressed and purified by 
the SSPF, all the aforementioned recombinant Cmr proteins were obtained in both 
tagged and untagged form. This enabled them to be assayed in pairs for in vitro 
interaction using Ni-NTA magnetic agarose beads as described in Materials and 
Methods (figure 3.12). This approach would enable us to study the topography of the 
native CMR protein complex by reconstituting the pairwise interactions involved. 
 The following combinations were tested: 
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• His-tagged Cmr3 with Cmr7 (figure 3.13 B)
• His-tagged Cmr3 with Cmr4 (figure 3.13 B)
• His-tagged Cmr3 with Cmr1
• His-tagged Cmr1 with Cmr7 (figure 3.13 A)
• His-tagged Cmr1 with Cmr4 (figure 3.13 A)
• His-tagged Cmr3 with Cmr1, Cmr4 and Cmr7 combined (figure 3.13 C)
 Tagged proteins were bound to the nickel-loaded beads and then incubated 
for 1 hour at room temperature with the appropriate partner. After thorough washing at 
low salt (100 mM NaCl) and imidazole (10 mM) concentrations the bound proteins 
were eluted from the beads with 500 mM NaCl, 500 mM imidazole and analysed on 
SDS-PAGE. Appropriate controls were carried out to test for binding of the untagged 
proteins to the magnetic beads. Of all pairs tested, only Cmr1 and Cmr3 were found in 
the eluate fraction, indicating a direct physical interaction, although the stoichiometry 
of the interaction cannot be determined from such a qualitative experiment. Whether 
the formation of this complex would provide an initial scaffold for the binding of the 
Cmr4 and Cmr7 was tested in the last experiment (figure 3.13 C), where all the 
available recombinant proteins were pre-incubated for 1hr at room temperature prior 
to binding to the nickel-coated beads. In all experiments, the amount of each protein 
was kept at 7.5 μg, which was the maximum bead capacity. 
flow-
through 1 
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non-interacting 
partner
flow-through 
2 (FT2)
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Figure 3.12: Experimental setup for detecting protein-protein interactions using Ni-loaded 
magnetic beads
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Figure 3.13: Interactions between recombinant Cmr subunits
(A) Pairwise interactions between his-tagged Cmr1/native Cmr4 (first 6 lanes) and his-tagged 
Cmr1/native Cmr7 (last 6 lanes). The collected fractions are labelled as  (FT1), flow-through 
after the his-tagged protein was added to the beads; (FT2) flow-through after the interacting 
partner was  added; (W1-2) washes  with increasing imidazole concentration; (E) elution with 
500mM imidazole; (M) protein size marker.
(B) Pairwise interactions between his-tagged Cmr3/native Cmr7 (first 6 lanes) and his-tagged 
Cmr3/native Cmr4 (last 6 lanes). Fractions labelled as  for (A). No interactions  were observed in 
either combination. 
(C) Interaction between his-tagged Cmr3 and native Cmr1, Cmr4 and Cmr7, combined. 
Proteins  were added sequentially and the fractions are labelled as (FT1), flow-through after the 
his-tagged protein was added to the beads; (FT2) flow-through after addition of Cmr1; (FT3) 
flow-through after addition of Cmr4; (FT4) flow-through after addition of Cmr7; (W1-3) washes 
of increasing NaCl and imidazole concentration; (E) elution with 500 mM NaCl and imidazole; 
(M) protein size marker.  Cmr1 and Cmr3 are clearly shown to interact. 
(D) Repetition of the experiment depicted in (C) investigating the effect of temperature and 
CRISPR DNA on the interaction. An identical image was obtained with the same experiments in 
the absence of CRISPR DNA. Fractions labelled as before with the addition of (B), sample 
incubated at 90oC in SDS-PAGE loading buffer. Interaction between Cmr1 and Cmr3 is  clearly 
observed in lane (B) at 37oC and 50oC.
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 No additional interactions were observed under the conditions tested, 
suggesting that other subunits and possibly appropriate CRISPR-related nucleic acid 
fragments play a structural role. Moreover, temperature-related conformational 
changes could facilitate interactions, considering that the physiological temperature 
range for S. solfataricus  is 70oC - 80oC. In order to investigate these possibilities, the 
experiment was repeated in the presence of CRISPR DNA sequences (CRISPR locus 
construct I, see Appendix I) and in three different temperatures (room temperature 
~21oC, 37oC and 50oC). In the assay depicted in figure 3.13 D, 50 ng of CRISPR DNA 
were added to a 25 μl protein mixture of his-tagged Cmr3 and non-tagged Cmr1, 
Cmr4, and Cmr7 (7.5 μg of each) and incubated for 30 min at different temperatures. 
The protein mixture was then added to the nickel-coated beads and processed as 
described in Materials and Methods. The presence of CRISPR DNA did not seem to 
mediate additional interactions between the Cmr subunits, although the already 
observed interaction between Cmr1 and Cmr3 became more pronounced at elevated 
temperatures compared to room temperature. A small amount of Cmr7 seems to be 
carried over the elution fractions at 50oC but it was not considered significant as the 
majority of the protein was found in the flow-through.
 3.7 Nucleic acid binding by recombinant CMR proteins
	 To assess the nucleic acid binding capabilities of the recombinant CMR 
proteins we performed gel mobility shift assays with various DNA or RNA substrates. 
In order to determine whether the protein exhibits sequence specificity, RNA 
oligonucleotides corresponding to the CRISPR repeat sequences of the CRISPR loci 
of S. solfataricus  were incubated with serial dilutions of the proteins at room 
temperature or 50oC prior to separation by native polyacrylamide gel electrophoresis. 
The substrates also included unspecific (20-mer and 45-mer ss/ds poly-T/AT DNA, 20-
mer poly-U RNA) sequences to investigate unspecific nucleic acid binding capacity. 
All the substrate sequences can be found in chapter 2, paragraph 2.6.1. 
Representative gels from multiple experiments are shown in figure 3.14. 
	 Only Cmr1 was clearly shown to bind single strand unspecific and CRISPR 
repeat RNA when left to interact for 20 min at 37oC, as illustrated in figure 3.14, third 
column, rows C & D. A preference for CRISPR-related RNA is observed which could 
be attributed to a theoretical secondary structure adopted by the RNA fragment, 
although an apparent dissociation constant (KD) could not be estimated as the protein 
could not be purified at a high enough concentration to bind all the available substrate 
and cause a complete shift on the gel. It was also investigated whether the interaction 
between Cmr1 and Cmr3 could alter the RNA binding ability of Cmr1 or whether the 
presence of the other recombinant CMR proteins (Cmr4 and Cmr7) also had an effect. 
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None of these approaches resulted in an observable change in the binding ability of 
Cmr1 (figure 3.15). 
	 None of the other recombinant Cmr proteins exhibited nucleic acid binding 
capacities with the substrates and under the conditions tested here. Results from this 
EMSA studies should not be considered definitive, as there are many limitations. They 
fail to detect transient and dynamic protein interactions, as non-stable protein-DNA 
complexes dissociate while migrating through the gel matrix. This could lead to 
underestimation of the apparent Kd or non-detection of the interaction.
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Figure 3.14: Electrophoretic Mobility Shift Assays investigating the binding affinity of 
recombinant Cmr proteins to various  nucleic acid substrates, carried out in collaboration with 
Paul Talbot. 
Reactions  are organised in rows  according to substrate: (A) 20-mer poly-T ssDNA; (B) 45-mer 
polyAT dsDNA; (C) 20mer-poly-U ssRNA; (D) 25mer CRISPR_F ssRNA; and in columns 
according to the protein tested. In each assay two-fold serial dilutions of protein were 
incubated with 1 μM of fluorescein-labelled substrate for 20 min at 37oC. Initial concentrations 
are indicated in the top left corner of each panel. Concentrations for each protein are from 
highest to lowest, in μM: Cmr7: 451, 225.5, 112.75, 56.37, 28, 14, 7, 3.5; Cmr4: 28.8, 14.4, 7.2, 
3.6, 1.8, 0.9, 0.45, 0.225; Cmr1: 18.25, 9.125, 4.56, 2.28, 1.14, 0.57, 0.285, 0.142; Cmr3: 25.6, 
12.8, 6.4, 3.2, 1.6, 0.8, 0.4, 0.2. In the third gel of rows C and D we can observe a shift in the 
highest concentrations as a result of binding of Cmr1 to ssRNA.
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Figure 3.15: Effect of Cmr3 on Cmr1 RNA binding. 
In lanes 1-4, serial dilutions of Cmr1 (in μΜ: 9.125, 4.5, 
2.3, 1.14) were incubated with 1μΜ of CRISPR_F ssRNA 
for 20 min at 37oC. In lanes 5-6, equimolar amounts  of 
Cmr3 were added to each reaction.  No change in the 
binding affinity was observed.
3.8 Isolation of the native CMR complex from Sulfolobus solfataricus
3.8.1 Antibody assisted purification of the SsoCMR complex
	 A purification scheme based on the structural stability, size and 
physicochemical properties of the complex was designed, including four successive 
chromatographic steps and antibody-assisted identification of the complex after each 
step. The experimental procedure described here was further optimized in the lab by 
Paul Talbot to produce a higher yield and a high purity sample of the SsoCMR 
complex (figure 3.20). The high expression levels, solubility and stability of 
recombinant Cmr7 made it an obvious target to raise antibodies against, which could 
be then used to track the complex along the purification pipeline. 
Step 1: Affinity chromatography    
 S. solfataricus  P2 cell lysate was prepared from 10-50 gr of cell pellet by 
standard procedure described in Materials and Methods. The soluble fraction was 
passed through a syringe-driven sterile 0.45 μm filter and subjected first to affinity 
chromatography on a 5 ml HiTrap Heparin HP column (GE Healthcare), equilibrated 
with 20 mM MES pH 6, 1 mM EDTA, 1 mM DTT (figure 3.16 A). In this context, this 
type of affinity chromatography makes use of the fact that heparin (being a sulphated 
glycosaminoglycan) mimics the polyanionic structure of nucleic acids, enabling the 
separation of nucleic acid - interacting molecules from the rest. Bound proteins were 
eluted over a 0 - 1 M NaCl gradient in 4 ml fractions and stored on ice until needed. 
Collected fractions were blotted on nitrocellulose membrane as described in Materials 
and Methods and anti-Cmr7 antibodies were used to detect fractions containing the 
CMR complex (figure 3.16 B). The respective fractions were pooled together and 
applied to the next column. As can be seen in figure 3.16 A, the CMR complex eluted 
at approximately 750 mM NaCl, indicating a tight interaction with the column and 
therefore a strong nucleic acid binding capability. 
        Cmr1          Cmr1+Cmr3
    1      2     3     4      5     6     7     8  
Concentration
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Figure 3.16: First step of SsoCMR purification by affinity chromatography.
(A) Chromatogram of the elution profile of HiTrap Heparin HP. The dot blot of the elution 
fractions  can be seen figure (B), where the fractions  containing Cmr7 have interacted with the 
anti-Cmr7 antibody and given a sharp signal. The positive fractions  correspond to the 
indicated area in the chromatogram, where a late elution peak is observed. Fractions  37-49 
were combined and subjected to the next purification step.
Step 2: Size exclusion chromatography
	 The CMR-containing fractions pooled from the heparin column were 
concentrated to an appropriate volume in a Vivaspin concentrator with 10 kDa cutoff 
limit, and loaded on a HiLoad 26/60 Superdex 200 gel filtration column (GE 
Healthcare), equilibrated with 20 mM MES pH 6, 200 mM NaCl, 1 mM EDTA, 1 mM 
DTT. Fractions of 4 ml were collected and dot blotted with anti-Cmr7 antibodies as 
before. As observed in figure 3.17, the complex eluted in a broad peak containing 
other high molecular weight molecules, in agreement with the size and stability of the 
structure. A more accurate size for the complex could not be estimated at this step, 
since the sample contains still many cell contaminants. 
Figure 3.17: Second step of SsoCMR purification by size exclusion chromatography.
(A) Gel filtration elution profile. (B) Dot blot of the collected fractions where we can observe that 
the positive fractions correspond to an early eluting peak, presumably due to the large size of 
the complex.
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Step 3: Cation exchange chromatography
	 The pooled fractions from gel-filtration chromatography were buffer exchanged 
to low salt buffer and subsequently applied to a 1 ml MonoS 5/50 GL (GE Healthcare) 
cation exchange column, equilibrated with 20 mM MES pH 6, 1 mM EDTA, 1 mM DTT. 
Bound proteins were eluted over a 0 - 1 M NaCl gradient in 1 ml fractions, and dot-
blotted as described. The complex eluted approximately at 250 mM NaCl (figure 3.18), 
indicating a rather weak or unevenly distributed positive surface charge. 
Figure 3.18: Third step of SsoCMR purification by cation exchange chromatography. 
(A) Elution profile of 1 ml MonoS 5/50 GL with a 0 - 1 M NaCl gradient. (B) Blotted fractions 
giving a positive signal when incubated with anti-Cmr7 antibody. Fragments  of this 
homogeneous peak were analysed by SDS-PAGE and Ruby Sypro staining, and protein 
identification was carried out by mass spectrometry. A representative fraction of the peak can 
be seen in panel (C), where we observe a complex mixture of bands, with both the CMR 
complexes and RNA polymerase subunits present, as detected by mass spectrometry.
Step 4: Anion exchange chromatography
 As a final purification step, a 1 ml MonoQ 5/50 GL (GE Healthcare) anion 
exchange column was employed. The pooled sample from the previous step was 
concentrated to an appropriate volume and buffer exchanged to 20 mM Tris-HCl pH 8, 
1 mM EDTA, 1 mM DTT prior to loading on the MonoQ column, equilibrated in the 
same buffer. Bound proteins were eluted over a 0 - 1 M NaCl gradient in 1 ml 
fractions, in which the presence of the CMR complex was detected by dot blot with 
anti-Cmr7 antibodies as before (figure 3.19). The complex eluted at approximately 
350mM NaCl, reflecting a weak    or unevenly distributed negative surface charge. 
SDS-PAGE analysis revealed that the two distinct peaks observed in the 
chromatogram correspond to the separation of the 12-subunit SsoRNA polymerase 
complex (sharp peak) from the SsoCMR complex (broader peak), which seems to 
contain only a few remaining contaminants (figure 3.19, D). The stoichiometry of the 
complex could not be determined at this stage, but it could be roughly estimated that 
there are equimolar amounts of Cmr1-6  and an excess of Cmr7. The complex-
containing fractions were pooled together, concentrated at approximately 100 μg/ml 
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and stored at -80oC until required.  Mass spectrometry analysis of the protein content 
of the samples will be discussed in the following paragraph. 
Figure 3.19: Fourth step of SsoCMR purification by anion exchange chromatography.
(A) Elution profile of the 1ml MonoQ 5/50 GL with a  0 - 1M NaCl gradient. The broad CMR 
elution peak is  divided into two sections indicated on the chromatogram and analysed by mass 
spectrometry and SDS-PAGE (C). In this  stage the CMR complex separates  from the RNA 
polymerase complex which elutes later from the column in a sharp peak. (B) Dot blot of the 
MonoQ elution indicating the Cmr7-containing fractions, which initially seem to cover a broad 
area between fr. 23-42. (C) When analysed by SDS-PAGE and Ruby Sypro staining, the peak 
fractions  (lanes  3-6) reveal a heterogeneous  protein composition and were subsequently 
analysed by mass spec (see paragraph 3.8.2). Lane description: 1, Gel Filtration CMR pool; 2, 
MonoS CMR pool; M, protein size marker (kD); 3, MonoQ fraction 23; 4, MonoQ fr27; 5, 
MonoQ fr30; 6, MonoQ fr32; 7, MonoQ fr34 RNA polymerase complex. (D) Schematic 
description of the protein composition of the final CMR complex pool enabled by mass 
spectrometry analysis. Component proteins are colour coded and defined by gene name and 
module type. Both SsoCMR complexes are present.
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Figure 3.20: Optimisation of the SsoCMR purification procedure by Paul Talbot with a larger 
starting culture. 
(A) Elution profile of the 1 ml MonoQ 5/50 GL with a 0 - 1 M NaCl gradient. (B) SDS-PAGE 
analysis  of the peak fractions. The SsoCmr family B complex elutes as a single monodispersed 
peak and is isolated from the SsoCmr family D cluster, as confirmed by mass  spectrometry 
(data not shown). The second sharp peak contains in an almost pure form the SsoRNA 
polymerase cluster. The adjacent gel image shows the purified recombinant CMR proteins for 
comparison.
3.8.2 Identification of the CMR complex components by mass spectrometry
	 The CMR-containing fractions collected after the last anion exchange 
purification step were combined and analysed by in-solution tryptic digest followed by 
LC-MS/MS mass spectrometry in house. This method would enable us to confirm the 
presence of all the CMR subunits and identify contaminants and interacting proteins. 
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Samples from two different CMR preparations were analysed, and from different parts 
of the broad MonoQ peak (see figure 3.19). Also, the presence of the SsoRNA 
polymerase complex in the second MonoQ peak was confirmed. 
 From the analysis results and the mass spec scores we can confirm that the 
dominant proteins in all samples are the subunits of both the CMR clusters in 
Sulfolobus  solfataricus. In table 3.2 are depicted only the protein “hits” with score 
above 100, and only CMR components with lower scores. The two clusters reside in 
different parts within the genome, and are adjacent to different CRISPR loci. The first 
cluster (family D) consists of genes sso1424-sso1432 and is located between near 
CRISPR loci B  and C, while the second cluster (family B) is comprised of genes 
sso1986-sso1992 and is neighboring CRISPR locus F.  The fact that they co-purify is 
not unexpected since their composition indicates similar size and physicochemical 
characteristics. It is also possible that both complexes have bound CRISPR RNA 
transcript, and therefore are physically linked through their RNA load. Different 
sections of the broad CMR elution peak from the MonoQ column during the second 
CMR preparation were analysed to detect differences in the protein content. In the first 
part of the peak (section A in figure 3.19) both complexes seem to elute but only CMR 
family B  is present in the late peak fractions (table 3.2). Whether this divergence 
reflects a difference in physicochemical properties such as weaker surface charge, or 
is a matter of in vivo abundance is unknown. 
	 The samples contained relatively few contaminants, with most of them 
common in both preparations (table 3.2). The major contaminants with scores as high 
as Cmr2 were an AAA-ATPase (Sso0176) and reverse gyrase whose presence can be 
explained by their affinity for nucleic acids and their potential interaction with RNA 
CRISPR sequences bound to the CMR complexes. Other contaminants with a much 
lower score include heat shock protein 20 (Sso2427), the thermosome subunits 
(Sso0862, Sso0282), mRNA and rRNA processing enzymes (Sso0939, Sso0940 ), a 
second AAA-ATPase (Sso0421), ALBA and a putative DNA helicase (Sso2450). The 
first two proteins belong to the chaperones group (hsp20, thermosome) and would 
potentially be needed to assist the complex assembly. The rest are either RNA 
processing enzymes or known nucleic acid interacting proteins (ALBA, AAA-ATPase, 
potential helicase) therefore they might be interacting with any complex-bound RNA. 
	 Subsequent protein preparations by Paul Talbot replicated these findings, and 
further optimisation of the purification method resulted in successful separation of the 
two CMR complexes. 
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Protein Family Purif A MonoQ
(Mascot score)
Purif B early 
peak MonoQ
(Mascot score)
Purif B   late 
peak MonoQ
(Mascot score)
Sso0176 AAA ATPase 1251 333
Sso1991 Cmr2 1287 1209 1061
Sso1989 Cmr1 938 654 531
Sso0420 Rev. Gyrase 653 87
Sso1988 Cmr5 624 168 140
Sso1429 Part of Cmr2 390 256
Sso1432 RAMP 378 262
Sso1990 Cmr6 338 346 338
Sso1987 Cmr4 336 73 18
Sso1992 Cmr3 312 522 390
Sso1427 RAMP 287 217
Sso1424 Cmr7? 282 256
Sso1426 Cmr4? 268 463
Sso1425 Cmr4? 228 110
Sso1986 Cmr7 217
Sso1428 Part of Cmr2 178 34
Sso1431 Cmr3 145 25
Sso2427 hsp20 103 221 360
Sso1430 RAMP 69
Sso0862 Thermosome alpha 
subunit
344 509
Sso0939 Pre mRNA splicing 
protein
196 322
Sso0804 hypothetical 175 143
Sso1442 hypothetical 150
Sso0421 AAA ATPase 132
Sso0282 Thermosome beta 
subunit
120 507
Sso2450 Putative 
DNAhelicase
115 269
ALBA 277 259
Sso0940 Pre rRNA 
processing
218
Table 3.2: Mass Spectrometry analysis of two different purifications of SsoCMR. 
Top hits with Mascot score above 100 are mentioned, and CMR-associated proteins  if their 
score is lower. 
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3.9 Initial functional characterisation of the native SsoCMR complex
	 During the time we isolated the native SsoCMR complex, little or no 
information was available regarding the functional details of different CRISPR systems, 
either bacterial or archaeal. The identification of E. coli CASCADE (Brouns et al. 2008) 
and the PfuCMR complex (Hale et al. 2009) had not been published at the time, 
therefore our initial characterization plan had to take in account all the possible roles 
of the complex within the CRISPR system. For this reason, it is obvious now why 
many of the experiments described in this paragraph had negative results, as they 
were designed to test hypotheses that were later proven to be incorrect. Nonetheless, 
these experiments are essential in the initial stages of characterisation of any 
hypothetical protein. 
	 Since very limited information could be extracted from the bioinformatics 
analysis of the CMR complex components and the structure of Cmr7, assumptions 
about the possible in vivo function of the CMR complex could be drawn only by 
considering its potential role in the context of the CRISPR operation system, 
specifically the interference stage. To participate in this stage, the Cmr complex would 
be predicted to exhibit a combination of the following activities:
• affinity for nucleic acids (either RNA or DNA, CRISPR related or unspecific 
sequences)
• nuclease activity, in terms of attacking the extrachromosomal invader nucleic acid, 
or processing the CRISPR transcript (information of the processing role of Cas6 had 
not yet been published)
• potential nucleotide incorporation or reverse transcription activity, based on the fact 
that Cmr2 was predicted to be a putative novel polymerase (Makarova et al. 2006), 
as explained in paragraph 3.1. 
The above possible activities were investigated with the substrate library available, 
which consisted of DNA and RNA versions of the repeat sequence of CRISPR locus F 
(CRISPR_compF), the repeat complement of locus B  (CRISPR_compB), and the in 
vitro transcribed first two repeat-spacer units of CRISPR locus A (figure 3.22; clusters 
A and B have the same repeat sequence). In retrospect, more appropriate substrates 
would have been DNA or RNA protospacer sequences in order to mimic the in vivo 
substrates during the interference stage. 
3.9.1 The SsoCMR complex does not bind ssDNA or ssRNA
 The electrophoretic mobility shift was used to determine the ability of the 
native SsoCMR complex to bind nucleic acids. The limitation of these assays was that 
the low yield and low concentration of the complex purified by the antibody-assisted 
method described in the previous paragraph might not result in a strong enough 
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interaction to produce an observable shift. Also, we were unable to determine an 
accurate protein concentration since the stoichiometry of the complex is unknown and 
the yield was too low to perform a Bradford assay. The crude estimated concentration 
of the purified SsoCMR complex used in the assays described in figure 3.21 was 110 
μg/ml.
 The effects of temperature, concentration and pH/salt conditions were 
investigated. In the reactions, 1 μl of the concentrated SsoCMR pool was incubated 
with 1 μM of fluorescein-labelled substrate either for 20 min at room temperature/
37oC, or 5 min at 50oC / 70oC, in binding buffer A (20 mM MES pH 6, 100 mM NaCl, 1 
mM EDTA, 0.1 mg/ml BSA) or B  (50 mM Tris-HCl pH 8, 100 mM KCl, 5 mM MgCl2, 1 
mM DTT). The substrates were RNA or DNA versions of the repeat complement 
sequence of CRISPR cluster F (CRISPR_compF), and the repeat complement of 
CRISPR cluster B  (CRISPR_compB). No interaction was observed with either the DNA 
or RNA substrates under the reaction conditions tested (figure 3.21). It has to be noted 
that these assays did not constitute an exhaustive screening of all the possible 
reaction conditions although the results were repeatable. For example, a full metal and 
buffer screen was not carried out, as the purified protein stock was limited. It is a 
strong possibility that the concentration of the protein stock was not high enough to 
result in a stable complex with the nucleic acid substrates. However, other catalytic 
assays typically require smaller amounts of protein, so it was considered more useful 
to investigate other possible activities.  
Figure 3.21: Binding of native SsoCMR to CRISPR ssDNA and RNA substrates.
Assays in gels A and B were carried out in binding buffer A. Description of gel lanes: 
(A) C1, control ssRNA CRISPR_compF; C2, control ssDNA CRISPR_compF; 3, assay with 
ssRNA CRISPR_compF; 4, assay with ssDNA CRISPR_compF; 5, assay with ssRNA 
CRISPR_compB; 6, assay with ssDNA CRISPR_compB; lanes 7-10 the same as 3-6 at 
70oC. 
(B) Two-fold serial dilutions (approximately 55 ng and 27.5 ng according to our crude estimate) 
of the original ssoCMR sample assayed in this  gel. Lanes 1+2, ssRNA CRISPR_compF; 
3+4, ssDNA CRISPR_compF; 5+6, ssRNA CRISPR_compB; 7+8, ssDNA CRISPR_compB; 
9, ssDNA CRISPR_compF; 10, ssRNA CRISPR_compF. 
(C) In this  assay, serial dilutions  of SsoCMR (55 ng, 27.5 ng, 13.7 ng and 6.8 ng) were 
incubated with ssRNA CRISPR_compB in binding buffer B. Lane C, positive control 
reaction with purified SsoCas2 which binds to ssRNA. The smeared appearance of the 
unbound RNA substrate in lanes 5,6 (B) and in gel (C) was most probably due to sequence 
A
RT
bound
unbound
70oC
7C1 C2 3 4 5 6 8 9 10
B
50oCRT
71 2 3 4 5 6 8 9 10
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forming secondary structures and can also be seen in the control lane C1 (A), therefore they 
were not regarded as a real shift due to protein binding.
3.9.2 The SsoCMR complex does not exhibit nuclease activity against CRISPR 
RNA
 In order to mediate the processing, interference or adaptation stage of the 
CRISPR activity, the CMR complex would need to display nuclease activity against 
either the CRISPR transcript or repeat sequence, or against protospacer-like 
sequences. Various concentrations of SsoCMR (initial estimated concentration 110 
μg/ml) were incubated with radiolabelled CRISPR transcript (constructed by in vitro 
transcription of the first two repeat-spacer units of CRISPR locus A as described in 
Materials and Methods) for 1 hour at temperatures ranging from 37 to 65oC in 50 mM 
Tris-HCl pH 8.5 or 20 mM MES pH 6, 100 mM KCl, 5 mM MgCl2, 5 mM MnCl2, 1 mM 
DTT and run on a denaturing 20% acrylamide / 7M urea gel as described in Materials 
and Methods. The substrate was heated at 65oC for 5 min before adding the reaction 
mixture in order to denature secondary structures. No nuclease activity was observed 
under these conditions (figure 3.23, A and B). As a possible explanation it was 
considered that the secondary structure of the substrate could be important for the 
protein activity, but this result was repeatable. The protein complex was also 
incubated at various temperatures with a ssRNA substrate representing the 
complement of the repeat sequence of loci A and B  (CRISPR_revB), but no activity 
was observed (figure 3.23 C). An illustration of the substrates used can be seen in 
figure 3.22. It was not considered relevant to measure nuclease activity against DNA 
substrates, as this would not be relevant in the CRISPR operation model. 
 	 These experiments, although they did not represent an exhaustive investigation 
of the potential nuclease activity of the CMR complex, indicated that it was not 
involved in the processing of the precursor CRISPR transcript or even the final stages 
of the formation of the final crRNA sequence that would mediate the interference. 
Figure 3.22: Substrates used for assaying the nuclease activity of the SsoCmr complex
A T7 promoter was cloned upstream of the first two repeat-spacer units of CRISPR locus  A, in 
order to generate the 152 nt CRISPR transcript by in vitro transcription with the T7 RNA 
polymerase. The repeat sequence of the locus (and of locus B) is  illustrated at the bottom. The 
substrates  used in assays are highlighted in yellow. The 5’ fluorescein label is indicated with a 
red star. 
    repeat 5’-GAUUAAUCCCAAAAGGAAUUGAAAG
complement 3’-CUAAUUAGGGUUUUCCUUAACUUUC-
T7 promoter repeat spacer
CRISPR locus T7 construct
CRISPR transcript 152 nt
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Figure 3.23: Nuclease assays of SsoCMR
(A) CRISPR transcript with two sets of repeat/spacer units  (152 nt) incubated with 110, 55 and 
11 ng of protein (lanes 1, 2, 3 respectively) for 1 hr at 37oC in the presence of MgCl2 / MnCl2. 
M, nucleotide size ladder. No cleavage products observed. 
(B) CRISPR transcript (152 nt) incubated with 0.4 μg of protein in the presence of MgCl2 / 
MnCl2 for 30 min at 45, 55 and 65oC. C, control reaction without protein; lanes 1-3 assay at 45, 
55, 65oC respectively; lanes 4-5, assay at 55, 65oC with a different protein batch. No cleavage 
products observed at elevated temperatures. 
(C) 25 nM of fluorescein-labelled ssRNA CRISPR_compB were incubated with 0.4 μg of protein 
at 45, 53 and 60oC for 30 min (lanes  1-3). Lane C, control reaction without protein. No activity 
was observed.
3.9.3 The SsoCMR complex does not exhibit polymerase activity
	 The stability and size of the CMR complex, its continuous presence in the cell 
in amounts comparable to RNA polymerase and the fact that its largest protein 
component (Cmr2) contains a palm-domain polymerase motif (Makarova et al. 2002) 
initially led to the hypothesis that it might take part in the adaptation stage of the 
CRISPR pathway, whereby novel invader protospacer sequences are inserted into the 
genome immediately downstream of the leader sequence of a given locus and 
become part of the CRISPR spacer library. This would require some form of reverse 
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transcription in the case of RNA viral sequences and incorporation of the resulting 
DNA sequences, or the processed DNA fragments of DNA extrachromosomal 
elements, to the CRISPR locus. 
 Reverse transcriptase activity was measured by performing in  vitro 
transcription with the SsoRNA polymerase as described in Materials and Methods 
(figure 3.24), but replacing the reverse transcriptase with the CMR complex in the 
primer extension step. The CRISPR locus constructs I and II cloned into the pCR2.1 
TOPO vector were used as substrates for transcription, as described in Materials and 
Methods. These constructs contain 245 nt (CRISPR I) or 165 nt (CRISPR II) of leader 
sequence of the CRISPR locus and four repeat-spacer units. A successful run-off 
transcription reaction would result in a transcript of defined length (since the 
substrates were linearized), which would then be detected by reverse transcription 
with a radiolabelled primer, complementary to an internal site or the end of the 
transcript. One μl (110 ng) of the CMR complex was used in each primer extension 
reaction which were incubated at 70oC instead of 42oC to imitate physiological in vivo 
conditions. The reverse transcription products were separated on a 10% 
polyacrylamide, 7 M urea gel (figure 3.25). As can be seen in the figure 3.25 A, the 
sequences produced by the SsoRNA polymerase/reverse transcriptase are close to 
the transcript size of 274 nt (construct with four repeat-spacer units), but no products 
were observed with SsoCMR. The reaction was repeated over a temperature range of 
50oC to 70oC with negative results (figure 3.25 B). All the appropriate controls were 
carried out in every assay. 
Figure 3.24: Outline of in vitro transcription with the SsoRNA polymerase
transcript 274 nt
CRISPR I: 519bp
CRISPR II: 417bp
transcription with SsoRNAP, 
TBP, TFB-1
reverse transcription 
with [γ-32P]ATP labelled 
reverse primers
Leader 245 bp
Leader 165 bp
primer extension 
DNA products primer for spacer 4
274nt
internal primer for 
spacer 2 
148nt
spacer 2 spacer 4
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Figure 3.25: Reverse transcriptase assays for SsoCMR
(A) S. solfataricus  in vitro transcription was carried out on CRISPR locus constructs, with the 
primer extension fragments  produced by reverse transcriptase visible in lanes  1 and 2: 1, 
transcription from CRISPR I, primer extension with +252r (fourth spacer); 2, transcription 
from CRISPR II, primer extension with +252r, complete length of transcript is  274 nt. Lanes 
3, 4, 5 contain negative control reactions without TBP, TFB1 and TBP/TFB1 respectively. 
Reactions  with SsoCMR instead of reverse transcriptase can be seen in lanes  6, 7 with 
CRISPR I and II transcripts as  substrates respectively. M, New England Biolabs  low MW 
DNA ladder. Dashed line indicates non-contiguous lanes on the gel.  
(B) Primer extension reactions with SsoCMR were repeated with CRISPR II transcripts  at 50oC, 
60oC, 70oC (lanes 1-3, respectively), and CRISPR I at 70oC (lane 4). No product was 
observed. The excess of radiolabelled primers can be seen at the bottom of the gel.
3.8 Discussion
	 The function of the CMR complex was revealed finally in an influential study by 
Hale et al. in 2009, where it was shown that the CMR complex is the effector RNA 
targeting agent in Pyrococcus  furiosus. The study presented in this chapter took place 
before such information was published, and the experimental strategy was designed 
in the light of the few experimental and bioinformatical studies available until then, 
namely the comparative genomic analyses by Jansen et al. (2002), Makarova et al. 
(2002 and 2006), Haft et al. (2005) and the characterisation of Cas6 from Pyrococcus 
furiosus (Carte et al. 2008). 
 Hale et al. (2008 & 2009) demonstrated that the six Cmr module proteins from 
Pyrococcus  furiosus  (Cmr1-6, type III system proteins with the current classification) 
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co-purify with two species of mature psiRNA sequences (and few contaminating 
proteins), and this RNP complex is sufficient to catalyze the homology-dependent 
cleavage of target RNA. The mature psiRNA species are generated from the Cas6-
assisted processing of the initial CRISPR loci transcripts, and consist of 37 or 31 
nucleotides of spacer sequence and 8 nucleotides of the upstream repeat sequence 
(referred to as “psi-tag”). After cleavage by Cas6 which generates the 5’ end of the 
psiRNA, further processing of the remaining repeat at the 3’ end is taking place by an 
unknown protein to produce the final mature psiRNA. The Cmr-bound psiRNA is 
responsible for the recognition and binding of the complementary foreign RNA 
element, and acts as a molecular “ruler” to guide the cleavage of the RNA invader by 
the Cmr complex (figure 3.26). Cleavage of the target RNA occurs 14 nucleotides from 
the 3’ end of the psiRNA regardless of the spacer length in the psiRNA species 
present, yields products with 3‘-phosphate and 5‘hydroxy termini and is divalent 
cation-dependent. After reconstitution analysis, the authors concluded that all 
subunits with the exception of Cmr5 were necessary for target binding and silencing. 
The catalytic subunit performing the cleavage is not yet identified, although Cmr2/
Cas10 containing an HD-nuclease domain is the strongest candidate. Thus the 
mechanistic details of psiRNA-guided RNA targeting in type III CRISPR systems were 
partially elucidated. 
Figure 3.26: Mode of action of the PfuCmr complex. 
The Cmr complex (Cmr1-6, indicated in blue) loaded with CRISPR psiRNA sequences  (orange) 
identifies the complementary invader ssRNA (black) leading to site-specific cleavage. The 
psiRNA acts as a molecular ruler, positioning the target ssRNA close to the active site of the 
complex so that the cleavage occurs 14 nucleotides upstream from the 3’ end of the psiRNA. 
In that way, different species of psiRNA with different lengths  will cause cleavage of the target 
RNA at two distinct sites. Adapted from Hale et al. 2009.
	 The isolation of the native Cmr complex from Sulfolobus  solfataricus  and the 
initial attempts to characterize its recombinant subunits are described in this chapter. 
All six S. solfataricus  cmr genes were cloned individually in appropriate vectors to 
allow for heterologous protein expression, but only Cmr1, Cmr3, Cmr4 and Cmr7 were 
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expressed and purified successfully during the course of this study. The remaining 
subunits were either insoluble (Cmr5) or did not express at all (Cmr2, Cmr6) in the 
heterologous E .coli system, indicating problems with protein stability and the lack of 
vital interacting protein partners. Co-expression of the unstable proteins in pairs with 
their adjacent cmr gene (e.g. sso1991-sso1992 or sso1990-sso1991) using 
appropriate vectors such as pETDuet and pACYCDuet was also attempted with 
unsuccessful results. The next experimental step would be to attempt recombinant 
expression of the complex subunits, individually or in pairs/clusters of 3, in Sulfolobus 
solfataricus  itself, employing the genetic manipulation methods made available by the 
work of Sonja-Verena Albers and colleagues (Albers et al. 2006). This method has 
proven successful with a number of otherwise unstable recombinant proteins or 
improved the catalytic activity of archaeal recombinant enzymes, and would 
theoretically provide the appropriate in vivo environment and post-translational 
modification machinery necessary to render the recombinant proteins stable and 
catalytically active. In order to achieve a complete biochemical, functional and 
ultimately structural characterisation of the Cmr complex, in  vitro reconstitution from 
its recombinant subunits is a priority. 
	 The stability and increased expression levels of recombinant Cmr7 were 
unique among the other recombinant Cmr proteins in this study. This characteristic 
proved extremely valuable for the isolation and study of the native Cmr complex, 
enabling also the crystallographic study of Cmr7. The abundance and stability of 
Cmr7 is explained partially by the complex stoichiometry, where we can clearly 
observe the excess of Cmr7 over the rest of the subunits. This fact along with its 
catalytic inactivity could indicate that the protein has a primarily structural role in the 
complex, providing a scaffold upon which the remaining subunits are assembled. 
Further insight into the complex stoichiometry and topology can be acquired by native 
mass spectrometry, single-particle EM and small-angle X-ray scattering (SAXS) 
analysis.
	 Regarding the investigation of the recombinant protein interactions, only Cmr3 
and Cmr1 were clearly shown to interact. Since all of the Cmr proteins have been 
shown to co-purify, it can be safely assumed that they interact physically. However, 
the topology of the native complex can limit the reconstruction of these interactions 
with the recombinant proteins in  vitro. These proteins may form part of a large protein 
complex but the order in which it is assembled and the individual pair interactions are 
still unknown. Moreover, it is reasonable to assume that Cmr2 is essential for the 
complex assembly, since it is the largest and also the predicted catalytic subunit. In 
retrospect, the CRISPR transcript or mature crRNA sequences processed by SsoCas6 
(see chapter 4) would have been a more suitable candidate to mediate Cmr subunit 
interactions in vitro, instead of the CRISPR DNA repeat sequences used here.
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 Cmr1 demonstrated the ability to bind ssRNA, exhibiting a slight preference for 
the ssRNA CRISPR repeat. The interaction would be characterised as weak, although 
the highest concentration of Cmr1 we were able to use was 18.25 μM, which was not 
high enough to give us an overview of the binding curve or a rough KD. The substrate 
in retrospect was not physiologically relevant, as in the context of the Cmr complex 
and drawing from the PfuCmr analysis the complex would be expected to bind the 
mature psiRNA comprising of the 8nt repeat psi-tag and the spacer sequence. 
Nevertheless, it is safe to assume that the affinity of the protein for ssRNA is a result of 
its physicochemical characteristics and the signature ferredoxin-like fold of the RAMP 
superfamily it belongs to. As a result, we can speculate that the role of Cmr1 within 
the SsoCmr complex involves the binding and potentially recognition of the mature 
psiRNA and perhaps its target. 
	 As a general comment, the weak binding properties determined by the EMSA 
and the failure to detect any other protein-nucleic acid interactions can be attributed 
to a number of factors such as unfavourable assay conditions (temperature, buffer 
composition, metal ion requirements), or the fact that the nature of the interaction is 
such that is easily disrupted.
 The native SsoCmr protein complex was successfully isolated and purified 
from S. solfataricus  cell lysate by four chromatographic purification steps, with 
antibodies raised against recombinant Cmr7 used to track the protein complex. This 
was made possible due to the integral stability of the complex, comparable to the 
SsoRNAP complex with which it co-purified for 3 of the 4 purification steps. It is 
almost certain that the complex co-purifies with CRISPR psiRNA species, although 
this aspect was not tested in this study. Further experiments including RNA isolation 
and sequencing would confirm the mature psiRNA sequences found in S. solfataricus. 
Mass spectrometry analysis of the purified complex in the two last purification steps 
(cation and anion exchange chromatography) revealed the presence of both CMR 
clusters in S. solfataricus  suggesting that they are both active and are regularly 
expressed in the cell, indicative of a system operating in “surveillance mode”. It is 
unknown whether the two complexes identify and interact with a different CRISPR 
locus thereby supplementing each other’s function within the SsoCRISPR system or 
they function redundantly. Further analysis of their respective RNA content would 
clarify this issue. Proteins belonging to the partial Cmr clusters in S. solfataricus 
(genes sso1514-sso1510 and sso1725-sso1730) were not detected, supporting the 
assumption that these clusters have degenerated and are inactive. 
	 As mentioned already in the respective paragraph, many aspects of the 
functional characterisation of the SsoCmr complex were designed before the 
information on PfuCmr was made available and the role of the complex was 
elucidated (Hale et al. 2009). In retrospect the negative results can be interpreted and 
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understood as the hypotheses they were designed to test were proven incorrect. The 
nucleic acid binding ability of the complex was examined with the wrong substrate, as 
DNA and RNA versions of the CRISPR repeat sequences were used instead of mature 
psiRNA sequences which is the physiological substrate. It has to be mentioned 
though that the protein material available was limited and the Cmr concentration 
obtained was very low, so an extensive screening would not be possible. 
	 The absence of any nuclease activity of the native complex against the 
CRISPR transcript or CRISPR repeat sequences was explained with the elucidation of 
the role of Cas6 in crRNA processing (Carte et al. 2008). Further investigation of the 
nuclease activity of the SsoCmr complex on the grounds of the psiRNA-guided RNA 
cleavage activity found by Hale et al. in P. furiosus  is needed. It is speculated that the 
SsoCmr complex could basically assume the same role in the interference stage of the 
CRISPR functioning, whereby it would identify and effectively silence invader RNA 
sequences guided by the bound psiRNAs. The mechanistic details of this activity 
however might vary from what is found for PfuCmr. 
	 The only hypothetical activity unaccounted for concerns Cmr2/Cas10. Apart 
from the obvious hypothetical function of the HD nuclease domain in cleaving the 
complementary target RNA sequences, the role of the conserved polymerase/cyclase 
domain remains unknown. It is now clear that the Cmr complex is not involved in the 
adaptation stage of the system, which the universal CRISPR-associated proteins Cas1 
and Cas2 are predicted to mediate, which in turn accounts for the fact that the 
complex did not exhibit reverse transcriptase or non-specific nucleotide incorporation 
activity. Future characterisation of the complex should address this issue, and perhaps 
the elucidation of the Cmr2 structure would enable us to gain some insight into the 
role of this domain. 
	 A pressing problem that would need to be solved before any subsequent 
biochemical characterisation of the SsoCmr complex is possible is the low yield of the 
native purification method described here. High-level recombinant expression of 
tagged Cmr subunits in Sulfolobus  solfataricus  using the arabinose-inducible system 
developed by Albers et al. (2006) would potentially overcome this problem and enable 
the purification of large amounts of the Cmr complex, as well as the ability to study its 
expression conditions and regulation in its native host. 
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Chapter 4
Purification and characterisation of 
Csa2-Cas5a: An archaeal CASCADE-like 
complex for CRISPR-mediated viral 
defence 
4.1 Introduction 
4.1.1 Biochemical and structural characterisation of the E. coli CASCADE 
 As described in chapter 1, a large multimeric complex composed of Cas type 
I-E proteins Cse1-5e (also known as CasA-CasE) was isolated from E. coli and shown 
to be implicated in target recognition and interference in this organism (Brouns et al. 
2008). The complex was named CRISPR-Associated Complex for Antiviral Defence, or 
CASCADE. Further biochemical and structural characterisation of CASCADE by Jore 
et al. (2011) enabled the understanding of the molecular mechanism which mediates 
specific interference in the context of the CRISPR system. Native mass-spectrometry 
in combination with propanol-mediated complex dissociation revealed that the 
stoichiometry of the intact CASCADE complex is CasA1B2C6D1E1-crRNA1 and has an 
experimental mass of 405 kDa, but also revealed the presence of the stable sub-
complexes CasB2C6D1E1-crRNA1 and CasC6D1E1-crRNA1, indicating    that CasA is 
loosely associated with the other subunits in the periphery of the complex. 
Transmission electron microscopy and small- angle X-ray scattering revealed the 
unusual quaternary structure of the full complex, which appears to have an 
asymmetric “seahorse” shape 10 x 20 nm in size, and comparison with the stable sub-
complexes enabled also the elucidation of the complex topology. As can be seen in 
figure 4.1, CasC is arranged in a semi-circular manner comprising the backbone of the 
complex, with CasD, CasE and CasA being attached to the “tail” end and the two 
CasB subunits located at the “nose” end. From the dissociation data it is 
demonstrated that the crRNA is strictly associated with the CasCDE core complex, 
and the authors suggest that it is bound either at the “tail” end of the structure, 
interacting with CasE, CasD and the end of the CasC backbone, in close proximity to 
the DNA - binding subunit CasA, or along the CasC backbone, thereby defining the 
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length of the assembly. Conformational change of the complex was observed upon 
target DNA binding. 
 The complex-bound crRNA was confirmed as the product of a single cleavage 
event by the processing endonuclease CasE, producing 5’ hydroxyl and a 2’, 3’-cyclic 
phosphate termini. This mature crRNA unit comprises of the 8 nt repeat-derived 5’ 
psitag, a complete spacer sequence and the remaining 21 nt of the repeat forming a 
hairpin on the 3’ end. The 5’ handle appears to be a generally conserved feature of the 
mature crRNAs in multiple CRISPR systems (Brouns et al. 2008; Hale et al. 2009), 
providing a protein binding platform for the effector complexes and perhaps indicating 
its important role in mediating self-nonself discrimination. 
	 In electrophoretic mobility shift assays CASCADE exhibited a high affinity for 
ssDNA and dsDNA containing sequences complementary to the complex-bound 
crRNA (reported Kd values were 8 and 790 nM respectively), and minimal affinity to 
non-target DNA resulting from the non-specific DNA-binding ability of CasA. It could 
also bind target ssRNA with a lower affinity.  Enzymatic and chemical footprint analysis 
of the CASCADE binding to ss and dsDNA demonstrated that the molecular basis of 
the specific target recognition is the formation of an R-loop, whereby the basepairing 
between the spacer in the crRNA and the protospacer in the target DNA strand leads 
to displacement of the non-target strand (figure 4.1, C). This process was shown to be 
ATP-independent, enabling the system to be constantly active in an economic and 
efficient way without wasting the cell resources. CASCADE alone did not catalyse 
degradation of the target DNA, in accordance with the initial study where the presence 
of Cas3 was also required to inhibit phage proliferation in vivo (Brouns et al. 2008). In 
the proposed model, CasA is responsible for the non-specific interaction of the 
CASCADE with DNA, which enables the sequence-specific scanning of ss and dsDNA 
species for protospacer matches. Target recognition by the CASCADE-bound crRNA 
induces the formation of an R-loop (in the case of a dsDNA invader), where Cas3 is 
recruited by an unknown mechanism and hypothetically catalyses the cleavage of the 
invader DNA by the HD-nuclease domain. The helicase domain fused to the HD-
nuclease domain in E. coli Cas3 is potentially implicated in unwinding the dsDNA to 
facilitate the R-loop formation, or in unwinding the RNA-DNA heteroduplex to enable 
degradation of the target DNA and perhaps rescue the crRNA. The ability of CASCADE 
to recognise dsDNA as its primary target is of great physiologic significance, since 
most invader DNA is in a double stranded form, and therefore provides a fast and 
effective way to silence potential threats at their source. 
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CASCADE 
components
alternative  
nomenclature
stoichiometry superfamily TIGRfam Function (if 
known)
CasA Cse1 1 YgcL TIGR02547 unspecific 
DNA binding
CasB Cse2 2 YgcK TIGR02548
CasC Cas7, Cse4 6 COG1857 TIGR01869
CasD Cas5e 1 COG1688 TIGR02593
CasE Cas6e, Cse3 1 RAMP TIGR01907 CRISPR 
RNA 
ribonuclease
Table 4.1: Composition of the E. coli CASCADE
Protein names in the first column are by Brouns  et al. (2008). Protein names  by Haft et al. 
(2005) and Makarova et al. (2011) are presented in the second column. Superfamilies and 
TIGRfam models presented according to Makarova et al. (2011).
Figure 4.1: Structure of the E. coli CASCADE and the Csy complex from P. aeruginosa
(A) EM structure of CASCADE revealing the seahorse-shaped complex. (B) Structural model of 
CASCADE, in the same orientation as the EM image, showing the location and arrangement of 
the Cas subunits and the bound crRNA. Dimensions refer to the EM image. (C) The R-loop 
formed by CASCADE, showing the non-complementary strand of the invader DNA displaced 
by the crRNA, which forms a heteroduplex with the target strand. Position of the protospacer 
adjacent motif is  shown with a yellow box, and the basepaired spacer sequence is highlighted 
in orange. The stem-loop secondary structure formed by the CRISPR RNA repeat of E. coli is 
shown in the 3’ end of the processed crRNA. (D) EM projection and (E) SAXS reconstruction of 
the Csy complex, revealing the crescent-shape particle. (A)-(C) Adapted from Jore et al. (2011), 
(D)-(E) adapted from Wiedenheft et al. (2011).
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 A homologous complex was recently isolated from Pseudomonas  aeruginosa 
(Wiedenheft et al. 2011), which harbours a type I-F system consisting of genes cas1, 
cas3, csy1, csy2, csy3 and csy4 (cas6f). Mass spectrometry and structural analysis by 
TEM and SAXS of this 350 kDa ribonucleoprotein complex revealed a subunit 
stoichiometry of Csy11∶Csy21∶Csy36∶Csy41∶ crRNA1, and a crescent-shaped structure 
120 x 150 Å (figure 4.1 D, E). The backbone of the particle is formed by the six 
subunits of Csy3, and it is proposed that the crRNA molecule is bound along the arch 
of the complex. The main structural difference with the E. coli CASCADE is the lack of 
the “tail” observed in CASCADE where CasA is located. The result of the lack of a 
CasA homologue is that the Csy complex exhibits strict sequence-dependent 
recognition of the target and it does not have a general sequence-unspecific affinity 
for DNA (Wiedenheft et al. 2011). Similar to CASCADE, biochemical characterisation of 
the Csy complex also revealed crRNA-mediated target recognition within a ssDNA or 
a dsDNA molecule and formation of an R-loop. Moreover, the authors demonstrated 
that the mechanism of target recongition is based in the initial binding of a shorter 
seed sequence at the 3’ end of the protospacer (Wiedenheft et al. 2011).
4.1.2 An archaeal orthologue of CASCADE
	 From the characterisation of the E. coli CASCADE described in the previous 
section, it becomes obvious that the minimal core of the complex consists of proteins 
CasC (COG1857), CasD (COG1688) and CasE, which belong to families Cas7, Cas5 
and Cas6e (Makarova et al. 2011). Members of protein superfamilies COG1857 and 
COG1688 were identified very early as part of the core of the CRISPR/Cas system, 
since its first discovery and initial association with DNA repair (Makarova et al. 2002). 
A representative of COG1857 is present in most subtypes of what is know known as 
Type I CRISPR/Cas system (except I-D and I-F), encoded typically upstream of a 
member of COG1688. The latter was identified as Cas5, a core CAS protein by Haft et 
al. (2005), characterised by a conserved 43-amino acid N-terminal domain (TIGRFAM 
entry: TIGR02593) and a member of the RAM superfamily. The C-terminal part of the 
protein sequence shared negligible homology and was used for subtype assignment. 
Three conserved motifs were identified among members of the COG1857 family, 
namely i) s-h-N (where s and h denote small and hydrophobic residues respectively), ii) 
a loop containing a conserved asparagine and iii) (Phe/Pro/His/Gly)-Gly, leading 
Makarova et al. to suggest that it is an enzyme (Makarova et al. 2006). This conserved 
gene cassette (COG1857 and COG1688) was shown to be a distant homologue of 
devR and devS respectively from Myxococcus  xanthus  DK1622, an autoregulated 
gene locus involved in fruiting body development, although this observation was of 
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little use in predicting roles for these proteins apart from suggesting their potential 
physical and functional association (Makarova et al. 2002). 
	 The high level of conservation across CRISPR subtypes, conserved gene 
synteny displayed by these two protein families and the elucidation of their key role in 
CASCADE has led to the establishment of Cas5 and Cas7 family proteins as core 
elements within CRISPR type I systems (Makarova et al. 2011a, 2011b). 
 It is unsurprising therefore that only these protein families have homologues 
across CRISPR/Cas type I system subtypes. In Sulfolobus  solfataricus  P2 we 
encounter a coexistence of types I-A (formerly known as Apern subtype) and III-B 
CAS systems interspersed between six CRISPR loci, in which three paralogues of 
Cas5a/Cas7 are encoded (ORF numbers sso1441/sso1442, sso1400/sso1399 and 
sso1998/sso1997 respectively, figure 4.2). All Cas7 protein sequences contain the 
superfamily conserved motifs (alignment in Appendix II). In this subtype (I-A), an 
additional protein (Csa5, TIGR01878) is always found encoded upstream from Cas7. 
No functional prediction exists for this small protein (~150aa) although its genomic 
context indicates a potential association with the archaeal CASCADE homologues. 
The rest of the CRISPR gene locus (I-A) comprises the Cas3’ (only the helicase 
domain) and Cas3’’ (HD-nuclease) homologues, Cas8a2 in one case, Cas6 (the 
predicted processing endonuclease), Csa3, Cas4, Cas2, Cas1 and Csa1, in a 
generally conserved order. Four type I-A cassettes are encoded in the S. solfataricus 
P2 genome (figure 4.2), but not all of them contain the full series of aforementioned 
genes or in some cases they are separated by non-CRISPR related genes.
Figure 4.2: Gene names and operon organisation of type I-A CRISPR/Cas in S. solfataricus
	 In this chapter it will be demonstrated that Cas5 and Cas7, referred to as 
Cas5a (or SsoCas5a) and SsoCsa2 (or SsoCsa2) in S. solfataricus  P2, form a stable 
protein complex in vitro and in  vivo which is proposed to be the archaeal counterpart 
of CASCADE (aCASCADE). Initial functional characterisation of the complex 
components will be presented alongside structural data obtained in collaboration with 
Nathanael Lintner and Dr. Martin Lawrence (Montana State University Bozeman), in 
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order to elucidate its role in CRISPR interference and understand the molecular basis 
of crRNA-mediated DNA recognition in this subtype. 
4.2 Site-directed mutagenesis of Csa2
 Multiple sequence alignments and structure-based threading enabled the 
identification of conserved residues within the Cas7/Csa2 family. Conservation among 
Cas7 family proteins is limited, and although the three characteristic Cas7 superfamily 
motifs described by Makarova et al. (2006) are present, they do not represent suitable 
candidates for catalysis. Conserved residues among the Csa2 sub-family and their 
location on the Csa2 structure will be discussed later, but of all residues, a histidine  at 
position 160 was selected for mutation analysis after close investigation of a DALI 
structural alignment between the RRM domains of SsoCsa2 and P. furiosus  Cas6 
(PfuCas6). The alignment indicated that the histidine-66 in P. furiosus  Cas6 is 
equivalent structurally to S. solfataricus  histidine-160, even though it is not part of the 
RNA-recognition motif which is the only conserved domain between the two proteins. 
The location of this residue however in regard to the RRM domain is similar, residing 
above the β-sheet of the RRM fold in a position potentially favourable for nucleic acid 
interaction (figure 4.21).
	 To investigate the role of the Asn cluster in nucleic acid binding, histidine-160 
was mutated to an alanine by site directed mutagenesis to generate the mutant Csa2 
H160A as described in Materials and Methods. A multiple sequence alignment of 
conserved residues among Csa2 family members can be found in Appendix II. 
4.3 Expression and purification of recombinant wild-type and mutant Csa2 and 
the Csa2-Cas5a complex
	 To determine whether Csa2 and Cas5a form a stable interaction in vivo the 
genes encoding S. solfataricus  Csa2 (sso1442) and Cas5a (sso1441) were amplified by 
PCR from genomic DNA and cloned into pDEST14 (for individual expression of Csa2) 
and pRSFDuetHISTEV (for co-expression of Csa2-Cas5a) as described in Materials 
and Methods. The constructs were fully sequenced to confirm their integrity. IPTG-
induced protein expression was achieved in E. coli BL21 (DE3) host cells as 
described. Purification of both wild-type and mutant Csa2 consisted of a 3-step 
purification involving affinity chromatography on a 5 ml HisTrap HP column, size 
exclusion chromatography on a HiLoad 26/60 Superdex 200 and a final affinity step 
on a 5 ml HiTrap Heparin HP (figure 4.3, E, F, figure 4.4). The same procedure was 
employed for the purification of the Csa2-Cas5a complex (figure 4.3, A-D) except for 
an additional heat step at 65oC for 20 min before the nickel-chelate affinity 
CHAPTER 4: Characterisation of the aCASCADE
103
chromatography in order to precipitate the majority of the mesophilic E. coli proteins. 
The identity of the proteins was confirmed by mass spectrometry analysis. The 
calculated molecular weights of 38,3  kDa (plus his-tag), 35,26 kDa (native) for Csa2 
and 30,44 kDa (plus his-tag) for Cas5a were confirmed on SDS PAGE. 
 Expression levels for both Csa2 and the complex were high, although a 
significant portion of the expressed protein was found in the insoluble fraction. SDS 
PAGE analysis revealed severe degradation products in the case of individual Csa2 
expression (figure 4.3  F), which were identified as such by mass spectrometry. 
Measures taken to avoid protein degradation included the addition of up to 20% 
glycerol in all the buffers, the rapid completion of the purification procedure and the 
execution of all the purification steps on ice. Protein breakdown was reduced but it 
could not be completely avoided, presumably because the protein’s stability was 
compromised due to the lack of interacting partner, Cas5a. It was found that the 
Csa2-Cas5a complex exhibited greater stability when purification procedures and 
short-term storage were carried out at room temperature (~25oC). Typical yields were 
approximately 2.6 mg/L of culture for Csa2 and 0.5 mg/L of culture for the Csa2-
Cas5a complex. 
	 Elution volumes of both the complex and Csa2 did not correspond to their 
theoretical molecular weight or provide accurate indications of their oligomeric state in 
solution, as is explained in paragraph 4.5. Furthermore, the behaviour of the proteins 
was inconsistent in each run, which explains the similar elution volume observed in 
figure 4.3 B, E.
	 The fact that Cas5a and Csa2 co-purify over three chromatographic columns 
confirmed their physical and functional association as a stable protein complex. 
Expression levels for Csa2 were higher than for Cas5a during co-expression, even 
though csa2 was cloned in the second cloning site further away from the inducible 
promoter.  The excess of Csa2 seemed to be separated from the complex during the 
third purification step through a heparin column, from which it eluted at an earlier 
stage, potentially as a result of differentially exposed protein surfaces. 
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Figure 4.3 : Purification of recombinant Csa2-Cas5a and Csa2 WT, H160A.
(A) Purification stages of Csa2-Cas5a monitored by SDS-PAGE, lanes represent protein sample 
after nickel-chelate (Ni) and gel filtration chromatography. (B) Chromatogram of Csa2-Cas5a on 
a Superdex 200 gel filtration column. (C) Chromatogram of Csa2-Cas5a purified by heparin 
affinity chromatography. (D) Fractions  of Csa2-Cas5a eluting from a heparin column, lane 
numbers correspond to elution fractions  of (C). The excess of Csa2 is  eluting as a small peak 
prior to the complex elution. (E) Purification of Csa2 WT by gel filtration chromatography on a 
Superdex 200. (F) Purified samples of the Csa2-Cas5a complex, Csa2 WT and Csa2-H160A on 
SDS-PAGE. Samples  contain 70 pmoles  of protein. The bands at ~19 kDa and ~22 kDa in the 
Csa2 WT/H160A samples were identified by mass  spectrometry as  N-terminal degradation 
products. 
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Figure 4.4: ESI-TOF mass spectrometry of Csa2 WT and H160A
Intact molecular weights  of proteins  determined by ESI-TOF mass  spectrometry to confirm the 
site mutation. (A) Mass  spectrum for the WT protein. The major peak corresponds to a 
molecular weight of 38159.6 Da (data processed to 0.1 Da). (B) Mass spectrum for Csa2-
H160A. The major peak corresponds to a molecular weight of 38096.1 Da (data processed to 
0.1 Da). The mass  difference of 63.5 Da is  in agreement with a replacement of the histidine-160 
with an alanine.
A
38159.60
B
38096.10
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4.4 Investigation of the native Csa2-Cas5a complex from Sulfolobus solfataricus 
P2 and its accessory proteins
 The native SsoCsa2-Cas5a protein complex was successfully isolated by 
Nathanael Lintner by expressing N-terminal affinity tagged Csa2 in S. solfataricus 
strain PH1-16 under the control of the araS promoter as described in Lintner et al. 
(2011). Csa2 carried a streptavidin and 8-histidine tag which enabled a two-step 
affinity purification using a Strep-Tactin and Ni-NTA resin, and finally a gel-filtration 
chromatography step on a Superose-6 column. Visualisation of the purified sample on 
SDS-PAGE and mass spectrometry analysis revealed the co-purification of Cas5a with 
minor contaminants (figure 4.5), confirming the in vivo presence of a stable CASCADE-
like complex, for which the term “aCASCADE” is proposed (Lintner et al. 2011).
	 To determine whether the Csa2-Cas5a complex was interacting with accessory 
Cas proteins that would potentially perform other aspects of a CASCADE-like 
function, samples of native aCASCADE partially purified only through the Strep-Tactin 
resin were subjected to in-solution tryptic digest and LC-MSMS. Identified proteins 
within the top 20 Mascot hits included the Csa2 and Cas5a paralogues, Sso1399 and 
Sso1440 respectively, Csa5 (Sso1443), Cas6 (Sso1437) and Csa4 (Sso1401/Cas8a2). 
Contaminants included biotin carboxylase (Sso2466) as it interacts with the strep resin 
and Alba (Sso0962), the ubiquitous nucleic acid binding protein. These findings were 
repeatable in three independently purified protein samples, the results of which can be 
seen in table 4.2. To determine whether the co-purifying proteins represented transient 
or more stable interactions, the protein samples were further purified by gel filtration 
chromatography on a Superose 12 10/300 GL (GE Healthcare). Only the core 
aCASCADE proteins (Sso1442/Sso1441) and their paralogues (Sso1399/Sso1400) 
were detected by mass spectrometry in the purified samples, indicating a weak and 
transient interaction with Cas6, Csa5 and Csa4. 
Figure 4.5: Isolation of native 
aCASCADE from S. solfataricus 
(A ) Stages of nat ive complex 
purification on SDS-PAGE: 1, sample 
a f t e r S t r e p Ta c t i n c o l u m n ; 
contaminants  such as ppB and AccC 
are visible  above the 50 kDa protein 
marker band. 2, sample after Ni-NTA 
purification; 3 and 4, purified sample 
after size exclusion chromatography. 
The multiple bands  observed for Csa2 
represent the tagged and endogenous 
untagged form of the protein, along 
with possible degradation products. 
We can observe the strong band of 
Csa2 which corresponds to the      
                                                                                           excess of Csa2 over Cas5a. Adapted   
                                                                                           from Lintner et al. (2011).
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	 Taking into account the role of Cas6 within the CRISPR system as the 
processing endonuclease of the primary CRISPR transcript, it can be suggested that 
the observed interaction is mediated by the presence of the CRISPR transcript in its 
various processing stages. This also explains the detection of Alba in the partially 
purified sample. Csa5 (Sso1443) is a small, basic (predicted pI 8.71), hypothetical 
protein 150aa in length. The gene encoding for Csa5 is located adjacent to the csa2 
and cas5a genes in conserved order in type I-A systems, possibly reflecting an 
aCASCADE accessory subunit.
Protein Family Expt A Expt B Expt C
Mascot 
score
coverag
e
Mascot 
score
coverage Mascot 
score
coverage
Sso1442 Csa2 24937 78% 33795 80% 32149 82%
Sso1997 Csa2 10012 49% 17988 57% 15410 52%
Sso1441 Cas5a 2040 53% 1770 57% 1726 63%
Sso1399 Csa2 999 66% 1189 40% 912 50%
Sso2466 Biotin 
carboxyl 
ase
593 33% 67 6% 377 59%
Sso1400 Cas5a 396 41% 622 22% 327 22%
Sso1443 Csa5 130 25% 372 65% 377 59%
Sso0962 Alba 95 53% 173 72% 173 46%
Sso1437 Cas6 92 17% 132 17% 61 18%
Sso1401 Cas8a2 - - 153 10% 84 8%
Sso2004 Cas6 - - 132 15% - -
Sso1998 Cas5a - - 60 10% 90 16%
Sso1996 Csa5 - - - - 77 29%
Table 4.2: Co-purifying Cas proteins in the partially purified native aCASCADE sample as 
identified by solution trypsin digestion followed by LC - MS/MS.
Sso1997 is  a Csa2 orthologue that is 92% identical to Sso1442. Therefore this hit probably 
represents Sso1442 in the sample, as  the sequence coverage is  not sufficiently high to 
distinguish between the two and no unique peptides for Sso1997 were found in this sample. 
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4.4.1. Nucleic acid content of the native aCASCADE 
	 The native aCASCADE purified from S. solfataricus  was examined by 
Nathanael Lintner for co-purifying nucleic acid, in accordance with the crRNA and 
DNA content of the E. coli CASCADE (Brouns et al. 2008). An RNA species of 60-70 nt 
was found to co-purify with the native complex over three chromatographic 
purification steps, showing no visible degradation when exposed to ribonuclease 
treatment, thus indicating its tight association with the complex. Additional co-
purifying nucleic acid species included low amounts of higher molecular weight RNA 
(2x or 3x the main species) and smaller amounts of ~300 nt DNA (figure 4.6, A and B). 
 To identify the origin of the major RNA species the 60-70nt bands were 
extracted, cloned and sequenced as described in Lintner et al. (2011). The cDNA 
sequences were indeed CRISPR-derived, with eight of the 16 sequenced clones 
featuring a complete spacer sequence with 8 nt of repeat sequence at the 5’ end and 
16-17 nt at the 3’ end, thus representing a complete repeat-spacer unit (figure 4.6 E). 
These crRNA fragments are analogous to the mature crRNA species produced by the 
PfuCas6 and the E. coli casE, and could represent the mature crRNA species in S. 
solfataricus. Whether the SsoCas6 is able to generate these fragments is examined 
later in this chapter. 
	 The repeat sequences in the cDNA clones represented all three of the repeat 
sequences encountered in the S. solfataricus  P2 CRISPR loci, indicating that the 
aCASCADE is able to recognise and interact with all the active S. solfataricus  CRISPR 
loci. The co-purifying DNA was not sequenced, therefore it is not known whether it 
represents nonspecific DNA interacting with the complex, or it is recognised by the 
bound crRNA in a sequence-specific manner. 
 Samples from the native aCASCADE provided by N.Lintner in Montana State 
University were also analysed for their nucleic acid content in the White lab to verify 
the aforementioned results. Basic phenol-chloroform extraction was performed on 
native StrepTactin-purified aCASCADE samples prior to size-exclusion 
chromatography on a Superose 12, and in two different parts of the broad elution 
peak (see figure 4.7 D). The extracted nucleic acid was labeled with [γ-32P] ATP and 
run on a 20% polyacrylamide / 7M urea gel. Sequencing of the fragments was not 
carried out due to time constraints. In figure 4.6 C, we can observe that the main 
component is indeed an RNA species 60-70 nt in length (confirmed by RNase A 
treatment), with a faint band of 130-140 nt. No changes in the RNA content of the 
complex were observed in the different samples, indicating firstly that this 60-70 nt 
species is an integral part of the complex, and secondly that it is not responsible for 
the puzzling elution profile of the complex on the Superose 12 column (discussed in 
paragraph 4.5).  
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	 The recombinant Csa2-Cas5a complex as was expected did not contain any 
nucleic acids, as indicated by the purified sample absorbance at 260nm. 
Figure 4.6: Nucleic acid content of the aCASCADE 
(A) Basic phenol-chloroform extraction of nucleic acids from StrepTactin-purified native 
aCASCADE, ran on denaturing PAGE. Identity of the nucleic acids was verified by DNAseI and 
RNAseA treatment, indicated on the respective lane. The second and third lanes are 
overloaded to compare the relative amounts of bound DNA and RNA. The predominant RNA 
species are marked with an arrow. (B) Denaturing PAGE illustrating the RNA co-purification 
with the aCASCADE through the purification procedure. The purification sample the RNA was 
extracted from is indicated on the respective lane. We can observe the gradual disappearance 
of the 4X and 2X RNA species, due to the isolation of the core aCASCADE (Csa2-Cas5a) from 
Cas6 and the other accessory (and potentially RNA-binding) proteins. (C) RNA extraction from 
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S. solfataricus repeat sequences
CRISPR cluster A: GATTAATCCCAAAAGGAATTGAAAG 
CRISPR cluster B: GATTAATCCCAAAAGGAATTGAAAG
CRISPR cluster C: GATAATCTCTTATAG.AATTGAAAG
CRISPR cluster D: GATAATCTCTTATAG.AATTGAAAG
CRISPR cluster E: GATAATCTACTATAG.AATTGAAAG
CRISPR cluster F: GCTAATCTACTATAG.AATTGAAAGD
CRISPR A/B   ATTGAAAG............................................. GATTAATCCCAAAAGGA
Clone1 A/B   ATTGAAAG TTAGTTTGTTGATCATTATTATTTTGTGATTGTTTGTCG..... GATTAATCCCAAAAGGA
Clone2 B     ATTGAAAG AGAACCACACTATATCACTAGCCGAACCGGCAATATTAACA... GATTAATCCTAAAAGGA
Clone3 B     ATTGAAAG ATATTATCGAAATCAACTACTCCACCAATATTAAACATTTT... GATTAATCCTAAAAGGA
Clone4 A/B   ATTGAAAG AGAACCACACTATATCACTAGCCGAACCGGCAATATTAACA... GATTAATCCTAAAAGGA
Clone5 A/B   ATTGAAAG ATTTCATATTCAATTGCTTTCTCAGTGTCGCAACCTAACTT... GATTAATCCCAAGAGGA
Clone6 B     ATTGAAAG GTATATTTCAAACCTGGAGATAGCGCAATTGCAATTGTCTTAAG GATTAATCCCAAAAGGA
Clone7 B     ATTGAAAG AGCATATGGATTGAACAAAATCGGTGACCCGGACGCAC...... GATTAATCCCAAAAGGA
CRISPR C/D/E ATTGAAAG ............................................ GATAATCTCTTATAGA
Clone8 D     ATTGAAAG TTCTGTTTCGAAGAAAACCCGCCTCAGATTCATTATGGG..... GATAATCTCTTATAGA
Clone9 C     .TTGAAAG AACATCTCTCCACCTAACACAATCCGATTAAAGTATATCCTCA. GATAATCTCTTATAGA
CRISPR F     ATTGAAAG ............................................ GCTAATCTACTATAGA
Clone10 F    ATTGAAAG TTAAAATTTCAATTTTTTTACTTTCTTCAATTTGTTTTCCAG.. GCTAATCTACTATAGA
5’-psitag 3’-handlespacer
cDNA clones from native aCASCADE
E
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purification samples of the native aCASCADE carried out in the White lab, ran on denaturing 
PAGE. The predominance of the 67 nt mature crRNA species is confirmed, along with the 
presence of a small amount of the 2X intermediate species. (D) Consensus repeat sequences 
from all active loci in S. solfataricus, colour-coded according to the CRISPR families  by Lillestol 
et al., (2009). Red, family II; green, family I, blue, family I cluster F. (E) Alignment of non-
redundant cDNA sequences from sequencing of the predominant aCASCADE-bound RNA 
species. This species is revealed to be the mature processed form of CRISPR transcripts. 
Repeat-derived sequences in both ends of the clones  are colour-coded according to (D), and 
suggest that aCASCADE is associated with all active CRISPR loci products. The underlined 
spacer matches  to a protospacer in Sulfolobus  icelandicus  Rod-shaped Virus  (SIRV). All figures 
except (C) and (D) adapted from Lintner et al. (2011).
4.5 Size determination and stoichiometry of the native and recombinant Csa2-
Cas5a complex
 In order to determine the size of the Csa2-Cas5a complex and therefore 
estimate the subunit stoichiometry, samples of native and recombinant complex were 
subjected to analytical gel filtration on a calibrated Superose 12 10/300 GL column 
(GE Healthcare). The column was equilibrated with 20 mM MES pH 6, 250 mM NaCl, 1 
mM EDTA, 0.5 mM DTT and sample volume was 100 μl, at a concentration of 
approximately 2 mg/ml. The elution volume of the complex in each sample was used 
to estimate its apparent molecular weight by comparison with a standard calibration 
curve, plotted as described in Materials and Methods. 
	 The elution profiles of two independent native complex samples produced 
inconsistent results. In the first purification the complex eluted over two consecutive 
peaks extending from an estimated size of 571 kDa into the void volume, while during 
the second purification it eluted over a broad peak corresponding to an apparent 
mass range of 50-550 kDa (figure 4.7 D). Samples from each peak were analysed by 
SDS-PAGE and in-solution LC-MSMS and verified the presence of the complex. 
Recombinant Csa2-Cas5a complex samples that were also subjected to analytical gel 
filtration on the same column exhibited a different behaviour, eluting quite late from the 
column with apparent masses of 24 - 34 kDa, indicating possible dissociation of the 
complex during the run. The calculated molecular weight of the complex with a 1:1 
stoichiometry should be 65.6 kDa. When recombinant his-tagged Csa2 was passed 
through the calibrated Superose 12 the results were again inconclusive, as the 
apparent masses in each run varied from monomer to dimer. Analytical size exclusion 
chromatography was also performed on the native Csa2-Cas5a complex expressed in 
S. solfataricus  by our collaborator, Nathanael Lintner in Montana State University. The 
native complex eluted from a Superose 6 column (GE Healthcare) mainly in a broad 
peak corresponding to a molecular weight range of 350-500 kDa (Lintner et al. 2011).
	 In order to resolve this ambiguity, samples of the recombinant Csa2-Cas5a 
complex and Csa2 from E. coli expression were sent for analytical ultracentrifugation 
(AUC) at the University of Dundee. Results for Csa2 revealed that it exists in solution 
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primarily as a monomer, with relatively small amounts of dimer and trimer and a 
dissociation constant of 4.5 μΜ. For the Csa2-Cas5a complex, the major consistent 
peak in the sample had a mass of 54-59 kDa, which corresponds roughly to a dimer 
with a 1:1 stoichiometry of Csa2 to Cas5a. A range of oligomeric species was also 
detected, but they represented a small percentage of the sample. These results 
should be regarded with caution as the presence of 10% glycerol in the sample 
caused some interference with the measurements (data not shown).
Figure 4.7: Analytical size-exclusion chromatography on native and recombinant Csa2-Cas5a 
complex. 
(A) SDS-PAGE of the native aCASCADE sample prior to size-exclusion chromatography on 
Superose 12, were multiple contaminant bands are apparent. In (B) and (C), protein samples 
from the respective elution peaks  in (D) are ran on SDS-PAGE. The presence of Cas5a in the 
purified samples  was verified by LC-MS/MS even though it is not detectable on the SDS-
PAGE. (D) Superimposition of the elution profiles of two independent native aCASCADE 
samples on Superose 12. In the second run, the excess  of Csa2 seems  to have dissociated 
from the complex and eluted as a separate peak (peak 4). 
1 
void volume
2
571 kDa
3
178 kDa
4
D
M(kD) peak 3 peak 4
Csa2
CA
M(kD) Strep
Csa2
Cas5a
50
40
70
30
25
20
100
peak 1 peak 2
50
40
70
30
25
20
100
B
50
40
70
30
25
20
100
15
CHAPTER 4: Characterisation of the aCASCADE
112
	  From the above results, we are unable to draw conclusions regarding the 
stoichiometry of the aCASCADE although from the AUC results it seems that the 
predominant species in solution is a dimer. However, taking into account the RNA 
content of the native complex, its affinity for nucleic acids and the TEM images 
(discussed in subsequent paragraphs) it is possible that higher order structures can 
form via RNA bridging or by recruitment of extra Csa2 subunits, which would explain 
the broad elution peaks during analytical gel filtration and the excess of Csa2 
observed on SDS PAGE (Lintner et al. 2011). In contrast, the recombinant complex 
does not co-purify with crRNAs as it would not recognise E. coli CRISPR sequences 
and therefore it should only exist as a dynamic monomer-dimer equilibrium, which is 
the case observed both in AUC and the late-eluting material on Superose 12. 
4.6  In vitro  protein interactions of the recombinant Csa2-Cas5a complex.
 In order to investigate the protein interactions between the core Csa2-Cas5a 
complex and the co-purifying CAS proteins, we used paramagnetic precharged nickel 
particles and tagged/untagged versions of the recombinant proteins as described in 
Materials and Methods. The following combinations were assayed, in presence and 
absence of 1 μg of CRISPR RNA transcript:
• His-tagged Csa2-Cas5a with Cas3 (Sso1440) (figure 4.9 A)
• His-tagged Csa2-Cas5a with Csa5 (Sso1443) (figure 4.9 A)
• His-tagged Csa2-Cas5a with Cas3, hisCas6 (Sso1437) and Csa5 (figure 4.9 B)
 12 μg of the tagged complex was bound to 20 μl of nickel particle solution in 
binding buffer and then incubated with 12 μg of the appropriate partner(s) for 15min at 
45οC. For Cas3, 1 mM ATP/MgCl2 was added to the reaction. After thorough washing 
with increasing concentrations of salt (NaCl) and imidazole, the bound proteins were 
eluted with 500 mM NaCl and 500 mM imidazole and visualised on SDS-PAGE. A 
schematic diagram of the assay can be seen in figure 4.8. Appropriate controls were 
carried out to ensure non-interaction of the untagged proteins and the nickel particles. 
No interactions were observed between the recombinant proteins either in the 
presence or absence of CRISPR transcript. Considering that the interactions identified 
during the purification of the native aCASCADE by mass spectrometry were weak and 
transient enough to be disrupted in subsequent purification steps, this result is not 
surprising. If the observed interactions in vivo are indeed a result of RNA bridging, 
then perhaps the amount of CRISPR RNA used was not sufficient to lead to a stable 
interaction in vitro, at least in the case of Cas6. It is also possible that the accessory 
subunit Csa5 is recruited to the complex to perform a specific function and is not 
constantly physically interacting with Csa2 or Cas5a.  As for Cas3, it is hypothetically 
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recruited to the complex accompanied by the HD nuclease after the target recognition 
in order to degrade the invader DNA, and therefore it was not identified as an 
interacting parter neither in vivo. 
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Figure 4.8: Experimental setup for in vitro protein interaction assay
(A) The assay procedure and order of addition of protein components is indicated with black 
arrows and numbering. Collected fractions and the eluted component in each step is 
illustrated above /below the arrows. 
(B) Purified recombinant proteins participating in the interaction experiments.
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Figure 4.9: Protein interactions of the recombinant Csa2-Cas5a complex
Interaction assay between his-tagged Csa2-Cas5a and Cas3 (first half of gel A), his-tagged 
Csa2-Cas5a and Csa5 (second half of gel A) and his-tagged Csa2-Cas5a with Cas3, hisCas6 
and Csa5 in combination (B). Collected fractions  are labelled as (FT1), flow-through after the 
his-tagged protein was added to the beads; (FT2) flow-through after the interacting partner 
was added; (W1-2) washes  with increasing imidazole concentration; (E) elution with 500mM 
imidazole; (B) Ni-NTA beads solution after elution heated at 90oC to denature and elute all 
bound proteins; (M) protein size marker. The smaller molecular weight bands  in lanes  with Cas3 
are degradation products. In gel (B), the presence of both the Csa2-Cas5a complex and Cas6 
in the elution fraction is  due to the 6xhis-tag on both Csa2 and Cas6 and not a real 
interaction.Tagged Cas6 was used to investigate whether its presence (± RNA) would mediate 
a bridging interaction between the rest of the assay components, as we were unable to cleave 
the his-tag off. 
4.7 Investigating the properties of the leader sequence of CRISPR locus A
	 Leader sequences of the CRISPR loci are always present upstream of active 
CRISPR loci but poorly conserved, and apart from their predicted role in the 
adaptation stage of CRISPR functioning they also direct the transcription of the locus 
in vivo. In order to determine whether the leader sequence directly upstream of the 
CRISPR locus A in S. solfataricus  P2 can act as a canonical promoter we performed in 
vitro transcription studies with CRISPR locus constructs and the S. solfataricus  RNA 
polymerase. As leader sequence we considered the genomic region 12333221 (end of 
gene sso1389) - 12333466 (start of the first CRISPR repeat in locus A). To investigate 
which elements of the leader sequence are required for transcription two CRISPR 
locus constructs were generated as described in Materials and Methods, consisting 
either of the whole leader sequence (245bp upstream from the start of the CRISPR 
locus) or part of it (165bp upstream) and four repeat-spacer units (CRISPR I, II, figure 
4.10). The constructs were cloned into pCR2.1 TOPO vector, linearised following 
digestion with restriction enzyme HindIII and used as transcription templates for the 
SsoRNA polymerase complex as described in Materials and Methods. Reverse 
complementary oligonucleotide primers for spacers 1 and 2 were used in the primer 
extension reaction to verify the presence of the desired transcripts. 
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Figure 4.10: CRISPR locus A constructs
Leader sequence is illustrated as a red box, repeats as  black arrows and spacers  as light grey 
boxes, numbered in the order they appear in the locus. Sizes are not to scale. 
	 As can be seen in figure 4.11, the CRISPR constructs I and II were transcribed 
by the SsoRNA polymerase producing fragments corresponding to the length of the 
repeat / spacer units. The primer complementary to spacer 2 is used as an internal 
primer when used for the transcripts produced by constructs CRISPR I and II in the 
primer extension reaction, verifying that the transcript is indeed the series of CRISPR 
repeats/spacers. Interestingly, the whole sequence (245bp) does not seem to be 
necessary for transcription, indicating that the transcription factor and RNA 
polymerase binding sites (BRE box and TATA box) are located within the last 165 bp 
adjacent to the start of the repeats.
Figure 4.11: In vitro transcription of CRISPR locus with SsoRNAP
The left side of the panel contains  an outline of the transcription reaction and the synthesised 
nucleic acid molecules. Colour-coding of leader/repeat/spacer regions as in 4.10. A denaturing 
20% PAA gel with the reaction products can be seen on the right side of the panel. Lanes: 1, 
transcription reaction with template CRISPR I - primer extension with spacer 4; 2, transcription 
reaction with template CRISPR II - primer extension with spacer 4; 3, transcription reaction 
with template CRISPR II - primer extension with spacer 2; 4 - 6, negative transcription controls 
of CRISPR II without TPB, TFB-1 and both TPB/TFB-1 respectively; 6, New England Biolabs 
low MW DNA ladder.
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 In order to map the transcription initiation site within the CRISPR leader 
sequence and gain some insight on the constituent promoter elements the CRISPR 
constructs used as transcription templates were sequenced by Sanger sequencing. 
The CycleReaderTM DNA Sequencing Kit (Fermentas) was used as described in 
Materials and Methods. CRISPR II (either as a PCR fragment or as a linearised pCR2.1 
TOPO construct) was used as template for the four sequencing reactions with the four 
different ddNTPs and the reverse complement oligonucleotide for spacer 2 was used 
as a primer for the kit’s thermostable Taq DNA polymerase. The reaction products 
were analysed on a denaturing 15% PAA / 7 M urea gel, and the sequencing 
information is obtained by comparing the length of the original transcript by the same 
primer with the specifically terminated strands and “reading” the reverse complement 
sequence on the primer-extended products. From the sequencing results in figure 
4.12 we can deduct that the transcription starts at position -22 of the leader sequence 
(where 1 is the first nucleotide of the first repeat) and the highlighted sequence (red) 
before the first repeat is transcribed:
5’-GATAAAGAGAAAACCGGTTAAGTTCGTTTTCATGAAGTTGTTTAAAAGTGTGAAAGTTCGAGTC
TCAATGCGACCGAAACGAATCTTTCTATAATAATTGAACGTTTATAAATGATAGGGTGTATTTCAAT
TTAACATAAAATCCTTGCGACCAGAAATTGTTAAATTAATTACAACTAAAATTGGTCGCATGAAGAG
TAAAGGGTAGTCATGAAGATTTATAAGTAAGAAAAGAGAAAGAAAGA
TAGGAAGTATAAAAACACAACA - 3’
Putative BRE and TATA motif sequences are located approximately 21 bp upstream 
from the transcription start site (highlighted in green and blue respectively), elements 
which appear to be conserved between leader sequences in Sulfolobales   (multiple 
alignment in figure 4.13).  
	 By demonstrating that the CRISPR locus contains a functional promoter 
sequence and can be transcribed by the S. solfataricus  transcription machinery in  vitro 
we have also established that the transcript we can generate is identical to the native 
CRISPR transcript produced in  vivo, and therefore is a valuable substrate to study the 
primary transcript processing and the mature crRNA biogenesis. 
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Mapping the transcription initiation site
Leader -143:
5’-TTTCAATTTAACATAAAATCCTTGCGACCAGAAAT
TGTTAAATTAATTACAACTAAAATTGGTCGCATGAAGA
GTAAAGGGTAGTCATGAAGATTTATAAGTAAGAAAAGA
GAAAGAAAGATAGGAAGTATAAAAACACAACA-3’
Termination mix
ddA
TP
ddT
TP
ddG
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CRISPR II
sequencing 
fragments 
initiation site:
 TAGG...
primer extension DNA product
transcript
148nt
Figure 4.12: Mapping the transcription initiation site
The top left side of the panel illustrates  the principle of using Sanger sequencing to map the 
transcription initiation site.  A 15% denaturing PAA gel with the sequencing reaction products 
is on the right. The first lane of the gel contains  the primer extension product from in vitro 
transcription of CRISPR II /spacer2 (see 4.11) and is overexposed compared to the rest of the 
gel as the product signal was weak. Lanes 2-5 contain the four sequencing reactions  with the 
four  different dideoxynucleotide termination mixes. 
Figure 4.13: Multiple sequence alignment of leader sequences of S. islandicus, S. solfataricus 
98/2, S. solfataricus P2 CRISPR A and B and Acidianus hospitalis. 
Transcription start site in S. solfataricus  cluster B highlighted in red, putative TATA and BRE 
boxes in blue and green respectively. Strictly conserved bases  highlighted in black. Alignment 
by ClustalW, shading by BoxShade server. 
Sislandicus           1 ATCTTTTTCGTATAATTGAACGTTTATAAATAATGGGGTATATTTCAATTGAATGGTAAA 
SislM.14.25_827347    1 ATCTTTTTCGTATAATTGAACGTTTATAAATAATGGGGTATATTTCAATTGAATGGTAAA 
Sso98/2               1 ATCTTTCTATAATAATTGAACGTTTATAAATGATAGGGTGTATTTCAATTTAACATAAAA 
SsoP2_1233281         1 ATCTTTCTATAATAATTGAACGTTTATAAATGATAGGGTGTATTTCAATTTAACATAAAA 
SsoP2_1260638         1 ATCTTTCTATAATAATTGAACGTTTATAAATGATACCCAATGTTTCAATTTAACATAAAA 
Acidianus             1 ------------------------------------------------------------
Sislandicus          60TCCTTGCGACCAAAAATTGTTAAATTAATTACAACTAGAATCGGTCACATGAGGAGTAAAGGATAATA
SislM.14.25_827347   60TCCTTGCGACCAAAAATTGTTAAATTAATTACAACTAGAATCGGTCACATGAGGAGTAAAGGATAATA
Sso98/2              60TCCTTGCGACCAGAAATTGTTAAATTAATTACAACTAAAATTGGTCGCATGAAGAGTAAAGGGTAGTC
SsoP2_1233281        60TCCTTGCGACCAGAAATTGTTAAATTAATTACAACTAAAATTGGTCGCATGAAGAGTAAAGGGTAGTC
SsoP2_1260638        60TCCTTGCGACCAGAAATTGTTAAATTAATTACAACTAAAATTGGTCGCATGAAGAGTAAAGGGTAGTC
Acidianus             1------------------------TTAATTACAACGAAAACCGGTCGCATGATGAACTAAGAGAAGTG
                                                             *transcription start 
Sislandicus         129 ATGAAGATTTATAAGCAAGAAAGGAGTAAAGTAAG-ATAAGAAGTATAAAAACACAACA 186
SislM.14.25_827347  129 ATGAAGATTTATAAGCAAGAAAGGAGTAAAGTAAG-ATAAGAAGTATAAAAACACAACA 186
Sso98/2             129 ATGAAGATTTATAAGTAAGAAAAGAGAAA-GAAAG-ATAGGAAGTATAAAAACACAACA 185
SsoP2_1233281       129 ATGAAGATTTATAAGTAAGAAAAGAGAAA-GAAAG-ATAGGAAGTATAAAAACACAACA 185
SsoP2_1260638       129 ATGAAGATTTATAAGTAAGAAAGGAGAAAAGAAAA-ATAGGAAGTATAAAAACACAACA 186
Acidianus            49 ATGAAAACTTATTAATGAGAAAAGAGAGAAATAAGGACAGAGATTAATAAAACA-AACA 102     
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4.8 Recombinant SsoCas6 is able to process the precursor CRISPR locus 
transcript and generate mature crRNA fragments
	 S. solfataricus  encodes four Cas6 orthologues (Sso1381, Sso1406, Sso1437 
and Sso2004) which belong to the Cas6 I-III superfamily (TIGR01877). Sequence 
analysis confirms that they contain the signature Cas6 motif within the C-terminal 
glycine-rich loop characteristic of RAMP proteins, which consists of the consensus 
sequence GhGxxxxxGhG, where h is hydrophobic and the intermediate sequence has 
at least one lysine or arginine (Makarova et al. 2002; Haft et al. 2005). The only 
characterised member of this superfamily, Cas6 from Pyrococcus  furiosus  (Carte et al. 
2008; Carte et al. 2010; Wang et al. 2011) belongs to a different family (Cas6 I-A, 
Makarova et al. 2011) and COG (PfuCas6 belongs to COG1853 while all the SsoCas6 
proteins to COG5551), and therefore share negligible sequence similarity with 
SsoCas6 (16%), limited to the C-terminal motif. Structure based threading by the 
Phyre server detects PfuCas6 as the closest structural neighbour with a 95% 
sequence coverage suggesting that SsoCas6 also comprises of a duplicate 
ferredoxin-like fold (figure 4.14), although the catalytic triad identified in PfuCas6 is 
only partially conserved (Carte et al 2010, Wang et al. 2011). 
  For this reason, the putative nuclease activity of the SsoCas6 orthologues had 
to be confirmed. The genes sso1437 and sso2004 were amplified from S. solfaraticus 
P2 genomic DNA, cloned in pDEST14, expressed in E. coli and purified by Dr. Shirley 
Graham using nickel-chelate and gel filtration chromatography. The ribonuclease 
activity of SsoCas6 was tested against radiolabelled RNA substrates comprising of 
the CRISPR repeat of locus B  and an in vitro transcript of the first two repeat-spacer 
units of CRISPR locus A. The transcript was generated by T7 in vitro transcription and 
nuclease assays were carried out as described in Materials and Methods. 1 μM of 
recombinant Sso2004 was incubated with the 152 nt CRISPR transcript for 30 min at 
45oC in reaction buffer (20 mM Tris-HCl pH 7.0, 100 mM potassium glutamate, 0.5 mM 
DTT, 5 mM EDTA) and cleavage products were analysed on a denaturing 20% PAA, 7 
M urea gel. SsoCas6 exhibited metal independent ribonuclease activity, and analysis 
of the cleavage pattern suggested that cleavage occurs at a single site within the 
repeat sequences of the transcript, yielding the products illustrated in figure 4.15A. 
Csa2 and Cas5a (individually or in complex) did not exhibit any nuclease activity in the 
absence of Cas6, nor did they affect the activity of Cas6 or modify the cleavage 
pattern when Cas6 was present (figure 4.15 A). 
 To confirm that SsoCas6 cleaves the CRISPR repeat sequence at a single 
position and determine the cleavage site, 1 μM of recombinant Sso2004 was 
incubated with 100 nM of a 25 nt oligonucleotide ssRNA CRISPR repeat sequence 
with a 15-U 5’ extension for 30 min at 45oC, and cleavage products were analysed on 
a denaturing 20% PAA, 7 M urea gel (figure 4.15 B). By running an alkaline hydrolysis 
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ladder of the substrate alongside the reaction, the cleavage site was mapped 8 nt 
from the 3’ end of the repeat sequence, at the position indicated by the asterisk: 
5’ - (15U) - GAUUAAUCCCAAAAGGA*AUUGAAAG - 3’
The crRNAs generated by this process are composed of the 5’ 8 nt psitag (or 5’ 
handle), the virus-derived spacer sequence, and the 17 nucleotides remaining of the 
repeat at the 3’ end (3’ handle) (figure 4.6 E), identical to the cleavage pattern obtained 
by the PfuCas6. This product is identical to the crRNA fragments extracted from the 
native aCASCADE, and combined with the fact that SsoCas6 is physically associated 
with the aCASCADE complex suggests that SsoCas6 is the primary CRISPR transcript 
processing endonuclease in  vivo. The Csa2-Cas5a complex did not exhibit any 
endonuclease activity against the CRISPR transcript in the absence of Cas6 (figure 
4.15A), providing further confirmation that SsoCas6 is responsible for the biogenesis 
of the mature crRNAs found in the effector complex. It is important to mention the 
analogy with the E. coli CASCADE where the processing endonuclease CasE (Cse3) is 
a subunit of the effector complex. 
	 It is hard to speculate about the reaction mechanism of SsoCas6 and potential 
catalytic residues without an available structure. In the Phyre-generated structural 
model, the catalytic triad of PfuCas6 (Tyr31, His46, Lys52 Carte et al. 2008) has been 
replaced by a glutamine at position 32, a threonine at position 45 and a conserved 
lysine at position 51. Most of the Cas6 conserved residues among the Sulfolobales, as 
identified by multiple sequence alignments, seem to cluster around the central cleft 
between the two predicted ferredoxin domains in the model (figure 4.14), suggesting a 
similar path for the RNA substrate as in PfuCas6. A multiple sequence of Cas6 
orthologues can be found in Appendix II.
Figure 4.14: Structure of PfuCas6 and model of SsoCas6
The structural model of SsoCas6 was  generated by the Phyre fold recognition server using 
PfuCas6 as  template. (P. furiosus  PDB code: 3I4H) Conserved residues in SsoCas6 are 
coloured in red, and the signature G-rich loop in blue. Residues corresponding to the PfuCas6 
catalytic triad are coloured in orange. The catalytic triad in the PfuCas6 structure is coloured in 
blue. Images generated with PyMOL.
SsoCas6 model
PfuCas6
PDB 3I4H
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Figure 4.15: CRISPR transcript processing by SsoCas6
(A) A radiolabelled transcript of the first two-repeat spacer units  of CRISPR locus  B  was 
incubated with Cas6 and other aCASCADE components and products were analysed on a 
20% denaturing PAA/Urea gel. Lanes are marked with the respective protein component in 
each assay. Cas6 is able to cleave the transcript at a single site in each repeat sequence, 
yielding the pattern illustrated in (C). Csa2 and Cas5a did not exhibit any catalytic activity on 
the transcript (lanes  6-8), individually or in complex, nor did they alter the cleavage activity of 
Cas6 (9-11). Cas6 did not cleave a control transcript lacking repeat sequences (lanes  13, 14). 
C, control reaction without protein; M, RNA Decade marker system (Ambion). (B) Mapping the 
Cas6 cleavage site within the CRISPR repeat sequence. Substrate is a synthetic RNA 
oligonucleotide corresponding to a CRISPR repeat with a 15U 5’ extension. Csa2 does not 
cleave the repeat sequence. L, alkaline hydrolysis  ladder of the substrate. (C) Schematic 
illustration of the CRISPR transcript indicating the cleavage sites  and the generated products. 
The cut site within the repeat sequence is  indicated with an asterisk. Adapted from Lintner et 
al. (2011).
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4.9 The recombinant Csa2-Cas5a complex binds crRNA and forms ternary 
complexes with target DNA
	 To determine whether the Csa2-Cas5a complex could bind mature crRNA units 
and utilise them as guides to recognise and target viral DNA in analogy to the E. coli 
CASCADE, electrophoretic mobility shift assays were carried out to assess its affinity 
for crRNA and DNA. The substrates used were based on the sequence of the first 
spacer of S. solfataricus  CRISPR locus A (A1) and their sequences can be seen in 
table 4.3. 
Name sequence notes
crRNA-A1
 
5’- 
AUUGAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAA
AUAAU GAUUAAUCCCAAAA 
60nt synthetic 
crRNA
crRNA-
A1_Δ3
5’- 
AUUGAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAA
AUAAU 
40nt crRNA
minus 3’ handle 
crRNA-
A1_Δ5
5’- 
GAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAAAUA
AU GAUUAAUCCCAAAAGGA 
60nt crRNA
minus part of 5’ 
psitag
A1P control
5’- 
AGGGUAUUAUUUGUUUGUUUUCUUCUAAACUAUAAGCUAGU
UC 
43nt control RNA
tA1f 
+PAM
 5’- TAATACGACTCACTATAGGGT 
ATTATTTGTTTGTTTTCTTCTAAACTATAAGCTAGTTC 
TGG AGAGAAGGTG 
72nt target DNA 
+PAM
tA1r 
+PAM
5’- CACCTTCTCT CCA   
GAACTAGCTTATAGTTTAGAAGAAAACAAACAAATAAT 
ACCCTATAGTGAGTCGTATTA 
72nt reverse target 
DNA +PAM
tA1f
-PAM 
5'- TAATACGACTCACTATAGGGT 
ATTATTTGTTTGTTTTCTTCTAAACTATAAGCTAGTTC 
CCC AGAGAGGTG 
72nt target DNA -
PAM
RNA_tA1f
5’- 
AGGGUAUUAUUUGUUUGUUUUCUUCUAAACUAUAAGCUAGU
UC UGGAGA
49nt target RNA
crRNA 
native
5’-
AUUGAAAGGAACUAGCUUAUAGUUUAGAAGAAAACAAACAA
AUAAUGAUUAAUCCCAAAAGGA
63nt native mature 
crRNA
Table 4.3: Synthetic oligonucleotides used in chapter 4
Spacer sequences are highlighted in red, the 5’ psi-tag sequence in crRNA is  in blue and the 
PAM  in DNA oligonucleotides is underlined. 
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4.9.1 Substrate analysis of crRNA 
 Firstly the affinity of the Csa2-Cas5a complex for crRNA was investigated by 
incubating increasing concentrations of the complex with 100 nM radiolabelled 
synthetic crRNA oligos at 55oC for 10 min in binding buffer (20 mM MES pH 6, 50 mM 
potassium glutamate, 0.5 mM DTT, 5 mM EDTA, 5% glycerol) prior to separation by 
native 10% PAA gels. In order to determine whether the complex binds the crRNA in a 
sequence specific manner and recognizes elements of the mature crRNA sequence 
such as the 5’ psitag or the 3’ handle, the following RNA substrates were used:
i) crRNA-A1: 60 nt sequence containing the 8 nt 5’ psitag, the spacer A1 sequence 
and 14 nt of the 3’ handle. This substrate represents the mature crRNA found in vivo, 
although due to the size limitations of synthetic oligonucleotides, 3 nt are missing 
from the 3’ end. 
ii) crRNA-A1_Δ3: 40 nt sequence missing the 3’ handle.  
iii) crRNA-A1_Δ5: 60 nt sequence containing the full spacer sequence and 3’ handle, 
but missing the first 3 nt from the 5’ psitag. 
iv) A1P: 43 nt control ssRNA substrate missing the 5’ psitag and the 3’ handle. 
The assays were repeated in triplicate for each substrate and processed using 
ImageGauge software. Quantification of the bound and unbound RNA fractions 
enabled the determination of the binding ratio of the RNA-protein complex as the 
percentage of bound to total RNA for each protein concentration: (bound RNA) / 
[(bound RNA) + (unbound RNA)]. An apparent dissociation constant, Kd, for each 
substrate was estimated by plotting the binding ratios over the protein concentrations. 
The estimated Kd values and typical assay images are presented in figure 4.16 and 
table 4.4. These values should be regarded with caution as this type of assay has 
relatively low sensitivity and is only accurate for proteins that form stable complexes 
with nucleic acids. The migration of unstable or transient protein-nucleic acid 
complexes through the gel matrix can result in complex disassembly, leading to 
overestimation of the apparent Kd values. In the case of Csa2-Cas5a, which is a large 
multimeric complex, migration of the RNA-protein complexes was extremely slow and 
a portion of the samples was held up in the wells of the gel, forcing us to adjust the 
assay conditions in a way that did not reflect the physiologically relevant state of the 
interaction. For these reasons, the Kd values mentioned here serve only to as a 
comparative measure for the affinity of the Csa2-Cas5a complex to the different RNA 
substrates and do not represent the actual Kd values. 
 From the results we observe that the complex exhibits an overall affinity for 
ssRNA, as it is able to bind all substrates with comparable Kd values. It is generally 
considered that the 5’ psitag is responsible for crRNA recognition and binding by the 
CAS effector complexes, as it is the only sequence present in all cloned crRNA 
sequences from the native aCASCADE, the E. coli CASCADE (Brouns et al. 2008) and 
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the P. furiosus  CMR complex (Hale et al. 2009). We were unable to detect a significant 
difference in the affinity values exhibited by he recombinant Csa2-Cas5a complex for 
the substrates tested here. For this reason it is not possible to identify which part of 
the crRNA is recognised and bound by this minimal aCASCADE core, suggesting that 
potentially other subunits are required. A synthetic RNA oligonucleotide with a 
complete deletion of the 5’ psitag was not generated therefore it is not possible to 
make assumptions about specific interactions, but it is possible that the protein 
maintains base-specific interactions with at least the last 5 nt of the 5’ psitag and 
various bases of the 3’ handle. The spacer sequence between the repeat-derived 
sequences of the crRNA is expected to be exposed and available for screening 
potential invader sequences by Watson-Crick basepairing, therefore the only 
interaction with the protein should be via the phosphate backbone. Whether this 
contributes to the relatively high apparent Kd values is unknown. 
Figure 4.16: Binding of Csa2-Cas5a to crRNA
Areas of photo-stimulated luminescence (PSL), corresponding to uncut substrate and cleaved 
product, were quantified using Image Gauge software and used to determine the dissociation 
constants for each substrate as described in the text. 
Table 4.4: Apparent Kd values for Csa2-Cas5a and the various RNA substrates
μΜ 0.5 1 2 3 5 0.5 1 2 3 5 0.5 1 2 3 5 0.5 1 2 3 5
crRNA-A1 Α1P ctrlcrRNA-A1_Δ5 crRNA-A1_Δ3
unbound crRNA
bound crRNA
substrate Kd (μΜ) comparative diagram
crRNA-A1 1.5
crRNA-A1_Δ5 2
crRNA-A1_Δ3 2.25
A1P control 2.4
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4.9.2 Csa2 is the main crRNA binding subunit of the Csa2-Cas5a complex
 Both subunits of the Csa2-Cas5a complex were tested for their ability to bind 
crRNA individually, in order to gain insight into the mode of protein - nucleic acid 
interaction and the role of each subunit in the complex. For this reason, because the 
Cas5a orthologue found in the native aCASCADE Sso1441 was poorly expressed on 
its own, the Cas5a orthologue Sso1998 was cloned and expressed in E. coli by Dr. 
Shirley Graham allowing for purification of the recombinant protein with a 6-histidine 
tag. Electrophoretic mobility shift assays were carried out to compare binding of Csa2 
(Sso1442), Cas5a (Sso1998) and the Csa2-Cas5a complex to crRNA-A1 under the 
conditions described in the previous paragraph. 100 nM of radiolabelled crRNA-A1 
were incubated with increasing protein concentrations at 55oC prior to separation on a 
native 10% PAA gel. Assays were repeated in triplicate, and results are presented in 
figure 4.17 A & B. Cas5a alone does not bind crRNA, but both Csa2 and the Csa2-
Cas5a complex exhibited similar affinities for the crRNA, with apparent dissociation 
constants between 0.5 - 1 μM. This observation confirms that Csa2 is the major RNA 
binding subunit of the complex. 
	 In order to identify potential residues involved in nucleic acid recognition and 
binding of Csa2, the conserved residue His160 (see 4.2) was mutated to an alanine. 
The Csa2-H160A mutant exhibited significantly reduced affinity for crRNA compared 
to the wild type as can be seen in figure 4.17 C, binding only ~10% of the substrate at 
concentrations where the wild type is capable of 100% binding. We are unable to 
predict the localisation of the crRNA in the Csa2 structure in the absence of a co-
crystal, but the solvent-exposed His160 is obviously involved in the interaction. 
bound crRNA
unbound crRNA
0.5 1 2 30 0.25 0.5 1 2 30.25 μΜ
Csa2 WT Csa2 H160ACas5a Csa2-Cas5a
0.5 1 2.50.5 1 2.5
CB
Csa2 Csa2-Cas5a
μΜ 0.5 1 2 3 50 0.25 7 0.5 1 2 3 50.25 7
unbound crRNA
bound crRNA
A
Figure 4.17: Comparative binding of aCASCADE individual subunits and the complex to crRNA 
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4.9.3 The crRNA - loaded Csa2-Cas5a complex recognises and binds target DNA
	 The next functional step in the process of viral interference of the E. coli 
CASCADE is the RNA-guided sequence specific targeting of invading DNA, and 
subsequent recruitment of Cas3 to catalyse the degradation of the invader sequence. 
The Csa2-Cas5a complex was assayed for similar activity by investigating its affinity 
for a radiolabelled target DNA in the presence or absence of crRNA. In the absence of 
crRNA-A1, the affinity of the complex for a ssDNA target was minimal (figure 4.18 A). 
Nevertheless, when Csa2-Cas5a was incubated with an excess of crRNA, the 
ribonucleoprotein complex formed was able to recognise and shift a labelled ssDNA 
complementary to the spacer A1 in the crRNA (substrate tA1f, table 4.3, figure 4.18 A) 
with an apparent dissociation constant of 750 nM. The recognition is mediated by the 
basepairing of the central spacer region of the crRNA and tA1f oligonucleotides, 
resulting in the formation of DNA-RNA heteroduplex and a stable ternary complex with 
Csa2-Cas5a. The reverse complementary DNA strand (tA1r), containing the spacer A1 
sequence, was not gel-shifted by the crRNA-loaded Csa2-Cas5a complex (figure 4.18 
A), indicating that the DNA targeting is entirely dependent on the existence of a region 
of complementarity between the crRNA and the target DNA and the formation of a 
heteroduplex. Moreover, the crRNA-Csa2-Cas5a complex did not exhibit affinity for a 
ssRNA target (RNA_tA1f) complementary to the spacer A1 (figure 4.18 B), indicating 
that the molecular recognition mechanism is specific for targeting DNA, possibly by 
interactions with the deoxyribophosphate backbone. 
	 Jore et al. (2011) have demonstrated that the molecular mechanism utilised by 
the E. coli CASCADE to recognise invader dsDNA is the formation of an R-loop by 
basepairing of the protein-bound crRNA with the complementary DNA strand and 
displacement of the non-complementary strand. The target DNA substrates used in 
our study were not long enough to observe the formation of an R-loop, although it is 
possible that a similar mechanism is in operation.
	 Thus we have demonstrated that the  mature crRNAs generated by Cas6 and 
loaded on the Csa2-Cas5a complex serve as guide RNAs that enable recognition and 
binding of the invader ssDNA. Predictably we did not observe any cleavage of the 
bound target DNA by the Csa2-Cas5a complex (figure 4.19). It is hypothesised that in 
analogy with the E. coli CASCADE, accessory CAS proteins are recruited to perform 
the silencing of the invader DNA. In E. coli this role is performed by Cas3, a predicted 
DEAD-box helicase fused to an HD-nuclease in the E. coli CAS  system. In Sulfolobus 
solfataricus  and other CAS systems these two functional domains comprise different 
proteins, where Cas3 is a DEAH/X-box helicase always encoded next to a protein with 
a predicted HD family nuclease domain. It is predicted that both proteins are required 
to interfere with virus proliferation, but it is unlikely that they interact physically with 
the Csa2-Cas5a complex as they were not found among the co-purifying proteins 
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during native expression. Therefore, in order to reconstruct and study the interference 
pathway for S. solfataricus in vitro it is necessary to express these proteins 
recombinantly. 
Figure 4.18: cr-RNA mediated binding of Csa2-Cas5a to DNA target
(A) Increasing concentrations of Csa2-Cas5a were pre-incubated with 100nM of unlabelled
crRNA for 3 min, and 25nM of labelled target ssDNA were added for 10 min at 55oC. Products 
were analysed on a native 10% PAA gel. Reactions  were repeated in triplicate, and typical 
assay images are presented here. (B) The Csa2-Cas5a complex showed minimal affinity for an 
RNA target complementary to the pre-loaded crRNA. Assay conditions  and substrate 
concentrations as  for (A). (C) Comparative binding of Csa2 and the Csa2-Cas5a complex to the 
crRNA/DNA target heteroduplex. Assay conditions as in (A). Both Csa2 and the complex 
display comparative affinity for the DNA target, with a slightly lower apparent Kd for the 
complex. This confirms that Csa2 is  the main subunit responsible for the nucleic acid 
0.05 0.1 0.25 0.5 1 2 0.05 0.1 0.25 0.5 1 2 μΜ
Csa2-Cas5aCsa2
DNA/RNA 
heteroduplex
bound 
DNA/RNA
C
A
0.5 1 2 40.250.5 1 2 40.250.5 1 2 40.25
target DNA tA1f target DNA tA1r
+crRNA-A1
Csa2-Cas5a (μΜ)
unbound 
labelled ssDNA
DNA/RNA 
heteroduplex
bound 
DNA/RNA
dsRNA
bound dsRNA
Csa2-Cas5a
0 0.25 0.5 1 2 4 μΜ
B
 
  5’-     AUUGAAAG GAACUAGCUUAUAGUUUAGAAGAAAACAAACAAAUAAU GAUUAAUCCCAAAA
                  ||||||||||||||||||||||||||||||||||||||
3’- GTGGAAGAGAGGT CTTGATCGAATATCAAATCTTCTTTTGTTTGTTTATTA GGGATATCACTCAGCATAAT-5’
D
CHAPTER 4: Characterisation of the aCASCADE
127
recognition and interactions, with Cas5a potentially involved in alignment and stabilisation of 
the heteroduplex. (D) The crRNA/target DNA heteroduplex bound by aCASCADE. Spacer 
sequence in red, the PAM is underlined and highlighted in blue and the crRNA 5’ psi-tag is  in 
bold. 
 As will be discussed in more detain in the following chapter, we were able to 
obtain a recombinant SsoCas3’ but we were not able to express any of the HD 
nuclease orthologues from S. solfataricus, either individually or in co-expression 
vectors with Cas3. The protein is either highly unstable or extremely toxic for E. coli, 
which leaves native expression in S. solfataricus as the only option. 
Figure 4.19: Absence of nuclease activity on DNA protospacer targets by aCASCADE
2μΜ of either recombinant or native aCASCADE were pre-incubated with 100nM unlabelled 
crRNA_A1 for 5 min at 55oC, and the reaction was initiated with the addition of 300nM of ss  or 
ds protospacer DNA targets and 1μΜ of Csa5 and Cas3 where indicated. Reactions  were 
incubated at 60oC for 20min, terminated by Proteinase K treatment for 10min at 37oC and 
analysed on denaturing 20% PAA/ 7M Urea gel. Protein components  are indicated on the gel. 
In ds  substrates, labelled strand is indicated with an asterisk. Lanes: 1, substrate ss  tA1f ; 2, 
substrate ds tA1f/*tA1r ; 3, substrate ds  *tA1f/tA1r ; 4-6, as  1-3 ; 7, substrate ss  tA1r ; 8, 
substrate ss tA1f ; 9, substrate ds tA1f/*tA1r ; 10, substrate ds  *tA1f/tA1r ; 11, substrate ds 
tA1f/*tA1r ; 12, substrate ds *tA1f/tA1r, 13, substrate ss  tA1r ; 14, substrate ss  tA1f ; 15, control 
ss tA1r ; 16, control ds *tA1f/tA1r ; 17, control ds tA1f/*tA1r. Some specific substrate 
degradation can be observed with the ss tA1f substrate and the native aCASCADE in the 
presence of Cas3 and Csa5 (lane 14), and it could  potentially be attributed to sub-
stoichiometric amounts  of the HD nuclease in the partially purified native sample, but this  result 
could not be confidently repeated. 
1 2 3 54 6 7 8 9 10 11 12 13 14 15 16 17
72nt
rec Csa2/Cas5a native aCASCADE
+Cas3,Csa5 +Cas3,Csa5 controls
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4.9.4 The protospacer adjacent motif (PAM) is not required for target DNA 
recognition by the recombinant Csa2-Cas5a complex
 Sequence analysis of the protospacers corresponding to spacers in CRISPR 
families of the Sulfolobales  revealed that they contain conserved dinucleotide motifs at 
the 5’ end, termed “protospacer adjacent motifs” (Lillestol et al. 2009). These motifs, 
as described by Lillestol et al., vary according to the CRISPR family the respective 
spacer belongs to, leading to the hypothesis that the PAMs may be implicated in the 
adaptation stage of CRISPR system functioning. Consensus motifs are CC for family I 
(with tolerance for T at either position), TC for family II and GT for family III. CRISPR 
loci of S. solfataricus  P2 belong to families II (clusters A and B) and I (clusters C, D, E, 
F). In  vivo experiments where Sulfolobus  strains were challenged with appropriate 
protospacer-carrying vector constructs, low transformation efficiencies and high levels 
of deletions in the transformants were obtained when the predicted PAM motif was 
present (Gudbergsdottir et al. 2011). These results indicate that the PAM sequences 
are required for invader DNA targeting in  vivo, possibly by mediating a self-non self 
discrimination mechanism. 
	 The significance of the PAM motif for the functioning of the minimal 
recombinant system described here was investigated by designing two different 
ssDNA protospacer targets for crRNA-A1 containing or not the predicted family II PAM 
motif (CCN). The respective oligonucleotide sequences can be found in table 4.3, 
termed tA1f+PAM (carrying the sequence TGG) and tA1f-PAM (carrying the sequence 
CCC) respectively. The affinity of the Csa2-Cas5a complex, pre-loaded with an excess 
of crRNA-A1, to both targets was comparable (fig 4.20A), indicating that there is no 
requirement for the presence of the PAM for the recognition of the ssDNA target in the 
minimal recombinant system assayed here. 
 To investigate the possibility that accessory aCASCADE proteins are 
implicated in the PAM recognition, we considered the role of the co-purifying protein 
Csa5. The gene encoding for Sso1443 (Csa5) was cloned and expressed in E. coli by 
project student Maryam Qurashi, allowing for purification of the recombinant protein 
through affinity and size-exclusion chromatography. As mentioned before, Csa5 is a 
small basic 150aa protein of unknown function encoded upstream of Csa2 in a 
conserved cluster containing Csa5, Csa2 and Cas5a. Its co-purification with the native 
aCASCADE from S. solfataricus  indicates a potential functional and physical 
association. Electrophoretic mobility shift assays carried out by Dr Shirley Graham 
indicated that Csa5 alone does not exhibit any affinity for RNA or DNA, therefore we 
investigated whether its presence could alter the affinity of the crRNA-Csa2-Cas5a 
complex to target ssDNA perhaps by inducing an allosteric conformational change to 
the proteins. Electrophoretic mobility shift assays carried out in the presence or 
absence of Csa5 showed no difference in the binding affinity of the crRNA-Csa2-
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Cas5a complex to the target ssDNA±PAM, confirming that there is no discrimination at 
this level (figure 4.20 B). Substrate degradation products observed in high protein 
concentrations are the result of contaminants in the Csa5 preparation. 
 
Figure 4.20: Effect of the Protospacer Adjacent Motif on crRNA -guided binding of DNA targets 
by the aCASCADE.
(A) The Csa2-Cas5a complex displays comparative affinity to complementary ssDNA targets in 
the presence of crRNA regardless  of the existence of a PAM. (B) The Csa2-Cas5a complex was 
incubated with ssDNA targets  ±PAM in the presence of crRNA and in the presence or absence 
of equimolar amounts of Csa5 in standard assay conditions  (55oC, 10min). No effect on DNA 
binding was observed. The apparent weaker binding of Csa2-Cas5a to DNA in (B) compared to 
(A) is  attributed to the general inconsistent behaviour of this protein in binding assays, 
depending on the purification batch, the length of time the protein was  stored at 4oC and assay 
conditions. ß
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4.10 Structural studies and discussion
4.10.1 The structure of Csa2 	
 In order to gain a better understanding of the molecular basis of the archaeal 
CASCADE the structure of recombinant Csa2 (Sso1442) from S. solfataricus  was 
solved by X-ray crystallography by Nathanael Lintner in the group of Martin Lawrence 
in Montana State University. For full crystallisation conditions, data collection and 
refinement details, refer to Lintner et al. (2011). Phases were determined by multi-
wavelength anomalous diffraction on a KAu(CN)2-soaked crystal which diffracted to 
2.0 Å resolution, and by collecting also a 2.0 Å resolution single wavelength dataset 
from a native crystal. The protein crystallised in space group P212121 with four copies 
of Sso1442 in the asymmetric unit. About 8% of the residues in each chain could not 
be modelled as the electron density was not defined. Structure coordinates were 
deposited in the protein data bank with accession code PDB ID: 3PS0. The final model 
consists of four Csa2 chains, but the crystal packing is not thought to represent a 
biologically relevant quaternary structure as it exhibits closed symmetry, incompatible 
with the results obtained with TEM (discussed below). The Csa2 monomer consists of 
three domains arranged vertically, 65 Å in length (figure 4.21 A). The central domain 
contains essentially an RNA-recognition motif, a ferredoxin-like fold comprised by the 
four strands of a central antiparallel β-sheet (β6, β7, β1 and β8) and helices α1 and 
α8, in the βαββαβ topology characteristic of this fold. This RRM motif is extended 
with a connecting 13-aa loop leading to helix α9, an additional fifth strand to the 
central β-sheet (β9) and helix α10 which comprises the C-terminus of the protein. 
Helices α9 and α10 are located on either sides (above and underneath respectively) of 
the central β-sheet, partially covering the β-sheet surface which is responsible for 
RNA binding in the typical RRM fold. Moreover, the characteristic sequence motifs 
containing the aromatic residues responsible for RNA binding are not conserved in the 
Csa2 central β-sheet (except for Tyr141), which suggests a distinct mode of RNA 
recognition. 
 The second and third domains of the Csa2 structure are located in opposite 
sides of the central RRM-like domain, and are termed “1-3” and “2-4” domains 
respectively. The former consists of residues 27-46 and 145-180, which form 
insertions one and three into the RRM domain. Specifically, helix α1 followed by a 
disordered loop and strands β2-β3 forming an antiparallel hairpin are inserted between 
the N-terminal β1 and α2, and helix α7 followed by a disordered loop (absent from the 
model) is inserted between β6 and β7. The “2-4” domain consists of insertions two 
and four “below” the central RRM domain. In particular, residues 68-136  extending 
from helix α2 are arranged into short helices α3, α4, α5, α6 and a protruding hairpin 
composed of antiparallel strands β4, β5, which forms the edge of the crescent-shaped 
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protein. Residues 192-216 form the fourth insertion, which consists of an extended 
connecting loop between β7 and the N-terminal half of helix α8.
 Interestingly, the N-terminal ferredoxin fold of Pyrococcus  furiosus  Cas6 is 
identified by the DALI structural comparison server as the closest structural neighbour 
of Csa2 (figure 4.21 B & C). The similarity is limited to the RRM domain, with an RMSD 
of 2.9 Å on 87 aligned residues. As described elsewhere, Cas6 is a metal-independent 
RAMP superfamily endoribonuclease with a tandem ferredoxin-like fold, with a 
conserved catalytic triad positioned at the opposite side of the central cleft formed by 
the β-sheets of the two domains (Carte et al. 2008). This similarity contains limited 
information regarding the function of Csa2, as the respective domains are surrounded 
by different folds in each protein and the functional sequence motifs are not 
conserved. 
 A closer inspection of the conserved residues within the Cas7 superfamily and 
the Csa2 family (Cas7 type I-A, TIGR02583) in particular, reveals that the majority can 
be mapped on two clusters on the protein surface, the first on the 1-3 domain and the 
second at the interface between the RRM and the 2-4 domain (figure 4.21B). The first 
cluster consists of residues Asn16, Pro46, His160, Arg162 and Glu178 and is referred 
to as the asparagine (Asn) cluster and the second as the glycine (Gly) cluster and 
consists of residues His55, Gln58, Gly121, Gly122, Phe123 and Ser135. These 
clusters form solvent-exposed, basic patches on the concave surface of the protein 
crescent, and would be suitable candidates for mediating nucleic acid interactions. 
The glycine cluster in particular is positioned in the “opposite side” of the β-sheet of 
the RRM domain, reflecting the relative positioning of the PfuCas6 active site with the 
central cleft (figure 4.21 C). This supports the hypothesis that the conserved Gly 
cluster plays a functional role, potentially in nucleic acid recognition and binding. 
Furthermore, we have demonstrated that mutation of the conserved His160 to alanine 
indeed abolishes the ability of Csa2 to bind crRNA. Additional conserved residues are 
located in the disordered α1-β2 and α8-β8 loops (Gly22, Asn23 and Asg240 
respectively). The apparent flexibility of the disordered loops and the β-hairpins in the 
1-3 and 2-4 domains along with the location of the conserved Asn and Gly clusters 
suggests their involvement in the recognition and binding of the crRNA, and the 
subsequent recognition and correct positioning of the target DNA (ss or ds). The 
nature of the conserved residues is such that it is unlikely that Csa2 exhibits a 
nuclease activity like Cas6, which was confirmed experimentally. With the RNA-
binding surface of the RRM domain partially covered, it is difficult to suggest a path 
for the crRNA. It was demonstrated however by RNAse protection experiments 
(Lintner et al. 2010) that the crRNA is protected completely, indicating that it is bound 
by the protein throughout its length. 
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Figure 4.21: Structure of SsoCsa2
(A) Cartoon representation of the Csa2 structure, illustrating the topology and connectivity of 
the various  secondary structure elements. Domains are coloured as follows: RNA-Recognition 
Motif (RRM) in violet, C-terminal extension of the RRM motif in yellow, 1-3 domain in red and 
2-4 domain in orange. (B) Location of conserved residues of the Csa2 family on the Csa2 
structure. (C) Cartoon representation of the structure of Cas6 from Pyrococcus  furiosus. The 
RRM domain which exhibits  similarity to the Csa2 RRM domain is  depicted in violet to enable 
comparison with the respective domain in (B). The location of the conserved catalytic triad is 
marked with sticks. Adapted from Lintner et al. (2011). 
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Csa2 front side 
Csa2 back side
Figure 4.22 : Electrostatic surface map of Csa2
Cartoon representations of the two facets of Csa2 and their respective electrostatic surface 
map, calculated with APBS tools  in PyMOLX11. Surface electrostatic potential is set at ±5 kT/e 
and colour gradient is red (acidic) to blue (basic). We can observe a large negative patch on the 
back side of the protein (non-concave side) corresponding mainly to the 1-3 domain that could 
mediate nucleic acid interactions. 
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4.10.2 Arrangement of the native aCASCADE and mechanistic implications 
 Negative stain transmission electron microscopy (TEM) was employed by 
Nathanael Lintner to visualise the structural organisation of the native aCASCADE 
sample, purified from S. solfataricus. The complex was arranged in right-handed 
helices with 14 nm pitch, forming protein filaments with 6 nm width and variable length 
(figure 4.23  A). For complete experimental details and processed images refer to 
Lintner et al. (2011). These filaments were observed only in the presence of Cas5a and 
crRNA, while Csa2 alone was shown to be predominantly monomeric/dimeric in 
solution. The excess of Csa2 over Cas5a in both the native and recombinant purified 
samples is comparable to the over-representation of CasC in the E. coli CASCADE, 
where it forms a semicircular “backbone” with 6 subunits. It is possible therefore, that 
the primary component of the helices is Csa2, with Cas5a and the other accessory co-
purifying proteins (Csa5, Cas6, Csa4)  serving to stabilise or control the nucleation and 
growth of the complex. The variable length of the helical assembly could also explain 
the inconsistent behaviour of the aCASCADE complex on the analytical size exclusion 
column and our inability to estimate the molecular weight. The open symmetry 
displayed in these assemblies is in contrast to the closed symmetry observed in the 
asymmetric unit of the crystal, and because the former were observed in the presence 
of the natural Csa2 protein partner, they are thought to represent biologically relevant 
arrangements. 
 Interestingly, it was observed that the length of the Csa2 monomer (65 Å) is 
comparable to the width of the helix, allowing multiple copies of the Csa2 structure to 
be modelled onto the helix. Two structural models were proposed by N. Lintner and M. 
Lawrence to account for the potential functional role of the helical assemblies (figure 
4.23 B). In the first model, the extended filaments bind multiple crRNA units and are 
used to screen target DNA simultaneously, perhaps by wrapping around it and 
inducing the formation of R-loops as observed for the E. coli CASCADE. In the second 
model, a shorter arch-shaped assembly composed of limited Csa2 subunits is binding 
a single crRNA, and sub-stoichiometric amounts of Cas5a and perhaps Csa5/Cas6 
form the nucleation/termination ends of this partial helix. This second model is 
reminiscent of the arrangement of the CasC backbone in the E. coli CASCADE, and 
would constitute a more flexible effector complex to patrol the cell for invading DNA, 
with the added advantage of adjustable length according to spacer length.  In any 
case, it was observed that the groove of the helical assembly is large enough to 
accommodate either dsDNA or an RNA/DNA hybrid (see Lintner et al. 2010).
 Our biochemical data suggest that Csa2 is the primary RNA-binding 
component of the Csa2-Cas5a complex, exhibiting a higher affinity for crRNA over 
control sequences. However, Csa2 can bind the control RNA substrate suggesting a 
general sequence-independent binding ability, perhaps as a result of its basic surface 
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patches. In an effort to analyse the crRNA elements responsible for this specific 
interaction, it was observed that both the conserved 5’ psitag and the 3’ handle 
contributed to the binding specificity, since the protein exhibited comparable affinity 
for substrates missing one or the other element. Since there is an obvious need for the 
bases of the spacer sequence to be solvent-exposed and accessible for basepairing 
with target DNA, sequence-specific interactions must be restricted to the conserved 
repeat-derived sequences. The 5’ psitag sequence seems to be a general feature of 
crRNAs in all systems studied so far, highlighting its importance as a universal 
recognition signal of cRNA by the effector Cas proteins. The Csa2-Cas5a complex 
must also be able to screen invader dsDNA for appropriate targets and stabilise a 
crRNA/DNA heteroduplex. A crystal structure of crRNA-bound Csa2 (±Cas5a) would 
help elucidate these mechanistic problems. 
Figure 4.23: Quaternary structural models of native aCASCADE
 (A) The right-handed helical structures of aCASCADE visualised by TEM. (B) Model of the
potential arrangement of Csa2 monomers in the observed helical assembly, and roles of the 
accessory subunits. The Csa2 subunits composing the crRNA-supporting core of a partial helix 
are coloured in alternating dark and light grey. Copies  of Cas5a and/or Csa5/Cas6 could be 
involved in inducing / terminating the polymerisation of Csa2. Adapted from Lintner et al. 
(2011).
	 In contrast to the observation made by Gudbergsdottir et al. (2011) that the 
protospacer adjacent motif (PAM) is required for in  vivo targeting in S. solfataricus, we 
do not observe such a requirement in the minimal molecular system identified here. 
The same conclusion was reached by Manica et al. (2011) in their genetic studies of in 
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vivo interference in S. solfataricus, where the protospacer of choice did not contain a 
PAM sequence in its original context. Since the recombinant Csa2-Cas5a complex is 
lacking some of its in vivo partners (Csa5, Csa4, Cas3, HD nuclease) we are not in a 
position to make definite assumptions about the importance of the PAM motif, 
especially since it is identified in sequence analyses of the S. solfataricus  protospacers 
(Lillestol et al. 2009). It cannot be ruled out that one of these accessory proteins (Csa5, 
Csa4) are responsible for this specific interaction, and perhaps it is required in order 
for the final step to occur, namely the recruitment of Cas3 and HD nuclease and the 
final degradation of the target DNA. It could also be the case that the PAM is 
recognised in a dsDNA substrate, but the molecular basis of such a possibility would 
require interactions between Csa2 and both the DNA strands simultaneously. It is also 
possible that this motif plays a key role during the adaptation stage and is essential for 
the recognition and selection of new spacers, in which case it may be recognised and 
bound by other Cas components. 
4.10.3 Emerging model for CRISPR-mediated interference in Archaea
	 This chapter describes the first identification and biochemical/structural 
characterisation of a CASCADE orthologue in Archaea. Comprised by subunits Csa2 
and Cas5a (or Cas7 and Cas5 respectively), orthologues of CasC and CasD, the 
native complex purified from S. solfataricus  is shown to co-purify with processed 
CRISPR-derived RNA. A number of transiently interacting proteins also co-purify with 
the Csa2-Cas5a complex indicating an accessory role, namely Cas6, Csa5 and Csa4. 
The conservation of these two superfamilies across CRISPR subtypes is indicative of 
their key role for the structure and function of CASCADE-like complexes, a hypothesis 
supported by the results presented here. The archaeal CASCADE demonstrates a 
crRNA - dependent DNA binding activity analogous to the E. coli CASCADE, and 
enables the formulation of a biochemical model for CRISPR - mediated antiviral 
defence in S. solfataricus, which is relevant to all the type I CRISPR subtypes 
harbouring CASCADE orthologues and type III-B  systems with Cmr orthologues 
(figure 4.24). This model does not describe the adaptation stage in which new spacers 
are acquired or synthesised, as experimental information for this stage is still very 
limited and is poorly understood. 
	 In the processing stage of CRISPR functioning, CRISPR loci are transcribed 
normally by the S. solfataricus  transcription machinery. In this context, we have 
demonstrated that the leader sequence directly upstream of the CRISPR locus in S. 
solfataricus  acts as a canonical promoter and can direct transcription of the CRISPR 
locus in vitro. Whether some form of transcriptional regulation is taking place is a 
matter of ongoing research. In the bacterial E. coli system, it has been shown that 
transcription of the both the CRISPR locus and the Cas operon is repressed by H-NS 
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and derepressed by activator LeuO (Pul et al. 2010; Westra et al. 2010). In Thermus 
thermophilus  the cAMP receptor protein seem to control transcription (Agari et al. 
2010), while in S. solfataricus  a novel Cas transcriptional regulator with a binding site 
for an allosteric effector molecule has been identified in the form of Csa3 (Lintner et al. 
2011). In all the archaeal in vivo systems studied up to now, CRISPR loci seemed to 
be continuously transcribed and processed (Tang et al. 2002; Hale et al. 2009; 
Lillestol et al. 2006, 2009), in accordance with a surveillance role in the cell, although 
there is no information as to whether their transcription is up-regulated in response to 
an infection. 
 Subsequently, processing of the CRISPR transcripts into mature crRNA repeat-
spacer units is carried out by Cas6 (or equivalent processing ribonucleases like CasE 
or Csy4), which recognises and cleaves at a single site within the repeat sequences, 
generating a mature crRNA composed by a  5’ 8 nt psitag with the characteristic 
conserved sequence GAAA(C/G) (Kunin et al. 2007), a complete spacer sequence and 
a less defined 3’ handle with the remaining repeat nucleotides. We have demonstrated 
that the SsoCas6 is a metal-independent ribonuclease that recognises and cleaves 
specifically crRNA repeats at the single site indicated by the asterisk: 
5’ - GAUUAAUCCCAAAAGGA*AUUGAAAG - 3’
Thus, the function of the SsoCas6 is equivalent to that of the euryarchaeal Cas6 from 
Pyrococcus  furiosus, even though the two proteins are highly diverged. Repeat 
sequences in S. solfataricus and also in the other subtypes associated with Cas6 are 
predicted to be unstructured (Kunin et al. 2007), therefore the mode of recognition 
must be sequence-specific as shown for PfuCas6. Members of the Cas6 superfamily 
are present in CRISPR/Cas subtypes I-A, I-B, I-D and also III-A and III-B. Distinct 
families are found in I-E (CasE) and I-F (Csy4). Conveniently representatives of each of 
these three clades have been characterised, revealing the variety of molecular 
mechanisms utilised by these proteins to recognize and cleave their target, and their 
co-evolution with the respective repeat types. The fact that Cas6 does not exhibit a 
stable interaction with the aCASCADE or CMR complex in both systems in which it 
has been studied reflects this functional versatility and its ability to collaborate with 
multiple types of effector molecules. Further structural studies of the SsoCas6 are 
needed to elucidate the molecular mechanism of crRNA recognition and cleavage. 
	  The next step in type I systems (with the exception of type I-D, where there 
are no CASCADE orthologues) is the incorporation of the processed crRNA in the 
aCASCADE, the assembly of which seems to be a crRNA-dependent process since 
the formation of helical aCASCADE assemblies was not observed in the absence of 
crRNA. The core aCASCADE complex is comprised by Csa2 and Cas5a (Cas7 and 
Cas5 respectively), with accessory co-purifying proteins including Cas6, Csa5 and 
Csa4. The complex stoichiometry is undefined, but an excess of Csa2 over Cas5a is 
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observed, reflecting the abundance of CasC over the other subunits in the E. coli 
CASCADE. Extended right-handed helical assemblies are formed by the Csa2-Cas5a-
crRNA complex in vitro, but whether this represents the physiological quaternary 
structure of the complex is unknown. The aCASCADE can recognize specifically 
ssDNA complementary to the spacer sequence in the crRNA, and form a stable 
ternary complex with the RNA/DNA heteroduplex. The E. coli CASCADE is also able to 
recognize dsDNA targets via the formation of an R-loop, whereby it displaces the non-
complementary strand and enables the basepairing of the crRNA with the target DNA 
strand. A possible recognition of target dsDNA should also be investigated for the 
aCASCADE, but was not carried out in the context of this thesis due to time 
constrains. Cas3 and the HD nuclease are presumed to be recruited to the 
aCASCADE-crRNA-DNA complex in order to catalyze the final degradation of target 
DNA. This step has not been biochemically characterised in any of the studied 
systems so far, but genetic studies in E. coli demonstrated that both CASCADE and 
Cas3 needed to be expressed to produce a resistant phenotype (Brouns et al. 2008). A 
bioinformatics analysis of the S. solfataricus  Cas3 and HD nuclease orthologues will 
be presented in the subsequent chapter. Even the presence of a single spacer is 
shown to be sufficient to confer complete resistance to the respective 
extrachromosomal element, indicating that this is a rapid and effective mechanism. 
 The Csa2-Cas5a complex did not recognise RNA targets, but an alternative 
route is potentially available in organisms that harbour type III-B Cas gene sets, like S. 
solfataricus, Pyrococcus  furiosus  and approximately 60% of the archaea according to 
the latest analysis by Makarova et al. (2011). The Cmr proteins of type III-B systems 
have been shown to form stable multimeric complexes in P. furiosus  (Hale et al. 2009) 
and S. solfataricus  (see chapter 3), which are able to perform crRNA-guided silencing 
of invader RNAs in vitro (Hale et al. 2009) as described in detail in Chapter 3. Whether 
this is the physiological activity of type III-B systems in vivo remains to be determined. 
If this is the case, the co-existence in the same genome of two systems that target 
DNA and RNA invader elements differentially while sharing the same pool of CRISPR 
spacers provides an obvious fitness advantage and increases the efficiency of the 
antiviral defence. The differential processing of the crRNA that associates with the two 
complexes (aCASCADE and Cmr) represents a type of “labeling” of the crRNA for 
incorporation into one or the other system. It would be interesting to investigate 
whether the spacer content of the two crRNA-protein complexes is different, or 
whether there is a bias towards a specific CRISPR locus family. The latter event would 
support the suggestion made by Lillestol et al. (2009), that individual CRISPR families 
might exhibit a preference towards specific groups of viruses of extra-chromosomal 
elements. 
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Figure 4.24: Emerging model for CRISPR interference in Archaea
Stages of CRISPR processing and target interference, as  deduced by the available 
experimental data up to date. The pathway on the left involving the aCASCADE would be 
available to all organisms harbouring type I systems (except perhaps type I-D), enabling the 
targeting of DNA extrachromosomal elements. The pathway on the right which involves the 
Cmr complex, would be available to organisms  which contain either autonomous type III-B 
systems or co-existing with other CRISPR subtypes. This  pathway would enable the 
recognition and destruction of any form of invader RNA. 
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Chapter 5
Initial biochemical characterisation of  
Cas3’ from S. solfataricus: a predicted 
CRISPR-associated helicase
5.1 Introduction
	 Helicases are a class of enzymes which can effectively couple the free energy 
derived from NTP hydrolysis to catalyse separation of duplex nucleic acids (NA). They 
are part of the much larger group of nucleic acid translocases, defined mechanistically 
by their ability to translocate directionally along nucleic acid strands in an NTP-
dependent fashion. This group of enzymes exhibits a high degree of functional 
diversity and members are known to play key roles in all aspects of cellular nucleic 
acid metabolism, including genome maintenance, replication and repair, transcription 
and RNA maturation. 
	 The identification of conserved sequence motifs and several structure-function 
studies on representative members of these groups have resulted in the classification 
of helicases-translocases into six superfamilies (Singleton et al. 2007). These 
superfamilies (SF1-6, figure 5.1 focusing on SF1 and SF2) differ primarily in the 
distribution and primary sequence of up to 11 signature motifs, which are limited to 
the core domain of the enzymes and provide them with the abilities to: i) bind and 
hydrolyse NTPs; ii) bind ss- or ds- nucleic acids; iii) convert the chemical energy from 
NTP hydrolysis to mechanical energy by certain conformational changes (reviewed in 
Singleton and Wigley, 2002; Tuteja and Tuteja, 2004; Singleton et al. 2007; Fairman-
Williams et al. 2010). Crystallographic studies have revealed that these conserved 
motifs are divided between two tandem RecA-like domains, at the interface of which 
the NTP binding pocket is located (reviewed in Caruthers and McKay, 2002; Singleton 
et al. 2007). The strict conservation of these core motor domains indicates that the 
specific activity of each enzyme family (be it a helicase, translocase or AAA-ATPase) is 
conferred by non-conserved, modular accessory domains and the potential 
interactions they mediate. These domains enable activities such as recognition of 
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Figure 5.1: Sequence and structural organization of the conserved motifs of SF1 and SF2 
NTPases - translocases
(a) Motif and domain organisation of the conserved helicase core focusing on SF1 and SF2. 
Characteristic motifs  are illustrated as boxes, distributed between the two motor domains  and 
colored according to their functional role: red, ATP binding and hydrolysis; blue, substrate 
nucleic acid binding; yellow, coupling of NTP hydrolysis and NA binding. Green asterisks 
indicate the typical positions for domain insertions. Distances  between motifs are not up to 
scale. Not all motifs are present in all superfamily members. (b) Consensus motif sequences (c) 
Topological organisation of the conserved motifs on the secondary structure elements of the 
RecA motor domains, indicating their spatial proximity and orientation. (d) Motif localisation on 
representative structures  of SF1 (UvrD) and SF2 (Vasa, DEAD-box family). Core motor domains 
are colored in gray in (b and (c), motifs  colored as  in (a), accessory domains in light pink and 
light green. Modified from Fairman-Williams et al. (2010)
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specific nucleic acid substrates, displacement of proteins or the complementary 
strand in a nucleic acid duplex and strand annealing. It is beyond the scope of this 
chapter to provide a full description of the various superfamilies and the specific roles 
of each motif, but instead we will focus on a phylogenetically distinct group of 
subfamilies of the SF2 superfamily of helicases-translocases, known as the DExH/D-
box protein families of RNA-remodeling proteins.
5.1.2 The DExD/H-box families of RNA-remodeling proteins
 These closely related families comprise the majority of the SF2 superfamily 
proteins, and include almost all known proteins with an RNA-remodeling or helicase 
activity that take part in various aspects of RNA metabolism (e.g. mRNA splicing, 
export and degradation, viral replication, miRNA and siRNA processing, transcriptional 
regulation, translation initiation; reviewed in Silverman et al. 2003; Cordin et al. 2006; 
Jankowsky and Fairman, 2007), as well as some DNA helicases/translocases. The 
individual families DEAD, DEAH, DExH and DExD share between 8-11 of the 
conserved sequence motifs of NTP-dependent NA translocases/helicases (Jankowsky 
and Fairman, 2007) and can be distinguished by variations between the motifs or the 
existence of additional family-specific motifs (e.g. the Q motif, Tanner et al. 2003) 
(figure 5.2). The name of each family derives from the amino-acid sequence of its 
Walker B  motif (motif II), one of the universally conserved signatures responsible for 
coordinating the Mg2+ ion and mediating hydrolysis of the β-γ bond of a bound NTP 
molecule via the first aspartic and glutamic acid residues (Pause and Sonenberg, 
1992; Tuteja and Tuteja, 2004). The other absolutely conserved motifs include motifs I 
(also known as Walker A) and VI. The Walker A motif (consensus sequence 
GXXXXGKT/S) is responsible for NTP binding via interaction of the invariable lysine 
with the β and γ pyrophosphates of the NTP  and stabilisation of the transition state 
during catalysis, while motif VI is exceptionally positioned for energy coupling and 
interacting specifically with residues in motif II (Cordin et al. 2006; Tuteja and Tuteja, 
2004; Caruthers and McKay, 2002). 
Figure 5.2: Phylogenetic relationships and motif conservation between the SF2 families and 
between SF1 and SF2 families
Motifs  are colored as in figure 5.1. Families that include RNA helicases are in bold. Modified 
from Jankowsky and Fairman, 2007. 
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	 The DExD/H-box group proteins manifest great diversity in terms of size and 
sequence, with lengths ranging from 400 to more than 1200 residues. They share 
however a conserved core of ~400 a.a. which contains the canonical sequence motifs. 
In terms of their structural organisation, crystal structures of DEAD-box proteins have 
been shown to comprise only of the minimal tandem RecA-like domains and a small 
N-teminal helix-loop-helix subdomain, with varying interdomain orientations 
connected by a flexible linker of varying size (e.g. the eukaryotic eIF4a, Caruthers et al. 
2000;  Vasa from Drosophila, Sengoku et al. 2006). DExH-box proteins in contrast 
contain auxiliary domains which either physically modulate the activity of the 
conserved core, mediate protein-protein interactions or are responsible for substrate 
recognition and specificity. Representatives of this family include the hepatitis C virus 
NS3 protein and the archaeal Hel308 (reviewed in Pyle, 2008). In DExH-box proteins, 
the additional domains tend to restrain the movement of the two motor domains 
keeping the NTP binding pocket in a functional conformation, resulting in the ability to 
hydrolyse ATP in the absence of nucleic acid. The flexibility of DEAD-box proteins on 
the other hand, is responsible for the cooperative nature of ATP hydrolysis and NA 
binding observed in many representatives of this group (Polach and Uhlenbeck, 2002; 
Yang and Jankowsky, 2005), as the binding of RNA and/or cofactors is necessary to 
rigidify the interface of the two motor domains and enable NTP hydrolysis (Jankowsky 
and Fairman, 2007). This crucial difference lies in the root of many observed functional 
variations between members of the two families (figure 5.3). 
 In general, DExH-box family members are processive helicases which are able 
to translocate along ss- or ds- NA (most enzymes tend to be specific for DNA or RNA) 
and unwind duplexes with a defined 3’ to 5’ directionality with respect to the loading 
strand. A single strand overhang to enable loading of the enzyme is usually required. 
The mode of substrate binding is non-sequence-specific, as the protein interacts 
mainly with the phosphodiester backbone without distortion of the nucleotide 
stacking. By contrast, few studied DEAD-box proteins have exhibited unwinding 
activity, limited to short duplexes (generally below 10 bp) and dependent on the 
internal stability of the duplex. The family members display varying degrees of 
sequence specificity, but there is a strict preference for RNA, at least in one of the 
bound strands (reviewed in Pyle, 2008). The presence of a single stranded NA 
(typically RNA) usually stimulates unwinding, but not in a single strand-duplex junction 
as for processive helicases. As demonstrated for the DEAD-box protein Ded1 a single-
stranded region in proximity (but not adjacent) to the duplex is used to facilitate the 
loading of the protein onto the duplex with a yet undefined mechanism (Yang and 
Jankowsky, 2006). Thus if follows that DEAD-box proteins can also unwind blunt 
duplexes, although at lower rates. The curious lack of directionality they exhibit when 
assayed for helicase activity can be explained by their specific mode of substrate 
binding and unwinding, as elucidated by crystal structures of nucleic acid-bound 
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DEAD-box proteins like the Drosophila Vasa (Sengoku et al. 2006). In this structure 
one of the single RNA strands is severely bent, in a way that prevents canonical 
basepairing and therefore is implicated in strand separation. This distortion is caused 
by a helix (α7) on motor domain 1, which adopts a different orientation in processive 
SF2 helicase structures. It remains unknown whether this is essentially an active 
mechanism, whereby duplex binding induces the substrate distortion and duplex 
destabilisation, or the protein simply exhibits affinity for a single-strand transient state 
of the duplex and prevents reannealing (Sengoku et al. 2006; reviewed in Pyle, 2008). 
A second model for duplex unwinding involves transient conformational changes that 
take place during ATP hydrolysis and cause duplex destabilisation (Cordin et al. 2006; 
Jankowsky and Fairman, 2007). In any case, DEAD-box proteins appear to have 
evolved as adaptable “ATP-regulated conformational switches” (Pyle, 2008) which are 
able to couple energy derived from NTP hydrolysis with a series of catalytic activities 
depending on the nature of protein partners or specific co-factors. 
Figure 5.3: Comparison of DExH-box and DEAD-box RNA helicases
The first two rows illustrate the domain organisation in the apo-form and upon ATP/RNA 
binding of two representative family members, the DExH-box HVC helicase NS3  (left column) 
and the DEAD-box helicase Drosophila Vasa (right column). Ribbon diagrams of the respective 
crystal structures are presented in the third row. The two motor domains  are colored in blue 
and purple, and the accessory domain of NS3 is in yellow. The bound RNA is  in red. Adapted 
from Pyle, 2008. 
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	 Additional functions of the DExH/D-box proteins apart from duplex unwinding 
include ATP-independent annealing of NA strands (e.g. Ded1, Yang and Jankowsky, 
2005; enzymes involved in group I and group II intron splicing, del Campo et al. 2009), 
stabilisation of RNPs or RNA structures (eIF4A; Andersen et al. 2006; Pan and Russell, 
2011), protein displacement (e.g. Ded1, NPH-II; Jankowsky and Bowers, 2006) or 
disruption of protein-protein interactions (reviewed in Jankowsky and Fairman, 2007; 
Pyle, 2008). In all cases, the role of additional domains or interacting proteins is 
crucial, as DExH-box proteins rarely function individually but instead many of them are 
integral parts of large multicomponent complexes (e.g. the eIF4F complex or the 
spliceosome; reviewed in Silverman et al. 2003). These protein co-factors act either to 
stimulate biochemical activity of the DExH/D-box proteins, promote target recognition 
or regulate them. 
 Two models have emerged to explain the mechanistic details for ATP-
dependent directional ss-translocation of processing DExH-box RNA helicases, 
alongside the previous “inchworm” and “rolling cycle” models and their variations 
proposed for DNA helicases (reviewed in Soultanas and Wigley, 2000, 2001). The first 
is termed the “Brownian motor” model and emerged after observation of the 
alternating states of NA affinity exhibited by NS3 (the DExH-box hepatitis C virus 
helicase) at different stages of the ATPase cycle (Levin et al. 2005). NS3 is able to bind 
ss/ds junctions in the absence of ATP, resulting in a directional forward move and 
duplex disruption. In the second step, binding of ATP would enable a short period of 
dissociation from the substrate and random “Brownian” movement before the next 
cycle. The second model, termed the “backbone stepping motor”, assumes a single 
nucleotide translocation event in every ATP-hydrolysis cycle. The phosphoryl oxygens 
on the backbone of the tracking strand interact with a conserved threonine in each 
RecA-like motor domain, the interdomain orientation of which alternates between 
closed and open states in every ATPase cycle. This results in a step-wise directional 
translocation along the phosphate backbone of the substrate. Single molecule studies 
on NS3 revealed that three base pairs are unwound every three cycles of ATP 
hydrolysis. The mechanism proposed to consolidate this is the following: a conserved 
tryptophan in the accessory third domain of NS3 is stacked in the ss/ds junction 
during the 3 nt translocation steps, and its sudden release due to mechanical tension 
buildup results in duplex unwinding (Myong et al. 2007). 
5.1.3 The CRISPR-associated putative DExH-box helicase Cas3
 A putative helicase was identified among the genes associated with the 
CRISPR arrays since they were believed to be a novel repair system (Jansen et al. 
2002; Makarova et al. 2002; Haft et al. 2005). Alignments of the amino acid sequences 
of Cas3 proteins revealed the seven conserved signature motifs for proteins of SF2, 
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with the consensus sequence D-E-X-H in motif II (Walker B) classifying  these proteins 
in the DExH/D family. The helicase core was always fused to or encoded next to a 
putative HD-nuclease domain, and was initially considered to be the prokaryotic dicer 
analogue in the context of the novel antiviral system (Makarova et al. 2006). Thus, the 
name Cas3 refers to the whole polypeptide comprising both the predicted helicase 
and HD-nuclease domains, while when encoded separately they are referred to as 
Cas3’ and Cas3’’ respectively. 
	 The HD family of predicted phosphohydrolases was first identified by Aravind 
and Koonin (1998), who also noticed that they frequently occur as accessory domains 
of helicases, polymerases and nucleotidyl-transferases, suggesting an implication in 
various aspects of nucleic acid metabolism. Members of this family are characterised 
by three strictly conserved (I, II, V) and two less widely conserved motifs (III, IV) 
including a conserved histidine (I), a histidine-aspartate pair preceded by two 
hydrophobic residues (hhHD - motif II) from which the family name derives, and a 
conserved aspartate (V). These motifs are not necessarily close in the primary amino-
acid sequence, but they are in close proximity in the tertiary structure of the 
polypeptide chain, where they are predicted to participate in coordination of a divalent 
cation necessary for catalysis. The catalytic activity of these enzymes is the hydrolysis 
of a phosphoester bond in a wide variety of substrates.
 According to the most recent classification of the CRISPR/Cas system by 
Makarova et al. (2011), Cas3 is the signature gene for all type I systems. In subtypes I-
A and I-B  the putative helicase and HD-nuclease domains are encoded separately 
(cas3’ and cas3’’), while subtypes I-C, I-D, I-E and I-F encode one multidomain protein 
(cas3). Studies in the E. coli type I-E system provided the first information about its 
role, when it was discovered that both the cascade set of genes and the cas3 gene 
were required for the resistance phenotype, but not for the precursor crRNA 
processing (Brouns et al. 2008). Similar observations were made for cas3 in 
Pseudomonas  aeruginosa (Cady and O’Toole, 2011). It was hypothesized that the 
function of Cas3 (containing both the helicase and HD-nuclease domains in this 
subtype) would involve degradation of the invader DNA via the HD-nuclease domain 
and release of the crRNA via the DExH helicase domain (Brouns et al. 2008, van der 
Oost et al. 2009; Jore et al. 2011). 
 Even though it was one of the few genes for which a functional prediction 
could be made, the first biochemical characterisation of a type I-E Cas3 orthologue 
was published in 2011 by Sinkunas and colleagues. Cas3 from S. thermophilus 
(referred to as SthCas3 in this chapter) was found to possess ATPase activity 
stimulated by ssDNA regions, ATP-dependent helicase activity and metal-dependent 
single strand nuclease activity attributed to the HD-domain (Sinkunas et al. 2011) 
Minimal levels of ATPase activity were observed in the absence of NA, but the 
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presence of ssDNA (and not dsDNA or RNA) greatly stimulated the rate of ATP 
hydrolysis (maximum rate ~38 moles ATP x moles-1 protein x min -1). ATPase activity 
was also supported by GTP instead of ATP and enhanced by divalent cations. In 
terms of helicase activity, SthCas3 was able to processively unwind dsDNA and RNA-
DNA heteroduplexes in an ATP/Mg2+-dependent manner, with a 3’ to 5’ directionality. 
Conserved aspartate residues in the N-terminal HD-nuclease domain of the SthCas3 
were identified as the catalytic residues responsible for the Mg2+-dependent unspecific 
degradation of ssDNA, but not dsDNA. Mutations in the helicase domain did not affect 
this activity. These results are in agreement with the general characteristics of 
processive DExH helicases as described by Pyle (2008), except for the apparent lack 
of ATPase activity in the absence of nucleic acid. The low ATPase rate even in the 
presence of ssDNA is consistent with the local RNP remodeling roles these proteins 
play in the various cellular processes they participate in. 
	 Shortly after, Howard et al. (2011) reported the purification and characterisation 
of Cas3 from E. coli and Methanothermobacter thermautotrophicus  (both type I-E 
systems). An additional activity for Cas3 was discovered, namely that it could anneal 
DNA and most importantly RNA strands into complementary dsDNA duplexes forming 
R-loop structures. This activity was dependent on Mg2+/Mn2+  and an active N-
terminal HD-nuclease motif, but independent of ATP. Mutations in the conserved 
sequence of the latter resulted in reduced R-loop formation, indicating a potential 
interdomain cooperation. Nuclease activity however was not detected in vitro, 
suggesting that it is not necessarily required for R-loop formation, although the 
authors do not preclude such an activity in  vivo. The E. coli Cas3 was also able to 
unwind R-loops in an ATP-dependent manner, and these two conflicting activities 
seem to be regulated by ATP concentration potentially triggering a conformational 
change (Howard et al. 2011). The levels of ATP hydrolysis were comparable in the 
presence or absence of ss/ds NA, in line with previous observations about modular 
DExH proteins (Jankowsky and Fairman, 2007). The observed differences between the 
biochemical abilities of two Cas3 orthologues of the same subtype (I-E), but from 
different organisms, illustrate the remarkable versatility of these enzymes and the need 
to characterise them in conjunction with the large nucleoprotein complex they 
associate with, namely CASCADE. 
	 The role for Cas3 in the context of CASCADE mediated interference in subtype 
I-E as proposed by Sinkunas et al. (2011), begins with an initial strand separation 
event on the dsDNA invader resulting in R-loop formation between the crRNA and the 
complementary protospacer (figure 5.4). Since both the CASCADE-crRNA complex 
and Cas3 have been shown to promote R-loop formation independently (Jore et al. 
2011; Howard et al. 2011), the exact series of events is unknown. Howard et al. 
suggest that CASCADE could initiate the crRNA invasion into the duplex and then 
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recruit Cas3 to extend and stabilise it, perhaps by further unwinding of the DNA 
duplex (Sinkunas et al. 2011). Within the R-loop structure, the HD-domain could 
cleave the displaced unpaired DNA strand at a single site, after which remodeling and 
unwinding of the crRNA-DNA duplex could take place to enable a second cleavage 
event in the protospacer strand. The result of this multi-stage procedure would be a 
double-strand cleavage product within the protospacer sequence of the invader DNA, 
reminiscent of the pattern observed by Garneau et al. (2010) in S. thermophilus. 
Moreover, the observation that CASCADE could recognise  and bind to protospacer 
sequences  regardless of the flanking PAM motif let to the proposal of an additional 
role for Cas3 by Sinkunas et al. (2011) in recognising the appropriate PAM motif in 
target protospacers. In support to this claim is the fact that one of the major functions 
of accessory domains in DExH helicases is to confer target sequence specificity 
(reviewed in Pyle, 2008). Given the observed differences in Cas3 biochemical activities 
between orthologues, its is unknown whether the mechanistic details of this last stage 
of CRISPR interference would be identical between subtypes, and even between 
members of the same subtype.
Figure 5.4: Proposed mechanism of action for Cas3 in type I-E systems
Detailed description in text. Adapted from Sinkunas et al. 2011.
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 The separately encoded HD-nuclease (Cas3’’) from S. solfataricus  (gene name: 
sso2001) was found to demonstrate metal-dependent endonuclease activity on 
dsDNA and dsRNA substrates, preferentially at G-C base pairs (Han and Krauss, 
2009). In contrast, the separately cloned and purified HD-nuclease subdomain of Cas3 
from T. thermophilus  demonstrated nuclease activity against single-stand DNA 
substrate, in agreement with the activity observed for Cas3 from S. thermophilus, the 
only difference being its stimulation by Mn2+, Co2+, Ni2+ and Zn2+ instead of Mg2+
(Mulepati and Bailey, 2011). The crystal structure of the HD subdomain of TthCas3 
was solved by Mulepati and Bailey (2011) and can be seen in figure 5.5. Comparison 
of this to an available structure for the stand-alone Cas3’’ from Methanocaldococcus 
jannaschii, solved by a structural genomics initiative, reveals an overall fold similarity 
indicating the proteins’ phylogenetic relations but also some key differences in 
topology and arrangement of conserved residues important for catalysis in both 
proteins (Mulepati and Bailey, 2011). Whether these structural differences are the basis 
for the distinct substrate preferences exhibited by the two classes of proteins remains 
to be seen. It should be expected however that since they represent separate 
evolutionary units Cas3’ and Cas3’’ might have evolved distinct modes of interaction 
with each other and with the subtype-specific effector complexes and distinct 
functional characteristics. 
Figure 5.5 Structure of the HD-domain of Cas3 from T. thermophilus
(A) Superimposition of the TthCas3 HD-domain (colored in yellow and red) and Cas3’’ from M. 
jannaschii (colored white). Structures  are largely superimposable, apart from an additional 
helix-β hairpin in TthCas3 (red). (B) Individual structures  of the TthCas3 HD-domain and 
MjaCas3’’. Adapted from Mulepati and Bailey, 2011. 
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5.2 Cas3’ in Sulfolobus solfataricus
 As mentioned in previous chapters, S. solfataricus  P2 harbours types I-A and 
III-B  CRISPR/Cas systems and encodes eight putative Cas3’ and Cas3’’ family 
orthologues (figure 1.21). This chapter deals with the purification and initial 
biochemical characterisation of the Cas3’ orthologue Sso1440 (referred to as 
SsoCas3’ throughout this chapter). Considering their predicted physical and functional 
association interdependence, several unsuccessful attempts were made to clone and 
purify a Cas3’’ orthologue in E. coli, either individually or by co-expressing it with 
Cas3’. This could be a consequence either of the protein’s structural instability or of 
the enzyme’s toxicity to the host cell. Either way, it is an indication that a protein 
partner (probably Cas3’) is required to provide folding stability and/or regulate its toxic 
activity.
 A close inspection and comparative sequence analysis of the SsoCas3’ amino-
acid sequence reveals the eight conserved domains characteristic of SF2 helicases. 
The arrangement and sequence of each motif can be seen in figure 5.6. The sequence 
of motif II (Walker B) is D-E-F-H, classifying this protein into the DExH-box family. 
I Ia Ic
N- -C
II III IV V VI
LPYRAIV
TTLDTF
DEFH
SAT
APTGYGKT LIHSKFSKKDR
TQVIEAGID
QRAGRVAR
C-terminal domain
Motor domain 1 Motor domain 2
Figure 5.6: Domain arrangement of SsoCas3’
The position and sequence of conserved helicase motifs (coloured bands) is  indicated on the 
putative motor domains of SsoCas3, shown in light and dark grey blocks. Motifs are coloured 
according to their function: black, involved in ATP hydrolysis  and substrate NA binding. The C-
terminal domain suggested to mediate protein interactions is  shown as an orange block. 
Distances between motifs  are not to scale. Consensus sequence motifs as in Fairmain-
Williams et al. 2010. 
 The C-terminal 145 residues of SsoCas3’ do not contain any recognisable 
domain although they are conserved within Sulfolobales. The protein fold recognition 
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server PHYRE predicts that this domain is largely helical and models it on the 
protruding terminal stalk-like domain of another DExH-box helicase, Mtr4, involved in 
RNA processing. In this protein, the stalk itself does not have a function but acts as a 
linker for an additional β-barrel globular domain that mediates RNA interactions (Weir 
et al. 2010). It is likely that this C-terminal domain mediates itself protein-protein or 
protein-NA interactions in SsoCas3’. The model generated by secondary structure 
threading can be seen in figure 5.7. 
Figure 5.7: Structural model of SsoCas3’, 
generated by Phyre2
The two core RecA-like motor domains are 
colored in yellow, green and blue rainbow, 
and the C-terminal domain of unknown 
function is colored in red. It is  predicted to 
consist of ~5 contiguous α-helicases, in an 
extended conformation potentially involved 
in protein-protein interactions.
5.3 Expression and purification of SsoCas3’
 The gene encoding for Cas3’ (Sso1440) was amplified by PCR from S. 
solfataricus  genomic DNA cloned into the Gateway pDEST14 vector to enable 
expression of the recombinant protein with an N-terminal hexahistidine tag. The 
sequence encoding for the first 14 residues from the annotated N-terminus was 
omitted from the amplified gene as multiple sequence alignments indicated that this 
part was not conserved and was probably a misannotation event. The construct was 
sequenced and expression was carried out in E. coli C43 (DE3) cells. The recombinant 
protein was purified to homogeneity by nickel-chelating and size-exclusion 
chromatography, as described in Materials and Methods. The protein eluted as a 
monomer from a calibrated analytical gel-filtration column (Superose 6  HR 10/30, 
Amersham Biosciences). The poly-histidine tag was cleaved by overnight incubation 
with the tobacco etch virus (TEV) protease. All steps were carried out on ice due to 
protein degradation at elevated temperatures. Maldi-TOF mass spectrometry was 
used to verify the integrity of the protein. The apparent molecular weight of the his-
tagged and native protein as observed on SDS-PAGE were in agreement with the 
calculated molecular weights of 59.406 kDa and 56.363 kDa respectively. The final 
purification step can be seen in figure 5.8. 
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	 Expression levels were high but degradation of the N-terminus occurred under 
all purification conditions tested, reducing the amount of active protein in the final 
sample. This is particularly common in multi-domain proteins such as helicases, as the 
flexible interdomain loops tend to be exposed and prone to protease degradation. 
Typical yields ranged between 0.45 - 1.4 mg/L of culture. 
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Figure 5.8: Purification of recombinant SsoCas3’
Chromatogram of SsoCas3’ ran on an analytical Superose 6 HR 10/30 on the left, where Cas3’ 
elutes  as a monomer with an apparent MW of 35 kDa according to the standard calibration 
curve. It is  unlikely that this peak represents  just degradation products, SDS-PAGE analysis  of 
the peak fractions (shown on the right) revealed that the peak composed predominantly of the 
intact protein (intense band at ~56 kDa). The fainter band at ~42 kDa was identified as N-
terminal degradation product and was present in all protein preparations. It is  unknown why 
the protein’s apparent molecular weight is  smaller than its  actual MW, but its multi-domain and 
flexible nature could result in a different behaviour that globular proteins. 
5.4 Site-directed mutagenesis of SsoCas3’ (Sso1440)
 The ATP-binding Walker A motif in SsoCas3’ was identified by multiple 
sequence alignments, and consists of the aminoacid sequence APTGYGKT (residues 
40-47). The  conserved lysine in position 46 which is essential for nucleotide binding 
was mutated to an alanine residue (referred to as K46) by site-directed mutagenesis 
using the QuikChange II Site-Directed Mutagenesis Kit (Stratagene). The gene was 
sequenced to confirm the mutation and was expressed and purified as described for 
the wild-type protein. The aminoacid substitution was verified by ESI-TOF mass 
spectrometry (figure 5.9). The SsoCas3’ K46A mutant would serve as a negative 
control for ATPase and helicase activity of the WT protein.
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Figure 5.9: ESI-TOF mass spectrometry of SsoCas3’ WT and K46A
Intact molecular weights  of proteins  determined by ESI-TOF mass  spectrometry to confirm the 
site mutation. (A) Mass  spectrum for the WT protein. The major peak corresponds to a 
molecular weight of  56413 Da (data processed to 0.1 Da). (B) Mass  spectrum for Cas3’-K46A. 
The major peak corresponds to a  molecular weight of 56355.5 Da (data processed to 0.1 Da). 
The mass  difference of 57.5 Da is  in agreement with a replacement of a lysine to an alanine. A 
second protein species was observed in both samples, with a consistent mass difference of 
42.8 Da. It is suggested that this represents an acetylation event. 
A.Cas3’ WT intact mass
mass difference 
42.8 Da - 
acetylation?
B.Cas3’ K46A intact mass
mass difference 
42.8 Da - 
acetylation?
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5.5 ATPase activity of SsoCas3’
 NTP hydrolysis is the common mechanism all helicases use to generate energy 
to translocate along single strand nucleic acids and catalyse strand separation. The 
hydrolytic reaction can be stimulated by the presence of nucleic acids, single or 
double stranded. Binding of the appropriate nucleic acid induces conformational 
changes that enable efficient NTP binding and hydrolysis. SsoCas3’ contains all the 
characteristic helicase motifs (I, II, VI) to catalyse NTP hydrolysis, so the ATPase 
activity of the protein was investigated by the malachite green colorimetric phosphate 
assay, as described in chapter 2. Wild-type and SsoCas3’ K46A (Walker A mutant) 
protein (2 μΜ) was incubated in the presence or absence of ss- or ds DNA, RNA or 
DNA/RNA heteroduplexes at temperatures ranging from 37oC - 65oC, in the presence 
of 1 mM MgCl2. All nucleic acid substrates used were annealed or single-strand 
oligonucleotides 25-40 nt in length (CRISPR-related substrates, tables 5.1, 5.2). 
Samples were taken across a 20 min time course and free phosphate levels were 
visualised with malachite green, a reagent producing a colour change upon interaction 
with free phosphate that can be monitored by absorbance at 650 nm. The intensity of 
absorbance is analogous to the levels of free phosphate in the sample, providing a 
qualitative assay to measure the rate of ATP hydrolysis. Results are summarised in 
figure 5.10. 
 Levels of ATP hydrolysis were significantly higher in the presence of ssDNA, 
compared to ssRNA, dsDNA or dsRNA. Minimal levels of free phosphate were 
detected in the absence of nucleic acid, due to the fact that enzyme conformational 
flexibility may lead to a basal level of ATP hydrolysis (Soultanas & Wigley 2000). The 
mutation of the conserved lysine to alanine in the Walker A motif of SsoCas3’ would 
render it incapable of hydrolysing ATP as this lysine interacts with the β-phosphate 
and acts to stabilise the transition state of the hydrolytic reaction (Tuteja and Tuteja, 
2004). Indeed, the SsoCas3’ K46A mutant exhibited basal background levels of ATP 
hydrolysis. This control also confirms that the ATPase activity observed is attributed to 
SsoCas3. Reaction rates, although extremely low compared to other helicases, were 
almost 5-fold higher when ssDNA was present, indicating an ssDNA-stimulated 
ATPase activity for SsoCas3’. 
 The effect of temperature on the ATPase reaction was also investigated, in 
order to determine the optimum temperature range for protein function. Reactions 
were carried out at 37oC, 45oC, 55oC and 65oC under identical conditions for 30 min 
with 1 μΜ protein and in the presence of ssDNA. Control reactions with only ssDNA 
were run in parallel to obtain the background levels of spontaneous ATP hydrolysis at 
different temperatures, which revealed a basal level of 6.24 pmoles phosphate.min-1. 
The levels of hydrolysed ATP increased with the temperature rise, with the optimum 
activity obtained at 55oC after which the ATP hydrolysis rate dropped. A high 
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temperature optimum is expected from an enzyme by a thermophilic organism such 
as S. solfataricus. Optimum growth for this archaeon is observed at 80oC, therefore it 
would be expected that the enzyme would be more active approaching this 
temperature. The fact that SsoCas3’ exhibits highest activity at 55oC could be related 
to the fact that the context of Cas3’ function in vivo differs greatly from the minimum 
experimental set up presented here, as it is predicted to interact tightly with an HD-
domain nuclease and potentially a CASCADE-like complex. 
 Considering that the natural Cas3’ substrates would most likely include an R-
loop, we also monitored the ATPase activity in the presence of a 25-base pair ds RNA-
DNA heteroduplex. Reaction rates were comparable to the rates obtained in the 
presence of dsDNA and dsRNA, indicating that this type of substrate does not 
stimulate ATP hydrolysis. We can therefore infer that SsoCas3’ exhibits an ssDNA-
dependent ATPase activity, in agreement with the results reported for the 
Streptococcus thermophilus  Cas3 (Sinkunas et al. 2011). However, the reaction rates 
for SthCas3 were reasonably higher than SsoCas3, reflecting the processive helicase 
activity for this DExH-box protein. One explanation could be suggested considering 
the differences in ATP hydrolysis modes between DExH-box and DEAD-box proteins 
as outlined in section 5.1.2. Even though SsoCas3’ is a DExD-box family protein, it 
lacks the additional domains of SthCas3 that potentially needed to maintain a high 
rate of ATP hydrolysis, therefore mechanistically resembling DEAD-box proteins’ mode 
of action. 
 CHAPTER 5: Characterisation of SsoCas3’
157
Figure 5.10: ATPase activity of WT and mutant SsoCas3’ 
(A) Course of ATP hydrolysis  by SsoCas3’ in the presence of ssDNA, ssRNA and RNA-DNA 
hybrids at 55oC. A linear curve fit was  applied to the data points. ATP hydrolysis in the 
presence of dsDNA and dsRNA was at the same levels  as  for dsRNA-DNA (not shown). 
ATPase activity  although very low is  clearly stimulated in the presence of ssDNA. Reaction 
rates in table (B) in pmoles phosphate. pmoles SsoCas3’ -1.min-1. (C) ATPase activity of 
SsoCas3’ in the presence of ssDNA at different temperatures illustrated by pink blocks. 
Background levels of ATP hydrolysis in the presence solely of ssDNA are presented in blue 
blocks.
C. Temperature dependence on ATPase activity of Cas3’
Temp 
oC
rate of ATP hydrolysis
+ssDNA
37oC 0.37 ± 0.08
45oC 0.59 ± 0.02
55oC 0.65 ± 0.01
65oC 0.33 ± 0.07
A. ATP hydrolysis at 55oC
Substrate rate of ATP hydrolysisWT
rate of ATP hydrolysis 
Walker A mutant
- 0.06
ssDNA 0.34 ± 0.022 0.08±0.03
ssRNA 0.08 ± 0.019
dsRNA-DNA 0.08 ± 0.037
B
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5.6 Helicase activity and substrate preference of SsoCas3’
 The helicase motifs present in SsoCas3’ indicate that it may have a duplex 
unwinding ability. In the context of the CRISPR system, this could involve either 
dsDNA, dsRNA or DNA-RNA heteroduplexes. To investigate the helicase activity of 
SsoCas3’ along with its respective substrate specificity and directionality of 
unwinding, 5’ fluorescein-labelled DNA and RNA oligonucleotides corresponding to 
the 25 nt CRISPR repeat sequence of locus B  with appropriate 3’ or 5’ 15-U or 15-T 
overhangs  (table 5.1) were purified and annealed to produce the double-strand 
substrates seen in table 5.2. Each substrate consists of a 25-base pair duplex region 
and a 15 nt poly-uracil or poly-thymine 3’ or 5’ extension (3’ overhang or 5’ overhang). 
The sequences of the single-stranded synthetic oligonucleotides used to generate the 
duplex substrates can be seen in table 5.1. A graphic representation of the basic 
structure of the double-stranded substrates can be seen in table 5.2. 
Table 5.1 Oligonucleotides used to generate substrates used in chapter 5
In substrate set #3, red fonts indicate the complementary spacer regions and blue the 5’ 
psitag. Single asterisks indicate the fluorescein label, double asterisks the radiolabel.
ss oligonucleotides used to 
make the ds substrates labeled 
with fluorescein (*) 
or [γ-P32]ATP(**)
sequence 5’ to 3’
ssDNA *CTTTCAATTCCTTTTGGGATTAATC
ssRNA *CUUUCAAUUCCUUUUGGGAUUAAUC
complement sequence. 15-U or 
15-T were added to the 5’ or 3’ 
end to make overhang ds 
substrates
GATTAATCCCAAAAGGAATTGAAAG 
(also in RNA form)
ssDNA **GCTCCTAGGTCCTTCGTGGCATCTG
ssRNA **GCUCCUAGGUCCUUCGUGGCAUCUG
complement sequence ± 15-U or 
15-T to make ds substrates
CGAGGATCCAGGAAGCACCGTAGAC 
(also in RNA form)
crRNA-A1
**AUUGAAAGGAACUAGCUUAUAGUUUAGAAG
AAAACAAACAAAUAAUGAUUAAUCCCAAAA 
tA1f 
+PAM
**TAATACGACTCACTATAGGGT 
ATTATTTGTTTGTTTTCTTCTAAACTATAAGC
TAGTTCTGGAGAGAAGGTG 
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Table 5.2: Structures of ds substrates used for helicase assays
A star represents  the 5’ fluorescein-labeled or radiolabeled strand. RNA is indicated by a 
dashed line, DNA by a solid line. 
 Initial assays revealed that SsoCas3’ was unable to unwind dsDNA or dsRNA 
substrates carrying either a 5’ or 3’ single-strand overhang region, but that it exhibited 
ATP-dependent activity against DNA-RNA heteroduplexes (figure 5.11). Assays were 
carried out at 37oC due to instability of the RNA-DNA heteroduplex at elevated 
temperatures, even though unwinding was faster at 45oC, therefore it is possible that 
the temperature optimum for protein activity is even higher than that (figure 5.12). The 
protein was pre-incubated with the respective substrate for 1 min at 37oC and the 
assay was initiated with the addition of 1 mM ATP. Substrate unwinding was followed 
over a 5 - 20 min time course, depending on the experiment, and products were 
analysed on native 12% polyacrylamide:TBE gels, as described in Materials and 
Methods. Appropriate controls to ensure the substrate stability, indicate the size of the 
unwound product and the absence of background activity without ATP were carried 
out in each experiment. About 5% of the substrate was unwound even at 37oC in the 
absence of protein. In the negative controls however, where the substrate is incubated 
with the protein in the absence of ATP, single strand unwound product was not 
observed, indicating that SsoCas3’ binds to the duplex and enhances it stability. 
 SsoCas3’ was able to successfully unwind both 3’ and 5’ overhang DNA-RNA 
heteroduplex substrates in the presence of ATP, regardless of whether the overhang 
region was DNA or RNA, suggesting a bidirectional helicase activity. The rate of 
unwinding increased proportional to the protein concentration, supporting that the 
effect was not caused by substrate melting (figure 5.13). The protein’s performance 
was high but inconsistent with different protein batches or reaction conditions making 
it difficult to calculate reliable unwinding rates, even though unwinding of 
Substrates structure
3’ overhang (3’oh) dsDNA or dsRNA
5’ oh dsDNA or dsRNA
3’ oh RNA-DNA
5’ oh RNA-DNA
5’ oh DNA-RNA
blunt RNA-DNA hybrid
3ʼ 5ʼ
3ʼ 5ʼ
5ʼ5ʼ
5ʼ5ʼ
5ʼ 5ʼ
5ʼ5ʼ
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heteroduplexes was always observed in an ATP/MgCl2-dependent manner. Since the 
rate of unwinding of both 3’ and 5’ overhang substrates was comparable, blunt DNA-
RNA heteroduplex substrates were prepared, consisting only of a 25-base pair duplex 
region, with sequence corresponding to the CRISPR repeat. SsoCas3’ was able to 
efficiently unwind the blunt heteroduplex with roughly the same rate as the 3’ and 5’ 
overhang heteroduplexes (figure 5.14A). Unwinding was not observed if ATP was 
replaced by non-hydrolysable ATP analogues, such as AMP-PNP (5’-adenylyl-β, γ-
imidodiphosphate) and ATPγS (adenosine 5′-O-(3-thio) triphosphate) (figure 5.14C). 
The Walker A mutant Sso1440-K46A which disrupts the ATP-binding domain of the 
protein was unable to function as a helicase confirming the existence of an energy-
driven catalytic unwinding mechanism (figure 5.14A). From this set of results it is was 
not clear whether the protein translocates on the RNA or DNA strand of the 
heteroduplex, although the ssDNA-stimulated ATPase activity described in the 
previous paragraph suggests that it could be the DNA strand. 
Figure 5.11: Helicase activity of SsoCas3’ on CRISPR substrates
Helicase activity was monitored as described in the text. The substrates used in each assay 
are depicted under each panel, corresponding to the structures as  outlined in tables  5.1 and 
5.2. The controls performed for each substrate are marked as: c+, size marker for the unwound 
product, boiled at 95oC for 2min; c-, end-point reaction without protein;-ATP, end-point 
reaction without ATP/ MgCl2. (A) Left panel, reaction with dsDNA substrates  and 250nM 
SsoCas3. Time course: 2’, 5’, 10’, 20, 45’. Right panel, dsRNA substrate. TIme course: 1’, 5’, 
15’. (B) Reactions with 200nM SsoCas3’ and 3’/5’ overhang RNA-DNA substrates. Time 
course: 30’’, 1’, 2’, 5’. 
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 Figure 5.12: Temperature dependance on the helicase activity of SsoCas3’
Protein concentration was 250 nM and samples were taken at 1’, 2’, 5’, 10’, 20. 
Figure 5.13: Helicase activity of SsoCas3’ is dependent on protein concentration
(A) Monitoring the influence of protein concentration (200 nM, 100 nM, 20 nM) at constant 
substrate concentration (5’ overhang RNA-DNA, 20 nM) on the helicase activity of SsoCas3. 
Time course: 15’’, 30’’, 1’, 2’. Almost 100% unwinding is observed at 10-fold excess of protein 
over substrate (200 nM), as  opposed to very little unwinding at a 1:1 ratio. Reasonable course 
of unwinding is observed with 100 nM protein (5:1 ratio), suitable to compare efficiency of 
unwinding of different substrates. (B) Helicase activity on 3’ and 5’ overhang RNA-DNA 
substrates  with 100 nM protein. Time points: 30’’, 1’, 2’, 5’. Inconsistencies  in the protein’s 
efficiency were observed among different purification batches or reaction conditions, leading to 
differences in unwinding rates such as between panels A and B. 
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Figure 5.14: Helicase activity of SsoCas3’ on blunt RNA-DNA heteroduplexes
(A) Comparison of the WT and WalkerA mutant activity on 3’ overhang and blunt RNA-DNA 
duplex substrates. Protein concentrations  are 50 nM (WT) and 100 nM (WalkerA mutant). Time 
course: 30’’ (only in WT), 2’, 5’, 10’, 20’. (B) Cartoon representation of the substrate preference 
and polarity demonstrated by Cas3 from S. thermophilus  (Sinkunas  et al. 2011). The displaced 
(labeled) strand could be either RNA or DNA. (C) Helicase activity is  not supported by non-
hydrolysable ATP analogues. Protein concentration: 100 nM; substrate 20 nM blunt 
heteroduplex; time course: 30’’, 2’, 5’, 10’.
 The ability of SsoCas3’ to unwind blunt heteroduplexes is in contrast to the 3’ - 
5’ directionality reported for the S. thermophilus  Cas3 (subtype I-E) (Sinkunas et al. 
2011). The Cas3 protein in this subtype however, is fused to the HD phosphohydrolase 
predicted to perform the degradation of the invader DNA (Brouns et al. 2008). Given 
the partial substrate melting in the control samples, it could be possible that the 
unwinding activity of Cas3 on blunt substrates results from single stranded DNA or 
RNA exposed as a result of thermal fraying, which would enable the loading of the 
enzyme onto the substrate and subsequent translocation and duplex disruption. In the 
absence of a crystal structure of the two orthologs, it remains unknown whether in the 
fusion protein the HD nuclease domain affects the function of the helicase domain by 
inducing conformational changes, thereby resulting in a different type of substrate 
recognition and mode of action. Nevertheless, potential cross-talk between the two 
domains has been suggested before. Howard et al. (2011) observed that mutation of 
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the HD motif inhibited R-loop formation by Cas3 in E. coli (subtype I-E), but this effect 
was reversed in the double Walker A - HD mutant. 
 In order to further investigate this matter and the substrate requirements of 
SsoCas3’, two additional sets of substrates were prepared. The first set (set #2 in 
table 5.1) consisted of a series of 25 nt RNA - DNA heteroduplexes with non-CRISPR 
related sequence, either blunt or with 3’/5’ RNA or DNA overhangs . The 
oligonucleotides were purified, 5’ end labeled with [γ-32P] ATP and annealed to 
produce the double strand substrates. Radiolabeling was used instead of fluorescein-
labeling to investigate whether the comparatively large size of fluorescein was altering 
the protein’s behavior. Curiously, under identical assay conditions SsoCas3’ was 
unable to unwind any of the 5’ overhang, 3’ overhang or blunt heteroduplexes (figure 
5.15). Altering the assay conditions (increasing or decreasing the buffer concentration 
of K-glutamate, increasing the protein concentration) did not stimulate the activity. 
Only on a single occasion unwinding of a 5’ RNA overhang heteroduplex was 
observed, but this result was not repeatable. Apart from experimental error (failure to 
determine the optimum conditions for activity), an explanation would be the 
requirement for certain structural features or repeat-related sequences (one of the 5’ 
or 3’ repeat-derived handles in mature crRNA sequences) in the duplex substrate to 
be recognized and bound by SsoCas3’ in order to perform the duplex displacement. It 
is uncommon for helicases to exhibit sequence specificity, unless the SsoCas3’ 
C-terminal domain of unknown yet function plays a role.  
Figure 5.15: SsoCas3’ in unable to unwind radiolabeled non-CRISPR related substrates
Reactions  were carried out at 37oC due to substrate instability, at a  protein concentration of 
200 nM. The same results  were obtained with RNA overhangs and a DNA labeled strand.  Data 
shown are representative of three repeat experiments. Time course: 2’, 5’, 10’.
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 In order to investigate this possibility, a third set of RNA-DNA heteroduplex 
substrates was generated (#3  table 5.1) that closely resembled the natural substrate in 
vivo. A single strand crRNA oligonucleotide (crRNA-A1) was annealed to a ssDNA 
sequence carrying a matching protospacer (tA1f, table 4.3), such that the produced 
heteroduplex consists of a 38-base pair duplex region flanked by unpaired forked 
strands (figure 4.18 D). This minimal substrate corresponds to the in  vivo state upon 
recognition of the DNA invader by the Cas effector  proteins - crRNA complex and 
subsequent binding, in some cases by displacement of the non-complementary 
strand and formation of an R-loop (Jore et al. 2011; Howard et al. 2011). SsoCas3’ 
was unable to unwind this substrate over a 60 min time course at 37oC or 45oC (higher 
temperatures were avoided due to substrate instability) (figure 5.16). This was 
unexpected, as this substrate contains most of the characteristics of the physiological 
substrate, with the exception of the R-loop context. Possible explanations for this will 
be presented in the discussion section. 
Figure 5.16: SsoCas3’ is unable to unwind “crRNA-protospacer”-like substrates
Protein concentration was increased to 500nM over ~25nM substrate. Time course: 1’, 2’, 5’, 
10’, 30’. The small quantity of single-stranded species in the last time point is unlikely to reflect 
protein activity, but is  probably a  result of substrate instability and well overloading. Two 
protospacer constructs were used, with and without an appropriate PAM sequence (see 
previous chapter), to test the hypothesis by Sinkunas  et al. on potential PAM recognition at this 
stage. No unwinding was observed with either substrate.  
5.6.1 SsoCas3’ is not able to process long duplex regions
 To assess the processivity of SsoCas3’ on longer duplex regions that the 
minimal 25 nt substrate used in the assays described before with the first set of 
substrates, a 151-base pair RNA-DNA heteroduplex with a 20 nt DNA overhang on the 
3’ end was generated. This substrate consisted of the in vitro transcribed initial two 
repeat-spacer units of CRISPR locus A described in chapter 4, and its complementary 
DNA. SsoCas3’ was incubated with this substrate for 60 min at 37oC in the presence 
of ATP, but no unwinding was observed (figure 5.17). Considering the proposed role 
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for this protein in the interference stage of CRISPR functioning, where the natural 
substrate for this protein would be the heteroduplex formed by the spacer region of 
the crRNA with the DNA target, this finding is not unexpected, although the Cas3 
orthologue from E. coli and S. thermophilus  were reported to unwind even longer 
duplexes between 70 - 1000 bp (Sinkunas et al. 2011; Howard et al. 2011). 
3ʼ
5ʼ ds
ss
wells
c- c+ -A
TP
30ʼ 60ʼ
Figure 5.17: SsoCas3’ is unable to unwind long duplex substrates. 
The duplex substrate consists of an in vitro transcribed CRISPR RNA transcript of two repeat-
spacer units, annealed to a complementary DNA with a 3’ overhang. Repeats are in black, 
spacers in red, the part of the leader sequence and the T7 promoter on the 5’ end is in blue. 
RNA transcript is indicated by a dashed line, complementary DNA sequences are colored with 
the same color scheme in a solid line. The radiolabeled phosphate is indicated with a star. 
5.7 Nucleic acid binding by SsoCas3’
 Electrophoretic mobility shift assays were carried out to investigate the nucleic 
acid binding characteristics of SsoCas3’. Given the fact that ssDNA stimulates ATP 
hydrolysis by SsoCas3’, it would be expected that the protein exhibits a higher affinity 
for ssDNA. Fluorescence anisotropy would be a significantly more sensitive and 
accurate indicator of nucleic acid binding, but the large amounts of protein required 
were unobtainable for SsoCas3’. 
 Increasing concentrations of SsoCas3’ were incubated with 20 nM of single 
strand DNA or RNA oligonucleotides corresponding to CRISPR locus B  repeat 
sequences under the same conditions used to test helicase activity (20 mM MES pH 
6.5, 100 mM potassium glutamate, 1 mM MgCl2, 1 mM ATP, 0.1 mg/ml BSA, 
incubation at 37oC for 30 min). Both oligonucleotides appeared to be effectively 
shifted, indicating complex formation with SsoCas3’ with an apparent dissociation 
constant of 5 μM (figure 5.18). This high Kd value could be attributed to the general 
non-specific affinity for nucleic acids this protein is expected to exhibit, and does not 
reveal any information about the specific characteristics of substrate recognition. 
Unfortunately, attempts to optimise binding failed, either due to transient interactions, 
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protein degradation in the sample, protein aggregation or the assay limitations 
explained elsewhere.
Figure 5.18: Nucleic acid binding by SsoCas3’
SsoCas3’ is able to bind both ssDNA and ssRNA (sequences in table 5.1). Concentration range 
(in μΜ): 10, 8, 7, 6, 5, 4, 3, 2, 1. At high protein concentrations  two bands  are observed 
representing complexes with increased protein:NA stoichiometry. 
5.8 Strand annealing and strand exchange activity of SsoCas3’
 A number of helicase families involved in DNA recombination and repair have 
been reported to exhibit strand annealing and strand exchange ability, such as the 
prokaryotic RecA, RadA and RecQ and the eukaryotic Rad51 (Cox and Lehman, 1982; 
Seitz et al. 1998; Seitz and Kowalczykowski, 2006). Taking into account the proposed 
role for Cas3 during the interference stage as outlined by Jore et al. (2010), whereby 
R-loop formation promoted by CASCADE would be followed by degradation of the 
invader DNA by Cas3 in E. coli, it would be reasonable to consider a potential 
annealing/strand exchange activity for SsoCas3’. Indeed, Cas3 from E. coli  (which is 
fused to an HD-nuclease domain, existing as a separate protein in S. solfataricus) has 
been shown to promote annealing of two complementary DNA strands, and most 
interestingly of ssRNA to complementary duplex DNA in the form of an uncut plasmid, 
resulting in the formation of an R-loop (Howard et al. 2011). This activity was shown to 
proceed in an ATP-independent fashion, but required magnesium as a co-factor and, 
curiously, an active HD-nuclease motif. Addition of ATP resulted in the reverse activity 
of unwinding the R-loops, raising questions about the co-existence and regulation of 
these antagonistic activities in vivo (Howard et al. 2011).
 We investigated the ability of SsoCas3’ to catalyse duplex formation using 
combinations of purified 25 nt 5’ fluorescein-labeled single strand DNA or RNA 
oligonucleotides (table 5.1). Assays were carried out at 37oC over a 20 min time 
course in the presence of 1mM MgCl2 and products were analysed on 12% native 
polyacrylamide gels. The reason such low temperatures were used even though the 
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enzyme has proven to exhibit optimum activity at 55oC was the instability of the RNA-
DNA heteroduplexes at elevated temperatures. Firstly, we observed efficient annealing 
of ssRNA to complementary ssDNA in the presence of SsoCas3’, as opposed to no 
heteroduplex formation in the absence of the protein (figure 5.19).
Figure 5.19: Strand annealing activity of SsoCas3’
Two complementary separately purified strands  (RNA and DNA) were denatured at 90oC for 2 
min and then incubated for a  maximum of 20min at 37oC in the presence or absence of 
SsoCas3. We can observe almost 80% annealing when SsoCas3’ is  present. Dashed line 
indicate non-contiguous lanes on the same gel. 
  Secondly, SsoCas3’ promoted the invasion of a single RNA strand into a 
complementary 25-base pair DNA-RNA heteroduplex (substrate), whereby it replaced 
the DNA strand and generate a dsRNA (product). The experimental setup is outlined in 
figure 5.20 A (reaction type 1). In this experiment, ~50% of the DNA strand in the 
labeled substrate was exchanged for the unlabelled longer RNA strand to produce the 
double stranded RNA product, as opposed to 0-5% in the absence of protein (figure 
5.20 B). The fact that ATP hydrolysis is not required for the strand exchange reaction 
and the small size of the participating oligonucleotides indicates that the exchange is 
likely to take place due to passive binding of both the ss- and the ds- species, so that 
strand rearrangement would proceed until equilibrium is reached. If that was the case, 
in the presence of ATP the result would have been the same, since the substrate 
heteroduplex would have been unwound actively by the protein (these substrates 
were shown to be effectively unwound during helicase experiments) and formation of 
the more stable dsRNA (which the protein cannot unwind) would have been favoured 
by passive binding. A possible explanation could be that at the low assay 
temperatures (30oC, due to substrate instability) the helicase activity of SsoCas3’ was 
not efficient. The reaction was repeated at 37oC, where indeed formation of the 
product dsRNA was almost 100% in the presence or absence of ATP (figure 5.20 C). 
The RNA-DNA heteroduplex substrate is more unstable at this temperature (control 2), 
which promotes the strand rearrangements and formation of the stable dsRNA in the 
absence of ATP. This is however still a protein-dependent procedure, as can be seen 
from the minimal formation of dsRNA in the control (c2).
ss
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 In order to clarify the requirements of SsoCas3’ in terms of the participating 
nucleic acid species, we investigated whether it could promote annealing of a ssDNA 
to a complementary RNA-DNA hybrid to displace either strand (reactions 2 and 3, 
figure 5.19 panel A), in the absence of ATP and at 30oC (figure 5.20 D). Strand 
exchange was not supported in either case, confirming the requirement for the 
invading strand to be RNA. Additional experiments and controls are needed to clarify 
this activity and determine whether it is an active reaction mechanism, reminiscent of 
the E. coli Cas3, or a product of passive equilibrium binding of the nucleic acid 
species for which the protein exhibits affinity. Further experiments should include 
potential magnesium-dependency as well as replacement of SsoCas3’ with other 
proteins with/without a general affinity for nucleic acids. 
 An RNA-DNA heteroduplex or a dsRNA most likely do not represent 
physiologically relevant substrates/products for the Cas3 protein family, especially in 
the light of recent studies elucidating part of its activity in type I-E systems (Jore et al. 
2011; Sinkunas et al. 2011; Howard et al. 2011). In retrospect, a more appropriate 
experimental setup should have involved invasion of a ssRNA into a dsDNA substrate, 
mimicking the displacement of the DNA strand during target recognition by the 
crRNA-loaded CASCADE-like complexes (Jore et al. 2011). The experiments 
presented in this paragraph were carried out prior to the publication of any of the 
aforementioned studies, and were halted due to increasing problems with enzyme 
production and stability and time constraints. Nevertheless, some useful observations 
can be made. In summary, these results suggest that SsoCas3’ effectively stimulates 
ATP-independent strand annealing to generate RNA-DNA heteroduplexes, and the 
invasion of an RNA strand into a complementary heteroduplex. Combining these two 
observations, and in line with the emerged reports on the activity exhibited for E. coli 
Cas3, it is reasonable to speculate that SsoCas3’ should be able to promote invasion 
of an RNA strand into a dsDNA duplex to form an RNA-DNA heteroduplex, or R-loop.
Figure 5.20: Strand exchange activity of SsoCas3’ (following page)
(A) Outline of the types of exchange reactions. Substrates are the CRISPR-related set #1 used 
for helicase assays (tables 5.1, 5.2). Region of complementarity is  25 bp. (B) Exchange reaction 
1 as  outlined in (A). Influence of ATP. Protein concentration: 500nM. Reaction temperature: 
30oC. Time course: 2’, 5’, 10’, 20’, 30’. Controls: c1, size marker; c2, end-point reaction A 
without protein. Almost 50% RNA strand exchange can be seen after 30 min incubation 
without ATP, in comparison to ~10% with ATP. No dsRNA is  formed in the absence of protein. 
Assay was performed at a low temperature (30oC) due to substrate instability. Arrows indicate 
the product formation (C) Exchange reaction at a higher temperature of 37oC. Protein 
concentration: 500nM; Time range: 2’-20’. ATP was  included unless  indicated. Under these 
conditions the RNA-DNA hybrid substrate is  more unstable and formation of dsRNA is 
promoted in a protein-dependent way. (D) Protein concentration: 1μM. Reaction temperature: 
30oC. Time course: 5’, 15’, 30’, 45’.  We can observe product formation only in reaction 1, 
where the invading strand is RNA. No ATP was included in the reactions. Dashed lines  indicate 
non-contiguous lanes on the same gel.
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5.8.1 Initial attempt to investigate R-loop formation by SsoCas3’
  To monitor whether SsoCas3’ could indeed promote the formation of an R-
loop, a pET151/D-TOPO plasmid was constructed harbouring a 28 nt protospacer 
complementary to spacer 1 in SsoCRISPR locus A. This would basepair to the central 
region of the 60 nt synthetic oligonucleotide ssRNA crRNA-A1 (table 4.3). Briefly, 5 μΜ 
of protein were added to 50 ng of duplex DNA plasmid and 1 μΜ of 5’ [γ-32P] ATP-
labeled crRNA-A1 and reactions were initiated with 1 mM of ATP/MgCl2 mixture. 
Samples were incubated at 55oC for 1 hour (in 20 mM MES pH 6, 100 mM potassium 
glutamate and 0.5 mM DTT), deproteinised by proteinase K treatment at 37oC for 15 
min and analysed on a 0.8% agarose gel. Products were visualised by EtBr staining 
and phosphorimaging. As the ability to generate R-loops is also a characteristic of the 
E. coli CASCADE (Jore et al. 2011; Howard et al. 2011), the reaction was repeated in 
the presence of the recombinant Csa2-Cas5a complex or native aCASCADE (provided 
by N. Lintner and M. Lawrence) as described in chapter 4.  
 Upon EtBr staining of the agarose gel we can observe that all three plasmid 
forms (supercoiled, linear, open circular) are present in all reaction and control samples 
(figure 5.21). However, a small amount of slow-migrating species appears caught in 
the wells in the reaction sample where both SsoCas3’ and the recombinant Csa2-
Cas5a complex are present (lane BR, figure 5.21). Phosphorimaging of the gel reveals 
the location of the radiolabeled crRNA, which would only be visible if involved in a 
large size complex, as any free single strand RNA would have migrated off the gel and 
into the buffer. Closer examination of the phosphorimaging image reveals a single 
band corresponding to a radiolabeled species which, if the two gel images are 
overlaid, corresponds to the slow-migrating species caught in the wells in figure 5.20, 
lane BR. These species could potentially represent R-loops or large ribonucleoprotein 
complexes resulting from insufficient proteinase K treatment. Radiolabeled species 
were not observed in reactions missing SsoCas3’ or the recombinant Csa2-Cas5a 
complex. 
	 Although these are only preliminary results, it could be a possibility that 
SsoCas6 and the core of the archaeal CASCADE (the Csa2-Cas5a complex) act 
cooperatively to promote target recognition via R-loop formation between the crRNA 
and the invading dsDNA. In this case, a question is raised about the absence of 
radiolabeled, slow-migrating species (potential R-loops) in the samples containing the 
native aCASCADE from S. solfataricus. Potential explanations include the very low 
protein concentration of the protein sample used and inactivation of the complex 
during long-term storage. Obviously it is unrealistic to make assumptions based on 
the minimal system assayed here since key system proteins are missing, such as the 
HD-nuclease and the additional components of the aCASCADE (e.g. Csa5, Cas8a2), 
therefore this aspect of Cas3 function in S. solfataricus remains to be elucidated. 
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Figure 5.21: Potential R-loop formation by SsoCas3’. 
UV visualisation (A) and phosphorimaging (B) of SsoCas3’ reactions after agarose gel 
electrophoresis to detect radiolabeled RNA. Reaction components can be seen in the table C. 
Reactions were performed with recombinant SsoCsa2-Cas5a complex (BR) or native 
aCASCADE (BN) (see chapter 4). Signal due to the presence of radioactive RNA species is 
detected (B) in the marker lane (due to the radiolabeled DNA size ladder) and in lanes BR . It is 
unknown why the linear species  of plasmid DNA migrates  faster than supercoiled plasmid. 
Restriction digestion of the plasmid (not shown) confirmed that the lower band observed in all 
DNA-containing lanes is indeed linear plasmid. An explanation could be the insufficient 
deproteinisation of the samples, resulting in reduced mobility for the protein-DNA complexes. 
	
5.9 Discussion and future work
 This chapter deals with the purification and initial biochemical characterisation 
of Cas3’ from Sulfolobus  solfataricus. The flexible nature of helicases renders them 
difficult to express in heterologous systems and study biochemically, therefore the 
information on the actual role of Cas3 within the CRISPR system has been limited. 
However, genetic studies and biochemical characterisation of the E. coli and S. 
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thermophilus  Cas3 orthologues and type I-E systems have led to the hypothesis that 
Cas3 is involved in the terminal interference stage of CRISPR function (Brouns et al. 
2008; Sinkunas et al. 2011; Howards et al. 2011; Cady and O’Toole, 2011; reviewed in 
Maraffini and Sontheimer, 2010; Al-Attar et al. 2011). The Cas3  orthologues 
characterised in these studies are helicase-nuclease fusions, in which both domains 
seem to be active with varying levels of efficiency. The degree to which the activities 
of the two domains have been seen to influence one another is not yet clear. In E. coli 
Cas3, mutations in the HD domain abolished R-loop formation, although a clear 
nuclease activity was not demonstrated under the conditions tested (Howard et al. 
2011). In S. thermophilus  Cas3, mutations in the HD motif had no effect on the 
protein’s helicase activity or vice versa, although it was not examined whether this 
protein catalyses R-loop formation. Both orthologues exhibited processive 3’ to 5’ 
unwinding of dsDNA and DNA-RNA duplexes, translocating on the DNA strand 
(polarity was only demonstrated for S. thermophilus  Cas3). ATP hydrolysis however 
was differentially stimulated in the two systems, with the E. coli Cas3 demonstrating 
high rates of ATP hydrolysis independent of nucleic acids (in agreement with the 
general model for DExH-box proteins), while S. thermophilus  Cas3 required the 
presence of ssDNA for efficient activity and the rates obtained were much lower than 
its E. coli counterpart. The situation in S. solfataricus  is even less clear, as the 
separately encoded HD-nuclease SsoCas3’’ has demonstrated a substrate specificity 
for dsDNA and dsRNA but was unable to cleave ssDNA (Han and Krauss, 2009).
 Cas3’ from S. solfataricus  was expressed in recombinant form in E. coli and 
purified to homogeneity. Unfortunately, attempts to express SsoCas3’’ recombinantly 
were unsuccessful. Co-expression trials of the two proteins in various dual vector 
systems were also unsuccessful. The eight sequence motifs characteristic of 
superfamily 2, DExH-box family proteins were detected in the primary sequence of the 
protein. As expected, SsoCas3’ is a multifunctional protein clearly shown to possess 
ssDNA-dependent ATPase, ATP-independent strand annealing and RNA strand 
exchange activities. Minimal ATP hydrolysis was detected in the absence of ssDNA, as 
well as in the presence of ssRNA or any double stranded species including RNA-DNA 
hybrids. The rate constants obtained were very low in comparison to the S. 
thermophilus  Cas3 which was also stimulated by ssDNA. SsoCas3’ was able to 
promote ATP-independent annealing of complementary RNA and DNA strands, as well 
as the invasion of an RNA strand into a complementary RNA-DNA heteroduplex. 
Almost 100% annealing of two separate strands in the presence of SsoCas3’ was 
observed in the timeframe of the reaction, as opposed to no annealing in the absence 
of protein. Regarding the strand exchange activity, in average about 50% of the single 
RNA strand was converted into heteroduplex product in the presence of SsoCas3’ in 
every assay replicate, in comparison to zero or 5% of strand exchange taking place in 
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the absence of protein. Invasion of a DNA strand into complementary heteroduplex 
was not supported by SsoCas3’. Considering the limited results we obtained, and 
given that additional controls must be carried out in order to characterise fully this 
activity, on first inspection the data suggest that annealing is probably promoted due 
to passive binding of nucleic acids by SsoCas3’. Strand rearrangement then is 
enabled between the proximal strands towards formation of a stable species. This 
effect was protein dependent, and clearly influenced by increasing temperature, 
potentially because the RNA-DNA duplexes became more unstable. A first attempt to 
extend this activity and investigate whether SsoCas3’ could promote the formation of 
bona fide R-loops, in the light of the results by Howard et al. (2011) yielded 
encouraging results, and should be investigated further. These results indicated a 
potential role for the Csa2-Cas5a complex in this activity. This is unsurprising, as this 
complex is suggested to form the core of the archaeal CASCADE, the bacterial 
counterpart of which has been shown to promote formation of R-loops in E. coli (Jore 
et al. 2011; Howard et al. 2011). It can be hypothesised that the promotion of strand 
rearrangement with a preference for ssRNA could be useful during the scanning of 
invader sequences for the correct complementary sequence to the aCASCADE-bound 
crRNA. Local remodeling of RNP complexes is a common activity displayed by DExH/
D-box proteins, which could be an additional activity for the helicase domain of Cas3. 
 The putative ATP-dependent helicase activity of SsoCas3’ is ambiguous. As 
described in the respective section, SsoCas3’ could effectively unwind one set of 
substrates comprising of the CRISPR repeat sequence of locus B, but not substrates 
with unrelated sequence or a mock physiological substrate consisting of the crRNA 
and the complementary DNA protospacer. In assays including the first set of 
substrates, SsoCas3’ exhibited a non-processive helicase activity specific for DNA-
RNA duplexes, but not for dsDNA or dsRNA substrates. The requirement for an RNA 
strand is consistent with the characteristics of all DExH/D-box proteins. An apparent 
lack of directionality resulted in the observation that it could unwind effectively blunt 
DNA-RNA duplexes, but we were unable to determine whether it translocates on DNA 
or RNA strands. The helicase activity was ATP-dependent and concentration 
dependent, suggesting that it is not an artefact. Moreover, inactivation of the Walker A 
motif by site-directed mutagenesis abolished activity. If we accept that this activity is 
real, then the observed enzymatic activity of SsoCas3’ overall is more reminiscent of 
the typical activity of DEAD-box proteins, rather than DExH-box proteins (described in 
5.1.2). This is where the role of the HD-nuclease must be considered. The 
indispensable role of additional domains in complementing, regulating and mediating 
the activities of the basic tandem RecA-like core fold in DExH-box proteins has been 
discussed previously. A similar point can be made about the role of interacting 
proteins and co-factors for DEAD-box proteins, which comprise essentially of this 
basic tandem Rec-A like motor fold. It could be hypothesised that this reflects the 
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relationship between the HD-nuclease and the helicase domains in Cas3 proteins, 
either as separate protein entities or as subdomains of the same polypeptide. 
SsoCas3’ comprises mainly of the two motor RecA-like folds, with the additional 
domain more likely to mediate protein interactions than influence the activity of the 
basic core, if the tertiary structure prediction by Phyre2 is correct. It is likely therefore 
that in this state SsoCas3’ resembles the topology and domain organisation of DEAD-
box proteins, although sequence motif conservation and substrate binding mode 
certainly differ. This could potentially explain the basic activity demonstrated by the 
protein at this stage, such as the low ATPase rates, requirement for ssDNA stimulation 
and the lack of directionality in helicase activity, or the absence of it. Moreover, DEAD-
box proteins that act as RNA “chaperones” typically promote a steady-state 
equilibrium between the two conflicting activities of annealing and unwinding in the 
presence of ATP, consistent with their role in RNP remodeling (Halls et al. 2007). The 
lack of helicase activity on the other substrate sets is puzzling, as it is unlikely for a 
helicase of this type to exhibit such strict sequence specificity, especially in the 
absence of its natural interacting partners. It is possible that the first substrate set of 
CRISPR repeat sequences is problematic and inherently unstable, and in reality 
SsoCas3’ does not display helicase activity in this form, although many questions are 
raised in this case as well. Even though we strove to carry out all experiments in 
triplicate, reliable reaction rates for all activities demonstrated by SsoCas3’ could not 
be obtained as the protein’s efficiency and behaviour was different depending on 
purification batches, potential contaminants, storage conditions and length, and assay 
components. 
 Either way, our results until this point indicate that characterisation of SsoCas3’ 
cannot be completed without its key partner, the HD-nuclease SsoCas3’’. Even though 
their interdomain interactions are not obvious from the studies of the fused proteins 
(Sinkunas et al. 2011; Howards et al. 2011), a physical interaction between the 
separate proteins is almost certain. On a first level, this interaction would potentially 
stabilise and alter the conformation of both proteins, with unpredictable effects on 
their activity. It is possible that this interaction would fine-tune the helicase and 
annealing activities of SsoCas3’, in agreement with the mechanisms of DExH-box 
helicases. Further research should focus on obtaining SsoCas3’’ and investigating the 
activities of both proteins in relation to one another and to the aCASCADE 
components,  in order to be able to elucidate the CRISPR interference mechanism. 
 Potential protein interactions of recombinant SsoCas3’ with other recombinant 
Cas proteins predicted to be involved in the interference stage (namely the core 
aCASCADE components and potential subunits) were also investigated and results 
are presented in Chapter 4. No stable protein interactions were observed for 
SsoCas3’, although the possibility of transient interactions cannot be ruled out. It is 
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thought that the CASCADE complex somehow recruits Cas3 to catalyse final cleavage 
of invader DNA, although the details of this mechanism are yet to be determined. 
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Chapter 6
Conclusions and future work
	 This thesis described the initial purification and characterisation of some of the 
key elements in CRISPR-mediated antiviral defence in S. solfataricus. The complexity 
of the CRISPR/Cas system in this organism, containing two different subtypes (I-A and 
III-B) with almost 60 cas  genes organised in multiple operons is both a challenge and 
an advantage. The existence of multiple reasonably conserved orthologues for a given 
cas  gene means that multiple candidates are available for solubility screening and 
crystallisation trials, a practical approach which proved extremely valuable during the 
course of this study. On the other hand, this situation makes genetic studies extremely 
complicated to interpret at a mechanistic level, and knockout studies almost 
impossible. 
 A general observation made during this study was that most of the Cas 
proteins in S. solfataricus  were extremely unstable during heterologous expression in 
E. coli or not expressed at all. This is not unexpected since the completion of this 
pathway requires a number of tightly regulated protein-protein interactions, and most 
of these proteins are predicted to or have been shown in other organisms to form 
small or large protein complexes (e.g. Hale et al. 2009; Brouns et al. 2008). Individual 
protein expression in this case fails due to the lack of the appropriate partner, which 
may stabilise the protein and in many cases alter its activity. Further effort needs to be 
put on towards overcoming the expression and solubility problems with the Cas 
proteins of S. solfataricus, and apart from co-expression studies which were 
attempted and in some cases successful (for example for the Csa2-Cas5a complex), it 
seems that the most promising strategy is the over-expression of recombinant 
proteins in their native strain, by using the genetic systems developed for S. 
solfataricus  by S. V. Albers (Albers et al. 2006). This would enable protein production in 
their native environment, where they can acquire any post-translational modifications 
potentially necessary for protein function, and where correct protein folding and 
protein stability is ensured by the endogenous expression of their appropriate 
partners. This strategy has been shown to improve the yield and enzymatic activity of 
over-expressed proteins in a number of cases, and can also be used to identify novel 
interacting partners by pull-down experiments, in a method similar to the one 
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employed here for the native aCASCADE and the Cmr complex. This work is ongoing 
and is being carried out by Dr Christophe Rouillon and Dr Jing Zhang (Professor 
Malcolm White’s group, St Andrews University).  
	 The attempt to reconstruct the S. solfataricus  Cmr complex is a case in point, 
as only four (Cmr1, Cmr3, Cmr4 and Cmr7) out of the six subunits were successfully 
expressed in recombinant form. Apart from the pairwise interaction between Cmr1 
and Cmr3 and the nucleic acid binding ability of Cmr1, little information was gained by 
the biochemical study of these proteins individually. In the absence of the predicted 
catalytic subunits of the Cmr complex (Cas10/Cmr2 and Cmr5, Makarova et al. 
2011b), it is evident that a meaningful characterisation of their role within the complex 
or of the complex itself cannot be achieved. 
	 The antibody-assisted isolation of the native Cmr complex from S. solfataricus  
described in Chapter 3 confirmed the constituent production of this complex under 
normal (not virus infected) growth conditions, and is a first step towards 
understanding its characteristics and function. We were unable to detect a nuclease or 
polymerase activity with this native complex, but the elucidation of the homologous 
complex in P. furiosus  indicated that our initial hypothesis was mistaken and further 
investigation is needed. The optimisation of the isolation process or the native 
overexpression conditions in order to increase the final yield is crucial for further 
experimentation. This will also enable structural studies of the Cmr complex, either by 
TEM, SAXS analysis or classic crystallography, which will be valuable in understanding 
the target recognition and interference mechanism. Native mass spectrometry should 
also be attempted in order to determine the exact stoichiometry of the complex, as 
demonstrated for the E. coli CASCADE and the P. aeruginosa Csy complex (Jore et al. 
2011; Wiedenheft et al. 2011). A small progress in this matter was made with the 
elucidation of the structure of Cmr7, described in chapter 3 and potentially providing 
the structural scaffold of the Cmr complex, as indicates its overrepresentation in the 
purified sample. 
	 It will be interesting to determine whether the Cmr complex in S. solfataricus  
has the same functionality as the P. furiosus  complex, namely that it mediates target 
RNA cleavage guided by the bound crRNA via a molecular ruler mechanism in vitro 
(Hale et al. 2009). The catalytic subunit in P. furiosus  was not identified, but it is 
predicted to be either the HD domain of Cas10, or Cmr5 (Makarova et al. 2011b). Site-
directed mutagenesis could be employed to determine this in the case of a similar 
activity of the SsoCmr, provided there is a method to overexpress the mutant proteins. 
Whether the targeting of RNA is also taking place in vivo is still unclear. Interestingly, 
the type III-A system of S. epidermidis  has been shown to target DNA in vivo 
(Marraffini and Sontheimer, 2008) and shares a similar Cas protein composition with 
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type III-B  systems. Moreover, no archaeal RNA viruses are currently known, making it 
difficult to speculate about the biological relevance of this function.  
 Chapter 4  described the purification and characterisation of a stable 
recombinant complex composed of Csa2 and Cas5a, two core proteins of type I-A 
systems. These proteins belong to families Cas7 and Cas5 and are orthologous to the 
CasC and CasD subunits of the E. coli CASCADE. It is demonstrated that Csa2 and 
Cas5a form the stable core of an archaeal CASCADE-like complex for antiviral 
defence, termed aCASCADE. The recombinant Csa2-Cas5a complex is able to 
specifically bind crRNA and recognise complementary target ssDNA in  vitro. Further 
studies are needed to fully characterise the recognition mechanism and substrate 
requirements, for example whether it can recognise and bind a complementary target 
in a dsDNA substrate, in a mechanism similar to the E. coli CASCADE. Mass 
spectrometry analysis of the native aCASCADE expressed in S. solfataricus  by N. 
Lintner in the group of Martin Lawrence in Montana State University Bozeman 
demonstrated that the aCASCADE consists of accessory subunits apart from the core 
Csa2-Cas5a complex, namely Csa5, Cas6 and perhaps Csa4 (Cas8a2), but these 
proteins are either not forming a stable interaction with the core complex or are 
present in sub-stoichiometric amounts. Nucleic acid extraction from the native 
complex carried out by N. Lintner revealed that aCASCADE co-purifies with the 
mature form of crRNA, which consists of the conserved elements identified in other 
organisms (Brouns et al. 2008), namely the repeat derived 8 nt 5’ handle and 21 nt 3’ 
handle interspersed by a spacer sequence. This was reminiscent of the products of 
pre- CRISPR transcript processing by Cas6 in P. furiosus, an activity which was 
verified here for the S. solfataricus Cas6. 
	 Transmission electron microscopy was employed to identify the structural 
characteristics of the native aCASCADE by N. Lintner. The formation of extended 
right-handed helices was observed, leading to the proposal of a structural model for 
the assembly of aCASCADE by N. Lintner and M. Lawrence. According to this model, 
aCASCADE under physiological conditions (not Csa2 overexpression) would adopt a 
semi-helical arch-shaped structure with a backbone composed by multiple (6-8) Csa2 
subunits and a single crRNA bound along the length of the arch. Cas5a and the 
accessory subunits could potentially nucleate and regulate the growth of the 
assembly, apart from mediating specific nucleic acid or protein interactions (Lintner et 
al. 2011). Taking into account the emerging structures for CASCADE and the Csy 
complex (Jore et al. 2011; Wiedenheft et al. 2011), we can observe the conservation of 
an arch-shaped core structure in all complexes, indicating its importance and 
presumably that it represents the core structure of all type I CASCADE-like complexes.
 Cas3 has been shown to be required for the final target cleavage and invader 
silencing in type I-E systems such as E. coli (Brouns et al. 2011). In type I-A systems 
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the identified SF2 helicase and HD nuclease motifs of this protein are encoded as two 
separate proteins, Cas3’ and Cas3’’. The purification and initial characterisation of 
Cas3’ from S. solfataricus  is described in chapter 5. The existence of DExH-box family 
motifs is generally associated with ATP-dependent RNP remodelling (Pyle, 2008), and 
does not necessarily imply a helicase activity. Therefore, the helicase, ATPase and 
strand exchange activities of SsoCas3’ which contains all the canonical DExH-box 
family signature motifs were investigated biochemically in this chapter. SsoCas3’ 
displayed a weak ssDNA-stimulated ATPase activity and an ability to promote strand 
exchange between single strand RNA and hybrid RNA-DNA duplexes. The results 
obtained from investigation of the helicase activity of SsoCas3’ were contradictory. 
With one set of substrates consisting of CRISPR repeat sequences SsoCas3’ 
exhibited the ability to unwind blunt DNA-RNA hybrids, but not dsDNA or dsRNA, in 
an ATP-dependent matter. However, we were unable to confirm this activity with 
different substrates, and therefore would be premature to characterise the protein as a 
de facto helicase. Moreover, it is not understood why the ATPase activity of SsoCas3’ 
was not stimulated by RNA-DNA hybrid duplexes but by ssDNA, unless the function of 
this protein involves  initial recognition of a single strand DNA region in order to carry 
out remodelling of an RNA-DNA hybrid, such as the one formed upon recognition of 
the DNA protospacer target by the crRNA-aCASCADE complex. Initial studies into the 
possibility of R-loop formation by SsoCas3’ and the Csa2-Cas5a complex gave 
positive results, indicating that a mechanism similar to the R-loop formation observed 
for E. coli CASCADE (Jore et al. 2011) and the E. coli Cas3 (Howard et al. 2011) could 
perhaps be taking place in S. solfataricus  as well. Further experimentation is needed 
to clarify this matter. 
 The situation of Cas3’ and Cas3’’ is another case that would benefit greatly 
from native expression in S. solfataricus. As discussed in Chapter 5, the behaviour of 
characterised Cas3 orthologues differs greatly from the behaviour exhibited here by 
SsoCas3’ and the behaviour of the individual HD-domain protein Cas3’’ from S. 
solfataricus  (Han et al. 2009). Since it is predicted almost certainly that these two 
proteins interact, and considering the role that accessory domains and interacting 
partners play in regulating the function of DExH/D-box helicases (Pyle, 2008), it 
becomes apparent that a physiologically relevant functional characterisation of any of 
these proteins cannot proceed without the other. 
 Expression of SsoCas3’’ is also essential to verify its predicted role along with 
Cas3’ in the final step of CRISPR/Cas interference in cooperation with the aCASCADE. 
Genetic studies in E. coli and biochemical characterisation of the type I-E enzyme 
(Brouns et al. 2008; Sinkunas et al. 2011; Howard et al. 2011) have led to the proposal 
that Cas3 is recruited by CASCADE to the site of crRNA-mediated protospacer 
recognition. Once present, it can perform the final cleavage of both strands of the 
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dsDNA target and perhaps catalyse localised remodeling of the CASCADE-crRNA-
DNA complex in order to release the crRNA and/or release the DNA strand for 
cleavage. Interaction between SsoCas3’ and the Csa2-Cas5a complex or the native 
aCASCADE in S. solfataricus  was not detected during this study, but considering the 
current unavailability of all proteins predicted to be involved that is hardly surprising. 
An explanation could also be that that an interaction might only take place under 
certain conditions or other signaling molecules might also be involved. 
 A feature of both native complexes characterised in this study (Cmr complex 
and aCASCADE) was their constitutive expression, indicated by the fact that it was 
possible to isolate them from crude cell lysate under normal growth conditions (for 
aCASCADE, see Lintner et al. 2011). This is a situation observed in all archaeal 
systems studied to date (Tang et al. 2005; Hale et al. 2009; Lillestol et al. 2009), 
suggesting that in these systems CRISPR/Cas is not under negative regulation as 
opposed to the situation observed in bacteria. This is in agreement with the system 
being in “surveillance” mode, constantly alert for potential extrachromosomal 
infections. The co-existence of types I-A and III-B  in S. solfataricus  indicates that this 
organism can target both DNA and RNA, widening the range of immunity. The 
prevalence of type III systems in thermophilic archaea perhaps reflects an adaptation 
to a specific need of these organisms, namely the need to silence some form of RNA. 
The source of this target RNA is yet to be determined, but it can be certain that the 
polymorphism and diversity of the archaeal virosphere will continue to surprise us. 
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APPENDIX I
CRISPR locus constructs
Repeat sequences are highlighted in yellow.
1. CRISPR I (5’ to 3’)
GATAAAGAGAAAACCGGTTAAGTTCGTTTTCATGAAGTTGTTTAAAAGTGTGAAAGTTCGAGTCTCAATG
CGACCGAAACGAATCTTTCTATAATAATTGAACGTTTATAAATGATAGGGTGTATTTCAATTTAACATAA
AATCCTTGCGACCAGAAATTGTTAAATTAATTACAACTAAAATTGGTCGCATGAAGAGTAAAGGGTAGTC
ATGAAGATTTATAAGTAAGAAAAGAGAAAGAAAGATAGGAAGTATAAAAACACAACAGATTAATCCCAAA
AGGAATTGAAAGGAACTAGCTTATAGTTTAGAAGAAAACAAACAAATAATGATTAATCCCAAAAGGAATT
GAAAGATTTTCAGCTGAAAATTTGAAATCTGTAGATTTGGATGGATTAATCCCAAAAGGAATTGAAAGTT
CCAAAATTGATCTTCTATTGCGTCTTTTATTGCTTTTGATTAATCCCAAAAGGAATTGAAAGATTGTAGT
CTTTATCAATCCACGTTTCTCTAATCTTG
2. CRISPR II (5’ to 3’)
CGTTTATAAATGATAGGGTGTATTTCAATTTAACATAAAATCCTTGCGACCAGAAATTGTTAAATTAATT
ACAACTAAAATTGGTCGCATGAAGAGTAAAGGGTAGTCATGAAGATTTATAAGTAAGAAAAGAGAAAGAA
AGATAGGAAGTATAAAAACACAACAGATTAATCCCAAAAGGAATTGAAAGGAACTAGCTTATAGTTTAGA
AGAAAACAAACAAATAATGATTAATCCCAAAAGGAATTGAAAGATTTTCAGCTGAAAATTTGAAATCTGT
AGATTTGGATGGATTAATCCCAAAAGGAATTGAAAGTTCCAAAATTGATCTTCTATTGCGTCTTTTATTG
CTTTTGATTAATCCCAAAAGGAATTGAAAGATTGTAGTCTTTATCAATCCACGTTTCTCTAATCTTG
3. CRISPR T7 (5’ to 3’)
TTGTAATACGACTCACTATAGGGATAGGAAGTATAAAAACACAACAGATTAATCCCAAAAGGAATTGAAA
GGAACTAGCTTATAGTTTAGAAGAAAACAAACAAATAATGATTAATCCCAAAAGGAATTGAAAGATTTTC
AGCTGAAAATTTGAAATCTGTAGATTTGGATG
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APPENDIX II
Multiple sequence alignments
A.2.1 Conserved motifs of Cmr2 family members 
! The following alignment illustrates conserved motifs between Cmr2 proteins 
and HD hydrolases. Alignment generated with COBALT, shading with BOXSHADE. 
Parts of the alignment where no conservation was found are not shown. Protein 
sequences: S. solfataricus  Sso1991, S. islandicus  YP_002836826.1 Cmr2 family, S. 
tokodaii Sto1979, S. solfataricus  Sso1729, Hyperthermus  butylicus  DSM 5456 HD 
hydrolase, Thermoanaerobacter tengcongensis  MB4 hydrolase, Archaeoglobus 
fulgidus DSM 4304 Afu1867, Nitrococcus  mobilis  Nb-231 HD superfamily, Thermotoga 
sp. RQ2 Cmr2 family, Syntrophus  aciditrophicus  SB HD hydrolase, Sorangium 
cellulosum 'So ce 56' HD hydrolase, Pyrococcus  furiosus  DSM 3638 Pfu1129, 
Methanocaldococcus  jannaschii DSM 2661 Mj_1672, Megasphaera micronuciformis 
F0359 Csm1, Fusobacterium nucleatum subsp. vincentii ATCC 49256 HD superfamily, 
Thermotoga petrophila RKU-1 metal dependent phosphohydrolase, Thermoplasma 
volcanium GSS1 HD superfamily hydrolase. 
                                     HD nuclease motif
Sso1991_Cmr2 1 MS--------------TDD-N--------------SREEFLNYKIMALLHDPPNKAWVITSRAH--------NLTVQLRS
S.isl Cmr2   1 MS--------------TDD-N--------------SREEFLNYKIMALLHDPPNKAWVITSRAR--------NLTEQLGS
Sto1979_Cmr2 1 MS--------------KMSLK--------------PMSEIIKEKFAALLHDPPNKPFIFSLNAF--------NEEKRISH
Sso1729_Cmr2 1 MR--------------RVGSK--------------NCSRGGENRKVLLYYLLINK----------------------LLK
Hbu_HDhydr   1 MS--------------RLH----------------------MVKLAALLHDPAWKPWIVASAFP--------GKTGTVGR
Tte_HDhydr   1 ------------------------------M-EKV-----WLLKLKAFLHDPPHKHWIISMDNEECIKKFQLQEKGRCHE
Afu1867      1 -----------MGQYFRVSGKYRGRENLPREVNKMADNEFWLNKIRAFFHDPPDKSFELKT------------HERRASF
Nmo_HDhydr   1 ------------------------------MTDRL-----WQAKLHARLHDPAEKALVLLRD--------PAGPEGGTSR
Cmr2_TherRQ2 1 ---------------------------------MSEREEFWKSKITALLHDPLVKAFDVKN------------HEDIAGE
Syn_HDhydr   1 ------------------------------MTWQIPDTSYWENKFAAYWHDPIDK--VISIQNH----------EERAAD
Sce_HDhydr   1 MSERDRDRDRNLAVAHPVHGR-TGDDEIEHHGTEADRTRFWQQKLLQLLHDPPGKAFFLRQGAG--------GHKAVAAD
Pfu1129      1 -----------M-----VNIK---------------------EKLFVYLHDPPDKALKIEN------------HEERSKK
Mja1672      1 ----------------------------MGNCNEYTA-----LKIGALLHDIGK----FIQRASDKPK--SKGHDKFGYE
Csm1_Mmi     1 ----------------------------MDQ-------LEARLQKAALLHDIGK----VYQRSG--LG--QGTHSEAGVA
Fnu_HDhydr   1 ----------------------------MDE-------KLICLQLGALLHDIGK----IVRRAG--LD--SKEHSKAGSN
Tpe_hydr     1 ----------------------------MRKGGESSLKDREELVVGALLHDIGK----VVRRAG---D--DRRHQIAGYD
Tvol_HDhydr  1 ----------------------------MDN-------DEFVLITASILHDIGK----IQQRYKL-----SEKHADLGYQ
Sso1991_Cmr2 44 V--RARK---SH-ERVAKYIINQLFGDINS------------------------------KT-------VDNADKLASSI
S.isl Cmr2   44 V--KARK---SH-ERVAKYIINQLFGDINS------------------------------KT-------VDNADKLASSI
Sto1979_Cmr2 45 V--KVAKTLISHLDFLGKNELDEISSKIYS------------------------------KKEKGCNSKVSDADSLASKF
Sso1729_Cmr2 31 Y--KELRRFFEN--------FYSIYKKSGS------------------------------RAK--ARKKVSAADVLASEY
Hbu_HDhydr   37 VLAKVAGKSAPAGELVKVEECEELMKKMKTYTIEADAHQLDAAAAAVAILDGLRDAPIIEKLILDEKGVVAEADKLAASL
Tte_HDhydr   45 IL---IKSKVIEPLLGEDLTEEE--EKL---IEKADTQAYP--------VNRILP-PVA----VKIRGEDVIFFDMFNKK
Afu1867      58 IL------GELKPSKSLKRIIKN----ADIQASSLQRVDLE-KSIHKKELKSTFD-RIHNTEKYEYIGQPIIRHPVTGEI
Nmo_HDhydr   38 VL---HERLFPQGMAG-DLRATV--RKADWWASAADRPQFP--------RDGKEG-PYARWSQVNFAEQPVPIHPLTGKA
Cmr2_TherRQ2 36 IL---K-TLGIEKSRGEE----------DRLASAMDRFPIPYEKDAKKQIHVSFD-ET------------LFVHPFSGE-
Syn_HDhydr   39 YL---Q-------IFGIDRPNDEFWQMADAIAAGFERGQVP--------SHSTDD-TKN--GAVDFAESPVITHPTTGKK
Sce_HDhydr   72 LF---Q-ATAGVPLKYVR---PG----PDWAASGADRPVSS----PPRPAHVSVD-WVKN---------PILTHPLASGT
Pfu1129      32 IL---S-SGNIQYSRTDK--VKQ----ADALSSKTQRFIIR-TKENKEPVIDFLG-R--SSGKYFHVGYPVFIHPISTEI
Mja1672      42 FL-----KEKFKNGFLNHLDEKTKDKILEIVKEHHNQ-KI-------------KD---------DLIGIVRLADWLSSGE
Csm1_Mmi     38 FL-----KPYYEN-------DDSL--VLRAVKYHHAD--MA-------KRLTKDD---------DLAYIVYEADNIAAGT
Fnu_HDhydr   38 YL-----KNNNLL-------ADRYKEIYDTIDYHHAK-YLS-------SADLKED---------SLAYIVYEADNIASGI
Tpe_hydr     44 FT-----NKV-----------KKFAVIQDYIHYHHEK-DLL-------KKSLENE---------KVWYVCF-ADNLSS--
Tvol_HDhydr  37 FI-----KEIKYS-------NKDMERIANLVKHHHHDPDKT-------ELDGRDK---------KLLKILQIADRKSAAH
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Sso1991_Cmr2 136 LNVTNTTNLNI---LKYQLFYLIYELI--WIDSRYENTP-A-ETRNPTHTIFDHLYATAAMMN-WIFSLEKE--------
S.isl Cmr2   136 LNVTNTTNLNI---LKYQLFYLIYELI--WIDSRYENTP-A-ETRNPTHTIFDHLYATAAMMN-WIFSLKKE--------
Sto1979_Cmr2 162 LGLTG---VSI---ETYNVFYFFYEFL--WVAKGYTVGP-A-DTRVPTHSIFDHLYATASIIN-WFLG------------
Sso1729_Cmr2 144 LDKTKIFKLIK---SVYFLIYTIYEPL--WIYFGLPVEV-E-DSRSPFYTIFDHLYASASMIN-WVYYDDRSDPKGKKGK
Hbu_HDhydr   183 --------------LLYNLFYLLLEPL--WYEVCRACIPLA-DTRTPTHTVFDHVYATAAMVN-WLYPGGGK--------
Tte_HDhydr   161 F---------H---WMRI-------------------HP-A-DTRAPNHSIYDHLVQTSTLV--SALPKPA---------
Afu1867      195 --EKLKEA-------------LEEEFSASFAEE-FVNLP-A-YTLSPDHTLFDHADATSAIF---GAEIDGK--KPV---
Nmo_HDhydr   154 DTADDTARLGE---LWRF-------------------LP-A-DTRIPDHSIWDHLDLVSAFA--GAFVADANGE-CA---
Cmr2_TherRQ2 135 --YILEGS--Q---F----------------------LP-A-DTRIANHSIIDHLDVTSALK---GC-VEGKQVKAS---
Syn_HDhydr   160 LAEKNIGGLGA---LWHR-------------------IP-A-DSRFPDHSIWQHNALCSAIS--SCVELGGRAEEVS---
Sce_HDhydr   200 DDARLQQACLQ---LWR---RLPEEPPPGVAEVVWRHQP-A-DSRAPDHSLWDHLRVTSSLSFLSGRRREGP-VMPW---
Pfu1129      162 --VKLKEGVKE---FAKSELKLKEEEAEKFAEE-FVNLP-A-DTRFPDHAIWTHLDLTSAL--------SVK--DPT---
Mja1672      170 IKDFK-GDVSF-----EELYQLMQKYTWCIPSVTMWKKAGSLKGGLPDVSLFDHSKTTCAIAC-CLYQMYVKENKKK---
Csm1_Mmi     160 FERRKPDDME-----VNEMLQVLEATLSYIPSSTATNQPA-------DISLYEHVKLTAAFAA-AMYR-WFKAEGIE---
Fnu_HDhydr   160 LNSFK-ENIN-----PEKLAIVLEACCSYFPSSSYVDTP--------DISYYDHVKLTAAISA-CFYL-YDKENNIQ---
Tpe_hydr     159 --SPTPEDVQEIFPTPDDVNFLTYKYFSFIPQETRVEGDM-------DISLYDHLKVTAMLAL-SLYD-YAKENDLK---
Tvol_HDhydr  150 IDKLNFNEPDK-YKFFNTLNSILYKDTVAIPSAFYYSKP--------DIPLYHHLKLTAAIAL-SLYR-NLKSSDIE---
                                                                                             
                                                                                                Zn ribbon  
Sso1991_Cmr2 436 TPESRL-KLFELTKFDK-LPQIGEK-----SKRGYEFCTSCGVLPAVIIMP---KEDEFEKKLIE--L-------GIARD
S.isl Cmr2   436 TPESRL-KLFELTKFDK-LPQIGEK-----SKRGYEFCTSCGVLPAVIIMP---KEDEFEKKLIE--L-------GIARD
Sto1979_Cmr2 449 SPHTQL-SNYNYY-----IDSIGE------TKRGFEYCSICGVLPAMLILP---KDENEYKKFVEEHT-------GKQFN
Sso1729_Cmr2 479 KVKEKY-KREILPKPNW-FTSFNKEFDYINGGKNWEYCTVCGNEPAIINFG---KENDDYSASTKCEILRLAYQNRYKVT
Hbu_HDhydr   505 AEEREYAKSVSIDAGFA-IAESLEEATSKPLKPEFHECSMCGRLPAIVHLADAAKVREFAERLGVPVV------------
Tte_HDhydr   434 LLLELTEKLLGARKSIREFEQLEQK-GRK--------CSLCGEFEVLPLD-----------------WEKLR--------
Afu1867      469 LYYEILTVLNAIESTH--FDKPAEPAGYK--------CTLCGEHLAIGGE---------SREMMENVWGKIH--------
Nmo_HDhydr   437 AVYDLVDRVLVAAKSVRAFDALEQH-GYR--------CSLTAEAEWLTDNPAHLSLPPGQRDQADTLWSRLG--------
Cmr2_TherRQ2 356 -------------------RKVSEHAGYK--------------------------------ENPGTFYRYLH--------
Syn_HDhydr   423 TSHSLVQSALAAEKSIRSVARTEEP-GEK--------CQMCSEFEVLHSKQWNGEVAGHYADHLKEFWSQLN--------
Sce_HDhydr   531 LLHHALVSRHGLRKAEAQGAAIAEESGEK--------CTLCGLRQALGAGDAGASV-DAQRETARAFWRRFD--------
Pfu1129      419 LLVKILDSLGERKVTEERFEKSEQLKGWK--------CHVCGENLAIFGD---------MYD---------H--------
Mja1672      409 ---FEYK-LEGLFE---PYNRGSE---NR--------CVICR--------------NEFDKNE-KGYAIRENE-------
Csm1_Mmi     378 ---YSKEQLEDMFDWGSELNSVGD-GMRE--------CNVCH--------------TSANPDLLRPYVLG----------
Fnu_HDhydr   380 ---YSLEQLKELFDENSSLNKIYS-YTEE--------CTICK--------------KAEDESILKKNALDFDE-------
Tpe_hydr     374 ---YTEKDLEAIFP--DDLNLIQEKGNHT--------CKICG--------------NRVDR------LFSIRE-------
Tvol_HDhydr  371 ---AKRMKMSEIFS-DNAIERDVKFGHSI--------TNMCE--------------SCGMDSI-----------------
                                Zn ribbon
Sso1991_Cmr2 497 EKDVRSIKNMI--SPGERLCPWCLVKRALGAEPR------LMRILLLG-DLCSVEKIVNEIVSKDVKIE-IPSTSDIASI
S.isl Cmr2   497 EKDVRSIKNMI--SPGERLCPWCLVKRALGAEPR------LMRILLLG-DLCSVEKIVNEIVSKDVKIK-IPSTSDIASI
Sto1979_Cmr2 507 DDQIEALKAIL--SPGEKLCPWCLIKRAIGVRPE------FLRVLITSEDLRSFEE-------KDVFI---PSVSHVAFY
Sso1729_Cmr2 554 DDDLKDLKVWF--KPGEKLGPLCIIKRGLYFRLR-----------------KNLEKVFKS--TDDIAYS-YYKNVIQPRI
Hbu_HDhydr   572 ---------LF--SEGESLCPYCLVRRLVSTSDA------IRRIMNGL-------NLYYSLNPRQLYTR-PPSTDELAAM
Tte_HDhydr   480 ----SKEKGLV--KEKEQLCGVCLAKRLFPKVMK--------------------EELNLSEEMKFP------STSEMATI
Afu1867      522 ----KRWPSHL--RSNERLCAVCAVKRF----------------------YPKFIETLDIFEGVGKVVPDIESVSEVAMC
Nmo_HDhydr   500 ----RKRPTWV--RKGEHLGALATLKRLWPTLFC--------------------EELKDTLNMSFSRF--VVSTHTMALA
Cmr2_TherRQ2 377 ----RLLTSKL--AARK-------MARL----------------------FPGYEEDVY---------------------
Syn_HDhydr   486 ----PEQKDDVDFKENERLCSVCLIKRLAPHILK--------------------NSNDHILCNVFRSIDNVPSTTEMALH
Sce_HDhydr   594 ----RNSDD-----GAERLCAVCTMKRVLVRAGVATDERGARRRVGLTAAWAGPATPLDDVCDRDELRVPFPSTATIAAQ
Pfu1129      465 ----DNLKSLW--LDEEPLCPMCLIKRY----------------------YPVWIRSK-----TGQKIR-FESVVDVALL
Mja1672      449 -------------SKSERICDYCASFVALTDILKNFQ---------MEKTIKFNKAYPIIHLTKNKDNL---------SL
Csm1_Mmi     422 -------------DDGTLACDTCNALA---------Q---------LGQDIL----------NKDVFII---------TS
Fnu_HDhydr   427 -------------EEGIELCSSCRGYI---------D---------LGKEVSS-----LYYSNNDKFII---------EK
Tpe_hydr     414 -------------GEEEIACDFCKEMY---------E---------LGKDLLIKSHVYLAERKNGKFEI---------FK
Tvol_HDhydr  408 --------------YDNAKCIGCLEEE---------N---------IGSSLYKYSN-----------II---------TD
Sso1991_Cmr2 613 -----------------LTID-PEEY-----WFSEKRRRYYFSLFRRH--------RITFPSPYYALVRADSDYLGDLLE
S.isl Cmr2   613 -----------------LTID-PEEY-----WFSEKRRRYYFSLFRRH--------RITFPSPYYALVRADSDYLGDLLE
Sto1979_Cmr2 604 -----------------LLRENPEEK-----GWKDV-------------------------SPYYALVRADTDYLGDLLE
Sso1729_Cmr2 656 -----------------LPCI-QKEY-----GVSDVNNAFIDAL-KGY--------R-----EFYAIVKADADDMTELAR
Hbu_HDhydr   676 -----------------YTKAGQKAK-----EILGLLEAIYDKLLGEF--------GEEFPHMLIAGILASEQRCASHLA
Tte_HDhydr   593 ---------------------TENFKVEEFQKMSQKITKLLEKHRVNP-------SR------YYAILQMDGDHMGKWLK
Afu1867      650 LRDFNTLLDTLGFDAAKLGLDDVKNYETMISELRERLSEVYKMLGEPP----------K----YYAILMMDGDEMGKLLS
Nmo_HDhydr   610 ---------------------DEG-------KAEAAISRLAHALGYKP-------ET------YYALLLMDGDYMGAWLS
Cmr2_TherRQ 2466 KFDSTT--------------DIARN------------NQANKEIEDPA----------KFKNGYIAVLLMDGDRMGDWML
Syn_HDhydr   574 ---------------------IDNR------------------------------DK------YYALLMMDGDNMGKLIN
Sce_HDhydr   744 GREQGDGAAQRGGLRDRDGKRVPRSKVEALRRAVESLRRAAKELDRPAGSARRAGDRIPAPGSQVALIALDGDRISQILL
Pfu1129      565 ----------------KKEIDEEK-----VKEVVDFLNAAYKEIGNPP----------K----YYAILVMDGDDMGKVIS
Mja1672      548 -----------------IAFPIIENETE--KRILDFDGLAEKAFERT---GTRK----------IGILKMDVDNLGEIFT
Csm1_Mmi     498 ------------ATRLWVGDYSVRKDDG--SGCLEFSELAELSGGGKEKAGIER----------IGVLRADVDNLGAAFV
Fnu_HDhydr       --------------------------------------------------------------------------------
Tpe_hydr     496 ----------------------------------EFEKIAEKAPGKK-----------------IASLLVDVDNLGKIFL
Tvol_HDhydr  486 ------------WRFILQAKYVPLYDDV--RSIKPFSDYFKDESEHK------M----------LGVLKADVDDMGLIVA
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Sso1991_Cmr2 789 GLLVEL-ELINKHK-GFVIYAGGDDLLAMLP-------VDEVLD-------FVKESRRAFAGVSTG--------------
S.isl Cmr2   789 GLLVEL-ELINKHK-GFVIYAGGDDLLAMLP-------VDEVLD-------FVKESRRAFAGVSTG--------------
Sto1979_Cmr2 750 ILLKEI-QLVNALG-GFVVYAGGDDLLAILP-------VENALQ-------FVENSRKIVAGIE----------------
Sso1729_Cmr2 771 TLLRDI-KTVEVENYGQIIYAGGDDVVALVP-------IDRLID-------TLIGLERNFVG------------------
Hbu_HDhydr   869 TALYDA-EIVAMLG-GFPVYAGGDDVAALAPGYISKGRLENLIKGYATRATHIKDSIRADTGFVPA--------------
Tte_HDhydr   690 FALQEVRRIVEETHYGKLVYAGGDDVLALLP-------VEEVL-------------------------------------
Afu1867      764 FSVNHVPDVVRKG-NGTLIYSGGDDVLVLLP-------VDTAFDVATELAMTFSTSWN----------------------
Nmo_HDhydr   704 FSTVIAREVVEREHIGRVLYAGGDDLMAMFA-------VSDLLSAMRRLRLAYSGLAPE---------------------
Cmr2_TherRQ 2562 FS-QFVGKIVDRH-NGMLVYSGGDDVLALLP-------ADSVLECANDIRKFFSGYLEYEIEIENGSDVERFR-------
Syn_HDhydr   658 FSIYGVASII-KDHDGRLIYAGGDDVYAFLP-------IGSALPAARKIRDYYTSIFRY---------------------
Sce_HDhydr   879 FAHTIVPWVVEREFSGRLIYAGGDDVLAIAP-------AGEALDLCARLAQLYSAAWVLDTSPGEGPWAWRAKTWTSSTS
Pfu1129      652 FSIREVRSVV-KD-EGLLIYAGGDDVLAILP-------VDKALEVAYKIRKEFGKSFE----------------------
Mja1672      645 ----------------YLVYAGGDDTLIVGAW-------DAVWELAKRIRGDFKKFVCYNPYITLSAGIVFVN---PKFE
Csm1_Mmi     614 ----------------HIVYSGGDDMFIVGAW-------DDLIELAVDIRRAFRRFT--NDKLTFSAGIGLFK---SAFP
Fnu_Hdhydr       --------------------------------------------------------------------------------
Tpe_hydr     560 ----------------MVIYSGGDDLYLVGGW-------NDVLDVAKELREAFGRFTA-NDFMTFSAGYVITD---EKTS
Tvol_HDhydr  572 ----------------YIVYSGGDDVTAVGEI-------NKLIKFISDFHNEFNKYFC--KKINISAGVTVVS---PKFP
 The following alignment illustrates the conserved “GGDEF” domain between 
Cmr2 family members, diadenylyl cyclases and response regulators. Protein 
sequences: S. islandicus  YP_002836826.1 Cmr2 family, S. solfataricus  Sso1991, S. 
tokodaii Sto1979, Thermotoga maritima MSB8 hypothetical protein TM1794, 
Archaeoglobus fulgidus  DSM 4304 Afu1867, Hyperthermus  butylicus  DSM 5456 HD 
hydrolase, Ignicoccus  hospitalis  KIN4/I hypothetical protein Igni_0328, S. solfataricus 
Sso1729, Thermoanaerobacter tengcongensis  MB4 hydrolase, Pyrococcus  furiosus 
DSM 3638 Pfu1129, Rhodopseudomonas  palustris  DX-1 response regulator receiver 
modulated diguanylate cyclase, Rhodopseudomonas palustris  BisB5 response 
regulator PleD, Bradyrhizobium sp. ORS278 response regulator PleD, Afipia sp. 1NLS2 
response regulator receiver modulated diguanylate cyclase, Nitrobacter hamburgensis 
X14 response regulator PleD.
Sisl_Cmr2    744 RKKLEKIDVEKEVENSLKYFRTILKEG---RIIVTPAWHVSISSALNRGLLVEL-ELINKHK-GFVIYAGGDDLLAMLPV
Sso1991_Cmr2 744 RKKLEKIDVEREVENSLKYFRTILKEG---RIIVTPAWHVSISSALNRGLLVEL-ELINKHK-GFVIYAGGDDLLAMLPV
Sto1979_Cmr2 705 EIEINDNDIERIISDLKDFLNKNVDRD---RLLLFPSWHVSISSMLNRILLKEI-QLVNALG-GFVVYAGGDDLLAILPV
Tmar1794     528 IEMFQETDD-------LKYAWEKLKEF----KTIQPAYHRGVSRTLGIFS-QLVGKIVDRHN-GMLVYSGGDDVLALLPA
Afu1867      731 LERVSD------------ALRVKAKTV---RRLITPAAHSSISRALKNFSVNHVPDVVRKGN-GTLIYSGGDDVLVLLPV
Hbut_HDhydr  836 PSSGCKKGC------------KALPKP---ATLVTPTYYMALSRGQMITALYDA-EIVAMLG-GFPVYAGGDDVAALAPG
Igni_0328    719 PKEVYGEND------------SSLP-----TVLVTPTYLFQLSYSLMTEALVDK-EIVEKNY-GLLVFAGGDDLLALVPA
Sso1729_Cmr2 745 -------------------IAKVINDG---NILMSPTYRVALSLAMMITLLRDI-KTVEVENYGQIIYAGGDDVVALVPI
Thten hydr   654 GEHIKQ------------HAKDNLSSILCKKHPTTPSLHQTLSRKISTFALQEVRRIVEETHYGKLVYAGGDDVLALLPV
Pfu1129      625 RDYV------------------EIPEA---KYYSTPQVHVAISQALANFSIREVRSVV-KDE-GLLIYAGGDDVLAILPV
Rho cyclase  326 LMIL---DID---------FFKSINDSYG---------HDAGDDVLREFALRIK-KSIRGID--LACRYGGEEFVIVMPE
Rho PleD     326 LMIL---DID---------FFKSINDSYG---------HDAGDDVLREFATRIR-KSIRGID--LACRYGGEEFVIVMPE
Brad PleD    326 LMML---DLD---------YFKSINDTYG---------HDAGDDVLREFAMRVR-KSIRGID--LACRYGGEEFVIVMPE
Afi cyclase  326 LMIL---DID---------FFKSINDTYG---------HDAGDDVLREFATRIR-KSIRGID--LAARYGGEEFVIVMPE
Nitr PleD    326 LMML---DID---------FFKSINDGYG---------HDAGDDVLREFAVRIR-KSIRGID--LACRYGGEEFVIVMPE
Sisl_Cmr2    819 D---------EVLDFVKESRRAFAGVS--------------------TGRLGNMCLENGFARIN-NAYYPSL-PIVGRSY
Sso1991_Cmr2 819 D---------EVLDFVKESRRAFAGVS--------------------TGRLGNMCLENGFARIN-NAYYPSL-PIVGRSY
Sto1979_Cmr2 780 E---------NALQFVENSRKIVAGIE-------------------------DASSYKGFIKIN-NSYFSQL-PLVGRSY
Tmar1794     595 D---------SVLECANDIRKFFSGHL--------EYEIEIESG----SDVERFRSENGVLYHNDKPFAPLMGRAATMSA
Afu1867      795 D---------TAFDVATELAMTFSTSW--------NGWEMLPGN----K----------------------------LSA
Hbut_HDhydr  899 Y-ISKG--RLENL--IKGYATRATHIKDSIRADTGFVPALIALY-TRKNYWGLLWAGRGFHRTPIGAVYPAP-VAYGRSY
Igni_0328    780 RSVSRGSGRAEPLGGLEEFLSRELL---EIVKEFYFSPALWVWWLTRLNHWGLLRSPVGFRYTD-NFFAPAL-LAYGRSY
Sso1729_Cmr2 802 D---------RLIDTLIGLERNFVG-------------------------------ENGFFKVR-QWYIPTF-YPHGRSF
Thten hydr   722 E---------EVLECAYELQNAFKEVL--------SSEA---------S----------------------------MSA
Pfu1129      682 D---------KALEVAYKIRKEFGKSF--------ENGSLLPGW----K----------------------------LSA
Rho cyclase  382 TDLHVAQ------MVAERLRRAIAGEP--------------------------FAVEKGTRRIE-----------VTISI
Rho PleD     382 TDLHVAQ------MVAERLRRAIAGEP--------------------------FGIEKGAKRIE-----------VTISI
Brad PleD    382 TDLHVAG------MVAERLRRSVANEP--------------------------FSVHKGEKRID-----------VTVSI
Afi cyclase  382 TDLHVAG------IIAERLRRSIANEP--------------------------FSIEKGTKRIE-----------VTISV
Nitr PleD    382 TNLHVAG------MVAERLRRSIAGEP--------------------------FAVHKGAKRID-----------VTISI
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PALM domain
Sisl_Cmr2    868 SVIIAHYA-DPLFFVINDSYNLLEEGKEMIRYRVMYNGEYKDAKKDVAIFRYQGLTSVI-----------PLSLKRPIV-
Sso1991_Cmr2 868 SVIIAHYA-DPLFFVINDSYNLLEEGKEMIRYRVMYNGEYKDAKKDVAIFRYQGLTSVI-----------PLSLKRPIV-
Sto1979_Cmr2 824 ILYFSHVK-YPLQLALEESYNLLEEGKERVKY-----DKYK---KDIVIFKYRNSVSFI-----------PLSLIRPYEE
Tmar1794     654 GIAIVHHK-FPLQVALKIARE-AEKRAK--NV-------YGRNAFCVTQVKRSGQMIFA-----GSTW----EIEEED--
Afu1867      826 GLLIVHYK-HPLYDALEKTRELLQ-KAK--KL--------GRNAIAVGLLKRSGSYYES-----VVNF----ETLE----
Hbut_HDhydr  972 GIYIVHYR-DPFMAAWRSAGDL-EEYKDVIAFTSPHGTTVSKDATFLAYGRVSSIAGVELGAVALPNMKPGAGKEKVITW
Igni_0328    855 GIAIRHYR-DPLAKVFEDASEL-EE--------SAKNVSKKKDGVGVSYGRLGA------RGVALSN---SLGVED----
Sso1729_Cmr2 840 SVRIANIA-DFMTNEIQMATELLNRVKK-VKWEFP-NGEEKRS-------KFSAILSTS-----------RTSYESVLP-
Thten hydr   748 GIVIVHHK-YPLYLALKEVQ-LAQKKAKDERQ-------YNRNAFCLKFIKGSGALKEC-----GGKW----ALMDFL--
Pfu1129      713 GILIVHYK-HPLYDALEKARDLLNNKAK--NV-------PGKDTLAIGLLKRSGSYYIS-----LVGW----ELIRVFY-
Rho cyclase  419 GLSTLERKGEPIPDLLKRADTALYRAKHDGRNRVVAAAA-----------------------------------------
Rho PleD     419 GLSTLERKGEPVRDLLKRADTALYRAKHDGRNRVVAAAA-----------------------------------------
Brad PleD    419 GISTLEQKGEPIADVMKRADTALYRAKNEGRNRAVAIAPVHQPSSFLPQAAGRGR-------------------------
Afi cyclase  419 GISMLEKKSEPVADVLKRADQALYRAKHDGRNRVVVADAA----------------------------------------
Nitr PleD    419 GLSILERKGEPVADVLKRADIALYRAKHDGRNRVVAQAA-----------------------------------------
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A.2.2 Multiple sequence alignment of Csa2 orthologues
	 Protein sequences as annotated from NCBI: S. solfataricus  P2 Sso1442, 
Sulfolobus islandicus  M.14.25 YP_002828994.1, S. solfataricus  P2 Sso1997, 
Acidianus  hospitalis  W1 Csa2 YP_004458920.1, Metallosphaera sedula DSM 5348 
Csa2 YP_001191228.1, Hyperthermus butylicus  DSM 5456 Hbut_0644 , Pyrococcus 
abyssi GE5 PAB1686, Methanocaldococcus  sp. FS406-22 Csa2 YP_003458587.1, S. 
solfataricus  Sso1399, Pyrococcus  horikoshii OT3 PH0920, Sulfolobus  tokodaii 
Sto0029, Candidatus  Korarchaeum cryptofilum OPF8 Csa2 YP_001736868.1, 
Archaeoglobus fulgidus  DSM 4304 Afu1871, Pyrococcus  furiosus  DSM 3638 PF0642, 
Methanocaldococcus  jannaschii DSM 2661 MJ_0381, Pyrobaculum aerophilum str. 
IM2 PAE0210.
Sso1442           1 M-I-------SGSVRFLVNLESLNGVESIG-NLTKHRTAPVVLK-TSTGYLVRYVPVISGEALAHAYQASLVD--IAKKE
Sisl_Csa2         1 M-I-------SGSGRFLVNLESLNGVESIG-NLTKHRTAPVVLK-TSTGYLVRYVPVISGEALAHAYQASLVD--IAKKE
Sso1997           1 M-I-------GGSGRFLVNLESLNGVESIG-NLTKHRTAPVVLK-TSTGYLVRYVPVISGEALAHAYQASLVD--IAKKE
A.hosp Csa2       1 M-I-------SGSARFLINVESLNGVESVG-NLTKHRTAPVVVK-TSTGYLIRYVPVISGESLAHAYQASLVD--IAKSM
Msed_DevR family  1 M--------ISGSVRFLVNVESLNGVESVG-NLSRHRTAPIVTRKSTGEYVIRYVPVISGESLAHAYQMALVE--IAEKM
Hbut0644          1 MPV-----FFSLSARILVNLEALNMAESVG-NVVRHRRAPVVLR-TDNGFVLRYVPVISGESLAHHYQKLLAD--IAIQR
Pab1686           1 M-M-----FLSVGVRFEANVEALNMVETAG-NYTKHRRVPYLVE-EDGKLKTIYVPAISGESLAHAYQEHLVK--EALRM
M/coccus_DevR fam 1 --M-----FISIGVRFEANVEALNMVETAG-NYSKHRRVPYIIE-EDGKLKTIYVPAISGESLGHAYQELLVK--ESKAL
Sso1399           1 MQLEVNNMWISFSVRYLVNVEDLNNVESAG-NYVRHRRAPLVFK-DKDSYTVTYVPAVSGEMIAHGYQMNLVE--LALQR
PH0920            1 M-M-----FLSVGIRFEANVEALNMVETAG-NYTKHRRVPYLIE-ENGKLKTVYVPAISGESLAHAYQEHLVN--EALSA
Sto0029           1 M---VKMKWVSFSARYLVNVEDLNNVESAG-NYVRHRRAPIIVK-EGNTYTVTYVPAVSGEMIAHGYQMNLVE--IAIER
CKc_DevR family   1 ----MADPFVSVRGRVLINVEALNMTESVG-NYVKHRRVPVIMP--E-TYATYFVPSVSGESIAHGYQQVLAE--EASGK
Afu1871           1 M-VVVSDVFVSVRGRVMLNVEAMNMTESVG-NYVKHRRVPVVLP--DAKYTTYFVPAISGESIAHGFQEVLAE--VGKKN
Pfu0642           1 M-M-----YVRISGRIRLNAHSLNAQGGGGTNYIEITKTKVTVR-TENGWTVVEVPAITGNMLKHWHFVGFVD--YFKTT
Mja0381           1 --M-----FLRISGRVRLNSHSLNAQGGGGTNYVEITKAKVSIK-NDDRWEILEVPAISGNMVKHWHFVSFVD--FFRET
Pae0219           1 M-V-----YVRVTARVEVQVSALSGLGAIG-NYNQVATARILHN-G----ALYEVPVITGNALKHWHAVYAVEAYQALGG
Sso1442          69 GLPVGSLSSQYEFIKFSTDEALKIEGIKEPKDYNDAR----RFEVEVMLKDVIADVGGFMYAGGAP---VRRTSRIKLGY
Sisl_Csa2        69 GLPVGNLSSQYEFIKFSTDEALKIEGIKEPKDYNDAR----RFEVEVMLKDTIADVGGFMYAGNAP---VRRTSRIKLGY
Sso1997          69 GLPVGNLSSQYEFIKFSTDEALKIEGIKEPKDYNDAR----RFEVEVMLKDVIADVGGFMYAGSAP---VRRTSRIKLGY
A.hosp Csa2      69 NLPVGLYSSQYEFIKYSSDEVLKEEGISAPSSSNDVR----RFEVEVLLKDIVSDVGGFMYAGKYP---VRRTSRIKFGY
Msed_DevR family 70 GLPVTHRTKQGELIK-FANDDV-LKEENIASPKDEKDAR--RFEVDVMLKDVVADVGGFMYAGKNP---VRRSSKFSVGY
Hbut0644         72 GLPVCSACSQGVFLK-HANDDV-FKKYDGIDGAKNKFKTGTDAEEYVVKNCVVEDVGGFLYTDKTV----KRTSRFRVGY
Pab1686          71 NLPVCEDCHRGEFYK-SMNKVH-LQKKISPIP-NDPR----KIEEAIIRKCVVEDVGGFLYAEKPP---VRRSSTFQVSY
M/coccus_DevR    70 NLPVCEDCEKFEFFK-SMNKNY-LKKKINPVPKDDKK----KIEEAIIKSCVIEDVGGFLYAEKPP---VKRTSAFQFSY
Sso1399          77 NLPVDSLAKQGILIKRGSDDKV--HEGTKCTDEKGSD-----YELCVINEDIVEDVAGFMNPNKLV----KRTSNVAFSY
PH0920           71 GLPVCDDCRRGEFYK-SMNKIH-LEKKVSPIP-DDPK----EIEEAIVKACVVEDVGGFLYAEKPP---VRRSSAFQVSY
Sto0029          74 NLPVEELAKQGILIKRGAGDSV--HK-TGCGDKNGSD-----YELCVIEEDIVEDVAGFLNPDKLV----KRTSNIAFSY
CKc_DevR family  71 GLPVCKLCSKGYFLK-STNDAV-FKESFGVNPPEGES----EFERAVIKGCVVEDVGGFLYAPARGGKNVKRTSNFFVGY
Afu1871          75 GLKVCKLCEKGIFLK-STNENV-FKESFSSDPPKDDF----EFEKTVIENCIVEDVGGFLYAPRAGG-NVKRTSNFYTGY
Pfu0642          72 PYGVN-LTERALRYN-GTRFGQGETTATKANGATVQL----NDEATIIKELADADVHGFLAPKTGR----RRVSLVKASF
Mja0381          71 DYKDN-LTERALRYN-GARFGQ-ETKAKKADGSEVEL----KDESEIIKNFADADVHGFLAPKTGV----RRVSLVKTSF
Pae0219          69 NMLNE-LCKRGIGLR---GFTV-DSTLKNPKPVTDECE---------ALKDFCNDLHGFLSPQEEKP--VKRDSLVKISF
Sso1442         142 MIPALRGDEIPAQ-LEAQFHVRFSNKPVSGSQ-----------AIFNVEVSSALYTFSFELDEDLIAVPSTFGEKVKGE-
Sisl_Csa2       142 MIPALRGDEIPAQ-LEAQFHVRFSNKPVSGSQ-----------AIFNVEVSSALYTFSFELDEDLIAVPSTVGEKVKGE-
Sso1997         142 MIPALRGDEIPAQ-LEAQFHVRFSNKPVKGSQ-----------AIFNVEVSSALYTFSFELDEDLIAVPSTVGEKVKGE-
A.hosp Csa2     142 MIPALTGEELPAQ-LEAQFHVRYSSK-VEERQ-----------AIFNVEVSSALYTLTFSLDDDLIAVPSTIGNEVEGE-
Msed_DevR       143 MIPSLKTDEIPAQ-LEAQFHVRYSVVSSKDKQ-----------AIYNVEVGSALYTVSFLLDDGLIGVPSNPGKADKEDE
Hbut0644        146 MVPALDALEAGAAATEAQFHVRYSPGAKQEEQ-----------AIYYVEIGSAVYVFSFALDASGVGARSMENEGASSRN
Pab1686         141 ALP-IKSMALFAT-AEPQLHARHAQLDTSSKK----G-NVSEQMIYYVETGTALYGFVFNLDLDGIGVSAITSEPVLGE-
M/coccus_DevR   141 ALP-IKSIAVYAT-TEPQLHARHAQTGEGKKE----G--VAEQMIYYVETGTAVYGFTFNIDLDAIGISSLTNKAVVDE-
Sso1399         146 MVP-AIDAVKAST-ISSQFHVRYANKELMDKYK---NEN--IQSLYNIETASASYVLTGYLNVNSVGKTQNYPVKEVDK-
PH0920          141 ALP-VKSVALFAT-SEPQLHARHAQIDASSKK----G-NVSEQMIYYVETGTALYGFIFNLDLDAVGISAITSKPILDD-
Sto0029         142 MIP-ALDAVKASA-VTSQFHVRYATKEMIDKYE---KENKNIQSLYNVETASASYVLTGYLNLSNIGVTQNYPVKEVKD-
CKc_DevR        145 MIP-TRESLESAV-IEPQLHTRYALGTPFVEE----GARAGGQMIYYIELSSAAYTFSFDLDTKYLGKATFSMENVGQT-
Afu1871         148 MIP-VRESIEGAV-IEPQLHSRYALGTPFVEG----G---QGQMIYYVELSSAVYTFSFDLDTRYIGRTTFSYEKAGTE-
Pfu0642         142 ILP-TEDFIKEVEGERLITAIKHNRVDVDEKGAIGSSKEGTAQMLFSREYATGLYGFSIVLDLGLVGIPQGLPVKFEENQ
Mja0381         140 ILP-TEDFIKEVD-ERLVYAVKHNRVDIDEKGAIKSGEEQTAQMLFNREYATGLYGFEIILDLGFVGVPQSSPS------
Pae0219         133 AVPVLEEGNLKAV---AKFAVQHNRVVPPTVNV--KQKEGEGMMLFKQEYGTGLYAFALRMDLAHIGNPLFDECNAEFQ-
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Sso1442         209 -----EELERQKAKRVKSAIKALYSLLSG-NFGGKRSRFLPSMKLMSLVVTKTD-FPF-MPEPAHDDDYIKTT-IMRLGK
Sisl_Csa2       209 -----EELERQKARRVDSAIKALYSLLAG-NFGGKRSRFLPSMKLMSLVVTKTD-FPF-IPEPGHDDSYIKTT-VMRLEK
Sso1997         209 -----EELERQKARRVDSAIKALYSLLAG-NFGGKRSRFLPSMKLMSLVVVKTD-FPF-IPEPGHDDSYIKTT-VMRLEK
A.hosp Csa2     208 -----EELEGQKTDRVKAAIKSLYSILTG-NFGGKRSRFLPSMKLMSMVVTVTD-FPF-IPEPGHTDDYIKVS-VERLNK
Msed_DevR       211 LL-------RIRGARVEASVRALYHLLTG-NFGAKRSRFLPQLELKSAVLTVTD-FPFVVEPG-HSDDYIKLS-HERAER
Hbut0644        215 EY---ILSLEDRLKRVEAAFDALAALLGGMAWGAKTSRFQPHWKILSLVASVSQPLPFNVSPG-HDKNYARET-VERACA
Pab1686         213 -----E----EIKKRREAALMALFRMLSSAQFGAKLSRFFPVGGITELVVSVTE-HPFVVTSP-IYEGYAEKT-EKRLEV
M/coccus_DevR   212 -----D----GIKKRREASLKAIFRMLSSQQFGAKLSRFFPVGNIMEVAIAITE-HPFSVTSP-IYDNYMEKT-EKRLKV
Sso1399         218 -----------KKDREKAALDALMLTLTQFLFGAKLTRFKPIVEIEALFVSASE-KPFNLPPV--TGDIKKYI-DLVNST
PH0920          213 -----N----EIKKRREVSLKALFRMLSSSQFGAKLSRFFPVGGITELIVTVTE-HPFVVTSP-IYDDYIERT-KRRLNI
Sto0029         216 -----------KKDREIASLDALMLTLTQFLFGAKRTRFNPLVEIEALVLSVSE-KPFNLPPI--NGDFNDYL-NLVKST
CKc_DevR        218 -----VVDGDERKKRIGAALDALSKFMIEMMFGAKKTRFLPVIEWESVVIAVSD-DVWTVPSP-FSKNYIERA-EEKVKK
Afu1871         218 -----V---GKRSERINAALEALKKFLIEFAFGAKKTRFLPVMEWDSLVVAVSD-DVWTVPSP-YTAGYIDNA-RKKKEK
Pfu0642         221 PRPNIVIDPNERKARIESALKALIPMLSG-YIGANLARSFPVFKVEELVAIASE-GPIPALVHGFYEDYIEAN-RSIIKN
Mja0381         212 ---NPVIEDDERKARIVSALKALIPMLSG-YIGANLARSFPVFKLEEMIAVVSE-KPIPALVHGFYEDYVEVS-KNVVEN
Pae0219         207 --------SDERKRRAKASVLALLPLLTG--AGSKQARALPIVAVREVLVAVSE-KPMPNLIHAVYPDYCETSIDTVGAY
Sso1442         280 AKGV-LNGNLAKAYVINNEGIEVGEGV-TVLSTVEDLVVKLEEE------------
Sisl_Csa2       280 AKSV-LNGNVAKVYVINNEGIEVGEGA-TVLSSVEDLVFKLKEK------------
Sso1997         280 AKSV-LNGNVAKVYVINNEGIEVGEGA-TVLSSVEDLVAKLKEK------------
A.hosp Csa2     279 AKSI-FNSKNVEVFTINNENIEVPSNV-KTLSSAEDLIDELIKSKK----------
Msed_DevR       280 AKSILMGKKVKTFAINRE-GLDTGKAE--VKSNPEEVVEALLKEVKG---------
Hbut0644        290 MTSVVKGFKASIVYYNGEGLMEPEGCNNVSVEKVGSYLEAIRRAKEETLELLRGKS
Pab1686         281 L-K--S-FNEDYFYTKTS---EDKLPE----EVLKEVIEYIREKEYI---------
M/coccus_DevR   280 I-A--DTFREEIKFMTTD---GEKTPE----ECLAEMINYVKDKNII---------
Sso1399         283 TDSF------AKILNIKRPVVKYYLKE--EKGNVNTPIDAFTVM------------
PH0920          281 L-K--N-FGEEIFITIAK---EDRVAE----EALKEAIDYLNEKGVF---------
Sto0029         281 ADSF------SSALEIDRPKIVFYVKG--VKGSLSNPVEVFKSVRG----------
CKc_DevR family 290 V-S--Y--NTKLFKYT-----GGAGFE----EVVIEAMNEAKRRAGVS--------
Afu1871         287 V-N--F--NTKLFVYP-----EGGSFE----EVVVEAIEEAKERAGK---------
Pfu0642         298 ARA--LGFNIEVFTYNVD---LGEDIEATKVSSVEELVANLVKMVGGKE-------
Mja0381         286 AKK--LGFEIEDFGYNVD---FGE-----SVSSVEELISKIIEKL-----------
Pae0219         276 LNGIGDTAKFYYYGGRCNADKVGNKINFKKVGSLHELIDAVINDVQSWIR------
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A.2.3 Multiple sequence alignment of Cas6 orthologues
! Protein sequences as annotated from NCBI: S. solfataricus  Sso2004, S. 
islandicus  Cas6 YP_002836977.1, Sulfolobus  islandicus  REY15A ADX84853.1, S. 
solfataricus  Sso1437, Metallosphaera sedula DSM 5348 Msed_1137, Metallosphaera 
cuprina Ar-4 Mcup_1148, Acidianus hospitalis  W1 YP_004458915.1, Sulfolobus 
tokodaii str. 7 Sto2642, Sulfolobus  acidocaldarius  DSM 639 Saci_1864, 
Staphylothermus  marinus  F1 Smar_0329, S. islandicus  YP_002828978.1. Residues 
highlighted in red are predicted by Phyre to be located in the central beft between the 
two ferredoxin--like domains (figure 4.14). The G-rich loop is colored in blue. 
Sso2004      1 M----------------------PLIF---KIGYNVIPLQDVILPTPSSKVLKYLIQSGKLIPSLKDLITSRDKYKPIFI
Sisl Cas6    1 M----------------------PLIF---KIGYNVIPLQDVILPTPSSKVLKYLIQSGKLIPPLKDLITSRDKYKPIFI
SislREY Cas6 1 M----------------------PLIF---KIGYNVIPLQDVILPTPSSKVLKYLIQSGRLLPSLKDLITSRDKYKPIFI
Sso1437      1 M----------------------PLIF---KIGYNVIPLQDVILPTPSSKVLKYLIQSGKLLPSLNNLITSRDKYKPIFI
Msed1137     1 MHRNLALHAPPKCSYYPRLTCQFMQLM---KMTFNVTPLHDVVLPPLSSKVLKYLVLSQQVLPFLEELVRSKDKQKPLFI
Mcup1148     1 M-ANVELNV--------------MQIV---RLNFSVRPLRDVVLPPMTSKVVKYLILSEKVLPFVKDLVESKRKQKPLFI
AhospCas6    1 M----------------------LA---LVKTTYNVTPLTDVVLPSPSSKVLKYLILSGKLFPSLANLVKSRDKQKPFFI
Sto2642      1 M---------------VEFFSE--KIV---KVEFSAVPESDVILPPLSSKVVKNLILSSKLLPSLSSLVQSGMKNKPLFI
Saci1864     1 M----------------------TLIVS---AEIDVIPKHDVILPLLTSKVAKFILSKNQ---QIGELIGSKKKYKELSI
Smar0329     1 M------LITDIIGSRLLYSAS-PRTYY--KAHIVLEVKGEAVLPPYTGKVVKTLLINAE--PGLEDVFSSNYNPKPIAI
Sisl Cas6    1 ------------------------MIVG----EVFVKPENDTIIP-FSSKIGKSLLLD----------------PKSVSI
Sso2004      56 SHLG--FNQRRIFQT-----NGNLKTITKGSRLSSIIAFST---QANVLSEVADEGI--FETVYGKFHIMIESIEI-VEV
Sisl Cas6    56 SHLG--FNQRRIFQT-----NGNLKTITKGSRLSSIIAFST---QANVLSEVADEGI--FETVYGKFHIMIESIEI-VEV
SislREY Cas6 56 SHLG--FNQRRIFQT-----NGNLKSITKGSRLSSIIAFST---QSNVLPEVADESI--FETVYGKFHIMIESIEI-VEV
Sso1437      56 SHLG--LNQRRIFQT-----NGNLKTISRGSKLSSTIAFST---QVNVLPEL-DEGV--FETIYGKFHITIESVEI-VEV
Msed1137     78 SNLA--LDGKRLYS------RGEPITVKAKTRLTGSVTFPF---SKEAFNVG--GGR--VKTVYGEYEISLKEVSV-LD-
Mcup1148     63 SNLG--LNGKRLYSTEEMIRRGDVIKVKAFTKMSASVSFPM---MGEIMNMG--GGR--VSTPYGDFEILLESINV-FN-
AhospCas6    56 SNLG--YGDVRLISD-----GSEVIKINANSRLKATLSFPF---LDGIQNEI-TEGV--YETPYGKFSFLLDSIEI-VDI
Sto2642      61 SNLGK--NGFRLFST------GKPVSVKAGEILNFFISFPY---YDGFFTEL-SSGS--FETGYGKFFIELEQLEV-IEL
Saci1864     53 SPLSS--NGRFLYAE----NDGKLLRAMRGEKLHFTFSVATSEVNEKTFDLD---GD--VSTSYGEFYVLLKTIYI----
Smar0329     70 STLAKRVNNKYLYLWKKS-GSDIVLKVDPGDTVEFWVGFTEDIASKMIEALTSLDGLKLFNTKWSLLEYNIESYKLPAKP
Sisl Cas6    36 SPL-R-YKGKYLV--KNA-SVPTYLEVIGGNVYSFEIGGDEKNVYSALINL-DSKYL--FNTFWKVIDVKVHEIEV-TSI
  
Sso2004      123 EKLKEEVEKHMNDNIRVRFVSPTLLSSKVLLPPSLSERYKKIHAGYSTLPSVGLIVAYAYNVYCNLIGK----KE--VEV
Sisl Cas6    123 EKLKEEVEKHMNDNIRVRFISPTLLSSKVLLPPSLSERYKKIDAGYSTLPSVGLIVAYAYNVYCNLIGK----KE--VEV
SislREY Cas6 123 EKLKEEVEKHMNDNIRVRFVSPTLLSSKVLLPPSLSERYKKIDAGYSTLPSVGLIVAYAYNVYCNLIGK----KE--VEV
Sso1437      122 EKLKEEVEKHMNDNIRVRFISPTLLSSKVLLPPSLSERYKRVNAGYSTLPSVGLIVAYAYNVYCNLIGK----KE--VEV
Msed1137     141 ----ETPSTSTRGNLRVSFLTPALLCSKIYLPPFLREKYRRKKIGFSLIPTPGLVVAYGYRQYLALLGKTD-SYE--NDI
Mcup1148     132 ----GFNSDVEGKNLKVRIVTPALLSSKIYLPPFL-ERYRKAKVGLSLIPSPGLLVASAYRTYLGLLGSTE-NEE--EDL
AhospCas6    122 KSLKN-VNNYENANIYVKFLTPTLLSSKILLPPSLASKYKQVNSGFSLLPSIGLIIAYAYRNYYAILGNTN-GEE--YAS
Sto2642      126 SSIKGVSE----GNFYVKFVTPALLSSKVLLPPSLKEKYKNVNPGYSLIPSVGLVVSYAYRVYRALYGNTS-NME--LDS
Saci1864     118 NQLKDIRHEIKERNVNLRFESPTLLSNKYMVPPVF--KKKKVRSMNRLIPQPSLIFSFLANLWNSIADERERIVKGDLEW
Smar0329     149 EEIPLDYRLDDAIAVKVEFRTPALL-----LDPYKKTRYKR------FLPTPGNVFSY---NIGDLLRLTRD-KE--YIE
Sisl Cas6    107 P--KNF---------ELEIMTPALI-----VSPYVKEKKKV------FTNKSEYVF---FNNVTDVTGLNRGDEK--LNE
Sso2004      197 RAFKFGILSNALSRIIGYDLHPVTVAIGEDSKGNLRKARGVMGW----IEFD-I-PDERLKRRALNYLLTSSYLGIGRSR
Sisl Cas6    197 RAFKFGILSNALSRIIGYDLHPVTVAIGEDSKGNLRKARGVMGW----IEFD-I-PDERLKRRALNYLLTSSYLGIGRSR
SislREY Cas6 197 RAFKFGILSNALSRIIGYDLHPVTVAIGEDSKGNLRKARGVMGW----IEFD-I-PDKRLKRRVLKYLLTSSYLGIGRSR
Sso1437      196 RAFKFGVISNALSRIIGYDLHPVTIVIGEDSKGNLRKARGVMGW----IEFD-I-PDEKLKRRALRYLLASSYLGIGRSR
Msed1137     214 KTFKLLVMANALSRVVGYRLYPETVVIGEDEKGRLRLTRGVKGW----IEFD-I-VG-KLKESAAKYLEVASFLGIGRSR
Mcup1148     204 KSFKLTVLVNGLSKVVDFELKPVTVIIGEDDKGRLRKSRGVEGW----IMFD-V-TG-KLKRAVAKYLSVASYLGVGKSR
AhospCas6    198 RAFKLGVLINAFTKIVGFNLRPKTVIIGRDSKKRLRETRGTIGW----IEFD-V-VHDKFKRLAIEYLLIASYLGLGRGR
Sto2642      199 KSFRLGVLSNSLSRVIGYKLKPLTVVIGNDNKGRLRTSRGFVGW----MEFD-I-PYKKLKKAISKYLIIASYLGIGKSR
Saci1864     196 TPYYIGRIADVAFAEIGYSLRPVTVIIGKDNNQRIRQARGFVGW----VKYEVINVNPRYLETFERLLGLAKIFGIGRSR
Smar0329     212 VVILVNALLNETYTVLE-TVKPVKYVYGN------KSLPGIIGYAKYMIDWD-LLAETKAKHLLENILLHASIMGIGTSR
Sisl Cas6    160 VIYSFAQLLWEEPSVM----KYTSVRYDD------KLVIGLTGK----LRYS-IK-GE--DEILVKVLENAIARGIGSSR
Sso2004      271 GIGFGEIRLEFRKIEE--KEG---------
Sisl Cas6    271 GIGFGEIRLEFRKIEE--KEGKYTSSDSKG
SislREY Cas6 271 GIGFGEIRLEFRKIEE--KEGKYTSSDFKG
Sso1437      270 GIGFGEIKLEFIKREE--NH----------
Msed1137     287 GIGLGEVHFKMVERGE----NSH-------
Mcup1148     277 GIGLGEIKLDLVDRSKVEQEGSN-------
AhospCas6    272 GIGLGEIKFELKRRKD--------------
Sto2642      273 GIGLGEVVVKIKS-----------------
Saci1864     272 GIGLGRVKVE--------------------
Smar0329     284 ANGFGHVTIKVIQSNE--------------
Sisl Cas6    222 RNGFGVVRVKGVDVSW-----------SR-                      
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